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 ABSTRACT 
 
Despite commercial interest and ethnobotanical data, the chemical composition and 
pharmacological activities of a number of indigenous Pelargonium species remain 
unexplored. Twenty-one Pelargonium species, from the section Pelargonium, were 
included in this study.  
 
The volatile compounds of 13 species were extracted by hydrodistillation and their 
chemical compositions determined by gas chromatography coupled to mass spectroscopy 
(GC-MS). The essential oil data was chemotaxonomically informative confirming 
taxonomic relationships between P. graveolens and P. radens; P. papilionaceum and P. 
vitifolium and between P. panduriforme and P. quercifolium. New chemical affinities were 
established among P. betulinum, P. hispidum and P. scabrum; P. capitatum (provenance 
WSBG), P. glutinosum and P. quercifolium (provenance SBG) and among P. graveolens, 
P. radens and P. tomentosum. The non-volatile compounds were extracted with acetone 
and the extracts were analysed using high performance liquid chromatography (HPLC). 
The representative flavonoid patterns of the Pelargonium species indicated that P. 
betulinum, P. capitatum, P. graveolens, P. hispidum, P. panduriforme and P. vitifolium 
have numerous similarities in their chemical profiles. Pelargonium scabrum and P. 
sublignosum share definite chemical patterns. The HPLC fingerprints of P. papilionaceum 
and P. vitifolium were chemically diverse. 
 
A microdilution bioassay was performed on the acetone extracts and the essential oils to 
assess their antimicrobial (both bacterial and fungal) potential. The essential oils and 
extracts were more selective for the Gram-positive test pathogens than for the Gram-
negative bacterium. The crude extracts of P. glutinosum (provenance SBG), P. 
pseudoglutinosum, P. scabrum and P. sublignosum exhibited considerable antimicrobial 
activity against the Gram-positive bacteria (B. cereus and S. aureus) with P. 
pseudoglutinosum exerting the highest activity (MIC = 0.039 mg/ml). The essential oils 
showed reduced antimicrobial activity compared to the plant extracts. Using the DPPH 
(2,2-diphenyl-1-picrylhydrazyl) assay, exceptional anti-oxidant activity was observed for 
the crude extracts of P. betulinum and P. crispum (IC50 values of 4.13 µg/ml and 4.49 
µg/ml, respectively, compared to ascorbic acid, IC50 = 4.72 µg/ml). The essential oils of P. 
quercifolium showed the greatest inhibition of 5-lipoxygenase activity (IC50 = 33.24 µg/ml 
 v
 - 38.67 µg/ml). The antimalarial activity of the non-volatile extracts was evaluated against 
the choloroquine-resistant Gambian FCR-3 strain of Plasmodium falciparum using the 
hypoxanthine incorporation assay. Pelargonium panduriforme (provenance SBG) exerted 
the greatest activity (IC50 = 1.34 ± 0.29 µg/ml). Other species possessing similarly potent 
antimalarial activity included P. citronellum (provenance NBG), P. citronellum 
(provenance SBG), P. quercifolium (provenance SBG) and P. radens.  
 
A microculture tetrazolium salt reduction (MTT) assay was used to determine the cellular 
toxicity of the acetone extracts and essential oils against transformed human kidney 
epithelium (Graham) cells. The acetone extracts of P. sublignosum and P. citronellum 
(provenance NBG) displayed the highest toxicities (IC50 = 11.89 ± 1.54 µg/ml and 19.14 ± 
0.98 µg/ml, respectively). Pelargonium vitifolium (IC50 = 178.48 ± 5.44 µg/ml) and P. 
tomentosum (provenance SBG) (IC50 = 195.13 ± 7.90 µg/ml) appeared to be non-toxic. The 
Pelargonium essential oils proved to be considerably toxic (IC50 ≤0.10 µg/ml - 30.30 ± 
1.81 µg/ml). 
 
The flavonoid derivatives detected in the Pelargonium acetone extracts may have 
contributed to their positive biological activities. The results from the MTT assay 
suggested that the antimicrobial and antimalarial activity of the extracts may be ascribed to 
general cytotoxic effects. The pharmacological properties manifested by the extracts and 
essential oils of certain Pelargonium species substantiates their use in traditional medicines 
and validates their commercial exploitation in the perfumery, cosmetic, food and 
pharmaceutical industries; however, their toxicity profiles must be considered. 
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 CHAPTER 1: GENERAL INTRODUCTION 
 
1.1 Plants provide therapeutic benefits 
The medical systems of the world have always valued the use of medicinal plants (Heinrich 
et al., 2004). The plant kingdom has provided therapeutic benefits to man dating back as 
far as the earliest recorded knowledge obtained from countless prehistoric references from 
ancient Egypt, Assyria, China and India. Early explorers of the New World documented 
the first findings of medicinal plants for many parts of the world (Heinrich et al., 2004). 
 
Throughout human evolution, religious practices and rituals have influenced the treatment 
of disease and the use of plants (Lawless, 1995). The unwritten purposes for which 
medicinal plant substances were used by the ancients are analogous to the purposes for 
which they are utilized nowadays; we have managed to decipher the secret modus operandi 
of Nature. Today, knowledge regarding the biosynthesis and biological effects of 
secondary plant metabolites has broadened extensively (Raskin et al., 2002).  
 
Bioscientific studies of the virtues and chemical properties of indigenous remedies used by 
native people throughout the world have resulted in the production of many therapeutic 
agents used in modern, conventional medicine (Heinrich et al., 2004). Today, opium from 
Papaver somniferum is used as an analgesic, aspirin compounds from Salix nigra are used 
for their analgesic, antipyretic and anti-inflammatory properties, digoxin from Digitalis 
purpurea is used for heart failure treatment, vincristine and vinblastine from Madagascan 
Periwinkle (Catharanthus roseus) are used as antineoplastic agents, taxol from Yew (Taxus 
baccata) is used for the treatment of ovarian and breast cancers, quinine from Cinchona 
species is used in the treatment of malaria, and caffeine from Coffea arabica is used as a 
stimulant (Dweck, 2001; Raskin et al., 2002).   
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 1.2 Drug development over the years 
1.2.1 From ‘Natural’ to synthetic  
Plant extracts were the first drugs, followed by natural compounds of which the chemical 
structure was known, followed by inorganic compounds (Chadwick and Marsh, 1990).  
The focus of the 17th and 18th centuries was to account for the clinical usefulness of 
medicinal plants. The introduction of synthetic acetyl salicylic acid to the medicinal world 
in 1897, unveiled the remarkable connection between plants and human wellbeing (Raskin 
et al., 2002). The transformation of plant-derived chemical compounds to chemically 
defined drugs began in the early 19th century. Drug discovery and manufacturing advanced 
with the advent of synthetic chemistry in the 1940’s and 1950’s. Vinblastine and 
vincristine, marketed in 1961 and 1963, respectively, were the last useful plant-derived 
drugs; plant extracts used to be a source of discovery for bioactive entities (Raskin et al., 
2002). The latter is the result of pharmaceutical companies setting aside their research and 
development budgets towards the synthesis of compounds. 
 
The 20th century marked the change over from extraction processing to manufacturing of 
synthetic analogues (Raskin et al., 2002). Synthetic compounds, identical in chemical 
structure and biological properties have partially substituted naturally-derived drug 
constituents. Due to cost and inefficiency as well as to fully achieve the therapeutic claims, 
natural extracts are eventually being replaced by synthetic molecules which have no 
association with the naturally-derived entity. Furthermore, combinational chemistry and 
computational drug design has decreased the discovery of natural drug products (Raskin et 
al., 2002).  
 
1.2.2 Back to ‘Natural’  
There has been an increased movement towards a more “green” ideology. In recent years, 
due to renewed interest in herbal and homeopathic medicines, plant-derived 
pharmaceuticals have become prominent in the market place, making it a favoured 
healthcare choice. Great interest has been focused on natural foods, cosmetics and drugs 
due to concerns of the toxicity and safety of modern compounds as well as concerns 
regarding aspects of ecology. The increased popularity of plant-based medicines can also 
be attributed to the general perception that products from Nature are inherently ‘safer’ due 
to the history of human use and long association of plants and humans. Religious and 
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 philosophical views may also play a role. Today, there is a wealth of products on the 
market which contain active plant materials (Raskin et al., 2002). Market research data 
reveal high levels of expenditure on phytomedicines. Phytopharmaceutical products, 
including prescription and over-the-counter products, account for 50% of the medicine 
market (Raskin et al., 2002). 
 
1.3 The rationale for the use of botanically-derived compounds 
A plant may be considered as a complex biosynthetic laboratory, synthesizing many 
diverse bioactive chemical compounds exerting curative effects. The plant’s defence 
system against predation, herbivores, microbial and viral infection is provided by such 
bioactive compounds. Only one third of all diseases can be treated efficiently and so after 
more than 100 years of pharmaceutical research, innovative and effective lead compounds 
are still needed (Mulzer and Bohlmann, 2000). The idea that complex biologically active 
compounds in plants have been selected and perfected by evolution for longer than drug 
companies must be realized (Raskin et al., 2002). 
  
Complex diseases are often treated with a single drug. The problem of resistance to 
anticancer, antimalarial and antimicrobial drugs coupled with the multifaceted nature of 
complex diseases brings to light the consideration that a combination of therapeutic agents 
should be used for the treatment of certain diseases. The traditional medicinal system uses 
the approach of combining botanical and non-botanical remedies for the treatment of 
complex diseases and in this way provides a more holistic approach to disease treatment 
and prevention. Plants produce an array of compounds to prevent the development of 
resistance and thus to protect themselves against pathogens. This suggests that the 
treatment of certain diseases with botanically-derived agents are less likely to lead to 
resistance problems as the biological effects exerted by plant products maybe the result of 
the multiple and synergistic effects caused by the interactions between many different 
biochemical compounds.  
 
The increasing cost of energy and chemical raw materials, pharmaceutically related 
environmental concerns as well as the fact that plants are the most abundant and renewable 
resource makes them more compatible as a source of drug discovery for the future. 
Furthermore, advances in metabolic engineering, biochemical genomics, chemical 
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 separation, molecular characterization and pharmaceutical engineering, have better 
equipped us to exploit the therapeutics of plants. Numerous bioactive compounds derived 
from plants are used as prototypes, where their structures are elucidated and can be used as 
templates for structural modification for the development of better and newer drugs 
(structure optimization programs) (Raskin et al., 2002; Heinrich et al., 2004).  
 
1.4 Plant species contain active constituents of medicinal value yet to be 
discovered 
It is mostly the developed countries which derive much benefit from the modern 
pharmaceutical products. About 65-80% of the world’s population (developing countries) 
uses traditional plant-based medicines for their primary health care due to the poverty and 
lack of access to modern medicines (Calixto, 2005). Governments of Third World 
countries advocate the movement towards traditional medical practices where plants are 
the main source of drug therapy (Evans, 1989). About 60% of South Africans seek advice 
from traditional healers in addition to using modern medical services (van Wyk et al., 
2002b). However, within the domain of the traditional drug discovery process, plants have 
received dwindled importance (Raskin et al., 2002). Very few plants can be 
bioscientifically and clinically recommended due to lack of extensive scientific research 
(Heinrich et al., 2004). Of the quarter million plant species in the world, only a small 
percentage has been chemically or physiologically studied. About 119 plant-derived 
compounds of known structure are used as commercial drugs. These 119 drugs are 
obtained from only 90 plant species out of the conservative estimates of about 250 000 
plants species on earth (Chadwick and Marsh, 1990). 
 
A good place to commence a systematic investigation of a plant is to first consider plants 
that have been claimed to be useful as folk medicines for particular pathological ailments 
i.e. the plant has been subjected to some human screening (Evans, 1989). In this way, 
credibility in terms of its effectiveness can be provided as a result of human experience in 
the past and present. One of the indigenous plant groups which have been used 
traditionally are members of the Geraniaceae. Root extracts of plants of the Geraniaceae 
family have been used for many years as native herbal medicines in South Africa (Seidel 
and Taylor, 2004). In the late 1800’s and early 1900’s there were several reports 
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 concerning the curative properties of Geraniaceae species (Maberley, 1897; Laidler, 1928; 
Watt and Warmelo, 1930; Watt and Breyer-Brandwijk, 1962). 
 
1.5 The systematic classification of the genus Pelargonium 
As a means of taxonomic classification, all plants are divided into ‘families’. The plant 
species used in this study belong to the Geraniaceae family which is subdivided into five 
genera, namely Erodium (heron’s bill), Geranium (crane’s bill), Monsonia, Pelargonium 
(stork’s bill) and Sarcocaulon (Figure 1.1). The genus Pelargonium contains about 280 
species and contains an array of variation in floral morphology and life forms. This genus 
was classed as the third largest angiosperm genus in the Cape Floristic Region (CFR) 
(Goldblatt and Manning, 2000). Pelargonium is a good example of the impressive 
evolutionary angiosperm radiations typical for the CFR (Bakker et al., 2004). The 
Pelargonium species are subgrouped into 16 recognized sections (Bakker et al., 2004) 
which are phylogenetically arranged. van der Walt (1985) taxonomically revised the 
section Pelargonium, which contains 24 species (Figure 1.1).  
 
1.5.1 The phylogenetic relationships in the genus Pelargonium 
Bakker et al. (2004) used DNA sequences from nuclear, chloroplast and mitochondrial 
encoded regions as sources of phylogenetic markers in order to reconstruct phylogenetic 
relationships among representatives of all currently recognized sections of Pelargonium. 
The use of DNA sequence data from the three different genomic regions provides the 
advantage of three separately evolving sets of characters in phylogenetic reconstruction 
and is useful for reconstructing deep-level phylogenies. The analysis included 153 taxa, 
four of which were not Pelargonium species. The datasets contained cpDNA trnl-F 
sequences for 152 taxa, nrDNA ITS sequences for 55 taxa and mtDNA nadl b/c exons for 
51 taxa. The phylogenetic hypotheses obtained from the three different genomic regions 
were generally similar with all incongruencies occurring only within some of the main 
clades and not between them. An overall phylogenetic hypothesis integrating the 
information in the three datasets was obtained for the genus Pelargonium L’Hérit. (Bakker 
et al., 2004). It was found that the genus consists of five main clades (A1, A2, B, C1 and 
C2) (Figure 1.1) some with different evolutionary patterns regarding biogeographic 
distributions, dispersal capacity, pollination biology and karyological diversification 
(Bakker et al., 2004). 
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Family  
 
Geraniaceae  
 
 Genera
 
 
 
 
 
 
 
Figure 1.1: Outline of the taxonomic classification of the family Geraniaceae (van der 
Walt, 1985; Bakker et al., 2004). This study is restricted to species contained in section 
Pelargonium. 
Erodium Geranium Monsonia Pelargonium Sarcocaulon
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 The five main clades are largely in agreement with the current sectional classification 
(Bakker et al., 2005) and are grouped into two subgeneric clades correlating with 
chromosome size, and further supported by evidence from hybrid formation (Gibby et al., 
1996), but not by any known morphological characters. In brief, clade A and B reside in 
the “small chromosome clade” which comprises about 80% of the currently described 280 
species, mostly with chromosomes of <1.5 µm in length (Albers and van der Walt, 1984; 
Gibby and Westfold, 1986; Gibby, 1990). The remainder of the genus contains about 55 
species with chromosomes of 1.5-3.0 µm long (Albers and van der Walt, 1984; Gibby and 
Westfold, 1986; Gibby, 1990). 
 
Clade A (the “winter rainfall clade”) contains over 70% of all currently described 
Pelargonium species and is largely confined to the South African Cape winter rainfall 
region (Bakker et al., 1999). It includes woody shrubs, shrubs (Ligularia and Pelargonium 
clades), stem succulents (Cortusina grade, Otidia clade), geophytes (Hoarea, Polyactium 
clades) and herbaceous annuals (Peristera grade). Clade A contains two main subclades, 
clade A1 and clade A2. 
 
Clade A1 comprises mainly woody evergreen diploid shrubs of the type section 
Pelargonium, confined mainly to the winter rainfall regions. Only P. radens and P. 
graveolens (both with 2n = 88), are found in the summer rainfall region. Species of the 
section Pelargonium clade are commonly infertile and natural hybrids are known (Albers 
and van der Walt, 1984), as also shown by the three independent incongruencies between 
the cpDNA and rDNA topologies. However, morphological and phytochemical characters 
also strongly support monophyly of the section Pelargonium clade. Clade A1 also contains 
the small herbaceous rosette subshrubs of section Campylia, mainly distributed in the 
Western Cape winter rainfall region, and P. nanum (section Peristera). 
 
Clade A2 (the “xerophytic” clade) comprises in total almost half of all Pelargonium 
species and six of its sections, namely Cortusina, Hoarea, Ligularia, Magnistipulacea, 
Otidia and Polyactium. The Ligularia/Hoarea clade consists of woody shrubs and 
geophytes. The species currently assigned to section Ligularia (Albers et al., 2000) form a 
paraphyletic group with regard to the Hoarea clade. However, only 12 of the 78 species 
representing the section Hoarea were included in this study. It will become evident 
whether this relationship holds once complete sampling of the Hoarea clade has been 
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 carried out since taxonomic sampling is significant in determining relationships. The 
Polyactium/Cortusina/Otidia clade includes stem succulents and geophytes and is 
morphologically well-characterized. The species currently assigned to section Cortusina 
form a paraphyletic group with regard to the Otidia and Polyactium clades. The Otidia 
clade consists of a small radiation of stem and leaf succulents, mainly occurring in the dry 
area of the Western Cape winter rainfall region and the Northern Cape coastal region. 
Nested within clade A2 is a radiation consisting of about 80 species from the section 
Hoarea, all of which are characterized by a series of tunicate tubers. Within clade A, the 
karyological diversification has been limited, with two independent reductions from x = 11 
to 10 in clade A1 and from x = 11 to 10 and 9 in the Hoarea clade of clade A2 (Gibby et 
al., 1996). In clade A, polyploidy has occurred independently several times. It has been 
suggested that clade A2 represents an adaptive radiation, probably in response to late-
Miocene and Pliocene aridifications.  
 
Clade B consists mostly of “weedy”, dwarf, herbaceous annual species, previously 
assigned to section Peristera. It also comprises section Reniformia, seven species from 
Australia and New Zealand, and P. cotyledonis (section Isopetalum) from St. Helena 
Island. The abovementioned large distributions indicate high dispersal capacity of species 
of the Peristera clade (Bakker et al., 1998). Within clade B, the karyological 
diversification has been more profound, with one reduction from x = 11 to 8 in the 
Reniformia clade, and five different chromosome numbers in the Peristera clade including 
polyploid series (Hellbrügge, 1997).  
 
Clade C comprises the Pelargonium species with large-sized chromosomes presently 
assigned to five different sections, distributed in Western and Eastern Cape, tropical 
eastern Africa, Madagascar and Asia Minor. Clade C1 includes the sections Chorisma, 
Jenkinsonia and Myrrhidium; the species are (sub)shrubs typically with wooden stems. 
Only P. redactum and P. senecioides (section Jenkinsonia) and P. myrrhifolium (section 
Chorisma) are annuals or short-lived perennials (Albers et al., 1995; van der Walt et al., 
1997). Clade C1 consists of two basic chromosome numbers (x = 11 in the 
Myrrhidium/Chorisma clade and x = 9 in the Jenkinsonia clade) among which two 
independent transitions were reconstructed. Clade C2 consists of species presently assigned 
to sections Subsucculentia (van der Walt et al., 1995) and Ciconium, as well as a clade 
consisting of the presumed allopolyploid species from Asia Minor, P. endlicherianum and 
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 P. quercetorum, the tetraploid P. caylae from Madagascar and P. karooicum (diploid and 
polyploid) from the Cape winter rainfall area. Clade C2 comprises three different basic 
chromosome numbers (x = 9, x = 10 and x = 17). 
 
1.5.2 Confusion over the nomenclature of Pelargonium 
Confusion has resulted from the vernacular use of the name geranium for a plant which 
should be correctly referred to as a pelargonium (van der Walt, 1977). The confusion 
between the genera Geranium and Pelargonium has existed before Linnaeus (1753) and his 
binomial system of classification where both genera were placed under the genus 
Geranium (Lis-Balchin, 2002d). In the seventeenth century when first introduced into 
Europe, all pelargoniums were called geraniums, most probably because of the similar fruit 
structure. About 200 years ago, botanists noted distinct differences and the two genera 
were separated (Miller, 2002). Although Sweet (1820) and other botanists reclassified them 
under two genera, acceptance by the general public and nurserymen is still low (Lis-
Balchin, 2002d). During the twentieth century, the name ‘geranium’ has become re-
established as a vernacular name for pelargoniums especially for the zonal cultivars 
(Miller, 2002). Our modern cultivated varieties are derived from Pelargonium species and 
not Geranium species. From the systematic classification shown in Figure 1.1, it is clear 
that Geranium exists as one genus and Pelargonium as another, both genera of which differ 
markedly from one another (van der Walt, 1977).  
 
1.6 Distribution of Pelargonium species 
The first Pelargonium species, Pelargonium triste, was collected in 1632 by John 
Tradescant at the Cape (Vorster, 1990). In the early 1700’s plants were brought to Europe 
and England to be planted in estate gardens. One of the first Pelargonium species to be 
introduced to England was P. triste (van der Walt, 1977). Pelargonium cucullatum was 
collected by Paul Hermann in 1672 from the slopes of Table Mountain (Vorster, 1990). 
This species was established in the Royal Botanical Gardens at Kew, England by 1690 and 
the gardens of Leyden had 10 species of Pelargonium by 1687 (van der Walt, 1977). 
 
Most Pelargoniums are found in the Southern Hemisphere, where almost the entire genus 
(about 200 species) is found in South Africa (Vorster, 1990). Most species occur in the 
wide coastal region stretching from the Namib Desert (North) to the Cape (South) and 
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 along the coast towards the eastern seashore (Figure 1.3). Most species occur as irregular, 
isolated groups distributed within the western coastal belt (van der Walt and Vorster, 
1983). The genus is a fundamental part of the Cape flora (van der Walt, 1977), where some 
species grow on the edge of scrubland, stony and sandy areas and others scramble through 
shrubs. The various microhabitats of the south-western Cape, which favour speciation, is 
the reason for the rich diversity of species in this region. 
 
The other 50 Pelargonium species occur throughout eastern tropical Africa, Arabia, Syria, 
western India, Australia and New Zealand and on the islands of Madagascar, St. Helena 
and Tristan da Cunha (Vorster, 1990) (Figure 1.3). Pelargonium species are also found 
growing naturally in Spain, California and Italy. It is speculated that the wide distribution 
of the genus is a result of continental drift (van der Walt and Vorster, 1988). 
 
 
St. Helena
Tristan da Cunha
New Zealand
 
Figure 1.2: The global distribution of the genus Pelargonium (van der Walt and Vorster, 
1988). 
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 1.7 General characteristics of the genus Pelargonium 
The genus Pelargonium is a group of annual or perennial herbs, shrublets or shrubs which 
are characteristically erect to decumbent, branched to many-branched. The stems are often 
woody at the base, soft-wooded or subsucculent, frequently viscid and aromatic, usually 
glandular and variously hairy (van der Walt, 1977). The stems bear irregularly marked, 
non-aromatic to aromatic leaves (Webb, 1984; van der Walt, 1985). All the species have 
petiolate leaves with stipules (Miller, 2002) and almost every lobed shape can be found; a 
few species have entire leaves (Webb, 1984). The obtuse to acute leaf margins are finely to 
coarsely dentate or serrate. Some leaves are soft and flannelly due to small, silky hairs and 
occasionally the leaves are sticky. Fine hairs give the green leaf a grey appearance (Webb, 
1984).  
 
The flowers have five petals and are zygomorphic. The two posterior spathulate or obovate 
petals are larger and broader than the three anterior ones. Flower colour ranges from white, 
pink, pinkish-purple to purple. Dark purple, wine-red or dark red markings occur on the 
posterior petals (van der Walt, 1985). Not more than seven stamens out of the ten bear 
fertile pollen (Miller, 2002). The adnate nectar tube is the most characteristic feature of the 
flower (Webb, 1984). A valuable tool for identification is the presence of aromatic oils in 
many species. A few species emit a scent from their flowers, but only at night (Miller, 
2002). A common feature of all five genera is the shape of the schizocarp (elongated fruit) 
which resembles a stork’s head or bill just before it is ripe and ready to disperse (van der 
Walt, 1977).  
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Figure 1.3: The stork-shaped fruit and zygomorphic flowers of Pelargonium capitatum. 
 
 1.7.1 The general morphology of the section Pelargonium 
This is a large section characterized by shrubs and subshrubs with woody, branched or very 
branched stems, variegated leaves (rarely entire and often lobed or palmately partite) and 
five-petalled flowers (van der Walt, 1977). The foliage is frequently aromatic and 
sometimes viscid (Miller, 2002). The posterior two petals, marked with darker spots or 
lines, are larger and broader than the anterior three (Webb, 1984; Miller, 2002). The 
flowers are white, pink or purple and have seven fertile stamens. The section has a basic 
chromosome number of x = 11 and the chromosomes, in comparison with those of the 
other sections of the genus, are relatively small (van der Walt, 1985).  
 
1.8 The essential oil of Pelargonium (‘geranium oil’) 
Many of the natural Pelargonium species and the hybrids and cultivars derived from them 
have scented leaves producing essential oil (Williams and Harborne, 2002). The species 
particularly rich in essential oil belong to the sections Pelargonium, Polyactium and 
Cortusina (Webb, 1984). High quality oil is contained in the leaves, stems and stalks of 
scented pelargoniums. Just before the plants bloom, they are harvested and processed to 
obtain the essential oil. Pelargonium essential oil is incorrectly declared as geranium oil; 
the species involved in the production of the oil are all Pelargonium and not Geranium. 
The geranium oil obtained from Geranium macrorrhizum in Bulgaria is both chemically 
and medicinally different to the commercial ‘geranium oil’ from Pelargonium species (Lis-
Balchin, 2002b). ‘Geranium oil’, as described by the International Standards Organisation 
(ISO 4731), is ‘the essential oil obtained by steam distillation from the herbaceous parts of 
Pelargonium graveolens L’Héritier ex Aiton, P. roseum Willdenow and their cultivars and 
hybrids’ (Lis-Balchin, 1990).  
 
Since the early 1800’s, the rose-scented ‘geraniums’ belonging to the genus Pelargonium 
have been cultivated commercially for their essential oil (Widmer and Collins, 1991). 
Commercial ‘geranium oil’ is derived from various Pelargonium cultivars growing mainly 
in Réunion, China, Egypt and Morocco (Hart and Lis-Balchin, 2002). Pelargonium 
capitatum, P. graveolens and P. radens are considered to have been used in cultivation 
programs to create and ennoble the rose ‘geranium’ cultivars. A very important 
commercial essential oil producer is the cultivar known as cv. Rosé, often referred to as P. 
graveolens, obtained from the hybridization of P. capitatum x P. radens (Demarne and van 
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 der Walt, 1989). Cultivars of P. capitatum x P. graveolens are less important commercial 
essential oil sources. Pelargonium odoratissimum, with a definite apple-like scent, is often 
incorrectly quoted as a source of rose-scented ‘geranium oil’ (Lis-Balchin and Roth, 2000). 
 
1.9 The traditional uses of Pelargonium species 
Pelargoniums are mentioned in old apothecary manuals. In South Africa, both the scented 
and unscented Pelargonium species were used as traditional remedies by the Sotho, Xhosa, 
Khoi-San and Zulus to treat various ailments (Watt and Breyer-Brandwijk, 1962). Some of 
the folk medicines were also used by the Dutch settlers who exported them back to 
Holland. The locals and Dutch commonly used P. grossularioides (Lis-Balchin, 1996). The 
fleshy tubers of Pelargoniums are commonly used to make infusions and decoctions. 
However, a traditional method of using Pelargonium roots is to boil the tuber in milk. The 
roots may also be chewed or powdered and mixed with food (Latté and Kolodziej, 2004). 
 
The ability of Pelargoniums to provide relief in cases of diarrhoea and dysentery was 
known to the earliest South African tribes (van der Walt, 1977); this was the main use of 
Pelargoniums in the past (Lis-Balchin, 1996). The large tubers of P. antidysentericum were 
used by the Khoi-San as a remedy for dysentery and anaemia (Miller, 2002). Infusions of 
Pelargonium luridum tubers are used to treat diarrhoea and dysentery. Numerous other 
species with similar fleshy underground parts are also antidiarrhoetic (van Wyk et al., 
2002b). The presence of highly astringent tannins may be responsible for the antidiarrhoeal 
effects (van Wyk et al., 2002b). The more tannin-containing roots of numerous 
Pelargonium species were used for syphilis (Lis-Balchin, 2002c).  
 
In South Africa, various Pelargonium species were employed as remedies for wounds, 
abscesses, fever reduction, colic, nephritis and suppression of urine, colds and sore throats, 
haemorrhoids, gonorrhoea, stimulating milk-production, anthelmintic infections and were 
also used as an insecticide (Lis-Balchin, 1996). Decoctions of the roots of Knowltonia 
vesicatoria (Ranunculaceae) were mixed with Pelargonium roots to treat colds and 
influenza (van Wyk et al., 2002b). The powdered leaves of Pelargonium inquinans were 
used to relieve headaches and common cold symptoms and were used as a deodorant by 
native tribesman (van der Walt, 1977). In traditional South African medicine, a variety of` 
ailments (gastrointestinal disorders, hepatic disorders and respiratory tract infections) are 
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 treated with “Umckaloabo” (Seidel and Taylor, 2004). This traditional drug originates from 
the root material of P. sidoides and P. reniforme (Kolodziej, 2002). “Umckaloabo” is also 
claimed to cure menstrual complaints such as dysmenorrhoea. The aerial parts of P. 
sidoides and P. reniforme are used in wound healing (Kolodziej, 2002). In folk medicine, 
the fresh flowers of P. endlicherianum have been used as an anthelmintic (Bozan et al., 
1999). The essential oils of some Pelargonium species are employed by the native 
population in southern Africa due to their effective insect repellent properties (Kolodziej, 
2002). Pelargonium radens leaves have been used as a folk remedy for splanchnic 
neoplasm (Hirose and Shibata, 1978). Ethnobotanical data, presented in Table 1.1, 
concerning P. betulinum, P. cucullatum, and P. papilionaceum (included in this study), 
provides information as to the type of formulations that were used, the methods by which 
they were administrated and the conditions treated. 
 
Table 1.1: The traditional medicinal uses of three species belonging to the section 
Pelargonium (Watt and Breyer-Brandwijk, 1962; van der Walt, 1977; May, 2000; 
Lawrence and Notten, 2001). 
 
Botanical name Common name Traditional use Distribution 
P. betulinum Birch-leaf 
pelargonium, 
Camphor-scented 
pelargonium, 
‘Kanferblaar’, 
‘Maagpynbossie’, 
‘Suurbos’. 
 
Fresh leaves were placed in boiling 
water and the camphoraceous 
vapour was inhaled to relieve 
coughs and other chest problems 
(van der Walt, 1977). The leaves 
were used in ointments as a 
wound-healing emollient. The 
plant was also used for the relief of 
flatulence and stomach pain 
(Lawrence and Notten, 2001). 
West coast to 
the east coast of 
the Western 
Cape. 
It is mostly 
confined to 
coastal areas. 
 continued .  .  . /38 
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 37/ .  .  .  continued  
Botanical name Common name Traditional use Distribution 
P. cucullatum Hooded-leaf 
pelargonium, 
Tree 
pelargonium, 
‘Wilde malva’. 
 
Traditionally, the roots and leaves 
were used as an astringent for colic 
and diarrhoea, as a wound-healing 
emollient and as an antispasmodic 
(van der Walt, 1977). The leaves 
were used as a poultice for bruises, 
stings and abscesses. This plant 
was also employed to cure kidney 
ailments, fevers, coughs and chest 
problems (May, 2000). 
South-western 
Cape, well 
represented in 
the Cape 
Peninsula. 
P. papilionaceum Butterfly 
pelargonium, 
‘Rambossie’. 
 
The leaves were used as an 
alternative to tobacco in South 
Africa and smoked possibly for its 
medicinal effects (Watt and 
Breyer-Brandwijk, 1962). 
South-western, 
southern and 
eastern Cape. 
 
 
1.10 Anecdotal information 
‘Geranium oil’ is one of the most commonly used oils in aromatherapy (Lis-Balchin et al., 
1996a). Many properties of ‘geranium oil’ have been quoted in aromatherapy books and 
are summarized in Table 1.2. Many of these properties are directly transcribed from 
Culpepper’s Herbal account (Culpepper, 1985) of real geranium for example Geranium 
robertianum, which has a completely different chemical composition (Lis-Balchin et al., 
1996a). Not all the claims made in aromatherapy of the supposed uses or properties of 
‘geranium oil’ are supported by scientific evidence (Lis-Balchin et al., 1996a). The 
scientific proof that inhalation of a pleasant odour and its action via the limbic system 
produces a relaxing effect should be accepted, as has massage (Lis-Balchin, 2002c). 
Theoretically, when the two are used together, several stress-related conditions such as 
dermatitis, asthma and intestinal problems could be relieved (Lis-Balchin, 2002c). The 
essential oil is used as a nervinum and expectorant (Steinegger and Hänsel, 1992). 
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 Table 1.2: The reported therapeutic uses of ‘geranium oil’ obtained from Pelargonium 
graveolens (Jackson, 1993; Lawless, 1995; Curtis, 1996).  
 
Characteristics The greenish-olive Bourbon oil has a rosy-sweet, minty scent. 
‘Geranium oil’ has an all-over balancing effect which extends to the 
skin, emotions and the hormone system. 
Principle 
components 
Citronellol, geraniol, linalool, isomenthone, menthone, phellandrene, 
sabinene, limonene. 
Skin care 
 
 
‘Geranium oil’ is a popular ingredient in skin care preparations. Due 
to its antiseptic and anti-inflammatory properties, it is useful in 
treating acne and other skin infections. It is known to relieve shingles 
(neuralgia), herpes blisters, bruises, burns, broken capillaries, cuts, 
dermatitis, eczema, ringworm, ulcers and infected wounds. It is 
appropriate for all skin types and has been reported to delay the 
process of skin aging. It is used as a gentle cleansing tonic and has a 
regulating action on sebum secretion and thus suitable for dry or oily 
(congested) skin. Dry, inflamed skin is relieved by its soothing, 
moistening and cooling or refreshing properties. It helps to prevent 
the formation of scar tissue and stretch marks as it has cicatrizing 
(healing) properties.   
Circulation, 
muscles and 
joints 
‘Geranium oil’ can be used as a circulatory tonic to increase poor 
circulation. As a lymphatic stimulant, it is detoxifying. Through the 
stimulatory action on various elimination processes, toxins and 
residues from metabolic processes which can cause diseases are 
removed from the system. This effect plays an integral role in many 
chronic diseases such as arthritis and helps to reduce cellulite and 
clear skin conditions. Through its detoxifying effects, it exerts 
uplifting and strengthening properties. ‘Geranium oil’ is also used for 
breast engorgement and oedema as it has diuretic properties.  
Respiratory 
system 
Relieves colds, tonsillitis, laryngitis and bronchitis.  
 
      continued  .  .  . /40
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 39/ .  .  .  continued  
Gastrointestinal 
system 
The cooling properties of the oil assist in the relief of symptoms 
occurring from heat in the abdomen. Such symptoms include 
constipation with dryness or burning and yellow diarrhoea. Gastritis 
and peptic ulcers are relieved by its anti-inflammatory properties. 
‘Geranium oil’ is known to have an antispasmodic action indicating 
its usefulness in relieving flatulence and diarrhoea. It is also used as a 
vermifuge (expels worms from the intestine). 
Genito-urinary 
and endocrine 
systems 
‘Geranium oil’ influences the hormone secretion of the adrenocortical 
glands and so is used to treat hormonally-related symptoms of 
menopause such as hot flushes and vaginal dryness. It also relieves 
period pains. Cystitis with burning urination is relieved by its anti-
inflammatory properties. 
Nervous system Pain associated with neuralgia and shingles is relieved by its 
analgesic properties. In aromatherapy, it is used to treat palpitations, 
panic attacks and anxiety as the scent has physical and emotional 
“balancing” properties. It has antidepressant and revitalizing 
properties. ‘Geranium oil’ is either sedative or stimulating depending 
on the individual. 
Other use The strong smell of the oil acts as a repellent to mosquitoes and head 
lice.  
 
 
1.11 In vitro pharmacological studies involving Pelargonium essential oils and 
extracts 
1.11.1 Experiments involving guinea-pig ileum preparations 
The traditional use of Pelargoniums in diarrhoea and dysentery signifies a potential 
antispasmodic action on smooth muscle. This possibility has been researched using isolated 
ileum and other muscle preparations and many species, scented and unscented, have been 
studied. The results suggest a definite antispasmodic action in some fractions (Lis-Balchin, 
1996). 
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 The majority of Pelargonium oils and commercial ‘geranium oils’ have a spasmolytic 
action on intestinal smooth muscle and decrease the response to electrical stimulation (Hart 
and Lis-Balchin, 2002). It was found that the essential oils of P. odoratissimum, P. 
exstipulatum and P. x fragrans have a postsynaptic spasmolytic effect on guinea-pig 
smooth muscle which was mediated via cyclic adenosine monophosphate (cAMP) in P. 
odoratissimum and P. x fragrans (Lis-Balchin and Roth, 2000). The involvement of cAMP 
in the mode of action of the latter two essential oils shows a similarity with commercial 
‘geranium oil’ and with other floral Pelargonium species (Lis-Balchin and Roth, 2000). 
Due to the relaxant effect of the oils of P. odoratissimum, P. exstipulatum and P. x 
fragrans, they have potential for use in aromatherapy products (Lis-Balchin and Roth, 
2000). Many essential oil fractions from various species have been found to be initially 
spasmogenic (contractile effect) followed by an antispasmodic activity (Lis-Balchin et al., 
1996c). In a study carried out by Lis-Balchin et al. (1997) all the essential oils tested, 
which were obtained by steam distillation from scented-leaf Pelargonium species, hybrids 
and cultivars, were spasmolytic. The results from this investigation support the exploitation 
of different Pelargonium oils for their spasmolytic actions and possibly other functions 
(Lis-Balchin et al., 1997).  
 
Citronellol, citronellal and geraniol (components of Pelargonium oil) have a spasmolytic 
action on guinea-pig ileum (Reiter and Brandt, 1985; Lis-Balchin and Hart, 1997). Geranyl 
acetate has been reported to have spasmolytic activity (Sticher, 1977). However, P. 
grossularioides oil contracts the tissue but upon washout (when tone returns to normal) it 
inhibits momentarily the contractions induced electrically (Lis-Balchin and Hart, 1994). 
Geranyl formate contracts guinea-pig ileum (Lis-Balchin et al., 1996b), as does citronellyl 
formate (Hart and Lis-Balchin, 2002). Alpha- and β-pinene cause an initial spasmogenic 
effect on intestinal smooth muscle (guinea-pig ileum) and then produce a spasmolytic 
effect (Lis-Balchin et al., 1999). According to temporary findings, α-pinene does not act 
via muscarinic cholinceptors or histamine receptors and the two enantiomers of α-pinene 
have different pharmacological activities (Lis-Balchin et al., 1999). 
 
The non-scented pelargoniums studied included several zonals, regals and ivy-leaved 
pelargoniums. The methanolic and water-soluble extracts of the leaves and roots were 
tested and all were spasmolytic on guinea-pig ileum. However, the P. grossularioides 
water-soluble and ethanolic extracts did not produce a spasmolytic action (Hart and Lis-
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 Balchin, 2002). The alkaloid extracts of the zonals were all spasmolytic (Lis-Balchin, 
1997). The methanolic and water-soluble extracts and alkaloid fractions of P. luridum 
(root) and the leaves of P. inquinans and P. cucullatum were also spasmolytic. Studies 
conducted on freshly-prepared hydrophilic and methanolic extracts have indicated that 
numerous scented Pelargonium species and cultivars produce an initial spasmogenic effect 
followed by a relaxation action. This suggests that the spasmogenic effect may be caused 
by phenolic compounds (Hart and Lis-Balchin, 2002). 
 
In conclusion, experiments conducted on isolated guinea-pig ileum revealed that the 
majority of Pelargonium oils and their components cause smooth muscle relaxation. This 
action is mediated through a mechanism that involves the enzyme adenylate cyclase and an 
increase in the concentration of the second messenger, cAMP. There is some verification 
of calcium channel blockade but only at levels higher than those necessary to produce 
significant spasmolytic effect. No conclusive results have been obtained with regard to the 
pharmacology of the central actions of Pelargonium as few studies have been carried out. 
Some evidence indicates that a few methanolic extracts use calcium channels at normal 
concentrations. However, numerous extracts have shown no such activity; this is in 
accordance with the mode action of their corresponding essential oils (Hart and Lis-
Balchin, 2002).  
 
1.11.2 Experiments involving uterine preparations 
Pelargonium grossularioides may be an abortifacient as its essential oil and water soluble 
extracts caused an isolated rat uterus to contract (Lis-Balchin and Hart, 1994). Uterine 
activity is reduced by both ‘geranium oil’ and geraniol at concentrations which are 
spasmolytic on intestinal muscle (Lis-Balchin and Hart, 1997); however, the mechanism of 
action has not been investigated. 
 
1.11.3 Experiments involving bronchial preparations 
Guinea-pig tracheal muscle is generally used to study the activity on bronchial muscle. 
Reiter and Brandt (1985) used an alternative preparation where less cartilage was involved 
(Hart and Lis-Balchin, 2002). Reiter and Brandt (1985) reported that the components of 
Pelargonium oil, namely citronellal, citronellol, geraniol and linalool, are all spasmolytic, 
with intestinal smooth muscle being more responsive than tracheal smooth muscle. Using 
 42
 guinea-pig ileum and trachea, linalool was found to be spasmolytic (Brandt, 1988). Lis-
Balchin and Hart (2000) found that α- and β-pinene also relax guinea-pig tracheal muscle. 
 
1.11.4 Experiments involving cardiac preparations 
Lis-Balchin and Hart (1994) reported that P. grossularioides essential oil reduces the force 
of contraction of a spontaneously beating perfused isolated heart. 
 
1.11.5 Experiments involving skeletal muscle preparations 
Two successful preparations, for the study of the activity on skeletal muscle, are the chick 
biventer cervices and the rat phrenic nerve hemi-diaphragm. It was found that P. 
grossularioides essential oil increases the rat diaphragm tone and reduces the size of the 
contraction when the phrenic nerve is stimulated and when the muscle is directly 
stimulated (Lis-Balchin and Hart, 1994). Hence, the oil has a myogenic action; however, 
the mechanism has not been investigated (Hart and Lis-Balchin, 2002). Using the chick 
biventer muscle preparation, commercial ‘geranium oil’ decreased the tone and did not 
change the size of contraction. Geraniol showed a spasmolytic action on the skeletal 
muscle. 
 
1.11.6 Receptor binding studies 
The binding of glutamate, an excitatory neurotransmitter in the brain, to its receptors on 
membranes prepared from the cerebral cortex of the rat is dose-dependently inhibited by 
linalool (Elisabetsky et al., 1995). The latter authors suggested that this action is in 
accordance with their findings that linalool produces sedative effects in animals. 
 
1.11.7 Antimicrobial activity 
Positive bactericidal and fungicidal activities were shown from the screening of crude 
extracts of certain species and cultivars belonging to Geraniaceae (Lis-Balchin, 1990). The 
traditional use of Pelargoniums in wound healing may be attributable to their antimicrobial 
action (Lis-Balchin, 1996) which has been well documented. Commercial ‘geranium oil’, 
numerous Pelargonium species and cultivars have proven to be strong antimicrobial agents 
(Lis-Balchin and Roth, 2000). 
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 Wollmann et al. (1973) reported that the essential oil of some Pelargonium species have an 
antimicrobial effect. Fifty commercial essential oils were studied at four different 
concentrations against a variety of 25 bacterial genera (Deans and Ritchie, 1987). 
‘Geranium oil’ was most effective against the dairy product organism Brevibacterium 
linens and the toxin-producing Yersinia enterocolitica. ‘Geranium oil’ was tested by 
Pattnaik et al. (1996) for antimicrobial activity by disc diffusion; only 12 bacterial strains 
out of a total of 22 (Gram-positive cocci and rods, Gram-negative rods) were inhibited. 
However, all 12 of the fungi tested (3 yeast-like, 9 filamentous) were inhibited. The leaves 
of Pelargonium x hortorum were found to be most active against Candida albicans, 
Trichophyton rubrum and Streptococcus mutans. These latter organisms cause common 
dermal, mucosal or oral infections in humans (Heisey and Gorham, 1992). Chaumont and 
Leger (1992) investigated the antifungal effects of vapours of essential oils and some 
volatile compounds. It was found that the vapours of ‘geranium’ Bourbon, citral, geraniol 
and citronellol inhibited the four different strains of fungi tested. It was reported by 
Chandravadana and Nidry (1994) that the antifungal activity of P. graveolens oil against 
Colletotrichum gloesporoides (a post-harvest fruit anthracnose fungus) was greater than 
that of citronellol or geraniol alone.  
 
An investigation of the bioactivity of 16 commercial ‘geranium oil’ samples from Réunion, 
China, Egypt and Morocco, showed variable antimicrobial activity between samples of oil 
(Lis-Balchin et al., 1996a). It was found that 8 to 19 out of 25 different bacterial species 
were inhibited. Clostridium sporogenes, Bacillus subtilis and Brevibacterium linens were 
inhibited by all the samples. Acinetobacter calcoacetica and S. aureus were inhibited by all 
but one sample. For all the other organisms tested, there were differences in inhibition. 
This study was in agreement with Deans and Ritchie (1987) where a ‘geranium oil’ sample 
inhibited 19 out of 25 bacteria. The anti-Listeria action of the ‘geranium oil’ samples was 
also variable; 3 to 16 out of the possible 20 Listeria monocytogenes strains were affected 
(Lis-Balchin et al., 1996a). The same study showed variable antifungal activity against 
three filamentous fungi. The samples were generally more effective against the two 
Aspergillus species (A. niger and A. ochraceus) than against Fusarium culmorum. The 
results indicated that the wide variability in bioactivity between commercial samples could 
not be directly correlated with the country of origin or the chemical composition. 
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 Lis-Balchin et al. (1996b) found that 16 ‘geranium oil’ samples were active against 8 to 18 
of the bacteria tested and 3 to 16 samples were active against 20 Listeria monocytogenes 
varieties. The same study involving three filamentous fungi indicated a wide range of 
activities within the group of samples when considering that the samples should be very 
similar. In the presence of 1 µl of ‘geranium oil’ per 1 ml of YES broth (yeast extract, 
glucose and amino acid supplement), the spoilage organism Aspergillus niger was inhibited 
by 0-94%, the mycotoxigenic A. ochraceus by 12-95% and the plant pathogenic Fusarium 
culmorum by 40-86%. Fusarium culmorum was less affected, with two exceptions, than 
the two Aspergilli. The growth of A. niger was more inhibited, with two exceptions, than A. 
ochraceus, whilst antifungal activity was poor (<40% inhibition) (Deans, 2002). 
 
The results of an earlier study (Lis-Balchin et al., 1996c), where the antimicrobial activity 
of 24 cultivars were tested against 25 bacteria and Aspergillus niger, were in line with the 
findings of the aforementioned study (Lis-Balchin et al., 1996b). The most sensitive 
bacteria were a group of mainly Gram-positive micro-organisms, while the least sensitive 
bacteria were a group of mostly Gram-negative organisms. Inhibition against A. niger 
ranged from 3-98%; growth enhancement was caused by two extracts. The activity in some 
cultivars was due to the level of monoterpenes present. 
 
Dorman and Deans (2000) studied several individual oil compounds for antibacterial 
activity. The ranking order of activity of ‘geranium oil’ components was linalool (mean 
inhibition zone diameter of 12.5 mm) > geranyl acetate (9.4 mm) > nerol (8 mm) > 
geraniol (7 mm) > menthone (6.8 mm) > β-pinene (6.3 mm) > limonene (6.1 mm) > α-
pinene (5.8 mm). These activities are somewhat modest in comparison with more phenolic 
compounds. Bacteria exhibiting the greatest level of inhibition included Clostridium 
sporogenes (11.5 mm) > Lactobacillus plantarum (10.5 mm) > Citrobacter freundii (9.9 
mm) > Escherichia coli (9.6 mm) > Flavobacterium suaveolens (9 mm). The mean 
inhibition zone diameters of the other bacteria tested were <9 mm (Deans, 2002).  
 
Pelargonium graveolens oil produced by hydrodistillation of dried ‘geranium’ leaves was 
evaluated against 25 different genera of bacteria selected for their agricultural, economic 
and health significance (Dorman and Deans, 2004). The oil displayed inhibitory activity 
against most of the micro-organisms tested. However, the oil did not inhibit the growth of 
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 A. hydrophila, A. faecalis, E. carotovora, E. coli, L. plantarum, Moraxella sp., P. vulgaris 
and Y. enterocolitica.  
 
Pelargonium essential oils added to quiche filling as a model food system showed effective 
antimicrobial activity comparable with that of commercial thyme, clove, ‘geranium’ and 
coriander oils (Lis-Balchin et al., 1998a). In a study conducted to assess the antimicrobial 
activity of Pelargonium essential oils and their corresponding hydrosols in a model food 
system, the results suggested the potential application of certain Pelargonium essential oils 
as food antimicrobial agents (Lis-Balchin et al., 2003).  
 
Several lipophilic Pelargonium extracts displayed pronounced antimicrobial effects (Lis-
Balchin et al., 1996c). The methanolic extracts (hydrophilic fraction) of certain 
Pelargonium species and cultivars were assessed for bioactivity against 25 test bacteria. 
All the extracts produced considerable antibacterial activity (Lis-Balchin and Deans, 1996). 
Bacteria with the greatest level of growth inhibition included Clostridium sporogenes, 
Yersinia enterocolitica, Serratia marcescens, Micrococcus luteus, Flavobacterium 
suaveolens, Bacillus subtilis, Alcaligenes faecalis, Enterococcus faecalis, Proteus vulgaris 
and Pseudomonas aeruginosa. The individual extracts were ranked by activity as follows: 
P. zonale (15.5 mm) > P. acraem (15.2 mm) > P. inquinans (13.7 mm) > P. scandens (12.9 
mm) > ‘White Boar’ (12.6 mm) > P. hybridum (10.5 mm) > P. cucullatum (8.2 mm) > P. 
capitatum (5.6 mm). However, the antifungal activity of the extracts was poor (Deans, 
2002). 
 
Lis-Balchin et al. (1998b) assessed the in vitro antibacterial activity of the volatile oils, 
petroleum spirit and methanolic extracts from a number of Pelargonium species and 
cultivars. Their activity was evaluated against Bacillus cereus, Proteus vulgaris, 
Staphylococcus aureus and Staphylococcus epidermidis. Considerable variation in activity 
occurred both between the cultivars and the different extraction techniques. The substantial 
antibacterial activity recorded indicated that Pelargonium essential oils and solvent extracts 
could be used as effective novel food or cosmetic antimicrobial agents (Lis-Balchin et al., 
1998b). In a study carried out by Lis-Balchin and Roth (2000), the antimicrobial activity of 
the essential oils of P. odoratissimum and P. x fragrans against B. cereus, P. vulgaris, S. 
aureus and S. epidermidis was similar. Furthermore, their microbiological activity was 
comparable to that of commercial ‘geranium oil’. The results indicated that P. 
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 odoratissimum and P. x fragrans essential oils could be employed in food preservation or 
household products (Lis-Balchin and Roth, 2000). 
 
1.11.8 Anti-oxidant activity 
The traditional uses for which Pelargonium species were employed may be related to their 
anti-oxidant action. It has been reported that Pelargonium species and the commercial 
‘geranium oil’ have anti-oxidant properties (Fukaya et al., 1988; Youdim et al., 1999; 
Dorman et al., 2000). 
 
The anti-oxidant values for 16 different commercial samples of ‘geranium oil’ showed 
variation (Lis-Balchin et al., 1996a), suggesting that anti-oxidants may have been added to 
some of the oils. ‘Geranium oil’ was evaluated for its anti-oxidant capacity using a 
procedure known as the thiobarbituric acid reactive substances determination, where egg 
yolk, one-day-old chicken livers or muscle from mature chickens were used as the 
medium. ‘Geranium oil’ demonstrated anti-oxidant activity; however, such activity was 
weak in comparison with that of oregano, thyme and nutmeg oils (Dorman et al., 1995). 
The in vitro anti-oxidant property of Monarda citriodora var. citriodora, Myristica 
fragrans, Origanum vulgare ssp. hirtum, Pelargonium sp. and Thymus zygis oils was 
evaluated by Dorman and Deans (2004). The least active oils were those of Pelargonium 
sp. and O.  vulgare at the top concentration levels. 
 
Lis-Balchin et al. (1996a) found no direct correlation between the source of ‘geranium 
oils’, their main chemical constituents and any of the bioactivities studied. Thus, the 
beneficial effects accredited to ‘geranium oil’ may be a result of the action of its odour via 
the limbic system.  
 
The methanolic extracts of representative species and cultivars of Pelargonium 
(Geraniaceae) were found to exert pronounced anti-oxidant actions; this together with the 
antibacterial activity suggests that Pelargonium extracts could be used in the food, 
cosmetic or other industries (Lis-Balchin and Deans, 1996). Tepe et al. (2005) carried out a 
study in which the methanolic extracts of P. endlicherianum, Verbascum 
wiedemannianum, Sideritis libanotica subspecies linearis, Centaurea mucronifera and 
Hieracium cappadocicum from Turkish flora were screened for in vitro anti-oxidant 
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 activity by two test systems, namely the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical 
scavenging assay and the β-carotene/linoleic acid assay. In both these aforementioned 
assays, the extract of P. endlicherianum demonstrated greater anti-oxidant activity than the 
other plant extracts tested. The results from this study support the use of P. endlicherianum 
in food as an additive and in anti-aging remedies (Tepe et al., 2005). 
 
1.11.9 Antitumour activity 
Pharmacological studies performed on three P. graveolens oil samples revealed that some 
of the major chemical compounds, namely citronellol, citronellyl formate, geraniol and 
citronellyl acetate, possess marginal antitumour activities (Fang et al., 1989). 
 
1.11.10 Anthelmintic activity 
The fresh and dried flowers of P. endlicherianum have been investigated for anthelmintic 
activity. The water distillate of the fresh flowers exhibited such activity (Baytop and 
Tarcan, 1962). 
 
1.11.11 Insecticidal activity 
It has been reported for many years that ‘geranium oils’ possess bactericidal, fungicidal as 
well as insecticidal properties (Saksena, 1984; Deans and Ritchie, 1987). The insecticidal 
activity of ‘geranium oil’ and some of its compounds (citronellol and geraniol) has been 
well researched (Wirtz and Turrentine, 1980; Dale and Saradamma, 1982). It was found 
that many Pelargonium species have an antifeedant action on insects (Lis-Balchin, 1996); 
insect larvae stopped eating vegetation and died when extracts were sprayed onto the 
vegetation. 
 
Methanolic leaf extracts of P. citrosa were tested by Jeyabalan et al. (2003) for their 
biological, larvicidal, pupicidal, adulticidal, antiovipositional activity, repellency and biting 
deterrency against Anopheles stephensi, a malaria vector. Pelargonium citrosa leaf extracts 
displayed substantial toxicity to the malarial vector. Larval mortality was dose dependent; 
the highest dose (4%) caused 98% mortality. The larval, pupal and adult developments 
were completely inhibited by the treatment. Oviposition and egg hatchability were also 
affected and the extracts inhibited the growth of the larvae. All the concentrations of the 
extract used in the study showed good repellent action against the adult mosquito. The leaf 
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 extracts exerted a detrimental effect on A. stephensi at 4%; this suggests that repellents can 
act as insecticides when concentrations exceed a certain threshold. The leaf extracts were 
also proven to have significant biting deterrency. The highly bioactive compounds of P. 
citrosa leaf extracts could be used to develop naturally occurring insecticides; an 
alternative to the expensive and environmentally harmful organic insecticides (Jeyabalan et 
al., 2003).  
 
1.12 In vivo pharmacological studies involving Pelargonium essential oils  
Tisserand and Balacs (1995) reported that ‘geranium oil’ and the components geraniol, 
linalool and citronellol cause a decrease in blood pressure in experimental animals. 
However, reliable results from human experiments are not available (Hart and Lis-Balchin, 
2002). 
 
The overall activity of mice is affected by the inhalation of vapour from essential oils and 
the ‘geranium oil’ components geraniol, linalyl acetate and citronellal are sedative 
(Buchbauer et al., 1993).  
 
In humans, certain brain waves, contingent negative variation (CNV), are affected by 
exposure to essential oil vapours. Oil vapours which depress CNV are considered to be 
sedative and those that increase CNV are stimulant (Lis-Balchin, 2002c); however, with 
regards to Pelargonium oil, both depression and stimulation have been reported from CNV 
studies in man (Torii et al., 1988; Manley, 1993). 
 
1.13 Clinical studies  
Pelargonium oil has not been the focus of well controlled clinical trials for either the 
inhalation of the vapour or application through massage (Hart and Lis-Balchin, 2002). 
Practically no trials have been carried out using ‘geranium oil’, since the choice essential 
oil has almost always been lavender oil (Lis-Balchin, 2002c). 
 
At an Aromatherapy conference, a study carried out at the London clinic concerning the 
use of essential oils for the treatment of chemotherapy-induced side effects of patients 
undergoing high dose chemotherapy was reported (Gravett et al., 1995); however, no 
scientific publications followed. Groups of patients were not randomly allocated and 
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 double-blinding was not attempted (Lis-Balchin, 2002c). The treatment of mucositis 
(damage to the mouth lining due to chemotherapy) with mouth washes often produces a 
burning sensation. The latter treatment was changed to one drop tea tree, one drop 
bergamot and one drop ‘geranium’ in half a glass of boiled warm water five times daily. 
Gargling with swallowing was allowed. The findings from this study did not indicate a 
statistically significant difference (Lis-Balchin, 2002c). Another group of patients suffering 
from chemotherapy-induced diarrhoea were treated with Buscopan® and ‘aromatherapy’ 
which consisted of 15 drops ‘geranium’, 10 drops German chamomile, one drop patchouli 
and 10 drops turmeric phytol mixed in sweet almond oil (50 ml). This was initially applied 
twice daily by abdominal massage but due to nausea and diarrhoea this was substituted by 
oral administration of small doses in an alcoholic vehicle. The findings did not indicate 
statistically significant differences between groups (Lis-Balchin, 2002c). 
 
A number of clinical studies have been performed (Heil and Reitermann, 1994; Dome and 
Schuster, 1996; Haidvogl et al., 1996) to provide credibility to the claimed efficacy and 
safety of the herbal product “Umckaloabo.” Clinical studies have shown that this herbal 
medicine has efficacy in ear, nose and throat (ENT) infections and respiratory tract 
infections. An extract of P. reniforme and P. sidoides may be a safe herbal product 
considering the mild to moderate side effects in patients treated with “Umckaloabo” proven 
by clinical studies (Kolodziej, 2002). Matthys et al. (2003) and Chuchalin et al. (2005) 
conducted a randomised, double-blind, placebo-controlled trial to evaluate the efficacy and 
safety of a Pelargonium sidoides preparation (EPs® 7630) in the treatment of acute 
bronchitis in adults. The results from both studies showed that EPs® 7630 was superior in 
efficacy compared to the placebo in the treatment of acute bronchitis in adults. The severity 
of symptoms was reduced and the duration of working inability was shortened for almost 
two days (Matthys et al., 2003). In addition, all adverse events were assessed as non-
serious. Therefore treatment with EPs® 7630 may be an effective alternative to antibiotics 
for the treatment of acute bronchitis.   
 
1.14 Toxicity of ‘geranium oil’ 
From the toxicological aspect, ‘geranium oil’ has been implicated rarely and all references 
are attributable to contact dermatitis and sensitization. Most references are due to geraniol, 
a main component of ‘geranium oil’ (Lovell, 1993). Patch tests to geraniol were negative; 
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 however, a few studies have indicated dermatitis to perfumes containing ‘geranium oil’ 
(Klarmann, 1958). Recent reports from Japanese studies (Nakayama, 1998) provided a list 
of Class A fragrances classified as common cosmetic sensitizers and primary sensitizers; 
‘geranium oil’ was included in this class. 
 
1.15 The commercial value of Pelargonium essential oils and extracts 
There is an increasing growth of the commercial use of natural products in all industrial 
sectors. Export earnings for producers come from the industrial utilization of medicinal 
plants. ‘Geranium oil’ is among the top twenty of essential oils and the annual world 
production is worth almost seven million pounds (Williams and Harborne, 2002). 
 
Due to its pleasant scent, ‘geranium oil’ is used in various cosmetic preparations such as 
soaps, creams and perfumes. ‘Geranium oil’ is employed in toiletries for its herbal 
character to reinforce the ‘Natural’ concept (Wells and Lis-Balchin, 2002). ‘Geranium oil’ 
and mixtures containing its constituents have been used for many years to make artificial 
rose oil (Wells and Lis-Balchin, 2002). Pelargonium graveolens is used as a substitute for 
the expensive attar of roses (van der Walt and Vorster, 1988). Pelargonium oils contain 
various monoterpenoids such as (+)-isomenthone and are extensively used in the 
production of perfumes (van Wyk et al., 2002b). ‘Geranium oil’ has green herbal, fresh and 
earthy characteristics and is often used in masculine fragrances. It is also used in women’s 
fragrances: Ivoire, Balmain (1980) contained ‘geranium’ as a heart note; Giorgio, Armani 
(1981) is a mixture of mandarin and ‘geranium’ and Paris, Yves St. Laurent (1983) 
contained ‘geranium’ as a top note (Wells and Lis-Balchin, 2002), just to name a few. 
Many scented-leaf pelargoniums have potential for use in the flavour and fragrance market 
(Lis-Balchin, 1990). The leaves of a few scented species are used as infusions to condition 
the hair and to freshen the skin. The leaves are also used as a basis for pot-pourri. 
 
Pelargoniums have found a culinary function, due to the growing popularity of the use of 
herbs. Several species with scented foliage are possible sources of aromatic oils which may 
be used for culinary flavouring (Miller, 2002). The food industry employs small amounts 
of ‘geranium oil’ in products such as non-alcoholic drinks, ice-creams, candy, baked 
goods, gelatines and puddings (Lis-Balchin, 1990). It is also used in most major food 
categories and in alcoholic and soft drinks as a flavouring agent. The various aromas of the 
scented-leaf pelargoniums are potentially useful in the food industry (Lis-Balchin, 1990). 
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 The aromas of some Pelargoniums are pleasantly floral and fresh, reminiscent of rosaceous 
fragrances and others are tropical fruit-like e.g. Pelargonium grossularioides and P. 
mollicomum and certain P. odoratissimum and P. x fragrans cultivars. Others have a rather 
balsamic smell e.g. P. exstipulatum and P. x fragrans (Lis-Balchin and Roth, 2000). 
Among the raw aromatic material employed in the food sector, aromatic substances 
containing a mint scent occupy a favoured position (Greenhalgh, 1979). Pelargonium 
tomentosum produces a strong and pleasant peppermint-scented essential oil (Demarne and 
van der Walt, 1990). Numerous Pelargonium essential oils and solvent extracts are 
strongly antimicrobial and could be used commercially in food processing (Deans, 2002).  
 
Pelargonium reniforme and the closely related P. sidoides are used as ingredients in a 
German remedy called “Umckaloabo”, which is used to treat bronchitis in children. The 
presence of umckalin and structurally related coumarins may be partly responsible for the 
activity of the medicine prepared from P. reniforme (van Wyk et al., 2002b). 
 
Various Pelargonium species have been proclaimed to be used as antispasmodics, 
antidysenterics and astringents, yet these species have not been commercially exploited 
(Lis-Balchin, 1990).   
 
The pharmacological properties of the extracts and oils of certain Pelargonium species 
validate their commercial exploitation in the cosmetic, food/beverage and pharmaceutical 
sectors.  
 
1.16 Rationale 
Studies involving Pelargoniums have intensively focused on the chemical composition of 
their essential oils (Williams and Harborne, 2002). Much research has revolved around P. 
capitatum, P. graveolens and P. radens oils and their hybrids, while the other indigenous 
oil-bearing Pelargonium species, of the section Pelargonium, have received little attention. 
There is still a great deal to be learnt about the non-volatile compounds present in the 
Pelargonium species. Furthermore, published investigations have revealed that various 
Pelargonium species possess positive pharmacological activities and since species within a 
family are chemotaxonomically related, there is the possibility that some of the species 
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 belonging to the section Pelargonium which hitherto remain unexplored may contain 
bioactive constituents. 
 
In addition, there is the increasing utilization of natural products in all industrial sectors 
and studies revealing potential bio-therapeutic properties of several Pelargonium oils and 
extracts have supported their potential niche within the realms of the food, cosmetic and 
pharmaceutical industries. The other unexplored species of the section Pelargonium are 
deserving of thorough investigation by conducting bioassays and chemical analyses. In this 
way, we are better equipped to further develop the therapeutic application and 
commercialization of Pelargonium species.  
 
1.16.1 Study objectives 
The aims of the study were: 
• To determine the chemical composition of selected Pelargonium essential oils using 
GC and GC-MS analysis and to assess if the compositions are chemotaxonomically 
informative. Phylogenetic relationships of certain Pelargonium species within section 
Pelargonium were evaluated by correlation with the chemotaxonomical appraisal of 
their essential oils. 
• To analyse the chemical composition of selected Pelargonium solvent extracts (non-
volatiles) using HPLC. 
• To investigate the in vitro bioactivities of the essential oils and solvent extracts. The 
activities investigated included antimicrobial, anti-oxidant, anti-inflammatory and 
antimalarial activity. Through the evaluation of these properties, the use of 
Pelargoniums in traditional medicines can be verified. 
• To determine which phytoconstituents are possibly responsible for the investigated 
activities displayed by the oils and solvent extracts. 
• To conduct in vitro toxicity studies to assess the feasibility of using the active oils and 
solvent extracts in commercial preparations. 
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 CHAPTER 2: PLANT MATERIAL COLLECTION AND SAMPLE 
PREPARATION 
 
2.1 Plant material collection 
The Pelargonium species (section Pelargonium) used in this study were chosen according 
to the availability of fresh plant material from the botanical gardens (SBG, NBG and 
WSBG) and according to the authenticity of taxonomic identification. Twenty-one species 
out of a total of 24 currently recognized species were included in the study. The studied 
species, their source and voucher details are given in Table 2.1. Preference was given to the 
collection from the Stellenbosch Botanical Garden of Stellenbosch University. The 
Department of Botany and Zoology at the University of Stellenbosch has been researching 
the taxonomy of the genus Pelargonium for several years. Plant material in their collection 
has been authenticated and the taxonomy confirmed. 
 
Table 2.1: The specific localities and voucher numbers of the Pelargonium species selected 
for the study. 
 
Species Source Voucher no. 
P. betulinum NBG A Viljoen 941 (WITS) 
P. capitatum WSBG A Viljoen 918 (WITS) 
P. capitatum Strand A Viljoen 951 (WITS) 
P. citronellum NBG A Viljoen 943 (WITS) 
P. citronellum SBG A Viljoen 1172 (WITS) 
P. cordifolium NBG A Viljoen 1173 (WITS) 
P. cordifolium WSBG A Viljoen 1174 (WITS) 
P. crispum NBG A Viljoen 1175 (WITS) 
P. cucullatum SBG A Viljoen 1176 (WITS) 
P. cucullatum WSBG A Viljoen 1177 (WITS) 
P. glutinosum SBG A Viljoen 939 (WITS) 
P. glutinosum WSBG A Viljoen 1178 (WITS) 
P. graveolens SBG A Viljoen 947 (WITS) 
P. graveolens WSBG A Viljoen 920 (WITS) 
         continued  .  .  . /55 
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 54/ .  .  .  continued 
Species Source Voucher no. 
P. graveolens WSBG A Viljoen 920 (WITS) 
P. greytonense SBG A Viljoen 1179 (WITS) 
P. hermanniifolium NBG A Viljoen 1180 (WITS) 
P. hermanniifolium SBG A Viljoen 1181 (WITS) 
P. hispidum  SBG A Viljoen 946 (WITS) 
P. panduriforme SBG A Viljoen 949 (WITS) 
P. panduriforme WSBG A Viljoen 926 (WITS) 
P. papilionaceum NBG A Viljoen 944 (WITS) 
P. pseudoglutinosum NBG A Viljoen 1182 (WITS) 
P. quercifolium SBG A Viljoen 940 (WITS) 
P. quercifolium WSBG A Viljoen 921 (WITS) 
P. radens NBG A Viljoen 942 (WITS) 
P. scabroide SBG A Viljoen 1183 (WITS) 
P. scabrum SBG A Viljoen 948 (WITS) 
P. sublignosum SBG A Viljoen 1184 (WITS) 
P. tomentosum SBG A Viljoen 950 (WITS) 
P. tomentosum WSBG A Viljoen 919 (WITS) 
P. vitifolium SBG A Viljoen 945 (WITS) 
 
Where: - NBG = National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical 
Garden, WSBG = Walter Sisulu Botanical Garden (Johannesburg). Voucher specimens of 
all the material collected are housed in the herbarium of the Department of Pharmacy and 
Pharmacology, University of Witwatersrand (WITS), Johannesburg. 
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 Table 2.2: The total taxa in section Pelargonium and an indication of the sampling carried out in this study.
 
Species sampled for essential oil testing Species sampled for extract testing 
Species GC-MS 
analysis 
MIC 
assay 
5-LOX 
assay 
MTT 
assay 
HPLC 
analysis 
MIC 
assay 
DPPH 
assay 
Antimalarial 
assay 
MTT 
assay 
P. betulinum 3 - - - 3 3 3 3 3 
P. capitatum 3 - - - 3 3 - 3 3 
P. citronellum 3 3 3 3 3 3 3 3 3 
P. cordifolium - - - - 3 3 3 3 3 
P. crispum - - - - 3 3 3 3 3 
P. cucullatum - - - - 3 3 3 3 3 
P. denticulatum - - - - - - - - - 
P. englerianum - - - - - - - - - 
P. glutinosum 3 - - - 3 3 3 3 3 
P. graveolens 3 3 3 3 3 3 3 3 3 
P. greytonense - - - - 3 3 - 3 3 
P. hermanniifolium - - - - 3 3 3 3 3 
P. hispidum  3 - - - 3 3 3 3 3 
P. panduriforme 3 3 3 3 3 3 3 3 3 
P. papilionaceum 3 - - - 3 3 3 3 3 
P. pseudoglutinosum - - - - 3 3 3 3 3 
P. quercifolium 3 - 3 3 3 3 3 3 3 
P. radens 3 3 3 3 3 3 - 3 3 
P. ribifolium - - - - - - - - - 
P. scabroide - - - - 3 3 - 3 3 
P. scabrum 3 - 3 3 3 3 3 3 3 
P. sublignosum - - - - 3 3 3 3 3 
P. tomentosum 3 3 3 3 3 3 3 3 3 
3 P. vitifolium - - - 3 3 3 3 - 
Where: - GC-MS = gas chromatography coupled to mass spectroscopy; MIC = minimum inhibitory concentration; 5-LOX = 5-lipoxygenase; MTT 
= 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; HPLC = high performance liquid chromatography; DPPH = 2,2-diphenyl-1-
picrylhydrazyl. 56 
 2.2 Sample preparation 
2.2.1 Essential oils  
Distillation was performed either on the same day of harvesting or the day after harvesting. 
The aerial parts (i.e. leaves, stalks and stems) of the fresh plant material were cut into small 
pieces and the essential oil was extracted by hydrodistillation using a modified Clevenger’s 
glass apparatus. This extraction process was carried out at room temperature for 3 hours, 
after which the essential oils extracted were collected in amber vials and refrigerated prior 
to analysis. 
 
2.2.2 Non-volatile extracts 
Fresh plant material (stems and leaves) of each species was dried in the oven set at 30°C. 
The yield of extractives is increased by the pre-drying of the plant material as this leads to 
rupture of the cell structure and subsequently improved solvent access (Harborne et al., 
1975). Once dried, the plant material was pulverized using a pestle and mortar. This 
powdered material was subjected to solvent extraction with acetone for 3 hours in a water 
bath set at 40°C. The extractant material and solvent were filtered (Whatman® filter paper 
no 41, pore size 20-25 µm) to remove any plant material debris. Following this, the plant 
material was rinsed twice with acetone and filtered after each rinse. The extracts were 
reduced under vacuum using a rotary evaporator (Büchi rotavapor R-114, waterbath B-
480) at 35°C. The resultant acetone extracts were further reduced in the fumehood and 
once concentrated to dryness kept at 4°C prior to analysis. 
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 CHAPTER 3:  ESSENTIAL OIL COMPOSITION AND 
CHEMOTAXONOMY 
 
3.1 Introduction 
Since the early 1800’s, the rose-scented ‘geraniums’ belonging to the genus Pelargonium 
have been cultivated commercially for their essential oil. Much research has been done to 
clarify the chemical composition of these cultivars (Widmer and Collins, 1991). ‘Geranium 
oil’ is a complex mixture of more than 120 monoterpenes and sesquiterpenes and other low 
molecular weight aromatic compounds (Lis-Balchin, 2002a). These are commercially 
important plant products employed extensively in the perfume, pharmaceutical and flavour 
sectors (Brown and Charlwood, 1986). Due to the difference in cultivars used, the climate, 
the country of origin, the time of the harvest, fertilizers used, etc., the chemical 
composition of the oil is variable (Lis-Balchin, 2002a). However, citronellol, geraniol and 
linalool, either free or in ester combination, are the major compounds making up about 60-
70% of the oil. The following terpenoids occur in oils from all localities: isomenthone, 
menthone, nerol, cis-rose oxides and trans-rose oxides, α-terpineol, α-pinene, myrcene and 
β-phellandrene (Williams and Harborne, 2002). Only a few investigations have been 
carried out to determine the volatiles present in other scented Pelargonium species, which 
are not used commercially (Widmer and Collins, 1991).  
 
In addition to correlating the data obtained in this study with previously reported analyses 
concerning the well-known Pelargoniums, the chemical compositions of those 
Pelargonium essential oils which have received little attention were investigated. Thirteen 
Pelargonium species (18 samples) out of a total of 24 (section Pelargonium) were selected 
for investigation of their essential oil composition. This study aims to broaden the existing 
knowledge concerning the volatile Pelargonium constituents and explores the possible 
chemotaxonomic application of the essential oil data of selected species belonging to the 
section Pelargonium. 
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 3.1.1  The current hypothesis of relationships in section Pelargonium 
Bakker et al. (2004) derived phylogenetic hypotheses for the genus Pelargonium L’Hérit. 
based on DNA sequence data from nuclear, chloroplast and mitochondrial encoded 
regions. The datasets contained cpDNA trnl-F sequences for 152 taxa, nrDNA ITS 
sequences for 55 taxa and mtDNA nadl b/c exons for 51 taxa. Following total evidence 
analysis of the three genomic DNA regions, a single hypothesis was constructed which 
revealed that the genus consists of five main clades (A1, A2, B, C1 and C2). Of particular 
interest, A1 is divided into two clusters, the lower one of which contains mostly the 
analysed species of section Pelargonium. This lower branch is further divided into two 
groups; the upper group contains, in addition to the analysed species of Campylia, P. 
denticulatum and P. quercifolium which are closely associated with one another. The lower 
group contains four subclusters, encompassing the other analysed Pelargonium species of 
section Pelargonium. The first subcluster contains only P. hispidum; in the second 
subcluster, Pelargonium tomentosum and P. papilionaceum are closely related; in the third, 
P. graveolens, P. radens and P. vitifolium are also closely associated. The karyological 
similarity (2n = 88) between P. graveolens and P. radens was reported by Albers and van 
der Walt (1984). The fourth subcluster comprises the remainder of the analysed 
Pelargonium species. Within this subcluster, P. alpinum, P. grandiflorum and P. 
sublignosum were grouped together and further, P. scabrum was clustered with two species 
from section Campylia, namely P. incarnatum and P. setulosum.  
 
Furthermore, the constructed hypothesis following optimization of the cpDNA trnl-
F/nrDNA ITS/mtDNA datasets indicated that P. hispidum is more closely associated to P. 
papilionaceum and P. tomentosum than to the other analysed species. Within the clustering 
of P. graveolens, P. radens and P. vitifolium, the latter two species are more closely 
related. With respect to the fourth subcluster and taking into account only those species 
which were included in our essential oil analysis, P. betulinum, P. citronellum and P. 
scabrum reside in this subcluster. Bakker et al. (2004) indicated that all the analysed 
species of section Pelargonium have a chromosome number of x = 11. 
 
An evaluation was carried out to assess if the essential oil compositions were 
chemotaxonomically informative by comparison to the latest species-level phylogeny for 
the section Pelargonium. The current phylogenetic relationships that were tested in this 
study included the occurrence of P. quercifolium as an outlying species, the association of 
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 P. hispidum with respect to the other analysed species, the relationship between P. 
tomentosum and P. papilionaceum, the close grouping of P. graveolens, P. radens and P. 
vitifolium and the clustering of P. betulinum, P. citronellum and P. scabrum. 
 
3.2 Materials and methods  
3.2.1 Thin layer chromatography  
Thin layer chromatography (TLC) was used for the qualitative analysis of the selected 
Pelargonium essential oils. It was performed as a preliminary study to provide information 
as to whether a chemical pattern of variation or uniformity exists between and among the 
selected species.  
 
3.2.1.1 Principle of the method 
TLC is a chromatographic technique of fractionating crude mixtures into their components 
by the movement of a solvent on a thin layer of suitable adsorbent (Smith and Feinberg, 
1972). It is viewed as a crude method for the identification of the separated chemical 
substances. It has the advantages of speed, low cost and simplicity (Jork et al., 1990). 
 
3.2.1.2 Protocol 
The essential oils were diluted with hexane in the ratio 1: 7. For each test sample, using a 
micro-pipette, spots of 2 μl each were applied 2 cm from the bottom of the silica gel plates 
(Alugram Sil G/UV254). When each spot was applied, the solvent was allowed to evaporate 
before another spot was applied. The mobile phase used was toluene: ethyl acetate (9.3: 
0.7). The atmosphere of the TLC tank was given time to become saturated with the vapour 
of the developing solvent. The plate was placed vertically in this solvent, without 
immersing the spots themselves. Once the solvent reached the solvent front (1 cm from the 
top edge of the TLC plate), the plate was removed from the tank and dried. Vanillin-
sulphuric acid spray reagent was prepared in the following way: 1 g vanillin was dissolved 
in 100 ml ethanol to make solution I and 10 ml sulphuric acid was added to 90 ml ethanol 
to make solution II. The plate was sprayed with 10 ml of solution I followed immediately 
by 10 ml of solution II. The plate was placed in the oven at 110°C for 5-10 minutes under 
observation and the separated compounds were evaluated visually (Wagner and Bladt, 
1996).  
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 3.3 Results and discussion 
    1       2      3        4       5       6       7       8       9      10     11     12     13     14     15     16     17    18 
Figure 3.1: Vanillin sprayed-TLC plate of the essential oils of selected Pelargonium 
species. The track numbers of the species are given in Table 3.1. 
 
Table 3.1: TLC plate track number and corresponding species name and locality. 
TLC plate track 
number Species Locality 
P. capitatum  1 WSBG 
P. tomentosum 2 WSBG 
P. tomentosum 3 SBG 
P. graveolens 4 WSBG 
P. radens 5 NBG 
P. graveolens 6 SBG 
P. quercifolium 7 WSBG 
P. panduriforme 8 WSBG 
P. quercifolium 9 SBG 
P. panduriforme 10 SBG 
P. glutinosum 11 SBG 
P. betulinum 12 NBG 
P. citronellum 13 NBG 
P. papilionaceum 14 NBG 
P. vitifolium 15 SBG 
P. hispidum 16 SBG 
P. scabrum 17 SBG 
P. capitatum 18 Strand 
 
NBG = National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical Garden, 
WSBG = Walter Sisulu Botanical Garden (Johannesburg). 
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 TLC demonstrated the most characteristic constituents present in the selected Pelargonium 
essential oils. Chemical variation appears to occur between the oil samples of P. capitatum 
(track 1 and 18); this may be due to the separation of different quantities. The profiles 
produced by the two samples of P. quercifolium (track 7 and 9) are similar. Pelargonium 
glutinosum (track 11) appears to be most comparable to P. quercifolium (track 9). Some 
degree of compositional variation exists between the P. panduriforme samples (track 8 and 
10). Pelargonium quercifolium (track 7) and P. panduriforme (track 10) produce analogous 
profiles. The two samples of P. graveolens (track 4 and 6) produce identical chemical 
compositions as do the two samples of P. tomentosum (track 2 and 3). The TLC profile of 
P. radens (track 5) is similar to those of the P. graveolens oils (track 4 and 6). 
Furthermore, the P. tomentosum oils (track 2 and 3) show similarities with P. radens (track 
5) and P. graveolens (track 4 and 6). Pelargonium betulinum (track 12) displays a 
chromatographic profile different from those of the other species as does P. citronellum 
(track 13). Pelargonium scabrum (track 17) appears to have some compounds in common 
with P. quercifolium (track 7 and 9) and P. glutinosum (track 11). Pelargonium hispidum 
(track 16) shares some similarities with P. capitatum (track 18). 
 
TLC indicated an unusual compound in the essential oils of P. papilionaceum (track 14) 
and P. vitifolium (track 15). Lis-Balchin and Roth (1999) found citronellic acid in only two 
Pelargonium species, P. papilionaceum and P. vitifolium and one cultivar, ‘Sweet Rosina’. 
This characteristic compound was verified as being citronellic acid by running TLC with a 
standard of citronellic acid and obtaining a retention factor (Rf) value. The TLC profiles of 
P. papilionaceum (track 14) and P. vitifolium (track 15) are evidently similar to one 
another and are anomalous compared to those of the other species. 
 
Since essential oils are complex mixtures of many different constituents, other techniques 
of analysis were used to provide a more detailed profile of their composition. 
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 3.4 Materials and methods 
3.4.1 Gas chromatography (GC) and gas chromatography coupled to mass 
spectroscopy (GC-MS) 
In order to characterize the patterns of chemical diversity and similarity displayed in the 
preliminary TLC study, GC analysis was performed on all essential oil samples. GC-MS 
analysis was carried out for further identification of the individual components in the oil 
mixtures. The method of choice for the identification of terpenoids, fatty acids and various 
other volatile compounds in complex plant extracts is GC coupled with mass spectroscopy 
(Spring, 2000). 
 
3.4.1.1 Principle of the method 
Gas chromatography is a separating device. Retention times of the chromatogram peaks are 
compared with those of reference compounds run under identical conditions to tentatively 
identify the peaks. Gas chromatography is also appropriate for quantitative analysis. Mass 
spectroscopy is a method of analysis which determines the molar mass of a substance and 
provides information about the molecular structures. The mass spectrum of a substance is 
unique to that substance. In this way one can compare the mass spectrum of a substance to 
that of previously recorded spectra resulting in the identification of that substance. Mass 
spectroscopy is used for positive peak identification (Gillespie et al., 1994).  
 
3.4.1.2 Protocol 
Analytical gas chromatography was performed using a Shimadzu GC-17A system fitted 
with J & W-DB1 column (30 m x 0.25 mm with 0.25 µm film thickness). Helium was used 
as the carrier gas (1 ml/min). The column temperature was programmed at 60°C for 1 min 
and then raised to 180°C for the total analysis time of 80 min. The injector port and flame 
ionization detector (FID) were set at 250°C.  
 
Identifications of the compounds in the oils were carried out by GC-MS analysis using a 
Hewlett-Packard 1800A GCD system. The system was equipped with an Innowax FSC 
column (60 m x 0.25 mm with 0.25 µm film thickness) and helium was used as the carrier 
gas at a flow rate of 1 ml/min. The following parameters were used: the GC oven 
temperature was kept at 60°C for 10 min and programmed to increase to 220°C at a rate of 
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 4°C/min, then kept constant at 220°C for 10 min and then programmed to 240°C at a rate 
of 1°C/min. Alkanes were used as reference points in the calculation of relative retention 
indices (RRI). Split flow was adjusted at 50 ml/minute. The injector and detector 
temperatures were set at 250°C. MS were taken at 70 eV. Mass range was from 35 to 425 
m/z. Component identifications were done by comparing their mass spectra and retention 
indices using Wiley GC-MS Library and BAŞER Library of Essential Oil Constituents. 
The latter is an in-house database generated with authentic standards. The percentage 
amounts were obtained from electronic integration measurements using flame ionization 
detection (FID).  
 
3.4.2 Cluster analysis 
Essential oil components can be useful taxonomic markers and cluster analysis, a 
multivariate statistical procedure, based on chemical composition facilitates this 
establishment of chemotaxonomical relationships between or among selected species. 
Cluster analysis was performed on the GC-MS data of 18 essential oil samples (13 species) 
to ascertain potential patterns of shared and diverse chemistry between and among certain 
Pelargonium species.  
 
3.4.2.1 Principle of the method 
Cluster analysis is performed on the combined matrix of qualitative and quantitative 
phytochemical data. Through this method of analysis a branching diagram referred to as a 
dendrogram is generated, which represents the degree of phenetic similarity among the 
species analysed by GC-MS. In this way relationships can be observed between and among 
species. An operational taxonomic unit (OTU) is the lowest taxonomic unit that can be 
classified in a study. The tips of the dendrogram are represented by the tips of the OTUs. 
The OTUs are clustered into groups according to similarity. The greater the coefficient 
value (r), the higher the level of similarity. 
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 3.4.2.2 Protocol 
Using quantitative and qualitative data from GC-MS analysis, a combined data matrix was 
created. The data for each species was tabulated into a matrix with the individual species as 
operational taxonomic units, where n = 18 were assigned as columns of individual species 
and n = 315 were assigned as rows of compounds. The data matrix was analysed by a 
phenetic program, NTSYS-pc software package, version 2.0 (Rohlf, 1998). Correlation was 
selected as a measure of similarity, and the unweighted pair-group method with arithmetic 
average (UPGMA) was used for cluster definition.  
 
3.5 Results and discussion 
The percentage amounts of the compounds identified in the selected Pelargonium essential 
oils are presented in Table 3.2. In addition to the summary given in Table 3.2, the essential 
oil composition of each species is included in the monograph section which has been added 
as an appendix to this dissertation. Figure 3.2 shows the dendrogram generated from the 
statistical analysis performed on a total of 315 different chemical compounds. Quantitative 
and qualitative chemical variability and similarity occurs between and among the analysed 
species. 
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1014 tricyclene      0.1 tr   0.6 tr   0.2 0.1 0.4 0.3  
1032 α-pinene 0.1 0.2    0.2 0.1 tr 0.6 0.3 tr  0.1 0.3 0.1 0.5 0.3  
1035 α-thujene         1.0 0.1   0.2  tr    
1048 2-methyl-3-buten-2-ol    0.1               
1076 camphene        tr tr 0.1    tr tr 0.1 tr  
1100 undecane     tr   tr   tr        
1112 anhydrolinalool oxide    tr    tr           
1118 β-pinene      0.1 tr tr 0.1 tr   tr 0.1 0.3 tr tr  
1132 sabinene         0.5 0.2   0.1 tr tr tr tr  
1136 thuja-2,4(10)-diene         0.1          
1146 δ-2-carene                 tr  
1159 δ-3-carene         0.3    tr      
1174 myrcene    tr  0.4 0.3    tr   0.9 1.4 0.8 0.4  
1176 α-phellandrene        0.1 4.3 8.8  0.8 1.1      
1188 α-terpinene        tr 0.2 0.1         
1195 dehydro-1,8-cineole    0.2               
1202 3-hexanol  0.1                 
1203 limonene    0.1 tr 0.6 0.6 tr 2.2 3.0 tr 0.3 0.2 0.8 0.2 1.5 1.3  
1213 1,8-cineole   tr  0.1   0.2   tr    1.3   0.1 
Table 3.2: The chemical composition of the hydrodistilled essential oils of selected Pelargonium species. 
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1216 3-methylcyclopentanone      0.1 tr       tr  tr tr  
1218 β-phellandrene      tr tr tr 1.4 4.0  0.3 0.2 0.1  0.6 0.1  
1225 (Z)-3-hexenal        tr   tr        
1230 butyl butyrate            0.1       
1246 (Z)-β-ocimene        tr tr 2.4 0.3  tr   tr   
1255 γ-terpinene        tr 1.0 0.3 tr 0.3 tr      
1266 (E)-β-ocimene        tr tr 0.2 0.1  tr   tr   
1280 p-cymene 0.2 0.1  0.1 0.5 0.9 0.9 0.1 45.4 37.6 tr 6.2 54.9 1.1 1.0 1.1 0.8 0.2 
1290 terpinolene        tr 0.1  tr  tr      
1327 3-methylcyclohexanone      0.1 tr       0.1     
1337 geijerene        0.1   tr       tr 
1348 6-methyl-5-hepten-2-one    0.4       tr       tr 
1353 cis-rose oxide  0.6    tr tr tr   0.1    0.1   tr 
1365 trans-rose oxide  0.3     tr    tr    tr    
1384 α-pinene oxide       tr       tr  tr tr  
1384 heptyl acetate 0.1                  
1385 allo-ocimene*          0.1 tr        
1391 (Z)-3-hexenol    0.1  tr  0.1   tr    tr    
1398 2-nonanone      tr  2.5       0.1    
1400 nonanal        tr   tr        
1400 (Z)-2-hexenol        tr   tr    0.1    
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1402 heptyl isobutyrate   0.5                
1406 fenchone                tr tr  
1413 rosefuran          0.1         
1419 photocitral B    0.2               
1429 perillene    0.1  tr 0.1  tr 0.1 tr  0.2 0.1 tr tr tr  
1429 (E)-2-octenal        tr           
1434 hexyl butyrate     3.2       8.2       
1450 trans-linalool oxide (furanoid)    0.1  0.1 tr 0.1   tr   0.1 0.1   tr 
1451 β-thujone         tr    0.1      
1452 1-octen-3-ol    tr    tr          tr 
1452 α,p-dimethylstyrene         1.4 0.2  0.2 0.5   tr   
1458 cis-1,2-limonene epoxide      tr tr       tr   tr  
1459 acetic acid   0.3 tr 0.3      tr       tr 
1464 (E)-2-hexenyl butyrate   0.5 tr 2.7       6.3       
1466 α-cubebene  0.5   0.2     0.1 tr    tr   tr 
1473 (Z)-3-hexenyl 2-methylbutyrate    tr    0.1       tr    
1475 menthone  0.9   0.7 5.1 1.0 0.1      1.9  41.1 36.1  
1478 cis-linalool oxide (furanoid)    0.1     0.5      0.1    
1481 (Z)-3-hexenyl isovalerate       tr 0.2       tr    
1482 cis/cis-photocitral    0.3               
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1487 citronellal                  tr 
1491 octyl acetate 5.7                 tr 
1492 cyclosativene            0.2       
1493 α-ylangene     0.1        0.1     tr 
1497 α-copaene 1.4 0.7  0.1    0.1 0.1 0.2  0.1   0.2   0.4 
1503 isomenthone  1.9  0.1 1.4 65.8 83.3 0.3  0.3 tr   84.5 tr 49.3 56.6  
1503 hexyl valerate     0.1       0.1       
1506 trans/trans-photocitral    0.6               
1508 heptyl butyrate     0.4       0.2       
1509 2-nonanol        0.2           
1528 α-bourbonene 0.2 0.1                tr 
1532 camphor   0.1  tr   tr       tr    
1535 β-bourbonene 2.8 1.5  tr 0.3 tr tr         tr tr 0.1 
1541 benzaldehyde    0.1     0.1  tr    0.1 tr tr  
1545 cis-α-bergamotene               tr    
1549 β-cubebene 0.2    0.1     0.3        tr 
1553 linalool  0.3 0.1 1.8 0.1 0.3 0.3 0.7 4.4  tr   0.6 0.7 tr 0.1 0.2 
1553 octanol 0.1 0.2 0.1    tr tr   tr       tr 
1556 8,9-limonene epoxide*                 tr  
1560 trans-dihydro-α-terpineol         0.2          
1562 isopinocamphone   0.3                
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1568 trans-α-bergamotene               0.3    
1569 neoisopulegol           tr       0.3 
1570 methyl citronellate           tr       0.1 
1571 trans-p-menth-2-en-1-ol       tr   0.6 tr  0.2 tr  tr 0.1  
1572 β-ylangene 0.1             0.2     
1574 hexadecane  0.2                 
1576 pentyl hexanoate     0.3              
1577 α-cedrene 0.6   0.5           0.3    
1580 cis-isopulegone       0.1       tr     
1583 isopulegol           tr     tr  0.3 
1584 trans-isopulegone                  tr 
1586 pinocarvone       tr            
1586 cyperene                 tr  
1587 methyl decanoate      0.1  0.1       4.2    
1588 β-copaene  tr                tr 
1589 cis-dihydro-α-terpineol         tr          
1589 isocaryophyllene  1.0      0.1           
1592 neomenthol                0.3 0.1  
1596 α-guaiene                tr   
1597 bornyl acetate  0.1 0.4      0.1          
1600 β-elemene       0.1     0.1    tr 0.1  
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1602 6-methyl-3,5-heptadien-2-one    tr       tr        
1604 2-undecanone        tr           
1604 thymol methyl ether         tr          
1606 p-menth-3-en-8-ol      tr tr            
1608 octyl butyrate   2.1         0.4       
1611 terpinen-4-ol   tr      0.6    0.2      
1612 β-caryophyllene 5.3  0.2 0.6 2.5   8.6  0.2 0.1 0.1   3.9 0.4  0.2 
1612 citronellyl formate  31.1    tr tr           0.1 
1613 β-cedrene tr   tr               
1614 hexyl tiglate     0.8       0.2       
1615 p-menth-1-en-9-al        tr           
1616 hotrienol         0.2          
1617 guaia-6,9-diene  0.5   0.3    0.1 0.1  0.1 tr tr     
1618 cadina-3,5-diene     0.3   0.1           
1620 β-cyclocitral           tr        
1620 ethyl decanoate        tr           
1624 cis-β-terpineol               tr    
1626 2-methyl-6-methylen-3,7-octadien-2-ol               0.2    
1628 aromadendrene    tr 0.7    0.3 0.2  0.1 0.1     0.1 
1632 neoisomenthol      0.4        0.2  tr tr  
1637 menthol     0.1 0.1 0.2 0.1      0.1  0.6 0.2  
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1638 cis-p-menth-2-en-1-ol       0.3        tr 0.1 0.1  
1639 trans-p-mentha-2,8-dien-1-ol    0.1               
1647 (E)-2-decenal     0.1      tr        
1651 sabina ketone         0.1          
1661 allo-aromadendrene 0.6 0.6   0.7    0.3 0.1  0.8 0.1 tr tr   0.1 
1662 isomenthol      0.1        tr     
1664 1-nonanol 0.1                  
1664 trans-pinocarveol         tr          
1668 citronellyl acetate  0.9      tr   tr    0.1    
1668 (Z)-β-farnesene 0.2     tr 0.1       tr 0.2   tr 
1674 γ-gurjunene  0.3            tr     
1677 epi-zonarene          0.1         
1678 cis-p-mentha-2,8-dien-1-ol                 tr  
1679 heptadecane  0.1      tr           
1681 (Z)-3-hexenyl tiglate        0.1           
1682 δ-terpineol               tr    
1683 carvotanacetone         0.1 0.1   tr      
1685 isovaleric acid                  tr 
1687 α-humulene 1.5    0.2   0.4   tr   tr 0.3 0.1 tr  
1688 selina-4,11-diene          tr         
1689 trans-piperitol    0.1               
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1690 cryptone  0.2    0.3 0.3  0.7 2.9  tr 1.4 0.3  0.2 0.3  
1693 β-acoradiene 0.5              0.1    
1694 neral    17.4               
1696 β-alaskene               0.1    
1698 geranyl formate  0.5                 
1704 γ-muurolene 1.9 0.4    0.1 tr 0.1       0.2   0.2 
1706 α-terpineol  0.3 0.3 0.2 0.2 0.1 0.2 0.5 0.5  0.3   0.1 2.8 0.1 0.1 0.2 
1707 ledene     0.9   tr 0.7   1.8 0.4   0.1 tr tr 
1714 (Z,E)-α-farnesene        tr           
1719 borneol   1.0    tr       0.1  tr tr  
1725 verbenone   0.7           tr     
1726 germacrene D 0.2         tr  0.1    0.1   
1730 δ-guaiene            tr 0.3      
1740 valencene            0.1  tr    0.1 
1740 α-muurolene 2.4 1.4 0.6  tr  0.3 0.1  0.3  0.5 0.2  tr   0.4 
1740 geranial    27.2               
1741 β-bisabolene      0.5          0.1   
1743 α-cadinene 0.2              tr    
1744 α-selinene  0.3                 
1748 piperitone      0.4 0.3 0.1   tr  tr 0.6  0.5 0.4 0.2 
1750 β-dihydroagarofuran   0.4  0.4   tr          0.1 
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1751 phellandral          0.7   0.3      
1751 carvone      0.1 0.1   0.4   0.4 0.1  tr tr  
1755 cis-dihydroagarofuran   0.2                
1755 bicyclogermacrene            0.1       
1758 cis-piperitol         tr 0.1   tr   tr tr  
1758 (E,E)-α-farnesene        0.2           
1763 naphthalene     0.5              
1765 geranyl acetate  0.2         tr        
1766 1-decanol 0.5  0.2     tr           
1772 citronellol  9.9    0.4 0.4 0.3   0.1   0.2    2.2 
1773 δ-cadinene 2.6   0.1  tr tr 0.3 0.1 0.7  1.2 0.5  0.7    
1776 γ-cadinene tr   tr tr   tr tr 0.1  0.1 tr  0.6    
1783 drimenene     0.1              
1783 p-methylacetophenone    0.2  0.1 0.1  0.8 0.7   0.7 0.1  tr tr  
1786 ar-curcumene 0.1   0.2           0.7    
1798 methyl salicylate    tr  0.1        0.1 tr    
1799 cadina-1,4-diene        tr           
1800 octadecane  0.1                 
1802 cuminaldehyde      tr 0.1  0.7 1.2  0.1 0.8 tr  tr 0.1  
1805 tridecanal   0.3                
1808 nerol    0.6    tr           
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1809 citronellyl butyrate  0.2 0.2    0.1 0.1 0.1  0.3   tr     
1811 p-mentha-1,3-dien-7-al                 tr  
1815 valeric acid                  0.1 
1823 p-mentha-1(7),5-dien-2-ol*         0.8 1.1  0.6 1.0   tr   
1825 geranyl propionate           tr        
1827 (E,E)-2,4-decadienal          0.1         
1829 octyl hexanoate            0.1       
1834 citronellyl isovalerate               0.1    
1837 myrtanol*   0.1                
1845 trans-carveol  tr    0.1  0.1 tr 0.3    0.1  tr tr  
1853 cis-calamenene 1.0 1.6 0.5  1.3 tr tr tr  0.4  0.1 0.2  0.2   0.1 
1857 geraniol    1.0    0.1 tr  tr    0.1   tr 
1864 p-cymen-8-ol  0.4  0.7  0.1 0.1 tr 4.0 2.9 tr 1.0 2.8 0.1 0.1 tr tr tr 
1865 isopiperitenone          0.1   0.1      
1868 (E)-geranyl acetone  0.4   0.2 tr  tr   tr       0.1 
1871 trans-calamenene 0.1                  
1882 cis-carveol        tr           
1885 2-phenylethyl propionate       0.2       0.1  tr   
1886 geranyl butyrate    0.1 0.3    0.1  0.1  0.2      
1889 ascaridole      tr             
1896 2-phenylethyl isobutyrate       0.1       0.1   tr  
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
1898 1,11-oxidocalamenene 0.1                 tr 
1900 epi-cubebol          0.2         
1916 α-agarofuran   2.8  0.1     1.1        0.5 
1918 β-calacorene 0.1                  
1937 2-phenylethyl alcohol    0.1   0.1            
1941 α-calacorene 0.4   0.1 0.2 0.1  0.1 tr 0.1  0.4 0.1 tr 0.3   tr 
1941 citronellyl hexanoate       0.1  0.1    0.1      
1949 (E)-jasmone        0.1           
1949 piperitenone      tr          0.1   
1953 palustrol     0.2    tr          
1965 citronellyl propionate              0.1     
1965 3-phenylpropyl acetate 3.0                  
1966 (E)-12-norcaryophyll-5-en-2-one        tr           
1969 (Z)-jasmone               0.1    
1980 2-phenylethyl butyrate           tr   tr     
1981 heptanoic acid               0.1    
1984 γ-calacorene 0.2     tr    0.1  0.1   0.1   tr 
1988 2-phenylethyl 2-methylbutyrate      tr        tr     
1992 2-phenylethyl isovalerate              tr     
1998 furopelargone A  0.1                 
2001 isocaryophyllene oxide 0.7  0.3 0.2 0.8          0.4 tr 0.1 tr 
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
2008 caryophyllene oxide 2.8 2.8 10.0 0.9 6.3 0.1 0.1 0.5 0.1 0.4 tr   tr 4.2 0.2 0.2 0.6 
2012 maaliol     0.2              
2020 caryophylla-8(14)-en-5-one               0.3    
2030 norbourbonone  0.5    tr tr       tr     
2030 methyl eugenol    0.1 0.3     0.1   tr  0.3    
2033 epi-globulol   0.6                
2040 octyl octanoate            0.2       
2045 humulene epoxide I tr  0.1         tr       
2050 (E)-nerolidol 0.1   tr 0.2 tr 0.5 0.2    2.8  0.4 0.9   0.1 
2057 ledol 0.1 0.2   0.4    0.3 0.1   0.2    tr  
2071 humulene epoxide II 0.8 0.5 0.1 tr 0.6     0.2    tr 0.1 tr tr 0.1 
2080 cubenol 2.5  0.6  1.0 tr 0.1  0.1 0.4   tr 0.1 0.3    
2084 octanoic acid        0.1   tr        
2088 1-epi-cubenol 0.6  0.5  0.2 0.1 0.1   0.3     0.1    
2096 neryl hexanoate             tr      
2096 elemol         0.6          
2098 globulol   0.1 0.2 0.9            tr  
2104 viridiflorol 0.3  24.0 tr 8.9    7.9   36.6 13.0   tr   
2105 geranyl hexanoate             tr      
2110 furopelargone B  6.1      tr  0.1    tr     
2113 cumin alcohol       tr  0.1 tr   tr   tr tr  
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
2127 10-epi-γ-eudesmol   6.9  0.3   0.1 0.1 6.3   tr     7.1 
2131 hexahydrofarnesylacetone tr 0.5    tr     tr    tr tr  0.1 
2140 2-phenylethyl valerate       0.2       0.1     
2143 cedrol 5.4  0.3    tr        0.7    
2144 spathulenol  0.4  0.6 6.9    3.8 1.9  6.2 5.9 tr  tr   
2170 β-bisabolol               tr    
2179 1-tetradecanol    0.1       tr 0.3       
2184 nonanoic acid        0.4   tr     tr  0.1 
2184 cis-p-menth-3-ene-1,2-diol             tr      
2185 γ-eudesmol   0.3      2.0   0.3       
2187 T-cadinol 18.9 0.5     tr tr     0.9  6.1   0.9 
2193 β-betulenal            0.2   5.6    
2196 ambrox     2.3       0.4       
2198 thymol      tr       0.3   tr   
2204 clovenol               0.4    
2205 eremoligenol   0.5                
2209 T-muurolol 1.7 0.3 0.1   tr 0.1   tr   tr tr 0.2  tr  
2210 agarospirol   0.4       0.5        0.4 
2211 2-phenylethyl tiglate      1.3 1.9       0.8  tr tr 0.3 
2219 α-muurolol 0.8 0.4 0.3       tr        tr 
2228 valerianol   0.9       0.8        tr 
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
2239 carvacrol    0.2  0.1   0.9 1.3  0.9 1.5 tr  tr   
2247 trans-α-bergamotol tr   0.1 1.2     0.2  0.6 tr      
2249 cadalene  1.1    0.1 0.3     0.3       
2250 α-eudesmol         0.9          
2253 4α-hydroxy-dihydroagarofuran   2.2       3.8         
2254 citronellic acid  tr  0.1  0.1 tr 0.8   96.2     tr tr 74.7 
2255 α-cadinol 4.5   0.1        0.3 0.1 0.1  tr tr  
2257 decyl decanoate        tr           
2257 β-eudesmol   2.9     tr 0.9 tr         
2272 14-acetoxy-β-caryophyllene               0.1    
2273 1-pentadecanol    0.1         tr      
2273 selin-11-en-4α-ol   0.2                
2279 sandaracopimaradiene     1.0           tr   
2281 decanoic acid  0.3 0.1   12.9 0.4 47.0      0.1 6.4    
2287 8,13-epoxy-15,16-dinor-labdane     0.4              
2287 8,13-epoxy-15,16-dinor-labd-12-ene     2.3       1.4       
2300 tricosane   0.1                
2308 nerolic acid    0.3               
2316 caryophylladienol I  0.2             0.2    
2324 caryophylladienol II  0.3  tr 0.1          2.3    
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% Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
2340 10-hydroxy-calamenene 0.5  tr   tr            0.2 
2349 geranic acid    36.0       0.2 0.1       
2357 14-hydroxy-β-caryophyllene  0.3          0.2   27.9    
2376 manoyl oxide   0.6  1.8       0.5       
2384 1-hexadecanol         tr   0.2       
2384 farnesyl acetone  0.4                 
2392 caryophyllenol II    0.1    0.1       0.9   0.1 
2396 8α-13-oxo-14-en-epi-labdane     1.8       0.5       
2407 hydroxy-α-calacorene* tr     0.1 0.1            
2411 2-decenoic acid*      3.9 0.1 31.3      0.1     
2415 14-hydroxy-4,5-dihydro-β-caryophyllene               1.2    
2438 kaur-16-ene     0.7              
2478 14-hydroxy-α-humulene               0.7    
2500 pentacosane  0.2 0.2    tr    tr        
2509 dodecanoic acid  0.5 0.1   0.1 tr 0.1    0.2   0.9    
2538 2-undecenoic acid*        0.1           
2609 14-hydroxy-4,5-epoxy-β-caryophyllene (β,β form)               0.3    
2617 tridecanoic acid   0.2    tr     0.2       
2622 phytol           tr  tr      
2663 14-hydroxy-4,5-epoxy-β-               1.1    
 % Amounts of identified compounds 
bet cap cap cit glu gra gra his pan pan pap que que rad sca tom tom vit RRI Compound 
N St W N S S W S S W N S W N S S W S 
Oil yield (%) 0.04 0.02 0.02 0.36 0.02 0.22 0.06 0.02 0.48 0.35 0.17 0.07 0.26 0.69 0.12 0.27 0.21 0.05 
caryophyllene (β,α form) 
2670 tetradecanoic acid  0.9     0.1     0.4 tr  tr    
2700 heptacosane  0.1 tr    tr    0.2      tr  
2822 pentadecanoic acid            tr       
2900 nonacosane 0.1      0.1 tr   0.1     tr tr  
2931 hexadecanoic acid 0.7 0.6 1.1    0.1 0.1   tr tr     0.1 0.2 
Total 73.0 75.3 65.6 92.8 59.2 95.7 94.1 97.3 92.0 90.5 98.1 84.2 89.7 95.1 83.3 98.3 97.9 91.3  
 
Where: - RRI = relative retention indices; tr = less than 0.05%; *correct isomer not identified; N = National Botanical Garden (Kirstenbosch), S = 
Stellenbosch Botanical Garden, St = Strand region, W = Walter Sisulu Botanical Garden (Johannesburg); bet = Pelargonium betulinum (L.) 
L’Hérit., cap = Pelargonium capitatum (L.) L’Hérit., cit = Pelargonium citronellum J.J.A. van der Walt., glu = Pelargonium glutinosum (Jacq.) 
L’Hérit., gra = Pelargonium graveolens L’Hérit., his = Pelargonium hispidum (L.f.) Willd., pan = Pelargonium panduriforme Eckl. & Zeyh., pap 
= Pelargonium papilionaceum (L.) L’Hérit., que = Pelargonium quercifolium (L.f.) L’Hérit., rad = Pelargonium radens H.E. Moore, sca = 
Pelargonium scabrum (Burm. f.) L’Hérit., tom = Pelargonium tomentosum Jacq., vit = Pelargonium vitifolium (L.) L’Hérit. 
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Figure 3.2: A dendrogram constructed from the essential oil composition of 18 Pelargonium samples. 
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 Pelargonium citronellum (NBG) exists as an outlier from the other clustered species, 
resulting in the first division where cluster (B) comprises 17 OTUs. A previous study, 
involving the analysis of the essential oil of four natural populations of P. citronellum from 
different localities in South Africa, revealed that the oil mainly contains a mixture of 
aldehydes with a lemon scent (Demarne and van der Walt, 1993). The aldehydes detected 
in the latter study include (E)-2-hexenal, photocitral B, epi-photocitral A, photocitral A, 
neral, geranial and other unidentified aldehyde compounds. The mixture of aldehydes 
detected in P. citronellum (NBG) oil includes photocitral B (0.2%), cis/cis-photocitral 
(0.3%), trans/trans-photocitral (0.6%) and benzaldehyde (0.1%). Furthermore, the 
aldehydes, neral (17.4%) and geranial (27.2%) occur as major constituents. These citral 
isomers were only detected in this species and are present in very high concentrations. 
However, geranic acid is the most abundant (36.0%) essential oil constituent in P. 
citronellum (NBG). Geranic acid occurs at greatly reduced levels in P. papilionaceum 
(0.2%) and P. quercifolium (SBG) (0.1%). The monoterpenes geraniol (1.0%) and linalool 
(1.8%) are present in lower concentrations in P. citronellum (NBG). The oxygenated 
sesquiterpene caryophyllene oxide occurs at a level of 0.9%.  
 
In the study carried out by Demarne and van der Walt (1993), small quantities of geranic 
acid (<0.5-4.7%) and large quantities of neral (26.9-37.4%) and geranial (35.8-47.9%) 
were found in P. citronellum. In the latter study, geranial always occurred at a higher 
concentration than neral, this was also noted in the analysis of P. citronellum (NBG). 
Demarne and van der Walt (1993) further documented that the monoterpenoids geraniol 
(<0.5-1.7%) and linalool (0.5-1.3%) were present at low levels. These identified amounts 
of geraniol and linalool are in agreement with this study. The eight main compounds 
encountered in the P. citronellum essential oil of three of the clones obtained from different 
origins in South Africa included linalool, photocitral A, “A” of lemongrass, neral, geraniol, 
geranial, geranic acid and germacrene D. The aforementioned compounds collectively 
represented 80% of the composition of these oils (Vorster, 1990). The sum of these 
compounds in the P. citronellum (NBG) sample, excluding photocitral A, “A” of 
lemongrass and germacrene D (since they are absent), is 83.4%. It was concluded by 
Demarne and van der Walt (1993) that only neral, geranial and sometimes geranic acid are 
present at more than 5%. However, in the P. citronellum oil sample analysed by Lis-
Balchin (2002a), citronellol (30.5%) and geranial (42.6%) were identified as the two major 
compounds. Neral occurred at lower levels of 2.6%. Linalool and geraniol contributed 
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 3.7% and 0.1%, respectively. Citronellol was not detected in the P. citronellum essential 
oils analysed by Demarne and van der Walt (1993) nor was it present in the P. citronellum 
(NBG) sample.  
 
Pelargonium citronellum appears to be a uniform species with respect to its essential oil 
composition. Within the genus Pelargonium, the only species which produce such large 
amounts of neral and geranial are P. citronellum and P. crispum (Demarne and van der 
Walt, 1993). Lis-Balchin (1991) recorded high levels of citral (neral and geranial) in the 
“citrus group” of scented ‘geraniums’ (‘Mabel Grey’, ‘Frensham’ and ‘Citronella’).  
 
Cluster (B) is subdivided into cluster (C) and (D). Pelargonium papilionaceum (NBG) and 
P. vitifolium (SBG) are chemically anomalous from the species grouped in cluster (D), 
since cluster (C) exists as an outlier. This second division is attributed to the predominance 
of citronellic acid in P. papilionaceum (NBG) and P. vitifolium (SBG). Other compounds 
common to both P. papilionaceum and P. vitifolium occur at much lower levels. 
Pelargonium vitifolium is closely related to P. capitatum and P. papilionaceum (van der 
Walt, 1977). The GC-MS results provide chemical evidence to support the taxonomic 
relationship established between P. papilionaceum and P. vitifolium. The degree of 
similarity between P. papilionaceum (NBG) and P. vitifolium (SBG) is very high (i.e. 
coefficient of similarity is almost 1). The GC profiles of P. papilionaceum and P. vitifolium 
are shown in Figure 3.3. The GC-MS results do not confirm a close association between P. 
vitifolium and P. capitatum. 
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Figure 3.3: Comparison of the GC profiles of the hydrodistilled essential oils of (a) P. 
papilionaceum (NBG) and (b) P. vitifolium (SBG). 
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 It was reported by Demarne and van der Walt (1992) that among the Pelargoniums only P. 
vitifolium synthesizes large amounts of citronellic acid. In this analysis, citronellic acid is 
the principal compound encountered in the oil profiles of P. papilionaceum (NBG) and P. 
vitifolium (SBG) (Figure 3.3) and contributes 96.2% and 74.7% to their total oil 
compositions, respectively. Of all the Pelargonium species analysed in this study, only P. 
papilionaceum (NBG) has such a high concentration of a single component. Citronellic 
acid occurs at 0.8% in P. hispidum (SBG) and at 0.1% in P. citronellum (NBG) and P. 
graveolens (SBG). Trace amounts were detected in P. capitatum (Strand), P. graveolens 
(WSBG) and both samples of P. tomentosum. About 85.9-89.3% citronellic acid was found 
in P. papilionaceum essential oil (Lis-Balchin and Roth, 1999) and 76.9-83.9% occurred in 
P. vitifolium essential oil (Demarne, 1989). These values correlate with those obtained in 
this study. The vernacular name ‘Rambossie’ given to P. papilionaceum is derived from 
the distinctive he-goat-like odour (fruity lemon scent) of the leaves. Pelargonium vitifolium 
and the cultivar ‘Sweet Rosina’ also emit this acrid, persistent odour (Houghton and Lis-
Balchin, 2002). The citronellic acid produced by P. papilionaceum and P. vitifolium 
species and cultivars could possibly be used as a strong fixative in perfumes (Houghton 
and Lis-Balchin, 2002). The majority of the other compounds detected in P. papilionaceum 
(NBG) occur in trace amounts. 
 
Citronellic acid is derived from the oxidation of citronellal which is a reduction product of 
geraniol (Wuryatmo et al., 2003). Trace amounts of the monoterpene alcohol geraniol were 
detected in both P. vitifolium and P. papilionaceum. Trace amounts of the aldehyde 
citronellal was found in P. vitifolium and was absent in P. papilionaceum. These amounts 
may be an indication that almost complete reduction of geraniol and almost complete 
oxidation of citronellal took place to yield large amounts of the end-product citronellic 
acid.  
 
Pelargonium vitifolium contains an essential oil profile which typifies this species 
(Demarne and van der Walt, 1992). Citronellic acid, citronellol and 10-epi-γ-eudesmol 
were the only three compounds occurring in amounts greater than 1% in the oil samples 
obtained from P. vitifolium plant material collected from five different localities in South 
Africa (Demarne and van der Walt, 1992). Furthermore, citronellic acid (77-85%) was 
consistently found to be the principal component. These findings correlate with the 
analysis of P. vitifolium (SBG); citronellol occurs at 2.2%, 10-epi-γ-eudesmol at 7.1% and 
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 citronellic acid at 74.7%. Very low levels of citronellol (0.1%) are present in P. 
papilionaceum (NBG), whereas 10-epi-γ-eudesmol is absent. Citronellol occurred at 2.6-
6.3% in P. vitifolium (Demarne, 1989) and at 0.2-1.6% in P. papilionaceum (Lis-Balchin 
and Roth, 1999). Pelargonium capitatum (Strand) contains 9.9% of citronellol. 
Pelargonium capitatum (WSBG) and P. panduriforme (WSBG) contain similar levels of 
10-epi-γ-eudesmol, 6.9% and 6.3%, respectively. Lis-Balchin and Roth (1999) identified 
0.1-5.0% geranic acid in P. papilionaceum, but it was absent in P. vitifolium. The latter is 
in agreement with the results obtained in this analysis. Pelargonium vitifolium is not 
considered for commercial essential oil production as its oil composition is not appealing 
and its oil yield is low (Demarne and van der Walt, 1992).  
 
Fifteen OTUs associate to form cluster (D), which contains three major clusters, (E), (F) 
and (G) (Figure 3.2). These three distinct groups diverge at a low degree of similarity in the 
dendrogram. The delimitation of these three separate clusters implies that the species 
grouped within each cluster have somewhat different chemical profiles to those of the 
species grouped in the other clusters, although some similarities may also occur. 
 
Cluster (E) contains two branches, (EA) and (EB), due to the quantitative differences of 
isomenthone and citronellyl formate and citronellol. These two branches separate at a low 
similarity coefficient. The subgroup (EA) is defined by the accumulation of high levels of 
isomenthone (>49.0%). The similarity in the compositions of the P. graveolens samples is 
represented by their close association within the cluster dendrogram (Figure 3.2). This is 
also true for the P. tomentosum samples. The dendrogram reflects a close relationship 
among P. graveolens, P. radens and P. tomentosum; quantitative and qualitative 
similarities occur in the chemical profiles of the aforementioned species. Common 
compounds of the latter species include α-pinene, p-cymene, menthone, isomenthone, 
linalool, cryptone, α-terpineol, p-cymen-8-ol and caryophyllene.  
 
Pelargonium tomentosum (WSBG) has an essential oil dominated by menthone (36.1%) 
and isomenthone (56.6%). The monoterpenic compounds limonene and p-cymene are 
present at 1.3% and 0.8%, respectively. Similarly, the majority of P. tomentosum (SBG) oil 
is accounted for by menthone (41.1%) and isomenthone (49.3%). Limonene (1.5%) and p-
cymene (1.1%) occur at levels similar to those in P. tomentosum (WSBG). There are also 
quantitative and qualitative resemblances in the minor compounds of the two P. 
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 tomentosum samples. The occurrence of menthone and isomenthone as the main 
compounds in P. tomentosum oil has been previously reported (Demarne et al., 1986; Lis-
Balchin, 2002a). Pelargonium tomentosum oil consists almost entirely of menthone and 
isomenthone (Williams and Harborne, 2002). Pelargonium tomentosum accumulated equal 
amounts of menthone and isomenthone (Lis-Balchin, 2002a). Similar levels of these two 
compounds occur in P. tomentosum (SBG). However, isomenthone occurs at a somewhat 
higher level than menthone in P. tomentosum (WSBG) as was found by Demarne et al. 
(1986). The strong peppermint scent is due to the presence of both these ketones in large 
quantities (Vorster, 1990). Pelargonium tomentosum has a culinary use due to its 
peppermint flavour (Williams and Harborne, 2002).  
 
In the P. tomentosum oil sample analysed by Lis-Balchin (2002a), limonene and p-cymene 
were present in similar relative amounts to those found in the P. tomentosum samples of 
this study (1.3-1.5% and 0.8-1.1%, respectively). Demarne et al. (1986) found limonene at 
3.9%, and p-cymene at lower levels of 0.2%. α-Phellandrene (2.8%), tricyclene (1.0%), α-
pinene (1.0%) and myrcene (1.4%) were detected above 0.9% (Demarne et al., 1986). α-
Phellandrene is absent, but tricyclene (0.3-0.4%), α-pinene (0.3-0.5%) and myrcene (0.4-
0.8%) occur at lower levels in both the oil samples in this analysis. The composition of P. 
tomentosum oil is very uniform, irrespective of the growing conditions (Vorster, 1990).  
 
It has been previously reported that not only is P. radens and P. graveolens 
morphologically and karyologically similar but they are also biochemically analogous (van 
der Walt and Demarne, 1988). Hence it was not surprising that the dendrogram (Figure 
3.2) revealed a very close affinity between these two species. Pelargonium graveolens 
(SBG) has a close chemical association with P. radens but not to the same extent as P. 
graveolens (WSBG) demonstrated (Figure 3.2). The coefficient of similarity for P. 
graveolens (WSBG) and P. radens is 1.00, this value being indicative of virtually identical 
chemical characteristics. This degree of similarity is demonstrated in their GC profiles 
(Figure 3.4), which are almost mirror images of one another.  
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Figure 3.4: Comparison of the GC profiles of the hydrodistilled essential oils of (a) P. 
graveolens (WSBG) and (b) P. radens (NBG). 
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 The major monoterpene identified in P. radens (NBG) is isomenthone (84.5%). Menthone 
(1.9%) and p-cymene (1.1%) are the only other two compounds present above 1%. With 
regards to the two samples of P. graveolens, the monoterpenic ketone isomenthone (65.8-
83.3%) also occurs as the principal component, menthone (1.0-5.1%) and p-cymene (0.9%) 
are also present. The relative concentration of isomenthone in P. radens oil is slightly 
higher than that in P. graveolens oil (Vorster, 1990). 
  
Other compounds common to the P. graveolens oil samples and P. radens (NBG), above 
0.5%, include limonene (0.6-0.8%) and 2-phenylethyl tiglate (0.8-1.9%). Pelargonium 
graveolens (SBG) contains 3.9% of 2-decenoic acid and substantial amounts of decanoic 
acid (12.9%); these compounds occur in low amounts (0.1-0.4%) in P. graveolens (WSBG) 
and P. radens. The compounds common to P. graveolens (WSBG) and P. radens (NBG) 
and which are not present in P. graveolens (SBG) exist in minor or trace amounts.  
 
Isomenthone represents more than 80% of the total oil yield for P. graveolens (WSBG) and 
P. radens (NBG). This was also found to be true for the essential oil of P. graveolens and 
P. radens analysed by van der Walt and Demarne (1988). Isomenthone occurred at 32.8-
81.8% and at 7.0-81.5% in the P. radens and P. graveolens oils, respectively, analysed by 
Lis-Balchin (2002a). Large quantities of isomenthone (± 80%) in the oils of P. graveolens 
and P. radens are responsible for their mint-scent (van der Walt and Demarne, 1988). The 
latter authors detected other major compounds in these oils, namely menthone (1.6-2.3%), 
myrcene (3.0-5.0%), (Z)-β-ocimene (1.4-6.0%), limonene (0.9-1.8%) and α-phellandrene 
(0.9-1.3%). (Z)-β-Ocimene and α-phellandrene are absent in the P. graveolens and P. 
radens oil samples of this study, menthone (1.0-5.1%), myrcene (0.3-0.9%) and limonene 
(0.6-0.8%) are present. The same authors reported that the isomeric terpenes citronellol, 
geraniol, linalool and nerol are either absent or present in very low amounts (always <0.5% 
of the total yield) in the oils of P. graveolens and P. radens. This is true for the analyses of 
these oils in this study; citronellol (0.2-0.4%) is present in the oil samples in very small 
quantities, geraniol and nerol are absent. Linalool occurs in small amounts (0.3%) in the P. 
graveolens samples, but occurs in slightly higher amounts of 0.6% in P. radens (NBG). 
However, citronellol has been found as a major compound (53.7%) in P. radens and at 
substantial levels (17.6%) in P. graveolens (Lis-Balchin, 2002a). Linalool (1.2-12.8%) and 
geraniol (19.1-41.9%) were also found in high amounts in P. graveolens (Lis-Balchin, 
2002a). Geraniol is always partially transformed into its isomer linalool during steam 
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 distillation. The total amount of geraniol and linalool remains constant in the essential oil 
(Demarne and van der Walt, 1989).  
 
Citronellyl esters and geranyl esters are completely lacking in P. graveolens and P. radens 
(Demarne and van der Walt, 1989). Citronellyl formate (11.2%) and geranyl formate (0.7-
4.2%) were detected in P. graveolens (Lis-Balchin, 2002a). Geranyl esters are absent in the 
oil samples of P. graveolens and P. radens (NBG) analysed in this study. Citronellyl 
formate occurs in trace amounts in both the P. graveolens samples and is absent in P. 
radens. Other citronellyl esters either occur in small quantities or are absent in the P. 
graveolens and P. radens (NBG) oils.  
 
Although P. radens and P. graveolens are chemically similar there are some differences 
which characterize these oils. The compounds which occur in the profiles of the P. 
graveolens oil samples but not in P. radens (NBG) and visa versa are present at very low 
levels. The presence of 2-phenylethyl tiglate in P. graveolens (0.6-0.8%) but not in P. 
radens was noted by van der Walt and Demarne (1988). 2-Phenylethyl tiglate is present at 
0.8% in the oil of P. radens (NBG) and occurs in an amount of 1.3% and 1.9% in P. 
graveolens (SBG) and P. graveolens (WSBG), respectively. van der Walt and Demarne 
(1988) reported that β-bourbonene (0.1-0.2%) and guaia-6,9-diene (0.1-0.2%) seemed to 
occur in P. radens and not in P. graveolens. However, guaia-6,9-diene (6.0%) has been 
detected in P. graveolens (Lis-Balchin, 2002a). Guaia-6,9-diene is present in trace amounts 
in P. radens (NBG) and is absent in the P. graveolens samples. However, β-bourbonene is 
absent in P. radens (NBG) but present in trace amounts in the P. graveolens oils.  
 
When comparing the GC-MS results of the P. graveolens samples in this study with the 
work by Lis-Balchin (1991), distinct differences are noted with regard to the major 
constituents. The major compounds in a P. graveolens cultivar were citronellol and 
geraniol (Lis-Balchin, 1991). β-Caryophyllene, geranyl formate and geranyl butyrate 
occurred at substantial levels in the latter P. graveolens cultivar, but are absent in the P. 
graveolens oil samples analysed in this study. Compounds common to the P. graveolens 
cultivar and the P. graveolens samples differ considerably in concentration, with higher 
levels for all the common compounds except isomenthone occurring in the P. graveolens 
cultivar. Hybrids or cultivars are developed to express certain desirable traits and some 
caution needs to be taken when extrapolating results obtained in this study which is based 
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 on authentic species to data previously reported for plants produced in cultivation 
programs. Different cultivars have been analysed by different authors (Lis-Balchin, 1991). 
There is often great variation in essential oil data between authors due to the confusion 
with regards to the authentication of the scented pelargoniums (Lis-Balchin, 1991). It is 
obvious that authentic species will have differences in their chemical compositions in 
comparison to hybrids or cultivars. Many Pelargonium hybrids bear no similarity to either 
parent (Houghton and Lis-Balchin, 2002).  
 
Rana et al. (2002) investigated the P. graveolens oil obtained from plants growing in the 
Himalayan region of Uttaranchal and found citronellol and geraniol to be the principal 
components. Other major compounds included linalool, p-menthone, citronellyl formate, α-
humulene and α-selinene. In this study, the P. graveolens oil samples (SBG) and (WSBG) 
have very low levels of citronellol (0.4%), citronellyl formate (<0.05%) and linalool 
(0.3%). Furthermore, geraniol, α-humulene and α-selinene were not present. Isomenthone, 
the principle compound in P. graveolens oil samples (SBG) and (WSBG) was not detected 
in the P. graveolens oil analysed by Rana et al. (2002). These findings indicate that oils of 
the same authentic species growing in different areas can differ in their chemical 
composition. These differences may be attributed to the environment, which is made-up of 
climatic and soil factors, in which the plant grows and develops (Richardson et al., 1954). 
Growth regulators, shading, distillation, storage, weeds, leaf ontogeny, drying and seasons 
all influence the chemical composition of Pelargonium species oil (Rana et al., 2002). 
Hence, such appreciable differences in chemical characters noted between the present data 
and published data may be attributed to the different environmental parameters associated 
with the different localities from where the plants were collected. It is important to note 
that the chemical differences could be accounted for by the different genetic make-up of 
the plants analysed; the genetic component being far more pronounced than the 
environmental effects. 
 
Putievsky et al. (1990) carried out a study to determine the influence of different intervals 
between the last irrigation and harvest on the essential oil content and composition. It was 
found that a short interval between irrigation and summer harvest leads to a higher percent 
of geraniol than of citronellol in P. graveolens. The levels of citronellol become higher 
than that of geraniol at a longer interval between the last irrigation and harvest. A longer 
interval creates a situation of water stress for the plant. In this study, the samples of P. 
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 graveolens have a high percentage of citronellol and are devoid of geraniol. It is thought 
that in ‘geranium’, citronellol and related dihydro derivatives of geraniol are formed by 
enzymatic reduction of geraniol (Putievsky et al., 1990). The activity of this enzyme is 
affected by water stress and other environmental factors and responds by increasing the 
content of citronellol in the essential oil (Putievsky et al., 1990). 
 
A Réunion-type and an African-type ‘geranium oil’ are known in commerce. The African-
type oil has a higher concentration of 10-epi-γ-eudesmol than of guaia-6,9-diene 
(Bhattacharya et al., 1993). The latter authors revealed that an essential oil of rose-scented 
‘geranium’ (Pelargonium sp.) cultivated under the semiarid tropical climate of Andhra 
Pradesh, South India possessed a composition similar to the African-type ‘geranium’. In 
this study, the oils from the species which are considered to have been used in cultivation 
programs to create and ennoble the rose ‘geranium’ cultivars, namely P. capitatum, P. 
graveolens and P. radens, were evaluated to determine which type of oil they could be 
classified as. The two samples of P. graveolens are devoid of both 10-epi-γ-eudesmol and 
of guaia-6,9-diene. Pelargonium capitatum (WSBG) has a substantial quantity of 10-epi-γ-
eudesmol (6.9%) and is devoid of guaia-6,9-diene. The latter compound is present in low 
amounts (0.5%) in P. capitatum (Strand) and in trace amounts in P. radens (NBG). 10-Epi-
γ-eudesmol is absent in both P. capitatum (Strand) and P. radens (NBG). Since P. 
capitatum (WSBG) oil has a high content of 10-epi-γ-eudesmol, this oil may be classified 
as an African-type ‘geranium oil’. It cannot be assumed that P. capitatum (Strand) and P. 
radens (NBG) are similar in composition to the Réunion ‘geranium oil’ as this oil is 
characterized by large quantities of guaia-6,9-diene (Bhattacharya et al., 1993). 
 
Demarne (1989) carried out a comprehensive study of the essential of P. capitatum. It was 
found that stable differences exist in the composition of several P. capitatum oils from five 
different origins in South Africa. Further, the work by Viljoen et al. (1995) established a 
high degree of variability in the composition of the analysed P. capitatum oils. The GC-MS 
results of the two P. capitatum oil samples analysed in this study also displayed variation; 
their OTUs are located in separate cluster groups, namely (E) and (F) which diverge at a 
low degree of similarity. The major essential oil constituents detected in P. capitatum 
(WSBG) include caryophyllene oxide (10%), viridiflorol (24%) and 10-epi-γ-eudesmol 
(6.9%). Compounds present in amounts of 1.0-2.9% include octyl butyrate, borneol, α-
agarofuran, β-eudesmol, 4α-hydroxy-dihydroagarofuran and hexadecanoic acid. 
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 Pelargonium capitatum (Strand) is represented by the upper branch (EB) of cluster (E). 
Citronellyl formate (31.1%) and citronellol (9.9%) are most abundant in this latter oil. 
Citronellol is employed by the food industry in citrus beverages (Lis-Balchin, 1990). 
Furopelargone B (6.1%) also occurs as a major constituent. This oil is also characterized by 
isomenthone (1.9%), β-bourbonene (1.5%), isocaryophyllene (1.0%), α-muurolene (1.4%), 
cis-calamenene (1.6%), caryophyllene oxide (2.8%) and cadalene (1.1%). Geranyl formate 
(0.5%) was only detected in P. capitatum (Strand) essential oil. The oxygenated 
sesquiterpene caryophyllene oxide is the only common compound in P. capitatum (Strand) 
and P. capitatum (WSBG) which occurs above 1.6%. 
 
The principal compounds detected in P. capitatum (Strand) correlate with previous 
published work. Citronellol and citronellyl formate were identified as the main compounds 
in three of the four main chemotypes of P. capitatum recognized (Demarne and van der 
Walt, 1989). α-Pinene was the main component in the other chemotype. α-Pinene is present 
at 0.2% in P. capitatum (Strand), but is absent in P. capitatum (WSBG). The latter oil was 
devoid of citronellol and citronellyl formate. Substantial amounts of geraniol, geranyl 
formate, guaia-6,9-diene, β-caryophyllene and germacrene D occurred in the chemotypes 
(Demarne and van der Walt, 1989). The aforementioned compounds are either absent or 
exist at lower levels in the two samples analysed in this study. Different chemotypes cause 
patterns of variation to occur in oil composition. Viljoen et al. (1995) identified eight 
chemotypes in a study performed on forty natural populations of P. capitatum selected 
along the coast of South Africa. It was concluded that several biochemical pathways exist 
in P. capitatum (Viljoen et al., 1995). The analysed oil samples in this study may represent 
different chemotypes of P. capitatum. 
Cluster (F) is divided into two subgroups (FA) and (FB). Pelargonium panduriforme (SBG) 
and P. quercifolium (WSBG) are grouped closely with P. panduriforme (WSBG) to form 
cluster (FA). Among all the oils analysed, the two samples of P. panduriforme and the 
sample of P. quercifolium (WSBG) contain the highest levels of p-cymene (37.6-54.9%). 
Pelargonium panduriforme (SBG) and P. quercifolium (WSBG) contain substantial 
amounts (7.9-13.0%) of viridiflorol. The above partly explains the particular assemblage of 
these samples within subcluster (FA) (Figure 3.2). Furthermore, the following compounds: 
α-phellandrene (1.1-8.8%), p-cymen-8-ol (2.8-4.0%) and spathulenol (1.9-5.9%) are 
present in these three samples, above 1%. 
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 p-Cymene (37.6-45.4%) is the main constituent in both samples of P. panduriforme. In 
addition to the compounds common to the three samples mentioned above, limonene (2.2-
3.0%) and β-phellandrene (1.4-4.0%) are other major compounds common to both the P. 
panduriforme samples. Another major component present in P. panduriforme (WSBG) 
includes 10-epi-γ-eudesmol (6.3%) followed by lesser amounts of (Z)-β-ocimene (2.4%), 
cryptone (2.9%), cuminaldehyde (1.2%), p-mentha-1(7),5-dien-2-ol (1.1%), p-cymen-8-ol 
(2.9%), α-agarofuran (1.1%), carvacrol (1.3%) and 4α-hydroxy-dihydroagarofuran (3.8%). 
The other major compound detected in P. panduriforme (SBG) is the oxygenated 
sesquiterpene viridiflorol (7.9%). Compounds occurring in quantities of 1.0% and more in 
this oil sample include α-thujene (1.0%), γ-terpinene (1.0%), linalool (4.4%), α,p-
dimethylstyrene (1.4%) and γ-eudesmol (2.0%). Linalool is employed by the food industry 
in citrus beverages (Lis-Balchin, 1990). 
 
The P. quercifolium oils have several common compounds present at high levels. The 
major component in P. quercifolium (WSBG) is the monoterpene p-cymene (54.9%). Other 
major compounds include α-phellandrene (1.1%), cryptone (1.4%), p-mentha-1(7),5-dien-
2-ol (1.0%), p-cymen-8-ol (2.8%), viridiflorol (13.0%), spathulenol (5.9%) and carvacrol 
(1.5%). Pelargonium quercifolium (SBG) oil is characterized by a high concentration of 
the sesquiterpene viridiflorol (36.6%). The following compounds collectively contribute 
35.1% to the total oil composition of P. quercifolium (SBG): p-cymene (6.2%), the esters 
hexyl butyrate (8.2%) and (E)-2-hexenyl butyrate (6.3%), ledene (1.8%), δ-cadinene 
(1.2%), p-cymen-8-ol (1.0%), (E)-nerolidol (2.8%), 8,13-epoxy-15,16-dinor-labd-12-ene 
(1.4%) and spathulenol (6.2%).  
 
The findings obtained in this study for the two P. quercifolium oil samples are in 
accordance with that of Widmer (1988) where p-cymene was present in high 
concentrations and good quantities of hexyl butyrate and viridiflorol occurred in P. 
quercifolium. Furthermore, P. quercifolium was characterized by large amounts of α-
phellandrene and good amounts of β-phellandrene, γ-terpinene and cis-3-hexenyl butyrate 
(Widmer, 1988). However, very low levels of β-phellandrene (0.2-0.3%) and γ-terpinene 
(<0.05-0.3%) were present in P. quercifolium (SBG) and P. quercifolium (WSBG) and cis-
3-hexenyl butyrate was absent in both samples. The main compounds reported in P. 
quercifolium oil by Lis-Balchin (2002a) were α-terpineol and β-pinene. p-Cymene 
occurred in substantial amounts (Lis-Balchin, 2002a). β-Pinene is absent in P. quercifolium 
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 (SBG) but present in trace amounts in P. quercifolium (WSBG), α-terpineol is absent in 
both the P. quercifolium oil samples. Furthermore, trans-ocimene, nerol and neral occurred 
above 1.0% (Lis-Balchin, 2002a); however, these compounds were not detected in the P. 
quercifolium oil samples analysed in this study.  
 
The two hydrodistilled essential oil samples of P. quercifolium produced moderately 
incongruent chemical patterns in this study. Pelargonium quercifolium (SBG) has a 
chemical profile more similar to that of P. capitatum (WSBG) and P. glutinosum (SBG) 
than to that of P. quercifolium (WSBG). Pelargonium quercifolium (WSBG) is grouped in 
(FA) and P. quercifolium (SBG) is situated in (FB). These two subgroups diverge at a low 
similarity coefficient value (<0.20). However, the OTUs belonging to the two samples of 
P. quercifolium still reside within the same cluster group (F). The chemical compositions 
of the oil samples may differ with the location where the plant is grown. Different local 
growth conditions such as soil, temperature, sunlight can influence the oil composition 
producing variations (Lis-Balchin, 1991). Moreover, genetic differences produce 
chemotypes depending on the condition of its growth and dominant constituents. Further 
investigations should be carried out to determine whether the chemical variation observed 
between the two samples is due to genetic or environmental factors. Plant composition is 
dependent on a complex interrelationship between many chemical, physical and biological 
factors associated with the environment (Richardson et al., 1954). 
 
With reference to cluster (FB), P. capitatum (WSBG) is more closely associated with P. 
quercifolium (SBG) than with P. glutinosum (SBG). This is possibly due to the quantitative 
difference of viridiflorol; P. capitatum (WSBG) and P. quercifolium (SBG) are 
characterized by high viridiflorol content (24.0-36.6%). A lower amount of 8.9% is present 
in P. glutinosum. Other compounds common to both P. capitatum (WSBG) and P. 
quercifolium (SBG) include octyl butyrate (0.4-2.1%), β-caryophyllene (0.1-0.2%), α-
muurolene (0.5-0.6%), cis-calamenene (0.1-0.5%), humulene epoxide I (<0.05-0.1%), γ-
eudesmol (0.3%), manoyl oxide (0.5-0.6%), dodecanoic acid (0.1-0.2%), tridecanoic acid 
(0.2%) and hexadecanoic acid (<0.05-1.1%). Generally, these common compounds occur 
in similar relative quantities in the two oil samples. The grouping of P. capitatum (WSBG) 
and P. quercifolium (SBG) has the same coefficient of similarity as the cluster (EA).  
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 The oil of P. glutinosum (SBG) is characterized by its richness in oxygenated 
sesquiterpenes, namely caryophyllene oxide (6.3%), spathulenol (6.9%) and viridiflorol 
(8.9%). The sum of the following compounds explains 22.5% of the essential oil 
composition: hexyl butyrate (3.2%), (E)-2-hexenyl butyrate (2.7%), isomenthone (1.4%), 
β-caryophyllene (2.5%), cis-calamenene (1.3%), cubenol (1.0%), ambrox (2.3%), trans-α-
bergamotol (1.2%), 8,13-epoxy-15,16-dinor-labd-12-ene (2.3%), manoyl oxide (1.8%), 8α-
13-oxo-14-en-epi-labdane (1.8%) and sandaracopimaradiene (1.0%). Lis-Balchin (2002a) 
identified two sesquiterpenic compounds in large amounts in P. glutinosum essential oil, 
the one occurred at 23.5-25.0% and the other at 20.7-26.4%. A previous analysis of P. 
glutinosum indicated large quantities of hexyl butyrate and (E)-2-hexenyl butyrate and 
substantial amounts of α-phellandrene, p-cymene, β-phellandrene and cis-ocimene 
(Vorster, 1990). Substantial amounts of α-phellandrene, p-cymene, hexyl butyrate and 
hexenyl butyrate were detected by Lis-Balchin (2002a). In P. glutinosum (SBG), α-
phellandrene, β-phellandrene and cis-ocimene are absent and p-cymene occurs at a level of 
0.5%. Myrcene, limonene and citronellol were detected in P. glutinosum in substantial 
amounts (Lis-Balchin, 2002a), only limonene was present in trace amounts in the P. 
glutinosum (SBG) oil sample. 
 
The following findings are responsible for the observed correlation of P. glutinosum (SBG) 
with P. capitatum (WSBG) and P. quercifolium (SBG). Caryophyllene oxide exists in its 
highest amounts (6.3-10.0%) in P. capitatum (WSBG) and P. glutinosum (SBG). Hexyl 
butyrate (3.2-8.2%) and 8,13-epoxy-15,16-dinor-labd-12-ene (1.4-2.3%) were only 
detected in P. quercifolium (SBG) and P. glutinosum (SBG) essential oils. Substantial 
levels (2.7-6.3%) of (E)-2-hexenyl butyrate occur in P. quercifolium (SBG) and P. 
glutinosum (SBG). The largest quantities (6.2-6.9%) of spathulenol were detected in the 
latter species. Compounds common to P. capitatum (WSBG), P. quercifolium (SBG) and 
P. glutinosum include β-caryophyllene, α-muurolene, cis-calamenene and manoyl oxide.  
 
Interesting to note is the presence of ambrox (2.3%) in the oil of P. glutinosum (SBG). This 
compound occurs at lower levels (0.4%) in P. quercifolium (SBG). Ambergris is a 
pathological metabolite of the spermwhale (Physeter macrocephalus L.) which 
accumulates as concretions in the intestinal tract. Since antiquity, ambergris has been one 
of the most highly valued materials used in perfumery (Bolster et al., 2001). It has a subtle 
odour reminiscent of seaweed, wood and moss but with a peculiar sweet, yet dry undertone 
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 of persistence. Ambergris is also valued for its supposed restorative and aphrodisiac 
properties (Sell, 1990). The commercially most important constituent of the scarce natural 
ambergris is (−)-Ambrox® (Figure 3.5), which is considered as the prototype of what 
perfumers understand as an ambery (ambergris) note and the release of ambergris scent is 
strongly related to structural features of the tetra-nor-labdane skeleton (Bolster et al., 
2001). (−)-Ambrox® has the character of the no longer employed natural ambergris and is 
fundamental in creating fragrances (Castro et al., 2002). An example of a perfume using 
(−)-Ambrox® is Extravagance D’Amarige Perfume by Givenchy. Today, (−)-Ambrox® is 
synthesized from the diterpene (−)-sclareol, the only practical starting material. Due to the 
high cost of (−)-Ambrox®, there is the ongoing search for new syntheses of (−)-Ambrox® 
from inexpensive, abundantly available labdanes (Bolster et al., 2001). 
 
H
O
 
 
Figure 3.5: The chemical structure of ambrox.  
 
A vast proportion of P. hispidum (SBG) oil consists of the fatty acids decanoic acid 
(47.0%) and 2-decenoic acid (31.3%). The sesquiterpene β-caryophyllene (8.6%) together 
with 2-nonanone (2.5%) represent a substantial proportion (11.1%) of the total oil 
composition. A previous study which involved three clones of P. hispidum from South 
Africa, concluded that their oil compositions were vastly different (Vorster, 1990). This 
previous analysis indicated that α-pinene was a dominant compound in the one clone, 
isomenthone in another and α-phellandrene, p-cymene, β-phellandrene and the alcohols 
cis-p-menthene-2 ol-1 and trans-p-menthene-2 ol-1 were major compounds in the third 
clone. These aforementioned compounds are either absent or occur at very low levels in the 
P. hispidum (SBG) oil sample of this study. It has been previously suggested that several 
chemotypes exist in P. hispidum (Vorster, 1990).  
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 The oil hydrodistilled from P. betulinum (NBG) is sesquiterpenoid-rich in nature. It is 
characterized by the oxygenated sesquiterpene T-cadinol occurring as the main compound 
(18.9%). Other major sesquiterpenes identified in P. betulinum (NBG) oil include β-
bourbonene (2.8%), β-caryophyllene (5.3%), α-humulene (1.5%), γ-muurolene (1.9%), δ-
cadinene (2.6%), caryophyllene oxide (2.8%), α-cadinol (4.5%), α-copaene (1.4%), 
cubenol (2.5%), α-muurolene (2.4%), cis-calamenene (1%), cedrol (5.4%) and T-muurolol 
(1.7%). Other main components identified include the esters, octyl acetate (5.7%) and 3-
phenylpropyl acetate (3.0%). Most of the compounds mentioned above occur in their 
highest amounts in P. betulinum (NBG). trans-Calamenene and 3-phenylpropyl acetate 
were only found in this oil sample. Interesting to note is the substantial amount (5.4%) of 
cedrol in P. betulinum (NBG). Several odourants with ambery odour characteristics have 
been developed from cedrene/cedrol such as Cedramber® 
(http://www.bojensen.net/EssentialOilsEng/EssentialOils01/EssentiaOils01.htm). 
 
HO
 
 
Figure 3.6: The chemical structure of cedrol. 
 
The main sesquiterpenic compounds detected in P. scabrum (SBG) include β-
caryophyllene (3.9%), caryophyllene oxide (4.2%), T-cadinol (6.1%) and 14-hydroxy-β-
caryophyllene (27.9%). Approximately 11% of the total oil composition is collectively 
made-up by p-cymene (1.0%), 1,8-cineole (1.3%), myrcene (1.4%), α-terpineol (2.8%), 14-
hydroxy-4,5-epoxy-β-caryophyllene (β,α form) (1.1%), 14-hydroxy-4,5-dihydro-β-
caryophyllene (1.2%) and caryophylladienol II (2.3%). Decanoic acid (6.4%) and its 
acetate, methyl decanoate (4.2%) are present at substantial levels. Interesting to note is that 
14-hydroxy-β-caryophyllene was the major component in the essential oils from buds of 
five Betula species growing in Turkey (Demirci et al., 2000). Furthermore, β-betulenal was 
isolated from Betula essential oils (Demirci et al., 2000). The aldehyde β-betulenal is 
present at 5.6% in this oil sample. β-Betulenal also occurs at a low level (0.2%) in P. 
quercifolium (SBG). The main compounds previously reported in P. scabrum were 
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 geranial and citronellol which contributed 32.5-44.6% and 5.7-18.1%, respectively to the 
total oil composition (Lis-Balchin, 2002a). Other compounds detected include terpinen-4-
ol (0-13.9%), neral (1.4-5.0%) and geraniol (0.1-3.9%). In the P. scabrum (SBG) sample of 
this study, geraniol is present in very low amounts (0.1%) and all of the other 
aforementioned compounds are absent. Myrcene, p-cymene and linalool occur in the same 
relative amounts in P. scabrum (SBG) as was detected in the sample analysed by Lis-
Balchin (2002a), but isomenthone occurs in trace amounts and γ-terpinene is absent in the 
P. scabrum (SBG) sample. There appears to be some variation with regard to the 
composition of P. scabrum essential oil.  
 
Cluster (G) represents a diverse entity. Pelargonium hispidum (SBG) branches off from the 
grouping of P. betulinum (NBG) and P. scabrum (SBG) at a low degree of similarity. This 
separation is due to the abundance of 2-decenoic acid (31.3%) in P. hispidum and the 
absence of this compound in P. betulinum and P. scabrum. A substantial amount of 2-
decenoic acid (3.9%) occurs in P. graveolens (SBG). The highest concentrations of T-
cadinol (6.1-18.9%) were detected in P. betulinum and P. scabrum, whereas trace amounts 
occur in P. hispidum; this also contributes to the partitioning of cluster (G). Furthermore, 
caryophyllene oxide occurs in P. betulinum and P. scabrum in good quantities (2.8% and 
4.2%, respectively). Pelargonium hispidum shares some chemical similarities with P. 
betulinum and P. scabrum. β-Caryophyllene, present in substantial quantities (3.9-8.6%), is 
common to P. betulinum, P. hispidum and P. scabrum. There are numerous other 
compounds common to all three of these oil samples, but which occur at lower levels.  
 
The dendrogram indicates that discrepancies exist in the coupled chemical profiles of P. 
betulinum (NBG) and P. scabrum (SBG). Pelargonium hispidum and P. scabrum both 
contain decanoic acid in high amounts (6.4-47.0%), but is absent in P. betulinum. 2-
Nonanone (2.5%) is found in P. hispidum and is present in P. scabrum at low amounts 
(0.1%), but is absent in P. betulinum. The high levels of octyl acetate (5.7%), α-cadinol 
(4.5%) and cedrol (5.4%) characterize P. betulinum oil, these compounds are either absent 
or present at very low levels (<0.05-0.7%) in the other oils analysed. The large content of 
14-hydroxy-β-caryophyllene (27.9%) typifies P. scabrum. This compound is detected in P. 
capitatum (Strand) and P. quercifolium (SBG) at very low levels (0.2-0.3%). Methyl 
decanoate (4.2%) and β-betulenal (5.6%) further distinguish P. scabrum oil as these are not 
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 widespread compounds and further do not exist in such high levels in those oils in which 
they were detected.  
 
The latest phylogenetic relationships pertaining to the section Pelargonium (Bakker et al., 
2004) were evaluated with respect to the chemotaxonomic assessment of the essential oil 
compositions. This chemical evaluation of the essential oils did not indicate P. 
quercifolium as an outlying species, but was associated with other species. In this study, P. 
hispidum was grouped with P. betulinum and P. scabrum and was not closely associated 
with P. tomentosum or P. papilionaceum. The dendrogram did not indicate a close 
relationship between P. tomentosum and P. papilionaceum. The chemical analysis 
indicated a close relationship between P. graveolens and P. radens; this is in agreement 
with the findings of Bakker et al. (2004). However, P. vitifolium was not closely grouped 
with these two aforementioned species. With regards to the clustering of P. betulinum, P. 
citronellum and P. scabrum, P. betulinum and P. scabrum were grouped together; 
however, P. citronellum occurred as an outlier. Overall, incongruencies occurred between 
the chemotaxonomic appraisal and the current phylogenetic hypotheses of relationships.  
 
GC analysis is an indispensable tool for chemotaxonomic studies of essential oils 
(Harborne, 1998). GC-MS data obtained in this study was used to generate a dendrogram 
which inturn established clusters of those entities exhibiting chemical affinities. GC-MS 
analysis confirmed many of the chemical similarities between and among certain species 
indicated by TLC analysis.  
 
The taxonomic affinity of P. graveolens and P. radens as suggested by karyological and 
morphological similarities (e.g. floral structure) was further supported by their correlating 
essential oil chemistry (van der Walt and Demarne, 1988). This study confirmed that P. 
graveolens and P. radens are closely related species. The close relationship reported 
between P. panduriforme and P. quercifolium (van der Walt and Vorster, 1988) was 
confirmed in this study. Pelargonium papilionaceum and P. vitifolium have many features 
in common (van der Walt, 1977). The chemical composition of their essential oils was 
found to be similar in this study. Furthermore, new affinities were revealed between certain 
species based on the preponderance of several common compounds. Chemical similarities 
were established among P. betulinum, P. hispidum and P. scabrum; P. capitatum, P. 
glutinosum and P. quercifolium and among P. graveolens, P. radens and P. tomentosum. 
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 A growing demand for natural raw materials has been created by the perfumery, cosmetic 
and flavour industries. Many natural fragrance plant materials for perfumery products have 
healing properties and thus are used in aromatherapy and in cosmetic products (De Silva, 
1995). The constituents detected in the Pelargonium essential oils may be of interest to the 
flavour, fragrance and cosmetic industries. 
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 CHAPTER 4: CHEMICAL COMPOSITION OF THE NON-
VOLATILE EXTRACTS 
 
4.1 Introduction 
4.1.1 The non-volatile chemical constituents previously found in Pelargonium 
species (section Pelargonium) 
The flavonoids myricetin and quercetin predominate in the species from the sections 
Hoarea and Pelargonium (Bate-Smith, 1973). Williams et al. (2000) established, from a 
survey of 58 Pelargonium species from 19 sections, that flavonols are the major leaf 
vacuolar flavonoid constituents in the genus Pelargonium. This study included P. crispum 
‘Whiteknights’, P. cucullatum, P. graveolens, P. quercifolium and P. tomentosum which 
were found to contain the flavonols myricetin, quercetin and kaempferol. In addition, 
isorhamnetin was found in P. crispum ‘Whiteknights’ and P. tomentosum, quercetin 3-
methyl ether occurred in P. quercifolium and P. tomentosum and the flavone luteolin was 
detected in P. graveolens, P. quercifolium and P. tomentosum. 
 
Glandular hairs on the leaf surface of many Pelargonium species not only produce 
terpenoid constituents but also flavonoid aglycones (Williams and Harborne, 2002). The 
major leaf exudate constituent in P. crispum is the flavone chrysin (5,7-dihydroxyflavone), 
accompanied by a C-methyl derivative of the corresponding 5,7-dihydroxyflavanone. 
Several flavonol (quercetin and kaempferol) methyl ethers were detected in P. quercifolium 
and P. tomentosum (Williams et al., 1997). Exudate flavonoids are usually present in plants 
which grow in alpine, arid or semi-arid conditions and it is generally assumed that they 
serve as a UV-screen to help in the adaptation of plants to such conditions (Williams et al., 
1997). 
 
Both hydrolysable (ellagitannins) and non-hydrolysable (proanthocyanidins) tannins are 
produced in large quantities in many species of the genus Pelargonium (Williams and 
Harborne, 2002). Pelargonium cucullatum, P. graveolens, P. quercifolium and P. 
tomentosum contain proanthocyanidins and P. crispum contains proanthocyanidins, 
ellagitannins and free ellagic acid (Williams et al., 2000). Okuda et al. (1980) found that 
geraniin, a characteristic ellagitannin of Geranium species, does not occur in the several 
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 Pelargonium taxa surveyed which included P. graveolens and P. tomentosum. Thorough 
chemical investigations of the Pelargonium tannins need to be carried out (Williams and 
Harborne, 2002). Another characteristic constituent of the genus Pelargonium is tartaric 
acid (Williams and Harborne, 2002).  
 
The Geraniaceae is not known as an alkaloid-producing family (Houghton and Lis-Balchin, 
2002) although alkaloids have been detected in Erodium (Medina et al., 1977; Mossa et al., 
1983; Lis-Balchin and Guittonneau, 1995). A main chemotaxonomic division in the genus 
Pelargonium, based on the presence or absence of alkaloids, was indicated by the study of 
representative species of all sections of the genus (Lis-Balchin, 1997). The species of the 
section Pelargonium included in the aforementioned study and which did not contain 
alkaloids were P. betulinum, P. capitatum, P. citronellum, P. cucullatum subspecies 
tabulare, P. denticulatum, P. graveolens, P. hispidum, P. tomentosum, P. vitifolium, P. 
‘viscossimum’ and P. ‘filicifolium.’  
 
This study aims to broaden the knowledge regarding the non-volatile chemical constituents 
of Pelargonium species and also attempts to indicate possible relationships between and 
among species. 
 
4.1.2 Flavonoids 
Flavonoids are a ubiquitous group of polyphenolic substances which occur in most plants 
and make-up a significant percentage of the chemical constituents of many species (Miller, 
1996). Flavonoids occur as normal metabolites in plant tissues, concentrating in seeds, fruit 
skin or peel, bark and flowers. The most apparent function of flavonoids in the plant 
kingdom is to act as pigments to attract birds and insect pollinators. These compounds are 
also involved in the control of plant growth and development and defence against 
infectious plant diseases (Harborne et al., 1975). Flavonoids have been reported to exert 
multiple biological activities including antibacterial, anti-inflammatory, anti-allergic, 
antimutagenic, antiviral, antineoplastic, antithrombotic and vasodilatory activities (Di 
Carlo et al., 1999). The anti-oxidant function of flavonoids underlies many of the 
abovementioned actions in the body (Di Carlo et al., 1999). Two benzene rings on either 
side of a three-carbon ring are common to flavonoid molecules. Various classes of 
flavonoids are created by the many combinations of hydroxyl groups, sugars, oxygens and 
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 methyl groups attached to the ring systems (Miller, 1996). Compared to most other plant 
compounds, flavonoids are more readily separated and detected on two-dimensional 
chromatograms and can be identified by simple methods i.e. by a spectrophotometer. Of all 
the plant constituents, flavonoids are favoured as taxonomic markers; there is the possible 
utility of flavonoids for chemical pattern comparison between species. Flavonoids are 
preferred to the terpenoids and alkaloids in systematic studies since they are universally 
distributed in vascular plants, they exhibit significant structural diversity, their chemical 
stability enables their detection in herbarium tissue and they are easily identified (Harborne 
et al., 1975).  
 
4.2 Materials and methods 
4.2.1 High performance liquid chromatography (HPLC) analysis 
HPLC analysis with ultraviolet detection (HPLC-UV) was carried out on the acetone 
extracts of 21 Pelargonium species. HPLC is used for the analysis of compounds not 
adequately volatile for analysis by gas chromatography (Hamilton and Sewell, 1977). High 
reproducibility, ease of automation and the ability to analyse the numerous constituents in 
botanicals, makes liquid chromatography advantageous (Ong, 2004). HPLC is well 
established for the analysis of plant extracts; it is ideally suited to both the qualitative and 
quantitative chromatographic analysis of non-volatile compounds (Harborne et al., 1975). 
HPLC can be a useful tool in chemosystematics where it assists in the characterization of 
species on the basis of their secondary metabolite contents (de Oliveira et al., 2001).  
 
4.2.1.1 Principle of the method 
A chromatograph uses a non-polar solid phase and a polar liquid phase. HPLC separates 
compounds on the basis of their interaction with the solid particles of a tightly packed 
column and the solvent of the mobile phase (Lindsay, 1987). High pressures are required 
for the elution of the analytes through the column before they pass through a diode-array 
detector (DAD) which measures the absorption spectra of the analytes for purposes of 
identification. HPLC-DAD screening, based on the ultraviolet-visible (UV-VIS) 
monitoring, is well suited to screening for metabolites which contain significant 
chromophores (Mulzer and Bohlmann, 2000).  
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 Photodiode-array (PDA) based instruments are the most powerful UV-VIS absorbance 
detectors in use today; very rapid collection of data over a selected spectral range is 
afforded (http//www.laballiance.com/la_info/support/hplc4.htm). Many compounds absorb 
UV radiation including those having π-bonding electrons and those with unshared 
electrons, e.g. olefins, aromatics and compounds having >C=O, >C=S, −N=O and −N=N− 
(Hamilton and Sewell, 1977). HPLC analysis provides information concerning the quantity 
of each chemical compound present and the UV spectrum further enables one to tentatively 
distinguish the class of compound under investigation (qualitative information). 
 
4.2.1.2 Protocol 
The samples were analysed using a Walters 2690 HPLC system (Phenomenex Aqua C18 
column, 250 mm x 2.1 mm at 80°C) equipped with a 996 photodiode array (PDA) detector. 
The samples were dissolved in methanol to obtain a concentration of 50 mg/ml and 10 μl 
of this solution was injected under the following conditions: mobile phase flow rate: 0.2 
ml/min, gas flow through the nebulizer: 30 L/h, nebulizer temperature: 80°C, expansion 
region temperature: 90°C and source temperature: 225°C. The initial mobile phase was 
10% acetonitrile in 10 mM aqueous formic acid and the solvent ratio was changed through 
a linear gradient to 90% acetonitrile, 10% 10 mM aqueous formic acid at 40 minutes. This 
ratio was maintained for 10 minutes where after the solvent ratio was changed back to the 
initial starting conditions. Final analysis involving integration and identification was 
performed using the Empower® software program. The chromatographic profiles produced 
for each species were evaluated spectrophotometrically for the presence of flavonoids. The 
different classes of flavonoids were tentatively identified by a comparison of their UV 
spectra against characteristic absorbance spectra of previously identified flavonoids 
(Markham, 1982). Most flavonoids have UV spectra with two major absorption maxima, 
one occurs in the range of 240-285 nm (band II) and the other in the range of 300-400 nm 
(band I). The band II absorption may have originated from the A-ring benzoyl system and 
the band I from the B-ring cinnamoyl system (Harborne, 1967). 
 
O BCA
 
 
O
 
Figure 4.1: The structure of a flavonoid molecule showing the ring systems. 
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 Flavones and flavonols have very similar spectra. They are identified by a characteristic 
absorbance maximum in the region 240-270 nm (band II). The position of the band I 
absorption indicates the type of flavonoid under investigation. The flavones absorb 
between 304-350 nm (Figure 4.2, (a)) while flavonols absorb between 352-385 nm. The 
UV spectra of isoflavones, flavanones and dihydroflavonols have a low intensity band I 
absorption which usually occurs as a shoulder to the band II absorption. Isoflavones have a 
band II between 245-270 nm and the band I shoulder occurs in the 300-340 nm region. 
Flavanones exhibit high absorbances at 270-295 nm and a broad shoulder at about 330 nm 
(Harborne et al., 1975) (Figure 4.2 (b)). 
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Figure 4.2: The chemical structure and corresponding UV spectrum of (a) flavone and (b) 
flavanone.  
Flavanone 
O
O
AU
0.00
0.20
0.40 230.9
293.6
0.60
nm 
 107
 4.3 Results and discussion 
The HPLC chromatograms of the Pelargonium acetone extracts and their respective tables 
with retention times, UV absorbance maxima, tentative identifications and percentage 
integrations of the major peaks detected for each species are shown in the monographs 
(Appendix A). Figure 4.3 shows the HPLC profiles of the analysed species in a stacked 
format for easy comparison. 
 
Comparison of the HPLC profiles revealed chemical diversity and similarity among several 
species. UV spectra resembling the flavonoid class of compounds were identified. It is 
assumed that such spectra are indicative of derivatives of compounds from this class. 
Flavonoid derivatives were detected in all the extracts analysed. Due to their easily 
identifiable UV spectra, flavonoids were used as a means to compare the species. Table 4.1 
highlights the numerous flavonoid derivatives detected in the Pelargonium extracts. The 
representative flavonoid patterns identified in the Pelargonium species provide valuable 
data for taxonomic purposes as such patterns can be used for exploring relationships 
between species and can be used to identify significant correlations between chemistry and 
taxonomy. The data suggests that the following taxa: P. betulinum (NBG), P. capitatum 
(Strand), P. graveolens (SBG), P. hispidum (SBG), P. panduriforme (SBG) and P. 
vitifolium (SBG) share rather characteristic chemical profiles. The similar flavonoid 
patterns of P. capitatum (Strand) and P. vitifolium (SBG) provide chemical evidence that 
these two species are related (van der Walt, 1977). Pelargonium sublignosum is distantly 
related to P. scabrum (van der Walt and Vorster, 1988). Their flavonoid patterns suggest 
that these two species are chemically related.  
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P. graveolens 
           (SBG) 
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Figure 4.3: HPLC profiles of the acetone extracts of selected Pelargonium species of the 
section Pelargonium. 
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bet cap cit cor cri cuc glu gra gre her his pan pap pse quer rad scab sca sub tom vit Rt 
(min) 
UV λmax 
(nm) Ft N St N W N S S S S S S S N N S S S S S S S 
11.07 260.4 D   +                   
12.38 278.0 C      +                
13.12 279.3 C   +                   
13.71 283.9 C  +              +      
14.31 278.0 C                 ++    + 
15.19 255.7, 353.2 A        ++              
15.44 265.0, 351.6 A  +                    
15.46 272.1 C    +                  
15.87 260.3, 357.3 A  ++     +   +     +       
15.93 255.7, 343.6 B        +     +         
16.25 255.7, 355.6 A  +      +   +++          + 
16.46 255.7, 353.2 A           +           
17.74 255.6, 354.0 A  + + ++ ++  + +  +++  ++      +++ +  + 
18.25 261.5, 348.0 B  +                    
18.40 262.7, 348.4 B +      + +   + + +       ++ ++ 
18.57 253.2 D      +                
18.61 255.6, 354.0 A + +++      ++   ++    +++      ++ 
19.22 255.7, 354.4 A  +      +   ++           
19.48 287.6 C   +                   
19.63 255.7, 350.8 B           +           
20.56 255.7, 354.4 A + +++      ++   +++ ++ ++  ++       
20.97 271.0 C   +                   
21.35 255.7, 346.0 B + +    ++ +    +++ +++ +++       +++ + 
21.82 272.2 C   +                   
22.07 243.8, 346.0 B             +         
Table 4.1: HPLC-UV results of the tentatively identified flavonoid derivatives present in the acetone Pelargonium extracts. 
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bet cap cit cor cri cuc glu gra gre her his pan pap pse quer rad scab sca sub tom vit Rt 
(min) 
UV λmax 
(nm) Ft N St N W N S S S S S S S N N S S S S S S S 
22.09 269.7 D         +             
22.98 280.5 C   +         +          
23.06 262.7, 350.8 B       +             +  
24.14 254.5, 348.4 B                    +  
26.93 255.6, 366.8 A      +     +         +  
27.52 284.1 C   +                   
27.87 255.7, 359.0 A               +++     ++  
28.23 260.4, 337.7 B               +       
29.24 267.5, 336.5 B   +    +       +        
29.26 291.0 C                   +   
29.68 249.7, 347.2 B               +       
30.16 268.7, 346.0 B   +            + +      
30.26 254.5, 355.6 A               +       
30.77 262.7, 363.9 A               +       
31.56 260.4, 338.9 B               +++       
31.73 288.8 C                  +    
31.89 275.8 C                  +    
32.17 268.7, 335.3 B       +++        +       
32.23 288.6 C   +      +++         ++ +   
32.49 267.4, 312.3 D         +++ +            
32.53 272.1 C                   ++   
32.62 268.7, 331.7 B              ++        
32.83 267.4, 336.1 B            +  +        
33.01 292.4 C                  + +   
33.02 254.5, 354.4 A  ++          +   ++       
33.16 266.2, 338.5 D                  ++ +++   
33.62 288.8 C                  + +   
 bet cap cit cor cri cuc glu gra gre her his pan pap pse quer rad scab sca sub tom vit Rt UV λmax Ft(min) (nm) N St N W N S S S S S S S N N S S S S S S S 
C 34.38 292.2         +         ++ +++   
A 34.53 253.3, 352.0               +       
B 34.56 268.5, 343.2              +        
C 34.86 292.4                  +    
C 35.28 290.0   +               + +   
B 35.56 267.5, 346.0                +      
B 36.00 267.4, 345.6  +                    
C 36.09 292.2                   +   
C 37.03 290.0   +                   
 
Where: - Rt = retention time (minutes); Ft = Flavonoid type: A = flavonol, B = flavone, C = flavanone, D = isoflavone; bet = P. betulinum, cap = 
P. capitatum,  cor = P. cordifolium, cri = P. crispum, cuc = P. cucullatum, glu = P. glutinosum, gra = P. graveolens, gre = P. greytonense, her = 
P. hermanniifolium, his = P. hispidum, pan = P. panduriforme, pap = P. papilionaceum, pse = P. pseudoglutinosum, que = P. quercifolium, rad = 
P. radens, scab = P. scabroide, sca = P. scabrum, sub = P. sublignosum, tom = P. tomentosum, vit = P. vitifolium; N = National Botanical 
Garden (Kirstenbosch), S = Stellenbosch Botanical Garden, St = Strand region, W = Walter Sisulu Botanical Garden (Johannesburg).  
+ = low concentration (≥0.2-5.0%), ++ = medium concentration (>5.0-10.0%), +++ = high concentration (>10.0-52.3%). 
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 A particular compound with a UV absorbance maximum in the 206.2-218.0 nm region 
occurs, in varying concentrations, in all the HPLC chromatograms at a retention time of 
about 3.98 min (Figure 4.4). This compound appears to be characteristic of the 
Pelargonium species. It is the major compound present in P. hermanniifolium, P. 
graveolens, P. greytonense and P. vitifolium.  
 
 
 
 
 
 
 
 
Figure 4.4: UV absorbance spectrum of the major compound (Rt = 3.98 min) identified in 
P. hermanniifolium, P. graveolens, P. greytonense and P. vitifolium.  
 
λmax values observed for the major peak of P. scabroide at Rt = 13.32 min and of P. 
radens at Rt = 13.09 min are similar.  
Figure 4.5: The UV spectrum of the major compound in (a) P. scabroide and (b) P. 
radens.  
 
The main compound in P. scabrum (Rt = 32.38 min; 266.3 nm and 359.0 nm) appears to 
be similar to the main compound present in P. sublignosum (Rt = 32.67 min; 267.4 nm 
and 359.4 nm). Pelargonium pseudoglutinosum has a major compound at Rt = 40.41 min. 
A similar compound occurs in P. glutinosum at Rt = 39.62 min.  
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Pelargonium betulinum (NBG), P. cordifolium (WSBG), P. crispum (NBG) and P. 
cucullatum (SBG) and P. scabrum (SBG) share some similarities in their chemical 
fingerprints. The major peak (2) (Figure 4.6) for each of the aforementioned species 
occurs near a Rt of 13.95 min and the λmax values observed for these major peaks are 
similar (220.3 nm and 278.0 nm). The compound occurring at Rt = 13.98 min in P. 
sublignosum appears to be similar to the compounds above. A number of other similar 
compounds occurred in all five abovementioned species (Figure 4.6 and Table 4.2). 
 
Table 4.2: Retention times and UV data of the similar major compounds of P. betulinum 
(NBG), P. cordifolium (WSBG), P. crispum (NBG), P. cucullatum (SBG) and P. scabrum 
(SBG). 
 
Retention time 
(min) 
UV λmax Peak number (nm) 
1 13.61 221.5, 281.5 
2 13.95 220.3, 278.0 
3 14.24 221.5, 278.0 
4 15.78 221.5, 278.0 
5 17.92 220.3, 278.1 
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Figure 4.6: HPLC profiles of P. betulinum (NBG), P. cordifolium (WSBG), P. crispum (NBG), P. 
cucullatum (SBG) and P. scabrum (SBG).  
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 P. vitifolium and P. panduriforme also accumulate high concentrations of a compound at 
about Rt = 14.01 min. It was confirmed through UV spectral analysis, that the compound 
occurring at this retention time in P. vitifolium is similar to the major compound present in 
the abovementioned species (Rt = 13.95 min). However, this is not true for P. 
panduriforme as the compound at Rt = 14.01 min produced a different absorbance 
spectrum; an absorbance maximum was observed at 209.7 nm. Figure 4.7 represents this 
comparison spectrophotometrically.  
 
 
Figure 4.7: HPLC chromatograms of P. cucullatum (SBG), P. panduriforme (SBG) and P. vitifolium
(SBG) with their respective UV absorbance spectra corresponding to the Rt = 13.95 min. Where: -
SBG = Stellenbosch Botanical Garden. 
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 The flavonoid derivatives at Rt = 17.74 min in P. crispum, at Rt = 17.60 min in P. 
cordifolium and at Rt = 17.75 min in P. scabrum appear to be similar to one another. 
Inspection of the UV data of the major compound of P. hermanniifolium at Rt = 17.89 min 
(maxima occurring at 255.6 nm and 354.0 nm) revealed this compound to be similar to the 
abovementioned flavonol compounds. In addition, P. panduriforme also contains a 
substantial amount of a similar flavonol compound at Rt = 17.74 min.  
 
Pelargonium hispidum (SBG), P. panduriforme (SBG), P. papilionaceum (NBG) and P. 
tomentosum (SBG) have a similar main compound at Rt = 21.35 min (peak 2 in Figure 
4.8) with UV absorbance maxima at 255.7 nm and 346.0 nm. This compound could 
possibly be a flavone as typical flavone UV spectra exhibit two major absorption peaks in 
the region 240-400 nm (Mabry et al., 1970). A substantial amount of a similar compound 
was noted in P. betulinum (Rt = 21.33 min), P. cucullatum (SBG) (Rt = 21.51 min) and P. 
vitifolium (Rt = 21.59 min). Another two compounds, one at Rt = 18.40 min (1) and the 
other at Rt = 34.22 min (3), were found to be common among P. hispidum, P. 
panduriforme (SBG), P. papilionaceum and P. tomentosum. The compound at peak (1) 
was identified as a flavone. The flavone derivative which occurs at Rt = 18.40 min appears 
to also occur in P. betulinum, P. glutinosum, P. graveolens and P. vitifolium. 
 
The HPLC fingerprints of P. papilionaceum and P. vitifolium (Figure 4.9) were assessed 
in tandem to determine if there was chemical evidence to confirm the taxonomic 
relationship established between P. papilionaceum and P. vitifolium by van der Walt 
(1977). The retention times and corresponding absorbance spectra of the major peaks of P. 
papilionaceum were obtained. The HPLC profile of P. vitifolium was assessed to ascertain 
whether or not peaks occurred at the same retention times as the major peaks found in P. 
papilionaceum. It was found that the absorbance data of these mutual peaks were different, 
except at Rt = 11.68 min the compound in P. papilionaceum is similar to that found in P. 
vitifolium (Rt = 12.01 min) as is demonstrated in Figure 4.9, peak (1). As mentioned 
before, the principal compound of P. papilionaceum occurs at Rt = 21.33 min and was 
identified as a flavone with UV absorbance maxima at 255.7 nm and 346.0 nm. The main 
compound of P. vitifolium occurs at Rt = 4.10 min with UV absorbance maximum at 208.6 
nm. Such findings noted from HPLC analysis are in disparity with the results obtained 
from the essential oil chemistry analysis which provided evidence of a chemotaxonomic 
relationship between the two species. 
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Figure 4.8: HPLC profiles of P. hispidum (SBG), P. panduriforme (SBG), P. papilionaceum 
(NBG) and P. tomentosum (SBG).  
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 Figure 4.9: Comparison of the HPLC-UV data of P. papilionaceum and P. vitifolium. (1) Rt = 11.68 min, (2) Rt = 13.35 
min, (3) Rt = 14.10 min, (4) Rt = 19.35 min, (5) Rt = 20.54 min, (6) Rt =21.33 min and (7) Rt = 33.05 min.  
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 HPLC is gaining increasing importance for the analysis of plant extracts (de Oliveira et al., 
2001). It is apparent from this study that HPLC can be of valuable use in plant 
chemosystematics assisting to characterize species on the basis of their secondary 
metabolite contents (de Oliveira et al., 2001).  
 
The HPLC assignments mentioned in the monograph section are tentative only. If these 
tentative identifications are confirmed then certain Pelargonium species can be utilized as a 
source for the isolation of natural flavonoids. The HPLC analysis results could form the 
basis of a more detailed study of leaf phenolics in Pelargonium. Flavonoids exert multiple 
biological activities (Di Carlo et al., 1999); a mixture of the aforesaid metabolites may 
afford the Pelargonium acetone extracts with positive in vitro biological effects which will 
be tested in the succeeding chapters.  
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 CHAPTER 5: ANTIMICROBIAL ACTIVITY 
 
5.1 Introduction 
Plants have been used for centuries to treat infections. The antiseptic qualities of aromatic 
and medicinal plants and their extracts have been recognized since antiquity, while 
attempts to characterize these properties in the laboratory date back to the early 1900’s 
(Martindale, 1910; Hoffman and Evans, 1911). In recent years, a large number of plant 
extracts and in some cases their constituents have been investigated for their antimicrobial 
properties against various bacteria and fungi (Moleyar and Narasimham, 1992; Urzua et 
al., 1998; Hammer et al., 1999; Inouye et al., 2001; Kalemba and Kunicka, 2003; Duarte et 
al., 2005). 
 
5.1.1 Resistance to antibiotics 
Microbial resistance to antibiotics (products of micro-organisms or their synthesized 
derivatives) has increased even though a number of antibiotics have been introduced by 
pharmaceutical industries in the past thirty years (Nascimento et al., 2000). It was found 
that two or three antibiotics of micro-organism origin were introduced each year (Clark, 
1996). Following a decrease in this development rate, the pace again quickened when 
scientists realized that the life span of any antibiotic is limited and so it is understood that 
conventional antibiotics have become less effective and new ailments are becoming 
unmanageable with these conventional medicines. The fact that bacteria have the genetic 
ability to transmit and acquire resistance to therapeutic agents (Cohen, 1992) is a concern 
considering the number of immunosuppressed hospitalized patients, many of which are 
multi-resistant. Higher mortalities are thus a result of new infections occurring in hospitals 
(Nascimento et al., 2000).  
 
In order to abate the problem of drug resistance the following needs to be considered: the 
uncontrolled usage of antimicrobials and a greater insight into mechanisms of resistance. 
Furthermore, the continuation for the search of natural or synthetic compounds, which 
could potentially be sources for the development of novel and efficient antimicrobials, is 
integral to curtail the problem of drug resistance.  
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 However, since the discovery of penicillins, not many lead compounds have had the 
capacity for the development of drugs to be employed for treating human infections (Pauli, 
2003). In addition, the use of botanical extracts as antimicrobial therapeutics dwindled 
almost completely due to the introduction of antibiotics in the 1950’s (Cowan, 1999). Due 
to the reliance on bacterial and fungal sources for compounds with antimicrobial 
properties, very few dispensed pharmaceuticals having higher-plant origins are actually 
intended for use as antimicrobial agents.  
 
5.1.2 Plants as therapeutic antimicrobials 
In the late 1990’s, plant-derived therapeutics regained popularity. There are a number of 
reasons for the renewed interest in plant antimicrobials. In recent times, the public has 
become aware of the problems related to overprescribing as well as to the incorrect usage 
of conventional antibiotic medicines. Moreover, many people are practicing autonomy in 
terms of their medical care and with many botanical therapeutics (plant extracts, mixtures 
and single plant compounds) being easily attainable over-the-counter from commercial 
outlets such as herbal or health food stores, widespread self-medication with these products 
is carried out by the lay community (Cowan, 1999).  
 
The rapid pace of extinction of plant species is also driving this trend towards plant-derived 
therapeutics (Lewis and Elvin-Lewis, 1995). Botanical extracts possessing known 
antimicrobial activities can afford great benefits to treatments. Thus, before the potentially 
bioactive phytochemicals which could be synthesized chemically, is lost, the knowledge 
concerning the traditional medicinal usage of plants gained by the indigenous people must 
be acquired (Borris, 1996). This would have particular benefits for developing countries 
with limited access to more expensive conventional antimicrobials. 
 
5.1.3 Secondary plant metabolites 
Plants synthesize aromatic compounds, most of which are phenols or their oxygen-
substituted derivatives (Geissman, 1963). Many of these compounds protect the plant 
against micro-organisms, insects and herbivores; the antimicrobial compounds are the 
plant’s defence system against predation. The numerous glandular hair components may 
play some role in protecting Pelargonium plants from herbivore or microbial attack in the 
natural environment (Williams and Harborne, 2002). Plants may prove to be valuable 
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 sources of novel antimicrobials in the treatment of resistant microbial strains due to the 
antimicrobial plant compounds which could possibly inhibit bacteria by a different 
mechanism to that of the currently used antibiotics. 
 
5.1.4 The use of botanical antimicrobials as preservatives in the food, cosmetic and 
pharmaceutical industries 
The presence of micro-organisms in consumer products constitutes a potential hazard. 
Firstly, deterioration of the product may occur. Micro-organisms possess a metabolic 
versatility whereby almost any formulation ingredient may undergo degradation in the 
presence of a suitable micro-organism. Secondly, the presence of micro-organisms may 
constitute an infection hazard to the consumer or patient (Bloomfield et al., 1988). 
Essential oils are often incorporated into food, pharmaceutical, cosmetic and household 
products, thus it is important to investigate whether natural substances possess inhibitory 
effects against micro-organisms (Pauli, 2001) as these substances could provide the dual 
function of flavouring/perfuming and antimicrobial activity. 
 
5.1.5 Reported antimicrobial properties of Pelargoniums 
Acute and chronic bronchitis, asthma and acute sinusitis have been treated by the 
inhalation of essential oils (Inouye et al., 2001). Ethnobotanical data indicates that the 
vapours from the boiled leaves of P. betulinum were inhaled to relieve coughs and other 
chest problems (van der Walt, 1977).  Pelargonium cucullatum was also traditionally used 
for this purpose (May, 2000). It has been found that through the inhalation of certain 
essential oils the respiratory tract fluid output increases and an anti-inflammatory effect is 
exerted on the trachea (Frohlich, 1968; Boyd and Sheppard, 1970; Burrow et al., 1983; 
Shubina et al., 1990). However, the use of the aforementioned Pelargonium species for 
respiratory conditions may have also been due to their antimicrobial properties. Many 
plant-derived essential oils are known to exhibit antimicrobial activity against a wide range 
of bacteria and fungi (Cox et al., 2001). 
 
Pelargonium species were used as traditional remedies to treat various ailments (Watt and 
Breyer-Brandwijk, 1962), many of which involve bacteria or fungi (Lis-Balchin and 
Deans, 1996). Numerous studies have concluded that ‘geranium oil’ possesses 
antimicrobial activity (Lis-Balchin et al., 1996a; 1996b; 1996c; 1998a; 1998b). Most of the 
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 Pelargonium oils studied by Lis-Balchin et al. (2003) showed potential against several 
micro-organisms in some food systems. Pattnaik et al. (1996) tested the antifungal effect of 
‘geranium oil’; all twelve of the fungi strains tested were inhibited by the oil. Four different 
strains of fungi were inhibited by the vapours of ‘geranium’ Bourbon (Chaumont and 
Leger, 1992). Results from an investigation carried out on a number of Pelargonium 
species and cultivars suggested that Pelargonium essential oils and solvent extracts could 
be used as antibacterial agents (Lis-Balchin et al., 1998b). Lis-Balchin et al. (1996c) 
established that the antimicrobial property of several lipophilic Pelargonium extracts was 
very pronounced. The hydrophilic extracts of representative species and cultivars of 
Pelargonium displayed considerable antibacterial activity (Lis-Balchin and Deans, 1996). 
 
5.2 Materials and methods 
The potential antimicrobial activity of the non-volatile extracts (26 samples) and essential 
oils (7 samples) was evaluated against four standard micro-organism strains which 
included two Gram-positive bacteria, Staphylococcus aureus (ATCC 12600) and Bacillus 
cereus (ATCC 11778), one Gram-negative bacterium, Klebsiella pneumoniae (NCTC 
1633) and one fungal strain, Candida albicans (ATCC 10231). The reference stock 
cultures were obtained from the National Health Laboratory Services (NHLS), 
Johannesburg and were maintained viable in the Department of Pharmacy and 
Pharmacology, University of the Witwatersrand.  
 
5.2.1 Minimum inhibitory concentration assay 
After the preliminary screening of the plant samples using the disc diffusion assay (Janssen 
et al., 1987), a more comprehensive assessment of their antimicrobial effects was carried 
out using the micro-well serial dilution assay (Eloff, 1998a). Such an assay was performed 
in order to quantify the antimicrobial activity for the test pathogens.  
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 5.2.1.1 Principle of the method 
Microbial growth is indicated by the presence of a reddish colour which is produced when 
p-iodo-nitrotetrazolium violet (INT), a dehydrogenase activity detecting reagent, is reduced 
by metabolically active micro-organisms to the corresponding intensely coloured formazan 
(Eloff, 1998a). The minimum inhibitory concentration (MIC) is defined as the lowest 
concentration that produces an almost complete inhibition of visible micro-organism 
growth in liquid medium. Thus, the MIC value is the concentration in the first well in 
which no colour change was observed (Baker and Tenover, 1996).  
 
5.2.1.2 Protocol 
The essential oils and plant extracts were dissolved in acetone to obtain stock solution 
concentrations of 128 mg/ml and 64 mg/ml, respectively. Sterile water (100 µl) was added 
to all the 96 wells of the microtitre plate. Aliquots of 100 µl from the stock solutions of the 
essential oils or plant extracts were added to the wells of row A. Serial dilutions (1: 1) of 
the initial concentrations were prepared vertically in the plate. The excess volume of 100 µl 
was discarded from the wells in row H. Culture (100 µl) containing a final density of 1 x 
106 CFU/ml was added to each well, thereby achieving final well concentrations ranging 
from 32 mg/ml to 0.250 mg/ml for the essential oils and 16 mg/ml to 0.125 mg/ml for the 
crude extracts. 
 
For each micro-organism, columns were reserved for the positive control and the negative 
control. Culture supplemented with the antibiotics ciprofloxacin (Oxoid) or amphotericin B 
(Oxoid) was used as the positive control for bacteria and fungi, respectively. Ciprofloxacin 
(Oxoid) and amphotericin B (Oxoid) were prepared in sterile water and DMSO, 
respectively, to produce a stock concentration of 1 mg/ml. The antibiotics were then 
diluted with sterile water to obtain a starting concentration of 0.01 mg/ml. For the 
observation of normal bacterial and fungal growth, control wells containing acetone (100 
µl) and no plant extract (negative control) were prepared.  
 
Sterile plate sealers were used to cover the microtitre plates to reduce evaporation of the 
well contents. The plates were incubated under normal atmospheric conditions, at 37°C for 
24 hours for bacteria inoculum and for 48 hours for yeast inoculum. After the incubation 
period, 40 µl of 0.4 mg/ml INT (SIGMA) was added to all the wells and left to stand for 6 
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 hours for the plates containing bacteria and 24 hours for the plates with yeast. The MIC 
was then visually assessed.  
 
The crude extracts producing an MIC ≤0.125 mg/ml were retested, the stock solution was 
diluted with acetone to obtain a lower starting concentration. Acetone did not inhibit the 
bacterial or fungal growth at the tested concentrations. 
 
5.3 Results and discussion 
Essential oils contain mixtures of terpenoids, particularly monoterpenes and 
sesquiterpenes, and various aliphatic hydrocarbons (Dorman and Deans, 2000). Terpenoids 
are active against bacteria and fungi (Cowan, 1999). The antibacterial properties of 
essential oils are mainly attributable to the phenolic components (Cosentino et al., 1999). 
Essential oils and perfumes have been widely investigated as antimicrobial agents 
(Bloomfield et al., 1988). Maruzzella and Bramnick (1961) found that 20% of a variety of 
perfumery chemicals at a dilution of 1: 500 inhibited at least one of the four test bacteria. 
The main groups of chemicals were ranked in order of decreasing activity as follows: 
aldehydes, alcohols, eugenol, acids, lactones, ethers, ketones, esters and acetals. Alcohols 
possess bactericidal activity by acting as protein denaturing agents, solvents or dehydrating 
agents (Dorman and Deans, 2000) and further, have antifungal activity (Pauli, 2001). The 
Pelargonium essential oils tested in this assay contain a mixture of the aforementioned 
compounds so one would expect the essential oils to exert good antimicrobial activity. 
However, the Pelargonium essential oils tested displayed generally low antimicrobial 
activity (Table 5.1). 
 
The non-volatile extracts showed promising antimicrobial activity (Table 5.2). Low 
antimicrobial activity (MIC = 8 mg/ml) was only observed for the extract of P. 
papilionaceum against B. cereus and for that of P. quercifolium (SBG) against K. 
pneumoniae. A similar trend was found by Lis-Balchin et al. (1998b) where methanolic 
and petroleum spirit extracts of Pelargonium species were more potent antibacterial agents 
than the steam-distilled volatile samples. A possible explanation for the reduced activity of 
the essential oils in comparison to the activity of crude extracts is that the essential oil 
constituents are volatile and so there is a resulting loss of active constituents which may be 
considerable due to long incubation periods (Pauli, 2001).  
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 Table 5.1: In vitro antimicrobial activity of selected Pelargonium essential oils. 
 
MIC (mg/ml) 
Antifungal 
activity Antibacterial activity Plant species Locality 
Klebsiella 
pneumoniae 
Bacillus 
cereus 
Staphylococcus 
aureus 
Candida 
albicans 
NCTC 1633 ATCC 11778 ATCC 12600 ATCC 10231 
P. citronellum NBG 16 4 4 4 
P. graveolens SBG r 8 8 2 
P. panduriforme SBG r 8 8 2 
P. panduriforme WSBG r 8 4 4 
P. radens NBG r 16 8 8 
P. tomentosum SBG r 8 8 8 
P. tomentosum WSBG r 16 8 8 
2.5 x 10-3 (a) 3.13 x 10-4 (a) 2.5 x 10-3 (a) 1.25 x 10-3 (b)Control - 
 
Where: - MIC = minimum inhibitory concentration (mg/ml); Microbial Strains: NCTC = 
National Collection of Type Cultures, ATCC = American Type Culture Collection; NBG = 
National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical Garden, WSBG 
= Walter Sisulu Botanical Garden (Johannesburg); r = resistant, MIC value >32 mg/ml; (a): 
ciprofloxacin; (b): amphotericin B; n = 3: triplicate measurements were performed for all 
samples.  
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 Table 5.2: In vitro antimicrobial activity of Pelargonium acetone extracts. 
 
MIC (mg/ml) 
Antifungal 
activity Antibacterial activity Plant species Locality 
Klebsiella 
pneumoniae 
Bacillus 
cereus 
Staphylococcus 
aureus 
Candida 
albicans 
NCTC 1633 ATCC 11778 ATCC 12600 ATCC 10231 
P. betulinum NBG 1 0.33 1.13 2 
P. capitatum Strand 1 1 2 1.5 
P. citronellum NBG 3 0.25 0.16 1 
P. citronellum SBG 3 0.41 0.16 0.5 
P. cordifolium NBG 1.5 0.25 0.75 0.75 
P. cordifolium WSBG nd nd nd nd 
P. crispum NBG 2 0.38 0.56 1.33 
P. cucullatum SBG 1.5 0.25 1 1 
P. cucullatum WSBG 3.33 0.5 2 2 
P. glutinosum SBG 2 0.078 0.078 1 
P. glutinosum WSBG 2 0.25 0.5 2 
P. graveolens SBG 2 2 4 3.33 
P. graveolens WSBG nd nd nd nd 
P. greytonense SBG 3.2 0.25 0.5 1.5 
P. hermanniifolium SBG 1.5 3 1.5 1.5 
P. hispidum SBG 2 4 4 3 
P. panduriforme SBG 2 2 2 2 
P. panduriforme WSBG 2 0.5 0.5 1 
P. papilionaceum NBG 4 8 2 1.19 
P. pseudoglutinosum NBG 2 0.039 0.039 0.54 
P. quercifolium SBG 8 0.33 0.16 2 
P. quercifolium WSBG 2 1 1 1 
P. radens SBG 2.5 0.5 2 2 
P. scabroide SBG 2 0.25 1 1 
P. scabrum SBG 2 0.059 0.078 0.38 
P. sublignosum SBG 2 0.13 0.078 0.5 
P. tomentosum SBG 2 2 2 2.33 
P. tomentosum WSBG nd nd nd nd 
P. vitifolium SBG 4 1 2 2 
- 2.5 x 10-3 (a) 3.13 x 10-4 (a) 2.5 x 10-3 (a) 1.25 x 10-3 (b)Control 
 
Where: - MIC = minimum inhibitory concentration (mg/ml); Microbial strains: NCTC = 
National Collection of Type Cultures, ATCC = American Type Culture Collection, NBG = 
National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical Garden, WSBG 
= Walter Sisulu Botanical Garden (Johannesburg); r = resistant, MIC value >32 mg/ml; nd 
= not determined due to insufficient extract for testing; (a): ciprofloxacin, (b): amphotericin 
B;  n = 3: triplicate measurements were performed for all samples.  
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 The results further indicate that both the essential oils and extracts have a more selective 
antibacterial action against the Gram-positive bacteria. This is in accordance with other 
studies which reported Gram-positive bacteria to be more sensitive to both the essential 
oils and extracts (Cosentino et al., 1999; Karaman et al., 2003). Gram-negative bacteria 
possess an outer membrane, containing hydrophilic polysaccharide chains (Figure 5.1), 
which acts as a barrier to hydrophobic compounds (Tassou and Nychas, 1995; Mann et al., 
2000), hence the microbial resistance of K. pneumoniae to the tested Pelargonium essential 
oils. Klebsiella pneumoniae was not resistant to P. citronellum (NBG) essential oil; 
however, this latter oil displayed very weak antimicrobial activity (MIC = 16 mg/ml) 
against this Gram-negative bacterium. 
 
Not all studies on essential oils have concluded that Gram-positives are more susceptible 
(Wilkinson et al., 2003). Zaika (1988) proposed that Gram-positive bacteria are less 
sensitive to the volatile oil antibacterial properties as compared to the Gram-negative 
bacteria.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: A comparison of the cell walls of the Gram-negative and Gram-positive 
bacteria. The Gram-negative bacterium’s outer membrane with polysaccharide chains is 
shown (Johnson, 2005). 
 
 
 130
 5.3.1 Essential oils 
The bioactivity of the essential oils would be assumed to correlate to the respective 
composition of the plant essential oils (Dorman and Deans, 2000). Isomenthone, a ketone, 
occupies a large portion (49.3-84.5%) of the oil composition of P. graveolens (SBG), P. 
radens (NBG) and the P. tomentosum samples. Substantial amounts (36.1-41.1%) of the 
ketone menthone also occur in the P. tomentosum oils. Ketone ranked low among other 
compounds in terms of antimicrobial activity (Maruzzella and Bramnick, 1961). This may 
explain the low antimicrobial activity of the abovementioned oils.  
 
Amongst the essential oils tested, P. citronellum (NBG) exerted the greatest activity 
against the bacteria, with P. panduriforme (WSBG) having the same MIC value of 4 mg/ml 
against S. aureus. The antimicrobial activity of P. citronellum (NBG) may be attributed to 
the two major compounds, namely neral (17.4%) and geranial (27.2%) (Figure 5.2), which 
were only detected in P. citronellum (NBG) oil. In a study conducted by Dorman and 
Deans (2000), the aldehydes cis and trans citral (geranial and neral) displayed moderate 
activity against the test micro-organisms (which included K. pneumoniae and S. aureus). It 
has been proposed that the highly electronegative arrangement of an aldehyde group 
conjugated to a carbon to carbon double bond (Moleyar and Narasimham, 1986) may 
inhibit the growth of micro-organisms by disturbing biological processes involving 
electron transfer and by reacting with protein and nucleic acid components. Geranic acid 
(36.0%) is the principle compound in P. citronellum (NBG) oil. As mentioned previously, 
acids among other perfumery chemicals have antibacterial activity (Maruzzella and 
Bramnick, 1961).  
 
geranial 
O
H
neral 
OH
 
 
 
 
 
 
 
 
Figure 5.2: The chemical structures of the two major aldehydes, geranial and neral, present 
in Pelargonium citronellum (NBG) essential oil. 
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 In a study involving Cymbopogon citratus, with major components being geranial and 
neral, noteworthy antibacterial and antifungal activities were recorded (Chalchat et al., 
1997). In addition, Araujo et al. (2003) found that the main component of M. officinalis oil, 
namely citral (geranial and neral: 58.3%), showed a marked fungitoxic effect. However, in 
a study by Ngassapa et al. (2003), geranial, neral, limonene, germacrene D, camphor, 
linalool, β-caryophyllene and myrcene were identified as the main components of the two 
samples of Lippia javanica (Burm. f.), which were found to be inactive against the fungi 
tested. The implication is that the compounds present in high concentrations in Lippia 
javanica (Burm. f.) oil may be interacting with one another in a way which antagonizes the 
antifungal activity of neral and geranial. This assumption is further supported by the fact 
that the major compounds in Lippia javanica (Burm. f.) oil (except for geranial, neral and 
linalool) are either present in small amounts or are absent in P. citronellum (NBG) oil 
which has antifungal activity (MIC = 4 mg/ml for C. albicans). Pelargonium citronellum 
(NBG) also contains the oxygenated monoterpene linalool (1.8%) known to possess good 
antimicrobial activity (Carson and Riley, 1995).  
 
Lis-Balchin et al. (1998b) found that Pelargonium essential oils showed substantial in vitro 
activity against S. aureus, Proteus vulgaris, B. cereus and S. epidermidis and concluded 
that Pelargonium essential oils could be used as novel food or cosmetic antimicrobial 
agents. The antibacterial activity of P. citronellum (NBG) against B. cereus and S. aureus 
suggest that P. citronellum (NBG) oil may delay microbial contamination. It is interesting 
to note that Pelargonium citronellum is a strongly aromatic shrub, with lemon scented 
leaves and is grown as a culinary herb (van der Walt and Vorster, 1988). Pelargonium 
citronellum (NBG) with its additional aromatic and flavouring properties could be 
employed as a natural food preservative. It also has the potential as a cosmetic or 
pharmaceutical preservative. However, in studies by Münzing and Schels (1972) and 
Blakeway (1986) the major restriction for the use of essential oils as preservatives was the 
high concentration of oil required to afford effective preservative action. At the required 
concentrations, cosmetic and toiletry preparations would have a ‘medicinal’ smell and so 
these required concentrations gave an olfactive limitation on the application of the oils. 
Moreover, oil toxicity and cost are the main limitations for the use of essential oils in 
pharmaceutical products. The toxicity of P. citronellum oil was evaluated (Chapter 10) to 
validate its potential use as an antimicrobial agent.  
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 The essential oil of P. graveolens was more active against the Gram-positive bacteria than 
the Gram-negative bacterium, this is in agreement with a previous report by Dorman and 
Deans (2000). In addition, P. graveolens inhibited K. pneumoniae and S. aureus to the 
same extent in a disc diffusion assay study carried out by Dorman and Deans (2000). The 
quantitatively determined results from the MIC assay in this study show that P. graveolens 
(SBG) inhibits S. aureus whereas it is resistant to K. pneumoniae. The different culture 
strains used in the two studies could be causing this difference in activity towards K. 
pneumoniae. Hammer et al. (1999) tested various essential oils and plant extracts for their 
antimicrobial effects. A variety of test micro-organisms were used including K. 
pneumoniae, S. aureus and C. albicans. The essential oil of P. graveolens showed greater 
activity against C. albicans than against S. aureus and failed to inhibit K. pneumoniae at 
the highest concentration. These findings correlate with the MIC results obtained for the 
sample of P. graveolens (SBG) essential oil. 
 
The antibacterial activity of essential oils is most probably attributable to several targets 
and mechanisms due to the many different chemical compounds present in essential oils. 
Figure 5.3 represents the locations and mechanisms in the bacterial cell as possible sites of 
action for essential oil compounds. The fact that essential oils are lipophilic enables them 
to partition in the lipids of the bacterial cell membrane and mitochondria, causing 
disruption of the structures rendering them more permeable. Following this, leakage of ions 
and other cell contents can occur. Ultimately death of the bacterial cell results from the 
extensive loss of cell content or the leakage of significant molecules and ions (Burt, 2004). 
The precise mode of action and antibacterial activity of individual essential oil compounds 
is influenced by their chemical structure (Dorman and Deans, 2000).  
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Figure 5.3: Locations and mechanisms in the cell of the bacterium which may act as sites 
of action for essential oil compounds (Burt, 2004).   
 
The yeast C. albicans was most sensitive to the oils of P. graveolens (SBG) and P. 
panduriforme (SBG), both oils producing an MIC value of 2 mg/ml. The essential oil of P. 
graveolens and its main components, geraniol and citronellol, exhibited strong activity 
against six fungal species of Trichophyton (Shin and Lim, 2004). Minor compounds play 
an important role in antimicrobial activity, probably by producing a synergistic or 
potentiating effect between other compounds (Burt, 2004). Citronellol (0.4%) in P. 
graveolens (SBG) may contribute to its observed fungal activity. Limonene, linalool and 
menthol, which have been reported to possess antimicrobial properties (Duarte et al., 
2005), are also present in this sample. Terpinen-4-ol has been shown to possess good 
antimicrobial activity against C. albicans (Williams, 1996). The monoterpenes linalool and 
limonene possess antimicrobial activity (Carson and Riley, 1995; Dorman and Deans, 
2000). Pelargonium panduriforme (SBG) contains 0.6% terpinen-4-ol, this compound does 
not exist in the other oils tested. Pelargonium panduriforme (SBG) essential oil also 
contains the highest amount of linalool (4.42%) in comparison to the other oil samples. The 
combined effects of terpinen-4-ol, linalool, limonene (2.2%) and other compounds in 
minor amounts may contribute towards the good antifungal activity (MIC = 2 mg/ml) 
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 displayed by this oil. Pelargonium graveolens (SBG) and P. panduriforme (SBG) samples 
may be sources of effective anti-Candida agents.  
 
With reference to the dendrogram (Chapter 3, Figure 3.2), P. citronellum (NBG), generally 
the most active oil, is clustered separately from the other essential oils. Pelargonium 
graveolens (SBG) and P. panduriforme (SBG) produced identical MIC values for all the 
test micro-organisms. However, these two oils have markedly different chemical 
compositions as is reflected in the dendrogram (Chapter 3, Figure 3.2). Pelargonium 
graveolens (SBG) and P. radens (NBG) produced similar MIC values for K. pneumoniae 
and S. aureus. These oils have a high degree of similarity. Pelargonium radens (NBG) and 
P. tomentosum (WSBG) are closely associated in the cluster dendrogram, this similarity in 
chemical composition is portrayed in their antimicrobial activities. The P. tomentosum 
duplicate samples are more similar in their chemistry than the P. panduriforme duplicate 
samples. This degree of similarity extends to their antimicrobial activity, where the P. 
tomentosum samples produced different activities against one micro-organism while the P. 
panduriforme samples differed in their activities against two micro-organisms.  
 
The MIC technique evaluated the essential oils in liquid medium and does not allow the 
effect of the vapour phase to be tested. One must consider that essential oils are highly 
volatile at room temperature and so the evaluation of the vapour activity would then 
provide a better indication of whether these oils are effective inhalation therapeutics. 
Investigation of the antimicrobial capacity of the vapours of the essential oils would 
provide an indication of their possible usage as disinfectants in hospital rooms and work 
environments. The vapours of essential oils can exert their antimicrobial activity by 
gaseous contact. Inouye et al. (2001) introduced a new parameter, minimal inhibitory dose 
(MID), as a measure of the vapour activity on exposure. Moleyar and Narasimham (1986) 
showed that the antimicrobial activity of volatile compounds results from the combined 
effect of direct vapour absorption on micro-organisms and indirect effect through the 
medium that absorbed the vapour (Inouye et al., 2001).  
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 5.3.2 Non-volatile extracts 
Several species showed substantial activity against the two Gram-positive bacteria. 
Inhibition was observed to be greater against B. cereus than against S. aureus i.e. B. cereus 
appears to be the more sensitive bacterium. Of particular importance are the acetone 
extracts of P. glutinosum (SBG), P. pseudoglutinosum, P. scabrum and P. sublignosum 
(Table 5.2). The acetone extract of P. pseudoglutinosum exerted the highest antimicrobial 
activity against B. cereus and S. aureus (MIC = 0.039 mg/ml). These findings highlight the 
potential use of the latter species as antimicrobial agents. In general, the crude extracts 
exhibited reduced activity towards the Gram-negative bacterium K. pneumoniae and to the 
yeast C. albicans (Table 5.2). The extracts of P. betulinum and P. capitatum were most 
active against K. pneumoniae. Candida albicans was found to be least resistant to P. 
scabrum which was the second most active test substance against B. cereus (MIC = 0.059 
mg/ml). Other extracts with substantial activity against C. albicans include P. citronellum 
(SBG), P. pseudoglutinosum and P. sublignosum. 
 
Equal activities against K. pneumoniae were noted for the duplicate samples of P. 
citronellum, P. glutinosum and P. panduriforme. Pelargonium citronellum samples also 
produced equal activities against S. aureus. In general, the duplicate samples showed 
varying antimicrobial activities. This suggests that the composition of extracts from 
different collections of the same species can differ. Plant composition is dependent on a 
complex interrelationship between many chemical, physical and biological factors 
associated with the environment (Richardson et al., 1954). 
 
It was found that P. betulinum (NBG), P. capitatum (Strand), P. graveolens (SBG), P. 
hispidum (SBG), P. panduriforme (SBG) and P. vitifolium (SBG) extracts share very 
characteristic chemical profiles (Chapter 4). Of these species, P. graveolens (SBG) and P. 
hispidum (SBG) produced the most similar MIC values. The two related species, P. 
capitatum and P. vitifolium (van der Walt, 1977), produced the same MIC values against 
the Gram-positive micro-organisms. Similar promising antimicrobial activity was 
displayed by P. scabrum and P. sublignosum, which have very similar flavonoid patterns 
(Chapter 4). Pelargonium vitifolium and P. papilionaceum produced similar MIC values 
except with respect to B. cereus. However, their HPLC profiles proved to be different 
(Chapter 4). 
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 The Pelargonium species tested by Lis-Balchin and Deans (1996) showed pronounced 
antibacterial activity, but poor antifungal activity. However, P. capitatum and P. 
cucullatum in particular showed no activity against K. pneumoniae and S. aureus, 
respectively. In this study, P. capitatum (Strand) and the P. cucullatum samples showed 
promising activity against the bacteria as well as C. albicans. In the study performed by 
Lis-Balchin and Deans (1996) the hydrophilic (methanolic) fractions were tested, whereas 
in this study the acetone extracts were tested. In the study performed by Lis-Balchin and 
Deans (1996) the lipophilic fractions were removed from the test extracts so that the 
potency of the hydrophilic fractions could be assessed. Acetone is a very useful extractant, 
it is able to extract both hydrophilic and lipophilic compounds (Eloff, 1998b). The 
presence of the lipophilic compounds in the acetone extracts may be responsible for the 
greater antimicrobial activity observed. Lis-Balchin et al. (1996c) established that the 
antimicrobial property of several lipophilic Pelargonium extracts was very pronounced. A 
further possible reason for the discrepancy between the two studies is the testing method 
used. The agar-well method used in the study by Lis-Balchin and Deans (1996) is useful as 
a preliminary check for antimicrobial activity prior to more detailed studies such as the 
MIC assay which provides a quantitative analysis of the antimicrobial activity. 
 
Phenolic compounds have been reported to exert antimicrobial properties. Flavonoids are 
abundant in all Pelargoniums (Bate-Smith, 1973). Pelargonium plant material was 
extracted with acetone which isolates flavonoid glycosides and the more polar aglycones 
such as hydroxylated flavones, flavonols, biflavonyls, aurones, chalcones and 
anthocyanidin (Harborne et al., 1975). HPLC-UV analysis (Chapter 4) confirmed the 
presence of flavonoid derivatives in the crude extracts of the studied Pelargonium species. 
Plants synthesize flavonoids in response to microbial infection (Dixon et al., 1983). Thus it 
is not surprising that they have been found to exert in vitro antimicrobial activity against 
many micro-organisms (Cowan, 1999). Green tea (Camellia sinensis) has been found to be 
active against multiple types of micro-organisms and contains the flavonoid catechin. The 
flavones and other phenolics in Thyme (Thymus vulgaris) have activity against bacteria 
and fungi. Tree bard (Podocarpus nagi) contains the flavonol totarol active against Gram-
positive bacteria (Cowan, 1999). Powers (1964) investigated the effects of more than 20 
flavonoids on bacteria. No compound was devoid of inhibitory activity toward one or more 
of the ten bacteria studied. The presence of flavonoids in the non-volatile extracts may 
account for their observed antimicrobial activity.  
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 Flavonoids are hydroxylated phenolic compounds occurring as a C6–C3 unit attached to an 
aromatic ring. It has been reported that the more hydroxylation, the greater the 
antimicrobial activity (Sato et al., 1996). However, the finding that flavonoids with no 
hydroxyl groups on their β-rings are more active against micro-organisms than those with 
hydroxyl groups (Chabot et al., 1992) provides an indication that the membrane of the 
microbe is the microbial target of flavonoids. Flavonoids with more lipophilic properties 
may also disrupt membranes of the micro-organisms (Tsuchiya et al., 1996). Flavonoids 
have the ability to complex with bacterial cell walls, with possible targets in the microbial 
cell being surface-exposed adhesions, cell wall polypeptides and membrane-bound 
enzymes (Cowan, 1999). A possible mechanism of action of the flavonoids is irreversible 
complexation with nucleophilic amino acids in extracellular and soluble proteins. This 
leads to inactivation and loss of function of the proteins. Such a mechanism of action 
provides considerable antimicrobial effects (Cowan, 1999). 
 
Furthermore, even though it has been reported that the solvents water, ethanol or methanol 
are used for the extraction of tannins (Cowan, 1999), it must be realized that tannins are 
present in Pelargoniums (Bate-Smith, 1973) and that this class of compound possesses 
antimicrobial effects (Smith et al., 2003), which have been widely recognized. They are 
toxic to filamentous fungi, yeasts and bacteria (Cowan, 1999). The physical and chemical 
properties of the polyphenolic skeleton of tannins are responsible for the anticipated 
interaction with biological systems (De Bruyne et al., 1999). Interesting to note is that 
acetone received the highest overall rating, among a variety of other extractants examined, 
for their ability to solubilize antimicrobials from plants (Eloff, 1998b). 
 
Staphylococcus aureus is commonly found on human skin and mucosa and can infect 
wounds. It is one of the most persistent infectious micro-organisms and is commonly found 
in nosocomial infections (Steenkamp et al., 2004). Even though the process of healing 
occurs by itself, an infection can hamper this process (Priya et al., 2002). Topical 
antimicrobial therapy is the most important part of wound management to prevent 
infection. The profound antimicrobial effects of Pelargoniums may be responsible for their 
ability to assist in wound-healing (Lis-Balchin, 1996). The extracts of P. glutinosum 
(SBG), P. pseudoglutinosum, P. scabrum and P. sublignosum, which displayed 
considerable activity against S. aureus (Table 5.2), may be potential sources of topical 
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 antimicrobial agents for the treatment of wound infections and may be sources of effective 
agents for nosocomial infections. 
 
The traditional therapeutic uses of P. betulinum (van der Walt, 1977; Lawrence and Notten, 
2001), P. cucullatum (van der Walt, 1977; May, 2000) and P. papilionaceum (Watt and 
Breyer-Brandwijk, 1962) may be validated by their antimicrobial effects as demonstrated 
by the acetone extracts. The antimicrobial properties of the Pelargonium species recorded 
in this study need to be assessed as being a result of selective or non-selective triggering of 
cell death. The cytotoxic effects of the extracts towards human kidney epithelial cells are 
presented in Chapter 10. The Pelargonium extracts with promising antimicrobial activity 
should be investigated further for the isolation of the antimicrobial compounds. A 
potentially effective formulation may be developed by combining the identified active 
components in an appropriate manner. Through the use of bioactive plant entities, novel 
ethno-therapeutic treatments of infections could be launched.  
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 CHAPTER 6:  THE ROLE OF ESSENTIAL OILS IN THE 
ANTIMICROBIAL ACTIVITY OF CRUDE EXTRACTS 
 
6.1 Introduction 
The aminoglycoside antibiotics are protein synthesis inhibitors. An aminoglycoside 
passively diffuses across the outer membrane via bacterial porin channels and then is 
actively transported across the bacterial cell membrane into the cytoplasm where it binds 
irreversibly to 30S-subunit ribosomal proteins (Katzung, 2001). Aminoglycoside transport 
is enhanced by cell wall synthesis inhibitors such as the penicillins. The concept of 
improving a drug’s antimicrobial action by enhancing its transport into the bacterium by 
concomitant administration of another drug was used as the premise to formulate a 
hypothesis: “essential oils enhance the antimicrobial efficacy of non-volatile compounds.” 
 
The results from Chapter 5 showed that the non-volatile extracts have greater antimicrobial 
activity than the essential oils. These extracts were obtained by acetone solvent extraction 
and were not completely devoid of essential oil constituents. This study was performed to 
determine if a pharmacological interaction (e.g. synergism or antagonism) exists between 
volatile and non-volatile components.  
 
6.1.1 Principle  
Essential oils are non-polar and thus are able to partition in the lipids of the micro-
organism cell wall and cause disruption of the structures rendering the cell wall more 
permeable (Burt, 2004) to the more polar non-volatile compounds (e.g. flavonoid 
glycosides). These compounds are able to move through the cell wall and into the micro-
organism where they can exert their activity. In this way the activity of the non-volatile 
compounds is enhanced. To test this hypothesis, the following was determined: 
1) The antimicrobial activity of the essential oil. 
2) The antimicrobial activity of the non-volatile extract (devoid of most essential oil  
     constituents). 
3) The antimicrobial activity of the plant extract containing both essential oil compounds   
     and non-volatile compounds. 
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 6.2 Materials and methods 
6.2.1 Protocol  
Fresh plant material of P. graveolens, P. quercifolium and P. tomentosum was collected 
from Walter Sisulu Botanical Garden (Johannesburg). For each species four samples were 
prepared: 
(1) Essential oil (EO) by hydrodistillation, 
(2) solvent extract of non-volatile compounds (NV) from the material remaining in the    
     Clevenger apparatus after obtaining the essential oil in (1) above, 
(3) soxhlet extract of fresh plant material (FMS) and  
(4) soxhlet extract of air-dried plant material (ADS). 
 
For each species the samples were prepared in the following way: 
(1) Fresh plant material was hydrodistilled to obtain the essential oil. Hydrodistillation was 
carried out as described in Chapter 2, Section 2.2.1.  
(2) The biomass (plant material and liquid) remaining after hydrodistillation was dried in 
the oven at 40°C. After drying, approximately 15 g of this material was subjected to 
soxhlet extraction with equal volumes of methanol and chloroform for 3-4 hours. A total 
solvent volume of 250 ml was used. This was performed to obtain a plant extract (NV) 
containing mostly non-volatile compounds (polar and non-polar) and devoid of the 
essential oil compounds liberated during hydrodistillation.  
(3) The same method as described in (2) above was carried out on approximately 25 g of 
fresh plant material to obtain a plant extract (FMS) containing the non-volatile compounds 
and to a lesser extent volatile compounds. 
(4) The same method as described in (2) above was carried out on approximately 15 g of 
air-dried plant material to obtain a plant extract (ADS) containing the non-volatile 
compounds and to a lesser extent volatile compounds. 
 
The soxhlet method was used to extract the fresh plant material and the air-dried plant 
material as opposed to the usual cold extraction method. The rationale for this is that the 
soxhlet method is a heat extraction method like hydrodistillation, thus making extracts 
obtained through (2), (3) and (4) more comparable. 
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 6.2.1.1 Soxhlet extraction method 
The plant material was pulverized, pressed into an extraction thimble and weighed, 
compensating for the weight of the thimble. In a round bottom flask, the solvent mixture 
(250 ml) of 1: 1 methanol and chloroform was heated to a temperature higher than the 
boiling points of each of the two solvents (Figure 6.1). The vapours moved through the 
outer chamber of the soxhlet apparatus and into the condenser. Following condensation, the 
liquid flowed back into the bottom of the soxhlet chamber. As this distilled solvent rose in 
the soxhlet chamber, it permeated through the cellulose extraction thimble, holding the 
Pelargonium plant material. This extraction was evident from making the observation that 
the solvent in the soxhlet chamber had a different colour than it had in its pure form in the 
round bottom flask. The solution was forced through the small inner tube as the solvent 
level rose. Due to a siphoning-effect the chamber was flushed (Figure 6.1). The flushed 
solvent, containing the extracted compounds, returned to the round bottom flask. 
Extraction with fresh solvent was repeated, the solvent was redistilled from the solution in 
the round bottom flask, condensing in the chamber. The solution in the round bottom flask 
became more concentrated each time the process was repeated since more was being 
extracted from the plant material. The extraction process was complete when the solution 
in the soxhlet chamber was the same colour as the pure solvent. The extraction process was 
carried out for about 3 to 4 hours. Once allowed to cool down, the extract in the round 
bottom flask was poured into petri-dishes to allow for the evaporation of the solvent 
mixture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 142
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: The process of soxhlet extraction 
(http://www.aquaculture.ugent.be//ATA/analysis/crudprot.htm). 
 
6.2.2 Phytochemical verification 
6.2.2.1 Thin layer chromatography 
TLC was carried out on all the crude extracts for each species to confirm if essential oil 
compounds were absent in the NV extracts and to verify their presence in the FMS and 
ADS extracts. The essential oil samples, obtained through (1), were used as references and 
were diluted with hexane in the ratio 1: 7. The crude extract samples were prepared using 
methanol. The solvent system toluene: ethyl acetate (9.3:  0.7) was used to develop the TLC 
plates. The TLC plates were sprayed with anisaldehyde-sulphuric acid reagent which was 
prepared in the following way: 0.5 ml anisaldehyde was mixed with 10 ml glacial acetic 
acid, followed by 85 ml methanol and 5 ml concentrated sulphuric acid, in that order 
(Wagner and Bladt, 1996). The anisaldehyde-sulphuric acid spray reagent detects 
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 terpenoids amongst several other compounds and thus was used to verify the presence of 
essential oil compounds in the extracts. After spraying, the TLC plates were heated at 
100°C for 5-10 min and were evaluated visually and under UV-365 nm.  
 
TLC analysis was again carried out on all the crude extracts for each species so that a 
comparison of the chemical patterns of the non-volatile compounds of the three types of 
crude extracts could be made. This was performed to determine whether the rigorous 
extraction process of hydrodistillation caused decomposition of the non-volatile 
compounds present in the biomass from which the NV extract was obtained. The ADS 
extracts were used in the study to verify the results produced by the FMS extracts. 
 
The NV, FMS and ADS extracts were dissolved in methanol to obtain a concentration of 
50 mg/ml and 5 µg of this solution was applied to silica gel plates (Alugram Sil G/UV254). 
TLC plates were developed in two different solvent systems to determine which system 
would produce the best separation of the compounds. The two solvent systems used were 
methanol: water: acetone: ethyl acetate: chloroform (1: 0.8: 3: 4: 1.2) and toluene: dioxane: 
acetic acid (9: 2.5: 1). The TLC plates were sprayed with two different reagents to 
determine which one would produce better visualization of the compounds. The first spray, 
anisaldehyde-sulphuric acid reagent was prepared as described above. After spraying, the 
plates were heated at 100°C for 5-10 minutes and viewed visually and under UV-365 nm. 
This reagent detects terpenoids, propylpropanoids, pungent and bitter principles and 
saponins. The second spray used was natural products-polyethylene glycol reagent 
(NP/PEG), which is used for the detection of flavonoids. The plates were sprayed first with 
10 ml of solvent A (diphenylboric acid-β-ethylamino ester in 1% methanol) and then with 
8 ml of solvent B (polyethylene glycol-4000 (PEG) in 5% ethanol) for colour development 
(Wagner and Bladt, 1996). The plates were evaluated under UV-365 nm. 
 
6.2.2.2 HPLC analysis 
The chromatographic profiles of the three types of crude extracts for each species were also 
obtained using HPLC analysis. This method is more sensitive than TLC and so provides 
more accurate data from which better chemical comparisons among the crude extracts can 
be made. The protocol as described in Chapter 4, Section 4.2.1.2 was used to analyse the 
samples. 
 144
 6.2.3 Antimicrobial activity 
The MIC assay as described in Chapter 5, Section 5.2.1.2 was carried out on all four 
samples of each species to assess the antimicrobial activity. The microbial test organisms 
used included K. pneumoniae (NCTC 1633), B. cereus (ATCC 11778), S. aureus (ATCC 
12600) and C. albicans (ATCC 10231). 
 
6.3 Results and discussion 
6.3.1 Phytochemical verification 
6.3.1.1 Thin layer chromatography 
The presence or absence of essential oil compounds in the crude extract samples could not 
be verified as it appears that TLC is not a sensitive enough method for the detection of 
such compounds in these extracts. GC analysis should therefore be performed.  
 
Hydrodistillation selectively removes the essential oil from the plant material resulting in 
the latter material being devoid of most essential oil constituents. Thus it is assumed that 
the NV extract, obtained after soxhlet extraction of the remaining biomass, did not contain 
many essential oil compounds. The ADS and the FMS extracts can be expected to contain 
essential oil compounds as the plant material used to obtain these extracts were not 
subjected to the process of hydrodistillation prior to soxhlet extraction. The ADS material 
may contain less essential oil constituents than the FMS extract as the plant material was 
air-dried prior to subjecting it to soxhlet extraction. 
 
With regards to the analysis of the non-volatile compounds of the crude extracts, good 
separation was achieved using the solvent system toluene: dioxane: acetic acid (9: 2.5: 1) 
and the spots were more easily visualized using the NP/PEG reagent. Fluorescent spots 
were observed under UV-365 nm indicating the presence of flavonoids in the extracts 
(Figure 6.2). 
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    NV FMS  ADS              NV  FMS  ADS            NV   FMS  ADS 
     P. quercifolium                 P. graveolens                 P. tomentosum  
 
 
 
 
 
 
 
 
 
 
Figure 6.2: The natural products-polyethylene glycol sprayed-TLC plate viewed at UV-365 
nm shows the presence of flavonoids in the crude extract samples. Where: - NV: solvent 
extract of non-volatile compounds; FMS: soxhlet extract of fresh plant material; ADS: 
soxhlet extract of air-dried plant material. All species were obtained from Walter Sisulu 
Botanical Garden. 
 
The chemical pattern of the ADS and FMS extracts were compared to that of the NV 
extract for each species. Intense fluorescent spots (UV-365 nm) were observed for P. 
quercifolium in all the extracts. In P. graveolens, the NV and ADS extracts both contain a 
flavonoid at the same Rf value. Two flavonoids are observed at lower Rf values in the FMS 
extract. In P. tomentosum, a flavonoid at the same retention factor (Rf) value occurs in all 
three extracts. It was noted that the compound/s occurring at the same Rf value in the NV 
and FMS extracts of P. quercifolium did not occur in the ADS extract (highlighted by the 
dashed box in Figure 6.2). Consistency was generally observed in the chemical patterns of 
the three types of crude extracts. 
 
6.3.1.2 HPLC analysis 
The HPLC profiles of the three types of crude extracts for each species are shown in Figure 
6.3, 6.4 and 6.5. The retention times, UV absorbance maxima, tentative identifications and 
percentage areas of the major peaks detected in each extract are summarized in Tables 6.1-
6.3. 
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Figure 6.3: HPLC chromatograms of the three crude extracts of P. graveolens (WSBG). 
Where: - NV: solvent extract of non-volatile compounds; FMS: soxhlet extract of fresh 
plant material; ADS: soxhlet extract of air-dried plant material. 
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Figure 6.4: HPLC chromatograms of the three crude extracts of P. quercifolium (WSBG). 
Where: - NV: solvent extract of non-volatile compounds; FMS: soxhlet extract of fresh 
plant material; ADS: soxhlet extract of air-dried plant material. 
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Figure 6.5: HPLC chromatograms of the three crude extracts of P. tomentosum (WSBG). 
Where: - NV: solvent extract of non-volatile compounds; FMS: soxhlet extract of fresh 
plant material; ADS: soxhlet extract of air-dried plant material. 
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 Table 6.1: HPLC-UV data of the major peaks detected in the HPLC chromatograms of the 
NV, FMS and ADS extracts of P. graveolens (WSBG). 
 
% Integration Retention 
time 
(min) 
UV absorbance 
maxima (nm) 
Tentative 
identification NV FMS ADS 
extract extract extract 
3.97 212.1  55.84 28.15 15.59 
4.59 260.3  0.96 - 2.69 
5.02 274.4  5.85 4.43 - 
6.21 283.9  0.86 1.07 1.13 
6.73 214.5, 273.3  2.05 - - 
7.36 201.6, 247.3  0.92 0.65 1.04 
7.85 256.7  - - 4.14 
9.64 207.4, 317.1  6.66 4.86 6.40 
11.07 203.9, 278.0  2.04 1.40 1.90 
11.82 218.0, 278.0  - 1.23 3.47 
11.97 219.1, 319.4  2.89 4.23 5.77 
12.27 209.8, 320.6  - 1.14 1.15 
12.68 294.5  - - 1.36 
13.39 221.5, 281.5  - 0.86 0.93 
13.71 227.4, 313.5  0.86 - 1.57 
13.99 268.5  1.68 3.11 3.40 
14.41 278.0, 307.6  - 0.92 1.96 
14.70 233.2, 308.8  - - 0.78 
15.55 301.6, 337.3  - - 1.94 
16.07 256.7, 357.5 flavonol - 1.25 1.87 
17.73 2555.6, 354.0 flavonol - - 0.82 
18.52 262.6, 348.0 flavone 1.13 5.15 4.60 
18.91 255.6, 354.0 flavonol 4.77 22.08 17.24 
19.36 255.6, 352.8 flavonol 1.01 2.67 3.84 
20.89 257.9, 352.8 flavonol 1.22 11.17 9.95 
21.40 265.0, 346.8 flavone - - 0.82 
22.27 266.2, 345.6 flavone - 0.63 1.31 
23.04 250.9, 372.8 flavonol - 0.71 - 
26.94 255.6, 369.2 flavonol 5.62 3.71 2.33 
29.79 265.0, 363.4 flavonol 0.75 0.59 - 
36.03 267.4, 344.4 flavone 1.05 - 0.69 
39.33 307.6  3.84 - - 
 
Where: - WSBG = Walter Sisulu Botanical Garden (Johannesburg). 
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 Table 6.2: HPLC-UV data of the major peaks detected in the HPLC chromatograms of the 
NV, FMS and ADS extracts of P. quercifolium (WSBG). 
 
% Integration Retention 
time 
(min) 
UV absorbance 
maxima (nm) 
Tentative 
identification NV FMS ADS 
extract extract extract 
3.97 213.3  42.76 34.81 31.89 
4.99 274.4  6.64 3.09 1.88 
6.75 214.5, 272.1  1.18 - - 
9.64 207.4, 317.1  3.67 4.27 3.41 
11.09 201.6, 278.0  4.32 4.31 4.16 
11.45 206.3, 260.3, 293.4  1.24 - 0.85 
11.82 216.8, 287.4  - 1.19 1.59 
12.06 219.1, 282.7, 317.1  1.51 1.37 1.43 
12.72 201.6, 283.9  - 1.13 1.06 
13.97 268.5  7.76 6.28 6.51 
14.37 206.3, 282.7  1.35 1.82 2.53 
14.69 278.0  - 1.25 1.01 
15.09 220.3, 270.9 flavanone - - 0.98 
15.64 207.4, 352.8 flavonol - 1.82 2.02 
17.54 207.4, 234.4  - - 1.21 
17.67 255.6, 354.0 flavonol - 1.96 - 
17.82 255.6, 354.0 flavonol 1.73 4.33 3.69 
18.52 254.4, 348.0 flavone 2.90 5.59 3.95 
18.91 255.6, 348.0 flavone - 1.02 0.88 
19.36 255.6, 352.8 flavonol - 0.97 1.09 
20.89 255.6, 354.0 flavonol 1.60 4.72 4.31 
21.11 201.6, 230.9  1.89 2.91 3.53 
21.66 255.6, 348.0 flavone 7.34 12.59 12.10 
3.21 23.16 234.4, 363.4  1.74 2.93 
23.77 233.2, 278.0 flavanone 2.70 1.74 3.32 
27.05 255.6, 372.8 flavonol 1.77 - - 
31.00 256.7, 351.6 flavonol - - 0.90 
32.12 243.8, 336.1 flavone 1.20 1.08 1.39 
33.29 267.4, 348.0 flavone 1.12 - 0.80 
41.60 408.8  - - 0.60 
51.79 261.5  3.08 - - 
 
Where: - WSBG = Walter Sisulu Botanical Garden (Johannesburg). 
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 Table 6.3: HPLC-UV data of the major peaks detected in the HPLC chromatograms of the 
NV, FMS and ADS extracts of P. tomentosum (WSBG). 
 
% Integration Retention 
time 
(min) 
UV absorbance 
maxima (nm) 
Tentative 
identification NV FMS ADS 
extract extract extract 
3.34 268.5  - 2.56 - 
3.84 263.8  1.47 15.68 - 
4.04 206.3  8.43 20.67 6.28 
4.60 257.9  - 0.78 - 
4.95 261.5  6.39 6.70 2.09 
5.53 278.0  3.69 - 0.91 
6.74 214.5, 272.1  3.10 - - 
7.37 247.3  2.07 1.21 0.93 
7.94 257.9  1.60 - 1.33 
9.36 209.8, 255.6, 293.4  3.69 - - 
9.82 206.3, 317.1  14.69 9.12 6.27 
11.12 205.1, 278.0  2.24 1.71 - 
11.41 209.8, 261.5, 293.4  1.49 - - 
11.82 214.5, 278.0  1.08 0.53 2.88 
12.05 208.6, 308.8  1.82 1.84 1.36 
12.37 208.6, 308.8  1.54 2.65 1.65 
12.74 308.8  - 1.24 1.16 
13.00 255.0, 281.5  - - 0.82 
13.44 221.5, 285.1  1.35 0.97 - 
13.76 205.1, 312.3  - - 1.32 
14.15 213.3, 319.4  - 2.10 - 
14.44 208.6, 283.9  1.68 3.74 2.73 
15.57 229.7, 289.8  - 1.18 - 
18.69 262.6, 349.2 flavone 3.76 4.15 8.78 
19.17 233.2, 314.7  - 0.92 - 
21.44 236.7  - 0.46 1.18 
21.72 255.6, 348.0 flavone 17.61 9.77 40.84 
22.01 256.7, 308.8 flavone 1.38 - - 
23.03 285.1 flavanone 1.41 - 0.98 
23.15 237.9, 368.0 flavonol - 1.43 - 
24.05 263.8, 342.0 flavone - - 1.00 
24.43 254.4, 348.0 flavone 1.10 - 1.76 
25.02 246.1, 289.8  1.09 0.91 - 
27.05 254.4, 368.0 flavonol 5.79 4.30 0.81 
28.60 255.6, 357.5 flavonol 9.01 4.44 12.71 
36.90 275.6  - 0.30 - 
41.65 278.0, 411.2  - 0.62 0.63 
51.78 261.5  2.55 - 1.57 
 
Where: - WSBG = Walter Sisulu Botanical Garden (Johannesburg). 
 152
 Quantitative and qualitative similarities were found among the three extracts of each 
species. For each species, many of the flavonoid derivatives and other non-volatile 
compounds present in the FMS and ADS extracts were present in the NV extract. Some 
compounds present in the FMS extracts were not detected in either the NV or the ADS 
extracts. Similarly, some compounds present in the ADS extracts were not detected in 
either the NV or the FMS extracts. This implies that the absence of these compounds in the 
NV extracts was not due to the influence of the process of hydrodistillation. In this way, 
the ADS extracts were used to show that when the plant material is processed by soxhlet 
extraction only, to obtain the FMS or ADS extract, some quantitative and qualitative 
chemical variation in the non-volatile component of the extract can still occur.  
 
The TLC and HPLC results therefore indicate that hydrodistillation did not cause 
decomposition of the non-volatile compounds of the biomass used to obtain the NV 
extract. Due to the consistency established in the chemical patterns of the NV, FMS and 
ADS extracts, it can be assumed that the NV extract is representative of the non-volatile 
component of the FMS and ADS extracts. The antimicrobial activity produced by the NV 
extract gives some indication of the antimicrobial activity expected to be produced by the 
non-volatile component of the FMS and ADS extracts. The latter extracts contain the 
volatile component in addition to the non-volatile component and having some idea of the 
expected antimicrobial activity of the non-volatile component of the FMS and ADS 
extracts assists in the evaluation of the effect of the volatile component on the non-volatile 
component of these extracts. 
 
6.3.2 Antimicrobial activity 
The MIC values obtained are summarized in Table 6.4 and graphically presented in Figure 
6.6. All the extracts of each species exerted antimicrobial activity against all the test 
pathogens. It is evident from the results that the extracts containing predominately non-
volatile compounds i.e. the NV extracts do not require the presence of essential oil 
compounds to exert antimicrobial effects.  
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 Table 6.4: The MIC values (mg/ml) recorded for the extracts and essential oil of P. graveolens, P. quercifolium and P. tomentosum. 
Klebsiella  pneumoniae Bacillus cereus Staphylococcus aureus Candida albicans 
NCTC 1633 ATCC 11778 ATCC 12600 ATCC 10231 Species 
NV FMS ADS EO NV FMS ADS EO NV FMS ADS EO NV FMS ADS EO 
P. graveolens 
(WSBG) 4 2 3 8 1.5 2 2 8 4 4 4 16 4 5 8 16 
P. quercifolium 
(WSBG) 4 6 2 8 2 4 2 6 4 8 2 16 4 3 3 8 
P. tomentosum 
(WSBG) 3 4 3 16 2 16 2 24 10 3 6 16 4 12 6 16 
2.5 x 10-3 (a) 3.13 x 10-4 (a) 2.5 x 10-3 (a) 1.25 x 10-3 (b) Controls 
 
Where: - MIC = minimum inhibitory concentration (mg/ml); n = 3, values were conducted in triplicate; Microbial strains: NCTC = National 
Collection of Type Cultures, ATCC = American Type Culture Collection; NV: solvent extract of non-volatile compounds, FMS: soxhlet extract 
of fresh plant material, ADS: soxhlet extract of air-dried plant material, EO: essential oil; WSBG = Walter Sisulu Botanical Garden 
(Johannesburg); (a): ciprofloxacin, (b): amphotericin B. 
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Figure 6.6: The MIC values (mg/ml) of the extracts and essential oil of three Pelargonium species. 
 The NV, FMS and ADS extracts of P. graveolens were equally active against S. aureus. 
Identical MIC results were produced by the NV and ADS extracts of P. tomentosum for K. 
pneumoniae and B. cereus. The MIC values obtained for the NV and ADS extracts of P. 
quercifolium for B. cereus were the same. These findings suggest that the essential oils did 
not have an influence on the antimicrobial activity of the non-volatile compounds or 
extract. 
 
The FMS and ADS extracts were expected to consistently produce the same results as they 
both contain some essential oil compounds in addition to the non-volatile compounds. The 
antimicrobial activity of both the FMS and ADS extracts of P. graveolens against K. 
pneumoniae, of P. quercifolium against C. albicans and of P. tomentosum against S. aureus 
were greater than the activity of their respective NV extracts. The presence of the essential 
oil compounds in the abovementioned FMS and ADS extracts could be responsible for 
their improved antimicrobial activity. However, there is little evidence from the results to 
support this. The FMS extracts generally exerted lower antimicrobial activity than the NV 
extracts. 
 
All the FMS and ADS extracts produced greater antimicrobial activity than the 
corresponding essential oils obtained by distillation. This suggests that the non-volatile 
compounds improve the antimicrobial property of volatile compounds. Essential oils 
extracted by hexane exhibit greater antimicrobial activity than the corresponding steam 
distilled essential oils. The difference in antimicrobial properties indicates a difference in 
the composition of oils obtained by solvent extraction as opposed to distillation (Burt, 
2004). It can be concluded that in the case of Pelargonium, essential oils do not enhance 
the antimicrobial activity of non-volatile extracts, since the ADS and FMS extracts did not 
consistently produce greater antimicrobial properties than the NV extracts. In most cases, 
comparison of the MIC values of the NV and FMS extracts suggest that the essential oils 
are decreasing the antimicrobial activity of the non-volatile extracts. However, the ADS 
extract produced lower antimicrobial activity compared to the NV extract in only three of 
the tested samples. One must consider that not all the essential oil components present in 
the EO sample are present in the FMS extract and ADS extract. In addition, the essential 
oil constituents present in the latter extracts may not occur in sufficient concentrations to 
produce improved activity via disruption of the lipophilic structures of the micro-organism 
cell wall. 
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 CHAPTER 7: ANTI-OXIDANT ACTIVITY 
 
7.1 Introduction  
7.1.1 Definition of a free radical 
A free radical is any chemical species which contains one or more unpaired valence 
electrons (Halliwell and Gutteridge, 1989).  
 
7.1.2 Free radicals in the body 
During normal aerobic metabolism free radicals are produced endogenously, and can react 
with almost all of the cell constituents. Superoxide radicals (O2•) and other active oxygen 
species are products of several cell redox systems such as xanthine oxidase and membrane-
related nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The oxidases are 
produced by various cells in order to accomplish useful bodily functions. The superoxide 
anion (low reactivity) can diffuse across large distances in the cell and in the presence of 
iron or copper a metal-catalyzed reaction, known as the Haber-Weiss reaction, can occur. 
The hydroxyl radical (•OH) is produced from this reaction (Halliwell and Gutteridge, 
1989). 
 
Through the formation of hydroxyl radicals a process known as lipid peroxidation occurs. 
In the outer atomic orbital of normal oxygen species, two electrons are present and this 
confers stability to the molecule. However, the presence of only one of these electrons in 
the outer orbital results in a highly reactive and unstable molecule. In order to complete 
their orbital pair, free oxygen radicals attract electrons from other molecules. The highly 
reactive hydroxyl radical (•OH) reacts with nearby biological molecules which are 
fundamental cellular components (Willson, 1978). The hydroxyl radicals interact with the 
polyunsaturated fatty acid side chain of membrane lipids which results in the production of 
lipid-derived free radicals, namely conjugated dienes and lipid hydroperoxides. These 
radicals cause oxidative damage or breakdown of membranes. The hydroxyl radicals also 
react with the amino acyl chains and thiol groups of proteins or the bases and sugar 
residues within nucleotides and nucleic acids resulting in DNA chain breakage (Repetto 
and Llesuy, 2002) and in this way molecular and cellular damage occurs.  
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 7.1.3 The body’s protective mechanisms against free radicals 
A certain physiological level of reactive oxygen species (ROS) is fundamental for 
regulation of cell function. An elaborate endogenous anti-oxidant system compensates for 
the production of ROS and other free radicals during metabolism.  
 
7.1.3.1 Intrinsic enzymatic anti-oxidant detoxifying mechanisms  
Several intracellular enzymes protect the cell against damaging oxygen-radical reactions by 
scavenging reactive oxygen intermediates (ROI): 
1. Superoxide dismutases (SOD) prevent the accumulation of the superoxide anion by     
catalyzing the dismutation of O2• to hydrogen peroxide. 
2. Glutathione peroxidase and catalase prevent the hydrogen peroxide from forming the    
hydroxyl radical (catalase catalyzes the reduction of H2O2 to water, glutathione peroxidase   
catalyzes the removal of H2O2 at the expense of glutathione oxidation). 
3. Glutathione lipoperoxidase prevents the accumulation of cytosolic lipid peroxides 
(Halliwell and Gutteridge, 1989; Winyard et al., 1994).  
 
7.1.3.2 Intrinsic non-enzymatic anti-oxidant detoxifying mechanisms  
1. A non-catalytic mechanism which protects the cells from the damaging effects of 
oxygen radicals involves the chelation of iron by transferrin. Due to this mechanism, the 
concentration of low molecular mass chelates of iron in normal human serum, capable of 
catalyzing the Haber-Weiss reaction, is effectively zero. Thus the formation of the 
hydroxyl radical is inhibited (Winyard et al., 1994).  
2. The breakdown of polyunsaturated fatty acids mediated by radicals is inhibited by 
vitamin E (α-tocopherol) and β-carotene, both of which are lipid-soluble anti-oxidants. 
Water-soluble molecules such as thiols, vitamin C (ascorbic acid) and uric acid scavenge 
oxygen radicals (O2• and •OH). In addition, reduced vitamin C regenerates oxidized 
vitamin E, and prevents oxidation of thiols in the cytosol. 
 
7.1.4 Imbalance between pro-oxidants and anti-oxidants in the body  
Free radicals are involved in several biochemical mechanisms in vivo, but when free 
radicals are produced in excess of local anti-oxidant defence mechanisms, they become 
highly reactive causing oxidative damage to the cell membrane and ultimately cell death if 
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 the damage continues. Many environmental, lifestyle and pathological factors cause a 
disturbance in the pro-oxidant/anti-oxidant balance with subsequent accumulation of 
excess free radicals resulting in oxidative stress (Rice-Evans and Burdon, 1994; Alfonso et 
al., 2003). These factors may increase the process of lipid peroxidation through the 
formation of excess hydroxyl radicals. Phagocytic cells upon stimulation have increased 
oxygen uptake and utilize the NADPH oxidase to release superoxide anions into 
extracellular fluid (Kleblanoff, 1982). Xanthine oxidase containing tissues, during 
ischaemia and reperfusion, appear to produce superoxide anions (McCord, 1985).  
 
7.1.5 Free radical-mediated pathology 
The free radical involvement in cell damage forms part of a more multifaceted deleterious 
process (Rice-Evans and Burdon, 1994). The aetiology and pathogenesis of various 
degenerative diseases such as neurodegenerative disorders, cardiovascular disease, 
inflammation and other chronic diseases have been linked to oxidative stress and hence 
associated with the oxidation of polyunsaturated fatty acids, lipoproteins and membrane 
lipids (Repetto and Llesuy, 2002; Willcox et al., 2004). The key oxygen-radical species 
mediating biochemical tissue damage in various pathological conditions is thought to be 
the hydroxyl free radical (Halliwell and Gutteridge, 1989).  
 
Human inflammatory fluids have been found to contain oxidized molecules which are 
products of free radical reactions (Winyard et al., 1994). In acute or chronic inflammation, 
the biological metabolic balance of the production and removal of oxygen radicals may be 
disturbed by a pathogenetic factor ultimately leading to cellular damage. The inflammatory 
process is another potential source of free radicals (peroxy and alkoxy radicals) (Jackson et 
al., 1983; Duncan, 1991). Due to the high reactivity of peroxy and alkoxy radicals with 
other polyunsaturated fatty acids, they can initiate the non-enzymatic lipid peroxidation 
process, whereby membrane fatty acids are degraded. Damaged cell membranes lead to 
further inflammation. Hence free radicals and inflammation are intimately linked. 
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 7.1.6 Anti-oxidants 
An anti-oxidant is any substance which can delay or prevent the oxidation of a substrate 
when present in small amounts relative to that oxidizable substrate (Rice-Evans and 
Burdon, 1994). Several different stages occur in the process of lipid peroxidation. Thus 
anti-oxidants can act in the five following ways in the oxidative sequence (Halliwell and 
Gutteridge, 1989).  
Anti-oxidants: 
1) Decrease localized oxygen concentrations; 
2) Prevent chain initiation by scavenging initiating radicals; 
3) Bind catalysts such as metal ions to prevent initiating radical generation; 
4) Decompose peroxides so that they cannot be reconverted to initiating radicals; 
5) Break chains to prevent continued hydrogen abstraction by active radicals. 
 
The activity of the endogenous anti-oxidant systems may be reinforced by anti-oxidants 
and in this way provides additional protection against oxidative stress. Lipid peroxidation 
and other free radical-mediated processes are inhibited by anti-oxidants and thus protect 
the body from several free radical-related diseases (Repetto and Llesuy, 2002). Anti-
oxidants of synthetic or natural origin may have a significant role to play in the 
maintenance of the pro-oxidant/anti-oxidant balance. Of current interest is the potential 
anti-oxidant protective effect of natural compounds on affected tissues. Research indicates 
that through sufficient anti-oxidant defence, protection can be afforded against free radical 
damage associated with specific diseases and lifestyle patterns and processes such as 
cancer, aging, circulatory conditions, arthritis, pollution and strenuous exercise (Packer, 
1991).  
 
7.2 Materials and methods 
7.2.1 The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging assay  
HPLC analysis provides standardized information with regards to the concentration of 
individual anti-oxidants in plant extracts. The prediction of a mixture’s anti-oxidant 
potency based on compositional data is difficult since the anti-oxidant pattern is rather 
complex. Thus the use of specific assays to assess the anti-oxidant activity of plant extracts 
is necessary (Schwarz et al., 2001). Test systems that evaluate the radical scavenging 
ability of anti-oxidants aim to simulate basic mechanisms involved in lipid oxidation by 
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 measuring either the reduction of stable radicals or radicals generated by radiolysis, 
photolysis, or the Fenton reaction (Schwarz et al., 2001). The anti-oxidant activity of 
compounds can be evaluated accurately, conveniently and rapidly using the DPPH method 
(Prakash, 2001). The quantitative measurement of the in vitro hydrogen donating capacity 
of 23 Pelargonium acetone extracts was carried out using the DPPH assay adopted from 
the colourimetric method described by Shimada et al. (1992). 
 
7.2.2 Principle of the method 
The DPPH molecule is a stable free radical with a low deterioration rate and low reactivity 
towards most compounds. As a result, only good hydrogen atom donors are likely to react 
with the stable radical (Schwarz et al., 2001). The DPPH radical has a dark violet colour 
due to the delocalization of an unpaired electron. Briefly, the stable DPPH radical has a 
strong absorption band at 550 nm, but upon reduction by an anti-oxidant or radical species 
its absorption decreases (Pinelo et al., 2004) and so bleaching of the purple coloured DPPH 
occurs at 550 nm (Figure 7.1). 
 
igure 7.1: The reduction of the DPPH radical by a hydrogen-donating compound. 
7.2.3 Protocol 
issolved in analytical grade methanol (Ultrafine Ltd.) to obtain a 96 
N N
NO2
NO2
O2N
.
+ FlOH
DPPH radical (purple) 
O2N
NO2
NO2
NN
H
+
FlO .
Reduced DPPH (yellow) 
 
F
 
DPPH (Fluka) was d
µM solution which was stored in a volumetric flask wrapped in foil and kept in the fridge 
at +4ºC. An initial stock solution of 10 000 µg/ml was prepared by dissolving 10 mg of 
plant extract in 1 ml of dimethyl sulfoxide (DMSO) (Saarchem). A 500 µg/ml solution was 
prepared, whereby 50 µl of the 10 000 µg/ml stock solution was diluted with 950 µl 
DMSO.  
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 For the primary screening of the extracts, each sample was tested at an initial concentration 
of 100 µg/ml. Fifty microlitres of the 500 µg/ml solution were added to wells 1B, 1C, 1D, 
2B, 2C, 2D. Eleven other test samples were plated out in the same way. For the control 
readings, 50 µl of DMSO was added to each well of rows A and H. DPPH solution (200 
µl) was added to the wells in column 1, 3, 5, 7, 9, 11. Analytical grade methanol (200 µl) 
was added to the wells in columns 2, 4, 6, 8, 10, 12; the reaction mixtures that contained 
extract and methanol were used to compensate for coloured extracts. The plates were 
shaken for two minutes using an automated microtitre plate reader (Labysystems Multiskan 
RC). After allowing the plates to stand for a period of 30 minutes at room temperature in 
the dark, the decrease in absorbance at 550 nm was measured using an UV-VIS 
spectrophotometer linked to a computer equipped with GENESIS® software. The 
percentage decolourisation as a measure of the free radical-scavenging activity of the 
extracts was calculated according to the following equation: 
 
 
% Decolourisation =    [Av controls – (Av sampleDPPH  – Av samplemethanol)]  x 100 
  
                                                                       Av controls 
 
 
 
Where: - Av controls = average absorbance of all DPPH control wells – average 
absorbance of all methanol control wells; Av sampleDPPH  = average absorbance of sample 
wells with DPPH and Av samplemethanol = average absorbance of sample wells with 
methanol. 
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Figure 7.2: A 96-well microtitre plate prepared for use in the DPPH assay. Purple wells 
indicate the absence of anti-oxidant substances and yellow wells signify anti-oxidant 
activity. 
 
For those extracts with ≥50% decolourisation at the starting concentration of 100 µg/ml, 
retesting of the samples was carried out at lower concentrations using serial dilutions. Five 
stepwise 1: 1 serial dilutions were prepared from each 500 µg/ml solution of plant extract 
using DMSO. Percentage decolourisation was plotted against the concentration of the 
sample and the IC50 values were determined using Enzfitter® version 1.05 software. IC50 
values indicate the concentration of sample required to scavenge 50% of the DPPH radical.  
Each experiment was done in triplicate. Vitamin C (L-ascorbic acid) was used as a positive 
control. 
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 7.3 Results and discussion 
The anti-oxidant activity of the Pelargonium acetone extracts are summarized in Table 7.1 
and presented in Figure 7.3. Lis-Balchin and Deans (1996) concluded that the anti-oxidant 
activity of methanolic extracts of representative species and cultivars of Pelargonium were 
very pronounced. This was found to be true for the acetone extracts of numerous species in 
this study. Pelargonium betulinum (IC50 = 4.13 ± 0.14 µg/ml) and P. crispum (IC50 = 4.49 ± 
0.18 µg/ml) displayed greater anti-oxidant activity than the positive control, vitamin C 
(IC50 = 4.72 ± 0.14 µg/ml). Other species showing remarkable anti-oxidant ability include 
P. cordifolium (NBG and WSBG), P. cucullatum (WSBG) and P. scabrum (Table 7.1). In 
the study conducted by Lis-Balchin and Deans (1996), the methanolic extracts of P. 
cucullatum showed pronounced anti-oxidant activity, this is in agreement with the result 
obtained in this study for the acetone extract of P. cucullatum (WSBG) (IC50 = 10.91 ± 
0.54 µg/ml). Pelargonium glutinosum (SBG), P. graveolens (SBG), P. hermanniifolium, P. 
hispidum, P. quercifolium (SBG) and P. sublignosum produced substantial activity. 
Pelargonium citronellum (SBG), P. panduriforme (WSBG), P. papilionaceum (NBG) 
showed limited activity (Figure 7.3.). 
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 Table 7.1: In vitro anti-oxidant activity (µg/ml) of Pelargonium acetone extracts. 
 
Species Locality DPPH IC50 s.d. (µg/ml) 
P. betulinum NBG 4.13 0.14 
P. capitatum Strand nd nd 
P. citronellum NBG 23.70 3.68 
P. citronellum SBG 84.01 16.08 
P. cordifolium NBG 5.01 0.55 
P. cordifolium WSBG 5.31 0.24 
P. crispum NBG 4.49 0.18 
P. cucullatum SBG 40.18 5.65 
P. cucullatum WSBG 10.91 0.54 
P. glutinosum SBG 16.41 0.33 
P. glutinosum WSBG 29.17 0.78 
P. graveolens SBG 14.49 0.46 
P. graveolens WSBG 26.81 1.80 
P. greytonense SBG nd nd 
P. hermanniifolium SBG 13.50 0.73 
P. hispidum SBG 12.78 0.45 
P. panduriforme SBG nd nd 
P. panduriforme WSBG 91.58 4.45 
P. papilionaceum NBG 81.24 13.44 
P. pseudoglutinosum NBG 52.38 0.67 
P. quercifolium SBG 17.15 0.58 
P. quercifolium WSBG 61.87 3.19 
P. radens SBG nd nd 
P. scabroide SBG nd nd 
P. scabrum SBG 7.15 0.11 
P. sublignosum SBG 17.61 3.18 
P. tomentosum SBG 28.16 2.65 
P. tomentosum WSBG 21.73 0.99 
P. vitifolium SBG nd nd 
Vitamin C - 4.72 0.14 
 
Where: - NBG = National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical 
Garden, WSBG = Walter Sisulu Botanical Garden (Johannesburg); nd = not determined 
due to insufficient extract for testing; s.d. = standard deviation; n = 3: triplicate 
measurements were performed for all samples.  
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Figure 7.3: The comparative DPPH radical-scavenging abilities of Pelargonium acetone extracts in terms of IC50 values.                        
Where: - (S) = Stellenbosch Botanical Garden, (N) = National Botanical Garden (Kirstenbosch), (W) = Walter Sisulu Botanical Garden 
(Johannesburg). 
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 An attempt was made to relate those species with similar anti-oxidant activity on a 
chemical level. Pelargonium betulinum, P. cordifolium (WSBG), P. crispum and P. 
cucullatum (SBG) and P. scabrum extracts share some similarities in their chemical 
fingerprints (Chapter 4). Pelargonium betulinum, P. cordifolium (WSBG), P. crispum and 
P. scabrum demonstrated exceptional anti-oxidant activity (IC50 = 4.13 ± 0.14 µg/ml – 7.15 
± 0.11 µg/ml). However, P. cucullatum (SBG) displayed moderate anti-oxidant activity 
(IC50 = 40.18 ± 5.65 µg/ml). The representative flavonoid patterns identified in the 
Pelargonium species suggested that P. betulinum (NBG), P. capitatum (Strand), P. 
graveolens (SBG), P. hispidum (SBG), P. panduriforme (SBG) and P. vitifolium (SBG) 
share very characteristic chemical profiles (Chapter 4). Due to insufficient extract, P. 
capitatum (Strand), P. panduriforme (SBG) and P. vitifolium (SBG) were not tested in the 
DPPH assay. It was found that P. graveolens (SBG) and P. hispidum (SBG) produced 
almost similar IC50 values. Pelargonium scabrum and produced greater anti-oxidant 
activity than P. sublignosum; these species had similar chemical profiles. 
 
The two samples of P. cordifolium displayed similarly high anti-oxidant activities (Figure 
7.3). Pelargonium tomentosum (SBG) and P. tomentosum (WSBG) displayed analogous 
IC50 values of 28.16 ± 2.65 µg/ml and 21.73 ± 0.99 µg/ml, respectively. The similar 
activity of the duplicate samples of the same species may be due to their similar chemical 
compositions. Notable differences were observed in the activities of the duplicate samples 
of P. citronellum, P. cucullatum and P. quercifolium. Such diverse radical-scavenging 
abilities may be attributable to the different chemistry of the duplicate samples of the same 
species. Further investigations involving HPLC analysis of the duplicate samples would 
allow for a comparison of their chemical compositions in order to gain a better 
understanding of the similarities and differences observed in activity. 
 
Flavonoids have been shown to be effective scavengers of ROS (Rusak et al., 2005). The 
superoxide anion (O2•), hydroxyl (•OH), peroxyl (ROO•) and alcohoxyl (RO•) radicals 
are trapped via the anti-oxidant activity of flavonoids (Repetto and Llesuy, 2002). 
Flavonoids act as anti-oxidants in vivo; they stabilize the membranes by decreasing their 
permeability and also bind to free fatty acids (Svoboda and Hampson, 1999). Flavonoids 
are potential therapeutics for free radical mediated pathologies (Repetto and Llesuy, 2002). 
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 The health benefits related to flavonoids have increased the significance of natural anti-
oxidants (Schwarz et al., 2001).  
 
The composition of the extracts and thus their anti-oxidant activity is greatly influenced by 
the extraction methods (Schwarz et al., 2001). Pelargonium plant material was extracted 
with acetone which isolates flavonoid glycosides and the more polar aglycones such as 
hydroxylated flavones, flavonols, biflavonyls, aurones, chalcones and anthocyanidin 
(Harborne et al., 1975). HPLC-UV analysis confirmed the presence of flavonoid 
derivatives in the Pelargonium acetone extracts (Chapter 4). These compounds may 
contribute to the anti-oxidant activity of the Pelargonium extracts. The presence of 
flavonoids is mainly responsible for the medicinal properties of folk plants. However, other 
organic and inorganic compounds such as coumarins, phenolic acids and anti-oxidant 
micronutrients e.g. Cu, Mn, Zn may also contribute to the medicinal properties of plants 
(Repetto and Llesuy, 2002).  
 
The Pelargonium species, in particular P. betulinum, P. crispum P. cordifolium and P. 
scabrum, are possible sources of anti-oxidant compounds. It is projected that these 
compounds may have potential use in the development of therapeutics for free radical- 
mediated pathologies. Sources of natural anti-oxidants are significant in the 
chemoprevention of diseases resulting from lipid peroxidation, since such anti-oxidant 
compounds protect against oxidative stress (Nakatami, 2000). 
 
Vitamins, minerals and botanical extracts are amongst some of the most popular substances 
incorporated into topical preparations used to defy skin aging. Natural products are used in 
cosmetic preparations due to their low mammalian toxicity (Aburjai and Natsheh, 2003). 
The daily application of skincare products containing anti-oxidant agents can mitigate and 
partially reverse the skin aging effects of free radicals. The appearance of fine lines and 
wrinkles can be improved by using vitamin C and E containing creams. Vitamin C restores 
the skin’s elasticity and resiliency by stimulating the production of collagen (Rabat, 2003). 
Pelargonium betulinum, P. crispum P. cordifolium and P. scabrum in this study showed 
similar anti-oxidant activity to that of vitamin C. Isolation of the active anti-oxidant 
compounds from these Pelargonium species may be potential ingredients for use in 
cosmetic preparations where they may play a role in the preservation and rejuvenation of 
the skin through their anti-oxidant action. 
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 The major bestower to skin aging is ultraviolet radiation; this is known as photo-aging. 
Flavonoids have considerable absorption between 200-380 nm and so function to screen 
the plants from UV radiation (Harborne et al., 1975). This suggests the possible utilization 
of flavonoids as UV-screen compounds to protect the human skin. In addition, the 
flavonoids may protect against UV radiation-induced peroxidation, probably by scavenging 
oxygen free radicals generated by UV irradiations (Bonina et al., 1996). Furthermore, 
phenolic substances enhance the solubility characteristics of compounds and the phenols 
are easily moved across biological membranes (Parke, 1968). This further advocating the 
potential use of Pelargonium extracts, containing many flavonoids, as ingredients in skin 
care preparations where they may have the dual action of anti-aging and sun protection. 
 
Oxygen may be highly damaging to food if not properly controlled. ROS initiates oxidative 
rancidity (lipid oxidation) of foods (Alfonso et al., 2003). Synthetic anti-oxidants as food 
additives are consumed in large amounts. There is increasing evidence that these agents 
have been associated with toxicity problems. Interest in the development of natural anti-
oxidants as food preservatives is escalating due to consumer preference for natural 
ingredients and concerns regarding toxic effects of synthetic anti-oxidants.  
 
The food industry requires the anti-oxidative properties of botanical extracts. Food with 
added natural anti-oxidants can be referred to as functional foods since the consumer is 
afforded greater health benefits by these products (Alfonso et al., 2003). Tocopherols, 
ascorbic acid, rosemary extracts, lycopene and some flavonoids are natural anti-oxidants 
which are available to be added to food in place of synthetic agents (Alfonso et al., 2003). 
Scavenging by stable radicals is a suitable method for predicting the inhibition, by 
botanical extracts, of primary oxidation product formation in food systems (Schwarz et al., 
2001). Such a prediction needs to be verified by assessing the anti-oxidant activity in a 
model food system. This verification would possibly highlight certain Pelargonium species 
as having a definite place in the food industry. 
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 CHAPTER 8: ANTI-INFLAMMATORY ACTIVITY 
 
8.1 Introduction 
Inflammation comprises a complex cascade of adaptive responses to tissue injury which 
are both local and systemic. The local responses involve recruitment of phagocytic cells 
and removal of foreign or endogenous material. These processes occur more efficiently 
through the changes brought on by the systemic responses. There is immense replication of 
functions amongst the biochemical mediators and regulators of inflammation due to the 
importance of this response to the survival of the organism (Whicher and Evans, 1992). 
When this response is exaggerated it can be the initiator of various ailments (Baylac and 
Racine, 2003).  
 
8.1.1 The biosynthesis of eicosanoids  
The hormone-like compounds produced by tissue cells and tumour-infiltrating leukocytes 
are referred to as eicosanoids, which are biosynthesized from the fatty acid components of 
the phospholipid structure of cell membranes, mainly from arachidonic acid (AA). 
Eicosanoids are classified into three classes, namely prostaglandins (PGs), leukotrienes 
(LTs) and thromboxanes, and have powerful activities in cell proliferation and tissue 
repair, blood clotting, blood vessel permeability, inflammation and immune cell behaviour 
(Fischer and Slaga, 1985).  
 
In the event of trauma, phospholipase A2 (PLA2) generates AA near the cell wall surface 
which is acted upon by enzymes (Figure 8.1). The synthesis of eicosanoids occurs via three 
enzymatic pathways. The first pathway is catalyzed by cyclo-oxygenase (COX) which 
produces endoperoxides that are instantly converted into series-2-prostaglandins and 
thromboxanes (Figure 8.1). The lipoxygenase (LOX) group of enzymes is involved in the 
second pathway, these enzymes create hydroperoxyeicosatetraenoic acids (HPETEs). 
HPETEs are converted into series-4 LTS and different hydroxyeicosatetraenoic acids 
(HETEs) such as 5-HETE, 12-HETE and 15-HETE. The third pathway involves 
cytochrome P450 which catalyzes the formation of 12-HETE and 16-HETE (Wallace, 
2002).  
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 Membrane Phospholipids 
Arachidonic acid (AA) 
Leukotrienes Thromboxanes       Prostaglandins 
Phospholipase A2 (PLA2) 
LTA4 
LTB4 LTC4 
LTD4 
LTE4 
5-Lipoxygenase Cyclo-oxygenase 
5-HPETE 5-HETE PGG2 
PGH2 
Thromboxane A2
Thromboxane B2 
PGI2 (prostacyclin) 
PGD2 PGE2 
PGF2α 
6-Keto-PGF1α 
5-HPETE = 5-hydroperoxyeicosatetraenoic acid, 5-HETE = 5-hydroxyeicosatetraenoic 
acid; LTA4 = leukotriene A4, LTB4 = leukotriene B4, LTC4 = leukotriene C4, LTD4 = 
leukotriene D4, LTE4 = leukotriene E4; PGG2 = prostaglandin G2, PGH2 = prostaglandin 
H2, PGD2 = prostaglandin D2, PGE2 = prostaglandin E2, PGF2α = prostaglandin F2α, 6-Keto-
PGF1α = 6-Keto-prostaglandin F1α. 
 
Figure 8.1: Metabolism of arachidonic acid (modified from Celotti and Durand, 2003). 
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 8.1.2 The role of 5-lipoxygenase in inflammation 
The 5-lipoxygenase (5-LOX) enzyme is present in macrophages and mast cells, but is 
expressed mainly in leukocytes. It is a soluble monomeric enzyme containing a non-heme 
atic cascade; once stimulated by the 
-lipoxygenase activating protein (FLAP), it catalyzes the first two steps in LT 
.1.2.1 The pathophysiological role of leukotrienes 
recent years has the inflammatory role of LKs been fully identified (Celotti and Durand, 
e powerful mediators of inflammatory and allergic responses through the 
mooth muscle tone and vascular permeability. Activation of neutrophil 
iron atom which is in the ferrous form in the resting state. During catalysis the iron cycles 
between ferrous and ferric states and so the enzyme is converted from an inactive reduced 
Fe (II) state to the active oxidized Fe (III) state. 
 
5-LOX is the initial key enzyme in the second enzym
5
biosynthesis from AA. Arachidonic acid is first converted into 5-HPETE (Figure 8.1) by 
the insertion of oxygen into the C-5 of AA (dioxygenase activity) and then through a 
dehydration step to the short lived epoxide LTA4 (epoxygenase activity). LTA4 is a 
common unstable intermediate converted by LTA4 hydrolase into the dihydroxy 
leukotriene B4 or converted via leukotriene C4 synthase, a specific glutathione-transferase 
enzyme, into LTC4, LTD4 and LTE4 which make-up the mixture previously known as the 
slow-reacting substance of anaphylaxis (SRSA) (Wallace, 2002).  
 
8
Borgeat and Samuelsson (1979) discovered LKs more than twenty years ago, but only in 
2003).  
 
LKs ar
modulation of the s
migration and chemotaxis and stimulation of superoxide production and lysosomal enzyme 
secretion is brought on by LTB4. Rheumatoid arthritis, psoriasis and inflammatory bowel 
disease have been associated with increased levels of this 5-LOX by-product (Tsuji et al., 
1998). 5-LOX compounds induce the activation of leukocytes resulting in tissue damage 
and hyperplasia. The pathophysiological role of leukotriene molecules has been well 
defined in various inflammatory and allergic conditions including asthma and allergic 
rhinitis (Rioja et al., 2002). Knock-out animal studies revealed a definite contribution of 5-
LOX and its products to the inflammatory response; mice deficient in 5-LOX exhibited a 
significant decrease in several inflammatory parameters (Celotti and Durand, 2003).  
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 In the early 1980’s, several global pharmaceutical companies realized that novel anti-
inflammatory agents could be developed from the discovery of 5-LOX inhibitors or from 
here are two isoforms of cyclo-oxygenase. Cyclo-oxygenase-1 (COX-1) is constitutively 
duces prostanoids important in homeostatic 
he effectiveness of conventional non-steroidal anti-inflammatory drugs (NSAIDs) for the 
 is curtailed by the high occurrence of the 
 has been reported that several botanical agents have the ability to modulate the 
l use as anti-inflammatory agents include 
particular leukotriene receptor antagonists (Young, 1999).  
 
8.1.3 The role of cyclo-oxygenase enzyme 
T
expressed in most mammalian tissues and pro
functions such as gastric cytoprotection, maintenance of renal function, and platelet 
stabilization and activity. Cyclo-oxygenase-2 (COX-2) is an immediate early response 
gene product in inflammatory and immune cells and synthesizes high levels of 
prostaglandins (Rioja et al., 2002). COX-2 synthesizes series-2-prostaglandins (e.g. PGE2, 
PGF2α) that contribute to pain, inflammation and swelling (Wallace, 2002). Previous 
research indicates important roles of COX-2 in several physiological processes such as 
wounds and ulcer healing, cardiovascular protection, regulation of bone resorption, renal 
function and female reproductive physiology (Celotti and Durand, 2003). 
 
8.1.4 Current anti-inflammatory agents 
T
chronic treatment of inflammatory diseases
serious side-effects of gastric ulceration, perforation or obstruction (Fries, 1996). The 
selective COX-2 inhibitors (e.g. Celebrex®, Vioxx®) were developed as anti-inflammatory 
agents in the hope of producing a new class of compounds with a reduced side effect 
profile. However, it has been found that cardiovascular concerns can emerge particularly if 
selective COX-2 inhibitors are used in patients with underlying heart diseases. 
Furthermore, there are potential kidney, liver or gastro-intestinal related complications due 
to selective COX-2 inhibition (Celotti and Durand, 2003). The above highlights the need 
for the development of safe anti-inflammatory agents. 
 
8.1.5 Botanical anti-inflammatory agents 
It
inflammatory process. Plants with traditiona
feverfew, Tanacetum parthenium; devil’s claw, Harpagophytum procumbens; hops, 
Humulus lupulus; Asian ginseng, Panax ginseng and milk thistle, Silybum marianum, just 
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 to name a few (Wallace, 2002). Pharmacological and pharmacognostic investigations have 
resulted in the development of many conventional anti-inflammatory agents such as 
salicylic acid which is a derivative of salicin obtained from the Salix and Populus 
subspecies (Trease and Evans, 1978).  
 
The application of multiple natural agents offers considerable synergistic effects due to 
eir different compounds providing multiple effects at varying points in the inflammatory 
ti-inflammatory properties are used for the 
eatment of various disease states. Essential oils contain lipid soluble compounds which 
apy 
nti-inflammatory agents may have a potential therapeutic application as adjuncts to 
rgery. Emerging 
 and its by-
roducts is a fundamental component in integrative cancer approaches (Wallace, 2002). 
OX as well as LOX inhibitors and so decrease the 
eneration of PGE2, LTB4, 5-HETE and 12-HETE and other inflammatory compounds, 
th
cascade. In addition, several botanical agents can be selected and combined to provide both 
COX and LOX inhibition (Wallace, 2002).  
 
Numerous essential oils with reported an
tr
are able to permeate through the skin barrier and interfere with enzymatic pathways 
occurring in the epidermis and beyond (Baylac and Racine, 2003).  
 
8.1.6 Anti-inflammatory agents within the realm of cancer ther
A
conventional cancer treatments such as chemotherapy, radiation and su
research is relating cancer initiation, promotion, progression, angiogenesis and metastasis 
to inflammatory effects. LOX by-products, the LTs and HETEs (LTB4, 5-HETE and 12-
HETE), have been implicated in tumour growth and advancement (McCarty, 2001). It has 
been proposed by limited research that LTs may exert a greater role than PGs in 
stimulating tumour growth, depending on the type of cancer (Wallace, 2002). 
 
Previously presented evidence suggests that the inhibition of lipoxygenase
p
Thus, the goal of integrative cancer therapies is not only to destroy the affected cells, but is 
also to incorporate molecular management of cancer physiopathology by employing a key 
strategy which appears to be inflammatory deregulation particularly modulated by dietary, 
nutritional and botanical agents.  
 
Numerous phytomedicines are C
g
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 which have demonstrated definite roles in cancer. The following botanical agents have 
demonstrated in vitro and/or in vivo anti-inflammatory actions and anticancer properties: 
boswellic acids (Boswellia serrata), bromelain (Ananas comosus), curcumin (Curcuma 
longa) and quercetin (Wallace, 2002).  
 
8.2 Materials and methods 
8.2.1 5-lipoxygenase (soybean) assay 
The in vitro anti-inflammatory activity of the essential oils of seven Pelargonium species 
l. (1983) as modified by Evans (1987). 
-lipoxygenase catalyses the oxidation of unsaturated fatty acids containing 1-4 pentadiene 
idonic acid is the biological substrate of 5-LOX, but the 
he assay was carried out in phosphate buffer which is an aqueous medium and so a non-
ween® 20 was employed to disperse the essential oil in the buffer. 
Saarchem) and Tween® 20 (Merck) to produce a 
tarting concentration of 100 µg/ml. The standard assay mixture was prepared in a 3 ml 
was assessed using the method of Sircar et a
 
8.2.1.1 Principle of the method 
5
structures. Within the body, arach
enzyme also accepts linoleic acid, which was used in this assay. In vitro, 5-lipoxygenase 
oxidizes linoleic acid into a conjugated diene which absorbs at 234 nm. 5-LOX activity is 
evaluated by the spectrophotometric measurement of this by-product at 234 nm. The initial 
reaction rate was measured spectrophotometrically and the decrease of this initial reaction 
rate is a measure of the samples inhibitory activity (Baylac and Racine, 2003).  
 
8.2.1.2 Protocol  
T
ionic surfactant T
Linoleic acid, rather than arachidonic acid, was used due to its ease of handling and 
stronger affinity for the 5-lipoxygenase enzyme resulting in greater UV absorbance 
readings (Baylac and Racine, 2003).   
 
Samples were dissolved in DMSO (
s
cuvette maintained at 25°C in a thermostated waterbath. The standard assay mixture 
contained 10 µl of plant extract solution, 2.95 ml of prewarmed (25°C) 0.1 M potassium 
phosphate buffer (pH 6.3) prepared with analytical grade reagents and 45 µl of 100 µM 
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 linoleic acid (≥99%) from Fluka. For the negative control the same mixture was prepared 
as above but a blank consisting of DMSO and Tween® only (no plant extract) was used. 
 
The enzymatic reaction was initiated by the addition of 100 units isolated 5-lipoxygenase 
or those test samples which displayed activity at 100 µg/ml, different dilutions were 
ordihydroguaiaretic acid (NDGA, Cayman), a synthetic 5-LOX inhibitor, was used as a 
(Cayman), diluted with equal volume 0.1 M potassium phosphate buffer (pH 6.3) 
maintained at 4°C. A single beam UV-VIS spectrophotometer (Analytikjena Specord 40) 
connected to a computer equipped with Winaspect® software recorded the increase in 
absorbance at 234 nm for 10 minutes at 37°C and so the enzyme activity was followed 
spectrophotometrically. When the enzyme was added to linoleic acid, stabilized with the 
buffer, the rate of the enzyme-catalysed conversion of the substrate to 9-hydroperoxy-
10,12,15-octa-decatrienoic was maximal. The transformation of the unsaturation site of 
linoleic acid (from diene 1-4 to diene 1-3) caused the increase in absorption at 234 nm 
(Baylac and Racine, 2003).  
 
F
prepared using DMSO and Tween® 20. The initial reaction rate was determined from the 
slope of the straight line portion of the curve. The percentage inhibition of enzyme activity 
attributable to the sample was calculated by comparison with the negative control. 
Percentage enzyme activity was plotted against concentration of plant extract. Thereafter, 
the IC50 values (the concentration of essential oil which produced 50% inhibition) were 
determined from the dose-response curves using Enzfitter® version 1.05 software.  
 
N
positive control (reference compound) in this assay. NDGA has been reported to exert 
strong inhibitory effects on the 5-LOX enzyme (Abad et al., 1995).  
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 8.3 Results and discussion 
The 5-LOX assay revealed that 5-lipoxygenase, the key enzyme involved in the 
biosynthesis of LTs, is a potential site of action for certain Pelargonium essential oils 
(Table 8.1). The oils of P. citronellum (NBG), P. panduriforme (SBG and WSBG), P. 
quercifolium (SBG and WSBG) and P. scabrum dose-dependently inhibited the activity of 
5-LOX. As the concentration of oil increases, there is concomitant decrease in the initial 
reaction rate determined from the slope of the straight line portion of the curve. The two 
samples of P. quercifolium showed the greatest inhibition of 5-LOX enzyme activity (IC50 
= 33.24 µg/ml - 38.67 µg/ml). Pelargonium citronellum (NBG), P. panduriforme (SBG 
and WSBG) and P. scabrum also displayed promising inhibitory activity (Figure 8.2). 
Pelargonium graveolens (SBG), P. radens (NBG) and P. tomentosum (SBG and WSBG) 
did not exert 5-LOX inhibitory activity (IC50 >100 µg/ml). 
 
 
Table 8.1: The in vitro 5-LOX inhibitory activity of the Pelargonium essential oils. 
 
Species 5-LOX inhibitory 
activity IC50 (µg/ml) 
Standard Locality (essential oil) error 
P. citronellum NBG 50.04 7.06 
P. graveolens SBG >100 - 
P. panduriforme SBG 45.58 1.13 
P. panduriforme WSBG 45.39 9.13 
P. quercifolium SBG 33.24 7.66 
P. quercifolium WSBG 38.67 4.31 
P. radens NBG >100 - 
P. scabrum SBG 54.68 5.29 
P. tomentosum SBG >100 - 
P. tomentosum WSBG >100 - 
Control - 5  
 
Where: - NBG = National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical 
Garden, WSBG = Walter Sisulu Botanical Garden (Johannesburg). 
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Figure 8.2: The IC50 values (µg/ml) in terms of 5-LOX inhibitory activity of the 
Pelargonium essential oils. 
 
 
With reference to the dendrogram (Chapter 3, Figure 3.2), the essential oils exhibiting 
enzyme inhibition are found in different clusters, (A), (F) and (G). The two samples of P. 
panduriforme have the same anti-inflammatory potencies. This is expected since these oil 
samples are closely associated in the cluster dendrogram. The P. quercifolium samples 
exerted similar inhibitory effects; however, they have a moderately low degree of 
similarity in the dendrogram. The difference in the IC50 values of the duplicate samples of 
P. panduriforme and of that of P. quercifolium was assessed and evident from the 
dendrogram; the P. quercifolium samples were not as closely associated with one another 
as the P. panduriforme samples. Pelargonium quercifolium (WSBG) oil showed 
reasonably similar activity to that of the P. panduriforme samples and these species are 
grouped in the same cluster subgroup (FA).  
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 Pelargonium citronellum (NBG) and P. scabrum produced similar IC50 values; however, 
they are not chemically similar. Pelargonium citronellum (NBG) occurs in cluster (A) and 
P. scabrum is located in cluster (G). This indicates that oils with varying constituents can 
produce similar anti-inflammatory activities. 
 
Pelargonium graveolens (SBG), P. radens (NBG), P. tomentosum (SBG) and P. 
tomentosum (WSBG) are all grouped into one cluster, namely subgroup (EA) (Chapter 3, 
Figure 3.2). The chemical similarity shared by these oil samples was demonstrated by their 
results obtained in this assay. Isomenthone occurred in very high amounts (49.3-84.5%) in 
subgroup (EA). This compound may exert antagonistic effects on any anti-inflammatory 
compounds which may be present in these oils, as in the other clusters containing the active 
species, P. citronellum (NBG), P. panduriforme, P. quercifolium and P. scabrum, 
isomenthone is either absent or present at very low levels. 
 
One is inherently inclined to think that the major compounds are responsible for the 
biological activities displayed by a species. Several chemical compounds have been 
reported by Baylac and Racine (2003) to produce in vitro inhibition of the 5-LOX enzyme, 
some of these compounds are present at low levels in the active oils (Table 8.2). These 
compounds may act collectively in a synergistic manner and may contribute to the anti-
inflammatory activity of P. citronellum (NBG), P. panduriforme (SBG and WSBG), P. 
quercifolium (SBG and WSBG) and P. scabrum. 
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 Table 8.2: The percentage amounts of the compounds, with proven in vitro inhibitory 
action on the 5-LOX enzyme, present in the active oils. 
 
% Amounts 
Compound 
cit pan pan que que sca 
NBG SBG WSBG SBG WSBG SBG 
Terpenic 
hydrocarbons       
γ-terpinene - 0.1 0.3 0.3 tr - 
α-pinene - 0.6 0.3 - 0.1 0.1 
Sesquiterpenic 
hydrocarbons       
β-caryophyllene 0.6 - 0.2 0.1 - 3.9 
germacrene D - - tr 0.1 - - 
Sesquiterpenic 
alcohol       
(E)-nerolidol tr - - 2.8 - 0.9 
Esters       
citronellyl 
acetate - - - - - 0.1 
bornyl acetate - 0.1 - - - - 
 
Where: - cit: P. citronellum; pan: P panduriforme; que: P. quercifolium; sca: P. scabrum. 
SBG = Stellenbosch Botanical Garden, NBG = National Botanical Garden (Kirstenbosch), 
WSBG = Walter Sisulu Botanical Garden; tr = trace: <0.05%. 
 
In a study carried out by Baylac and Racine (2003) it was found that essential oils rich in 
citral could not be spectrophotometrically assessed due to the strong absorption of citral 
(neral and geranial) at 234 nm. This phenomenon was observed when the 5-LOX assay 
was conducted on P. citronellum (NBG) which contains 44.6% citral (17.4% neral and 
27.2% geranial), the second most predominate compound present in the oil. Pelargonium 
citronellum (NBG) showed moderate inhibition of the enzyme (IC50 = 50.04 µg/ml) and as 
reported by Baylac and Racine (2003), essential oils rich in citral such as lemongrass and 
Litsea cubeba have acclaimed anti-inflammatory activity in aromatherapy. 
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 ‘Geranium oil’ (P. graveolens) is used in aromatherapy for its anti-inflammatory virtues 
(Lawless, 1995). In this assay, an IC50 value greater than 100 µg/ml was recorded for P. 
graveolens (SBG). This indicates that there is maybe another mode of action responsible 
for its reported anti-inflammatory activity. The numerous beneficial effects of ‘geranium 
oil’, which are accredited to ‘geranium oil’ regardless of its chemical composition, may be 
due to its action as an odour via the limbic system (Lis-Balchin et al., 1996a). 
 
Ethnobotanical data reported that the vapours from boiled fresh leaves of P. betulinum 
were inhaled to treat coughs and other chest problems (van der Walt, 1977). Pelargonium 
cucullatum was also documented as a remedy for coughs and related-chest problems (May, 
2000). The essential oils of P. betulinum and P. cucullatum may explain their traditional 
use. LTs play a key role in respiratory ailments such as asthma (Rioja et al., 2002). 
Unfortunately, insufficient essential oil was available for testing so as to determine whether 
their use in respiratory conditions is related to their anti-inflammatory effects mediated 
through the inhibition of the 5-LOX enzyme.  
 
The results obtained from the in vitro 5-LOX assay suggest that certain Pelargonium 
essential oils may have a physiological role in modulating the 5-LOX pathway. The 
pathophysiological effects of LTs can be antagonized or avoided by targeting LT 
production through 5-LOX pathway inhibition (Prasad et al., 2004) and so P. quercifolium, 
P. panduriforme, P. scabrum and P. citronellum may have promising therapeutic 
applications in various inflammatory and allergic conditions. Further studies are required to 
elucidate the exact mechanism of inhibitory action of selected Pelargonium essential oils 
on the 5-LOX enzyme. The aforementioned Pelargonium essential oils may be useful 
ingredients in cosmetic products as the oils not only possess pleasant aromatic qualities but 
may offer skin soothing activity, through their inhibition of the 5-LOX enzyme (Baylac 
and Racine, 2003). 
 
Investigations involving different combinations of selected Pelargonium essential oils 
should be carried out to assess whether synergistic or antagonistic effects are produced. 
The synergistic effects of the essential oils can be tested by combining the IC50 
concentration of one essential oil with that of another essential oil. These mixtures of 
essential oils can be tested on 5-LOX as described above. The resultant effect can then be 
analysed by comparing the total percent 5-LOX inhibition, obtained from the sum of the 
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 inhibition of the individual samples of essential oil, to the percent inhibition produced in 
the assay.  
 
The benefit which certain Pelargonium essential oils can contribute to pharmaceutical anti-
inflammatory agents should be assessed. Natural anti-inflammatory approaches offer a 
non-toxic and comprehensive strategy for controlling inflammatory eicosanoids. 
Development of these approaches, which control the responses that lead to tissue damage 
in the inflamed area, could provide an alternative to the conventional NSAID therapy for 
the modulation of various inflammatory diseases with reduced adverse gastric effects 
(Rioja et al., 2002).  
 
Those Pelargonium oils with demonstrated inhibitory action on 5-LOX may have potential 
anticancer actions and so may have applications in integrative cancer therapies. Research 
directed in evaluating the effect that natural anti-inflammatory strategies exert in cancer 
patients is necessary (Wallace, 2002).  
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 CHAPTER 9: ANTIMALARIAL ACTIVITY 
 
9.1 Introduction 
One of the greatest health burdens facing Africa is malaria. Malaria is one of the top three 
killers among communicable diseases as it has been estimated that at least 300 million 
people die from the disease each year (Clarkson et al., 2004). 
 
9.1.1 The life cycle of the malaria parasite 
Malaria is caused by parasitic protozoa of the genus Plasmodium and is transmitted from 
one human to another by the bite of infected female Anopheles mosquitoes (Figure 9.1). 
Following this, sporozoites are released into the bloodstream and move to the liver where 
they mature into schizonts. These rupture and release merozoites which enter the 
bloodstream and infect red blood cells (RBCs). The merozoites undergo asexual 
multiplication in the RBCs, which rupture within 48 to 72 hours infecting more RBCs. 
Some of these parasites may develop into gametocytes which can be ingested be a 
mosquito during a blood meal. In the mosquito’s gut, the parasite undergoes another cycle 
resulting in sporozoites which migrate to the salivary glands, in preparation for the 
mosquito’s next blood meal (William, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1: The life cycle of the malaria parasite (http://www.ncmls.kun.nl/molbio/mal.asp). 
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 The first symptoms usually occur 10 days to 4 weeks after infection. The typical symptom 
of malaria is a violent fever lasting 6-8 hours, recurring every two or three days. As the 
disease progresses, anaemia and enlargement of the spleen develop (William, 2004). 
 
9.1.2 Antimalarial chemotherapy 
The first treatment used for malaria was found in South America. For centuries, the bark 
from the Cinchona tree has been used to treat fevers. It was found that the bark which 
contains the alkaloid quinine has antimalarial properties (William, 2004). Cinchona 
pubescens and several other species offered the only effective treatment for malaria, for 
more than 300 years (van Wyk et al., 2000b).  Medicinal plants or structures modelled on 
plant lead molecules have been sources for the majority of antimalarial agents. Such agents 
include the quinoline-based antimalarial drugs, artemisinin and its derivatives (Clarkson et 
al., 2004).  
 
In the last 30 years, few antimalarial drugs have been developed (Ridley, 2002). The 
increasing resistance of vectors to insecticides and the increasing prevalence of drug 
resistant strains of Plasmodium falciparum have caused an ongoing recrudescence of 
malaria. These abovementioned developments, the difficulty of developing efficient 
vaccines and the fact that the control and treatment of malaria depends on relatively few 
chemoprophylactic and chemotherapeutic drugs emphasize the necessity for novel, 
affordable antimalarial compounds (Clarkson et al., 2004; Zirihi et al., 2005). The search 
for new antimalarial drugs from traditional remedies has been prompted by the isolation of 
artemisinin, from Chinese traditional medicine, which has a different chemical structure 
and mechanism of action to that of quinine (Qinghaosu Antimalarial Coordinating 
Research Group, 1979). Research is now being focused on obtaining drugs with different 
structural features, since present antimalarial agents, due to parasites developing resistance 
to them, have become ineffective (Peters, 1998).  
 
Within the South African traditional healthcare system, treatments of various illnesses 
including malaria and its associated symptoms are mainly based on the use of herbal plant 
remedies (Watt and Breyer-Brandwijk, 1962). It is essential to obtain more scientific 
information with regards to the efficacy and safety of the herbal medicines in use. The 
validation of traditional practices could lead to innovative strategies in malaria control. A 
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 range of medicinal plants, from other parts of Africa, have been tested for antiplasmodial 
activity and have shown potential as effective Western medicines. Many plants related to 
these tested plants occur in South Africa and not much is known about their antiplasmodial 
activity (Prozesky et al., 2001). 
 
9.1.3 Insect deterrent property of Pelargonium species 
Insect repellents protect humans and animals from haematophagus insects e.g. mosquitoes, 
ticks, fleas, blackflies and cockroaches (Ahmad et al., 1995). By reducing the contact 
between man and insect vectors, repellents hinder the transmission of diseases. The 
avoidance movements of insects are caused by the action of repellents on the olfactory, 
chemoreceptor or gustatory senses of insects (Jeyabalan et al., 2003). 
 
The essential oils of some Pelargonium species are employed by the native population in 
southern Africa due to their effective insect repellent properties (Kolodziej, 2002). In 
particular, the essential oils of P. graveolens, P. capitatum, P. odoratissimum and P. radula 
(Cav.) L’Hérit. (syn. P. radens H.E. Moore) used in perfumes can be used to deter insects 
(Simmonds, 2002). The repellent properties of certain essential oil compounds such as α-
pinene, limonene, carvone and β-myrcene explain the reported insect deterrent properties 
of certain Pelargonium species (Kolodziej, 2002). The strong smell of ‘geranium oil’ acts 
as a repellent to mosquitoes (Lawless, 1995). The insecticidal activity of ‘geranium oil’ 
and some of its compounds (citronellol and geraniol) has been well researched (Wirtz and 
Turrentine, 1980; Dale and Saradamma, 1982). Due to insufficient quantities of the 
Pelargonium oil samples in this study, testing could not be carried out to assess if the oils 
have, in particular, an inhibitory effect on the malaria protozoa.  
 
Very little information exists with regard to the effect of ‘geranium’-derived compounds on 
non-‘geranium’ feeding insects. However, existing information indicates that active 
molecules are present in Pelargoniums. The herbal medicine of “Umckaloabo” originating 
from P. sidoides and P. reniforme has shown activity against the intracellular protozoan 
Leishmania donovani (Kolodziej, 2002). Jeyabalan et al. (2003) studied the effects of P. 
citrosa leaf extracts on Anopheles stephensi. The results of this study showed that P. 
citrosa leaf extract has potent mosquitocidal, repellent and growth regulatory and ovicidal 
activity (Jeyabalan et al., 2003). Pelargonium citrosa leaf extracts may provide a natural 
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 alternative for malaria vector control (Jeyabalan et al., 2003). In order to minimize human 
contact with vector and nuisance mosquitoes, the use of protection measures i.e. the 
application of repellents to exposed skin have long been supported (Gupta and Rutledge, 
1994). Pelargonium citrosa leaf extract could be employed in a similar capacity.  
 
The pressing need for new antimalarial compounds substantiates the investigation of 
Pelargonium species for possible antimalarial activity. 
 
9.2 In vitro antiplasmodial activity 
The in vitro semi-automated microdilution assay technique which measures the ability of 
the extracts to inhibit the incorporation of [3H]-hypoxanthine into the malaria parasite was 
used (Desjardins et al., 1972; van Zyl and Viljoen, 2002). Acetone extracts were tested 
against the choloroquine-resistant Gambian FCR-3 strain of Plasmodium falciparum.  
 
9.3 Materials and methods 
9.3.1 Principle of the method 
Nucleotides are activated precursors of the nucleic acids DNA and RNA and are 
intermediates in biosynthetic pathways. Nucleotides also play a role in many biochemical 
processes occurring in the mammalian host and in the parasite, particularly those pathways 
involving energy transfer and biosynthesis. Intra-erythrocytic-stage plasmodia are unable 
to synthesize purines de novo (Gero and O’Sullivan, 1990). The parasite relies on host-
derived hypoxanthine as a source of purine precursors for nucleic acid synthesis and 
energy metabolism (Olliaro and Yuthavong, 1999). Hence, parasitic growth was estimated 
by the in vitro parasitic uptake of radioactive [3H]-hypoxanthine. 
 
9.3.2 Protocol 
9.3.2.1 Cell culture 
The parasite culture was maintained in 25 ml of culture medium consisting of 10.4 g/L 
RPMI-1640 with L-glutamine, 5.9 g/L HEPES buffer (N-2-hydroxyethyl-piperazine-N′-2-
ethane-sulfonic acid), 4.0 g/L D-glucose, 44 mg/L hypoxanthine and 50 mg/ml gentamicin  
sulphate dissolved in 1 L autoclaved milliQ water (Millipore®) and filtered through a 
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 Sterivex-GS 0.22 µm filter unit. The culture medium was further supplemented with 10 ml 
10% (v/v) human plasma and 4.2 ml 5% (w/v) NaHCO3. Every alternate day, human 
erythrocytes were added to the culture. The human plasma (South African Blood 
Transfusion Services) used in the assay was heat inactivated at 56°C in the water bath for 2 
hours, centrifuged at 3000 rpm for 20 minutes and aliquoted into sterile 50 ml tubes and 
stored at 20°C until required. The donated blood was collected in citrate phosphate 
dextrose adenosine-1-containing tubes to prevent coagulation and stored at 4°C for a 
maximum of two weeks. Before use, the whole blood was washed three times in PBS 
(phosphate buffer solution, pH 7.4) by centrifuging it at 2000 rpm for 5 minutes to remove 
the plasma and other blood cells. The PBS solution contained 8.0 g NaCl, 0.3 g KCl, 0.73 g 
Na2HPO4.2H2O and 0.2 g KH2PO4 dissolved in 1 L sterile water and the solution was 
autoclaved at 120°C for 20 minutes and stored at 4°C. Following the washing step, the 
erythrocytes were resuspended in experimental medium to avoid dehydration and stored at 
4°C. The experimental medium was prepared in the same way as the culture medium; 
however, it did not contain gentamicin sulphate and hypoxanthine. Cultures were gassed 
with 3% O2, 5% CO2 and 92% N2 for approximately 30 seconds before being incubated at 
37°C. 
 
9.3.2.2 Assessment of parasite growth 
The parasitaemia and morphology of the parasites were assessed daily to evaluate parasitic 
growth. A thin smear was prepared in the following way: a small amount of blood, from 
the bottom of the culture flask, was placed on and smeared across a clean slide. Methanol 
was used to fix the smear after which it was dried and placed in Giemsa stain diluted with 
Giemsa buffer (1: 10) for 20 minutes. The Giemsa buffer solution contained 3.5g KH2PO4 
and 14.5 g Na2HPO4.12H2O dissolved in 1 L of distilled water and autoclaved at 120ºC for 
20 minutes. The slide was washed with water and once dry, the parasitic morphology was 
examined microscopically using the oil immersion objective (1000x) and the percentage 
parasitaemia was calculated using the following equation: 
 
( )cells uninfected  infected cells Total
100 x cells infected ofNumber     iaParasitaem % +=  
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 5% (w/v) D-sorbitol was used to synchronize the cultures every second day when the 
parasites were mostly in the ring stage (Lambros and Vanderberg, 1979). The assay was 
conducted when the parasitaemia was between 2 to 3%.  
 
9.3.2.3 Hypoxanthine incorporation assay 
Each extract was prepared in DMSO to obtain a stock concentration of 10 mg/ml which 
was serially diluted with experimental medium. The following dilutions were made:           
1 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.1 mg/ml, 0.01 mg/ml, 0.001 mg/ml and 0.0001 mg/ml. 
For the drug controls, chloroquine and quinine, various concentrations (10 µM to 0.00001 
µM) were prepared using experimental medium. The various concentrations of plant 
extracts (25 µl) were plated out in triplicate in a 96-well plate. The synchronous parasite 
suspension (200 µl), predominately in the ring stage, was adjusted to a 0.5% parasitaemia 
and 1% final haematocrit and added to the wells containing the various concentrations of 
plant extract. Eight wells of 200 µl untreated parasite and four wells of uninfected red 
blood cells were used to obtain control values. Plates were maintained for 24 h in a candle 
jar under micro-aerobic (3% O2, 5% CO2, 92% N2) and humidified conditions at 37°C.   
 
Labelled [3H]-hypoxanthine (5 mCi, Amersham Pharmacia Biotech, UK) stabilized in 
ethanol: water (1: 1 v/v) was adjusted to 18 µCi with experimental medium and 25 µl of this 
was then added to each well and parasites were maintained for a further 24 hours under 
humidified conditions at 37°C. The labelled parasitic DNA was harvested onto a glass-
fibre GFB-filtermat by a Titertrek® cell harvester. Once the filtermats were dry, liquid beta 
scintillation fluid was added and the incorporated [3H]-hypoxanthine radio-active counts 
determined. The radioactivity incorporated into the treated parasites was compared with 
that in the control parasites maintained on the same plate in order to determine the growth 
inhibition for each extract concentration. The percentages of parasite growth, calculated 
using equation (1) below, were plotted against their respective concentrations. The 
concentrations causing 50% inhibition of parasite growth (IC50) were calculated from the 
log sigmoid dose-response curves generated by Enzfitter® software. Chloroquine and 
quinine, antimalarial agents, were used as positive controls. 
 ( ) ( )
( ) ( ) 100cpm control RBCMean  - cpm control parasiteMean 
cpm control RBCMean  - cpm sampleTest growth   Parasite % ×= (1)        
                                 
Where: - cpm = counts per minute; RBC = red blood cells. 
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 9.4 Results and discussion 
All the acetone extracts displayed considerable antimalarial activity, with IC50 values 
ranging from 1.34 ± 0.29 µg/ml to 22.46 ± 3.21 µg/ml (Table 9.1). Most of the IC50 values 
obtained fall below 15.00 µg/ml (Figure 9.2). Pelargonium panduriforme (SBG) showed 
the greatest activity with an IC50 value of 1.34 ± 0.29 µg/ml which is 22 and 45 times 
greater than the IC50 values of chloroquine and quinine, respectively (Figure 9.3). Other 
species possessing similarly potent antimalarial activity include P. citronellum (NBG), P. 
citronellum (SBG), P. quercifolium (SBG) and P. radens. Pelargonium cucullatum (SBG) 
and P. pseudoglutinosum produced very similar activities (Figure 9.2). Pelargonium 
crispum and P. graveolens (SBG) extracts were found to exert the lowest activity (IC50 = 
21.00 ± 4.33 µg/ml and 22.46 ± 3.21 µg/ml, respectively). Pelargonium crispum and P. 
graveolens (SBG) are 350 and 374 fold less active than the chloroquine control, 
respectively and are 700 and 749 fold less active than the quinine control, respectively. 
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 Table 9.1: The in vitro antimalarial activity of selected Pelargonium acetone extracts 
against the P. falciparum chloroquine-resistant Gambian FCR-3 strain. 
 
Species Locality Antimalarial activity s.d. IC50 (µg/ml) 
P. betulinum NBG 16.23 2.75 
P. capitatum Strand 9.81 0.34 
P. citronellum NBG 1.58 0.65 
P. citronellum SBG 1.74 0.79 
P. cordifolium NBG 10.84 0.75 
P. cordifolium WSBG 10.17 2.43 
P. crispum NBG 21.00 4.33 
P. cucullatum SBG 7.42 0.35 
P. cucullatum WSBG nd - 
P. glutinosum SBG 11.07 1.15 
P. glutinosum WSBG nd - 
P. graveolens SBG 22.46 3.21 
P. graveolens WSBG 9.48 1.17 
P. greytonense SBG 13.21 1.89 
P. hermanniifolium SBG 13.54 3.95 
P. hispidum SBG 12.23 1.93 
P. panduriforme SBG 1.34 0.29 
P. panduriforme WSBG nd - 
P. papilionaceum NBG 5.15 0.36 
P. pseudoglutinosum NBG 7.93 0.75 
P. quercifolium SBG 2.66 0.36 
P. quercifolium WSBG nd - 
P. radens SBG 1.90 0.39 
P. scabroide SBG 15.94 0.16 
P. scabrum SBG 16.10 0.02 
P. sublignosum SBG 9.01 1.22 
P. tomentosum SBG 17.62 4.84 
P. tomentosum WSBG 13.83 0.61 
P. vitifolium SBG 9.18 1.61 
Chloroquine - 0.06 0.003 
Quinine - 0.03 0.002 
 
Where: - NBG = National Botanical Garden (Kirstenbosch), S = Stellenbosch Botanical 
Garden, Strand = Strand region, WSBG = Walter Sisulu Botanical Garden (Johannesburg); 
s.d. = standard deviation; nd = not determined due to insufficient extract for testing; n = 3: 
triplicate measurements were performed for all samples. 
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Figure 9.2: The in vitro antimalarial activity of selected Pelargonium acetone extracts. Where: - (N) = National Botanical Garden (Kirstenbosch), 
(S) = Stellenbosch Botanical Garden, (St) = Strand region, (W) = Walter Sisulu Botanical Garden (Johannesburg). 
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Figure 9.3: Dose-response curves for P. graveolens (SBG), P. panduriforme (SBG) and 
quinine. 
 
Substantial evidence supports the fact that hypoxanthine, formed by the host during ATP 
catabolism, is the main source of purines for P. falciparum. The antimalarial activity of the 
extracts could be due to their inhibitory effects on the parasite-specific enzymes utilized in 
purine salvage. Hypoxanthine salvage is a potential target for new drug discovery (Olliaro 
and Yuthavong, 1999). Pelargonium species may exert their antimalarial activities through 
other mechanisms which may involve the principle antimalarial chemotherapeutic targets 
(Figure 9.4) which have been classified into three categories (Olliaro and Yuthavong, 
1999): 
1) Targets responsible for processes occurring in the Plasmodium digestive vacuole; these 
mainly include haemoglobin digestion and haem detoxification. The membrane of the 
digestive vacuole appears to be involved in drug accumulation and extrusion. 
2) Enzymes involved in macromolecular and metabolite synthesis. This includes nucleic 
acid metabolism, phospholipids metabolism, glycolysis and tubulin assembly. 
3) Targets responsible for membrane processes (including trafficking and drug transport) 
and signalling. 
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Figure 9.4: The principal chemotherapeutic targets in Plasmodium protozoa (Olliaro and 
Yuthavong, 1999). 
 
Bidens pilosa L. (Asteraceae) is among the numerous plants used in Brazil to treat malaria. 
An investigation showed that the in vivo activity of the ethanol roots extract against P. 
falciparum depends on the presence of polyacetylene and flavonoids (Oliveira et al., 2004). 
The antimalarial properties of the Pelargonium extracts may be attributable to the various 
flavonoid derivatives detected in the extracts (Chapter 4). The major flavonoids identified 
in each species should be isolated and tested for antimalarial activity.  
 
The samples of the same species collected from different localities produced very similar 
antimalarial activities. However, the P. graveolens samples produced different IC50 values; 
P. graveolens (SBG) is about two fold less active than P. graveolens (WSBG).  
 
It was concluded from Chapter 4 that P. betulinum (NBG), P. cordifolium (WSBG), P. 
crispum (NBG) and P. cucullatum (SBG) and P. scabrum (SBG) acetone extracts exhibit 
several similarities in their HPLC profiles (Chapter 4, Figure 4.6). The aforementioned 
species each contain a dominant compound (Chapter 4, peak 2 in Figure 4.6) at retention 
time of approximately 13.95 minutes with similar λmax values (220.3 nm and 278.0 nm). 
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 Pelargonium betulinum (16.23 ± 2.75 µg/ml) and P. scabrum (16.10 ± 0.02 µg/ml) exert 
almost identical antimalarial activities. Pelargonium cucullatum (SBG) and P. cordifolium 
(WSBG) share similar IC50 values of 7.42 ± 0.35 µg/ml and 10.17 ± 2.43 µg/ml, 
respectively.  
 
A flavone occurs as the main compound in P. hispidum (SBG), P. panduriforme (SBG), P. 
papilionaceum (NBG) and P. tomentosum (SBG) at a retention time of about 21.35 
minutes with UV absorbance maxima occurring at approximately 255.7 nm and 346.0 nm 
(Chapter 4, peak 2 in Figure 4.8). Pelargonium hispidum (SBG) and P. tomentosum (SBG) 
exhibited similar activities (IC50 = 12.23 ± 1.93 µg/ml and 17.62 ± 4.84 µg/ml, 
respectively). However, of these species, the IC50 values of P. panduriforme (SBG) and P. 
papilionaceum were found to be most similar (IC50 = 1.34 ± 0.29 µg/ml and 5.15 ± 0.36 
µg/ml, respectively).  
 
The similar flavonoid patterns of P. capitatum (Strand) and P. vitifolium (SBG) (Chapter 4) 
provide chemical evidence that these two species are related (van der Walt, 1977).  It was 
found that P. capitatum (Strand) and P. vitifolium (SBG) have very similar antimalarial 
activities. Pelargonium sublignosum, with a similar flavonoid pattern to P. scabrum, 
produced an IC50 value almost 2-fold greater than that of the latter species. Pelargonium 
glutinosum (SBG) has a substantial amount of a compound similar to the major compound 
present in P. pseudoglutinosum (Chapter 4). These species produced similar IC50 values of 
11.07 ± 1.15 µg/ml and 7.93 ± 0.75 µg/ml, respectively. Pelargonium papilionaceum and 
P. vitifolium, with different chemical compositions (Chapter 4), exerted similar 
antimalarial activities (Table 9.1).  
 
Pelargonium citronellum (NBG), P. citronellum (SBG), P. panduriforme (SBG), P. 
quercifolium (SBG) and P. radens (SBG) extracts have the potential to be employed as 
effective plant-based medicines for the treatment of malaria. The antimalarial activity of 
the crude extracts may be due to their general cytotoxicity effects. For the therapeutic 
potential of these extracts to be considered, they must then have greater selectivity for the 
Plasmodium parasite than for human cells. In order to obtain a better insight into the 
possible mode of antimalarial action of the Pelargonium extracts, the MTT assay was 
carried out on the crude extracts. The toxicity data obtained is presented in Chapter 10.  
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 CHAPTER 10: TOXICITY  
 
10.1 Introduction 
From the earliest of times, plants have been used to cure sickness and alleviate suffering. 
However, our ancestors discovered that some plants have the ability to produce various 
ailments such as skin irritation and that some can even result in death.  
 
10.1.1 History of toxicology  
Toxicology is derived from “tox” meaning ‘bow’ or ‘arrow’. Poisoned weapons have been 
and are still being used for the procurement of food, for the protection against wild animals 
and in tribal warfare. Through mans search for remedies he discovered toxic substances 
which when applied to the point of a weapon were able to elicit desirable effects e.g. 
curare. As man attempted to make his weapons more lethal to his enemies and prey, he 
experimented with plant juices and in so doing, discovered that the names given to plants 
and herbs correspond to the toxic effects they exert on animal life. For example, cowbane 
(water hemlock) has a lethal effect on cattle. Highly toxic plant principles were combined 
to produce an effective hunting poison.  Plants are the main providers of active ingredients 
for African poisons (Neuwinger, 1996). 
 
All herbalists, during the medieval and Renaissance European era wrote about toxic plants. 
Centuries ago, poisoning was considered a fine art and to be poisoned was as ordinary as 
becoming ill with a disease. The members of primitive tribes, in order to exert power over 
their enemies, kept to themselves their acquired knowledge of plants, in particular of those 
plants which caused stupor, delirium and death (Thompson, 1931). We owe much of our 
attained knowledge of the properties and uses of many vegetable poisons by primitive 
races to archaeological research. However, little or no information regarding other 
botanical substances has been obtained. Tribes guard their knowledge of poisons which is 
only known by certain chiefs or by the tribal medicine men that pass on the knowledge to 
their successors. Poisonous plants form an integral part of South Africa’s flora (van Wyk et 
al., 2002a). Our knowledge of the active principles of plants indigenous to South Africa is 
limited. A great deal of knowledge of the plants employed by man for their toxic effects on 
animals and humans remains to be discovered. 
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 10.1.2 Plant toxins 
Plants are factories and store-houses of a variety of chemicals with more than 200 known 
plant-derived amino acids compared to only 30 in mammals. There are probably thousands 
of sensitizing chemicals in plants (Mitchell and Rook, 1979). Toxic substances present in a 
large number of plants worldwide can either cause skin irritation or when ingested in 
sufficient quantities over a short or a prolonged period of time can exert detrimental effects 
on the systems of animals or man and can even result in death.  
 
Plant toxins have no role in the growing or fruiting process. Three main hypotheses have 
been put forward to explain the physiological significance of the toxic principles present in 
plants. One or more of the following may be accountable for the production of plant toxins. 
Toxic substances are (a) products of catabolism (b) a protection to deter people and 
animals from eating the plants (c) intermediates in the anabolic processes in plants (Steyn, 
1934). One should consider why some plants and not others protect themselves from being 
eaten. If this were the case then those plants most eaten by stock would most likely 
produce poison. In addition, plants would have concentrated poisons in the parts growing 
above ground in order to protect themselves. However, many poisonous plants, concentrate 
a large portion in their roots or bulbs. The hypothesis that these substances are excretory 
products is supported by the fact that they are concentrated in the bark. The hypothesis that 
these substances are normal products of the metabolic process is supported by the fact that 
poisons disappear from certain plants when they are grown in darkness (Steyn, 1934). 
 
10.1.3 Toxic components as therapeutics 
Most poisonous plants have found a function within traditional and modern medicine. The 
dangerous effects that certain plants exert on bodily functions are what make those plants 
valuable therapeutics. Arrow poisons have provided a tool in research for the unearthing of 
effective therapeutics. For example, ouabain and k-strophanthin are used for acute cardiac 
insufficiency, physostigmine is used for the treatment of glaucoma and myasthenia gravis, 
d-tubocurarine is used in anaesthesia for its muscle-relaxant properties, reserpine is used as 
an antihypertensive drug and ajmaline for disturbances of cardiac rhythm (Neuwinger, 
1996).   
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 Ergot is an unusual form of the fungus Claviceps purpurea which grows in the ovaries of 
certain varieties of grasses, but is today mainly found in rye. The consumption of rye 
contaminated with ergot was recognized at the end of the 18th century to be the cause of a 
dreadful disease which is known today as ergotism. The symptoms of this disease include 
dementia, prolonged vasospasm which may result in gangrene and stimulation of the 
uterine smooth muscle which in pregnancy may result in abortion. Today, ergot is utilized 
in medicines for migraines (dihydroergotamine), hyperprolactinaemia (bromocriptine) and 
postpartum haemorrhage (ergonovine maleate) (Katzung, 2001). Through scientific 
research, what once caused terrible agony and death through its toxic properties has now 
been employed into a medicinal agent of great worth. 
 
The tobacco plant (Nicotiana tabacum) yields nicotine, one of the most poisonous 
substances, yet it is used daily by millions of people worldwide for its pleasurable 
stimulant effects.  
 
10.1.4 Traditional medicines  
The most fundamental aspect of health care is to do no harm (Oath of Maimonides); to 
assure that what is taken by humans for medicinal purposes is safe (Cordell and Colvard, 
2005). It is considered by many users of traditional medicines that such medicines are safe 
for human consumption. This assumption is partly based on widespread prior field 
experience (Cordell and Colvard, 2005). Due to the amazing floral and cultural diversity in 
South Africa, a large number of plant species are used for their medicinal properties (Light 
et al., 2005). However, few plants have been scientifically studied for their efficacy and 
safety (Calixto, 2005). The number of phytotherapeutic products from various traditional 
medicine systems has considerably increased and these products are entering the 
commercial market in developed and developing countries. Due to the lack of clear and 
agreeable quality control and marketing regulations, the issues of safety and efficacy are 
being both understated and ignored (Cordell and Colvard, 2005). 
 
When biological activity is identified, through the screening of a plant, such activity is 
classified according to potency; the ‘most active’ is usually selected for isolation. 
However, often the therapeutic window between effectiveness and toxicity (Figure 10.1) is 
too narrow and so the compound falls short of expected therapeutic values at the stage of 
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 toxicity trials. In animal studies, the therapeutic index of a drug is used to estimate the 
potential benefit of the drug in humans (Katzung, 2001).  
 
Maximum safe concentration
Therapeutic window 
Concentration 
Minimum effective concentration
                    Time 
 
Figure 10.1: The therapeutic window of a plasma concentration-time curve following a 
single extravascular dose of a drug (modified from Aulton, 1999). 
 
Medicinal plants, like orthodox medicines, have to be biologically active to be efficacious, 
it follows then that overdosing leads to the possibility of poisoning (van Wyk et al., 
2002a). “Only the dose determines that a thing is not a poison”, states the Paracelsian 
dictum (Neuwinger, 1996). Steenkamp et al. (2000) showed that traditional medicines 
containing pyrrolizidine alkaloids can cause poisoning and fatality. Several of the deaths 
occurred in children who were given the same dosage as adults. This information is vital 
and needs to be channelled to traditional healers. Researchers need to sideline the pursuit 
of new drug leads and focus on comprehensive toxicity studies of traditional medicinal 
plants (Jäger, 2005).  
 
10.1.5 Toxicity of Pelargonium species 
There is no published literature regarding the toxicity of Pelargonium extracts (Lis-Balchin 
and Deans, 1996). However, there have been several reports of dermatitis due to 
Pelargonium-derived ‘geranium oil’.  
 
Keil (1947) reported that geraniol, a compound found in ‘geranium oil’, causes 
sensitization.  ‘Oil of geranium’ has been reported to cause contact dermatitis and cheilitis 
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 (Klarmann, 1958). Cosmetic preparations containing ‘geranium oil’ may cause dermatitis 
in hypersensitive individuals (Mitchell and Rook, 1979). The species of this genus have 
been reported to cause dermatitis; one case of dermatitis from picking scented pelargonium 
leaves has been reported (Lis-Balchin and Deans, 1996). According to Agrup (1969) patch 
testing with the leaf of Pelargonium species can cause irritant reactions and reactions 
registered as allergic should be accepted with caution. In a study conducted by Hjorth 
(1968), four out of 52 patients tested showed a positive reaction. However, in another study 
using 400 people, none of the persons tested, showed a positive reaction (Fregert and 
Hjorth, 1968). The reports of dermatitis from species of this genus are lacking in adequate 
detail to affirm an allergenic effect (Mitchell and Rook, 1979). 
 
Ethnobotanical information indicates that P. betulinum and P. cucullatum were used to 
relieve coughs and other chest problems, in preparations for wound-healing and for the 
relief of gastro-intestinal related problems (van der Walt, 1977; May, 2000; Lawrence and 
Notten, 2001). The leaves of P. papilionaceum were smoked for their medicinal properties 
(Watt and Breyer-Brandwijk, 1962). The implied methods of administration include 
inhalation, local superficial application to the skin and ingestion of the preparations. A 
plant maybe harmless when absorbed through the skin and lungs but harmful when 
ingested (van Wyk et al., 2002a). Most traditional remedies are used as teas or as alcoholic 
essences (Lis-Balchin and Deans, 1996). Thus it is important to perform toxicity studies on 
the volatile and non-volatile Pelargonium extracts as such studies will provide an 
indication of the possible toxic effects these extracts will exert if used internally.  
 
The results obtained from preceding Chapters revealed that Pelargonium crude extracts 
have potentially important biological properties related to antimicrobial (Chapter 5), free 
radical scavenging (Chapter 7) and antimalarial (Chapter 9) effects and that certain 
Pelargonium essential oils have promising anti-inflammatory activity (Chapter 8). Hence, 
Pelargoniums are potentially valuable therapeutic agents. The toxicity profiles of selected 
Pelargonium species were determined in order to appraise their potential for medicinal use. 
Furthermore, an attempt has been made to relate the antimicrobial (Chapter 5) and 
antiplasmodial (Chapter 9) activities of the Pelargonium acetone extracts to their 
cytotoxicity.  
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 10.2 Materials and methods 
10.2.1 Microculture tetrazolium assay 
Pelargonium acetone extracts and essential oils were assessed for in vitro cytotoxicity 
using microculture tetrazolium (MTT) colourimetry as described by Mosmann (1983). 
Transformed human kidney epithelium (Graham) cells were used in the assay. 
 
10.2.2 Principle of the method 
A mitochondrial enzyme, succinate-dehydrogenase (SDH), present in living cells cleaves 
the tetrazolium ring of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) (MTT) and reduces it to an insoluble purple formazan 
reaction product (Figure 10.2) (Mosmann, 1983). When solubilized, the formazan product 
can be measured spectrophotometrically. The absorbance recorded is directly proportional 
to the viable cell number per well which inturn is directly proportional to the amount of 
formazan produced (Alley et al., 1988). 
 
CH 3
CH 3
+NN
N
N
S
N
N
N
NH
N
S
N
CH 3
CH 3
SDH 
MTT (yellow) Formazan (purple) 
 
Figure 10.2: The structure of MTT and the formazan reaction product. 
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 10.2.3 Protocol 
Culture medium consisting of HAM F10 solution, 5% (v/v) foetal calf serum (FCS) and 
0.5 mg/ml gentamicin sulphate was used to maintain transformed human kidney epithelium 
(Graham) cells. The HAM F10 solution consisted of 9.38 g of HAM F10 medium 
(Highveld Biological, South Africa) and 1.18 g of NaHCO3 in a total volume of 1 L of 
sterile water. The FCS was inactivated at 56ºC for 2 hours, before use. The culture medium 
was replaced every second day and once the cells reached confluency, they were 
trypsinised with 4 ml of 0.25% Trypsin / 0.1% Versene EDTA (Highveld Biological, South 
Africa) at ambient temperature to obtain single cell suspensions of the Graham cells. The 
cells were centrifuged at 1500 rpm for 5 minutes to remove the trypsin. Once the cells were 
resuspended in experimental medium, 1 ml of the resuspended cells was used to seed a new 
culture and the remaining cell suspension was used in the MTT assay. The experimental 
medium was prepared in the same way as the culture medium except no gentamicin 
sulphate was added. Following this, 50 µl of the trypsinised cell suspension was stained 
with 0.2% (w/v) Trypan blue in a 1: 1 ratio and the number of cells per ml of cell 
suspension was determined using a haemocytometer. Before using the cells, ≥95% cell 
viability was confirmed.  
 
The cell suspension was then adjusted with experimental medium to 0.25 million cells/ml 
and 180 µl of the adjusted cell suspension was dispensed in 96-well microtitre plates and 
incubated under humidified conditions at 37ºC in 5% CO2 for six hours to allow the cells to 
adhere to the bottom of the wells. Thereafter, the various concentrations of plant samples (a 
total volume of 2 µl of essential oils and 20 µl of acetone extracts) were plated out in 
triplicate in 96-well microtitre plates. The essential oil samples were prepared as follows: a 
stock solution of 10% was prepared by dissolving 10 µl of the test essential oil in 90 µl of 
DMSO and a 1: 10 serial dilution was performed to produce concentrations ranging from 
1% to 1 x 10-11 %. Experimental medium was used to prepare concentrations of the acetone 
extracts and control drugs ranging from 10 µM to 1.0 x 10-5 µM.  
 
HAM solution (18 µl) was added to each well containing essential oil sample to ensure a 
total volume of 200 µl per well. Experiments for each test compound were carried out in 
triplicate. For each plate, 11 peripheral wells were utilized for the untreated cell controls 
and one peripheral well for the blank cell-free control (Figure 10.3). Chloroquine and 
quinine were used as positive controls. The plates were incubated under humidified 
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 conditions at 37ºC in 5% CO2. MTT (USBTM) solution (12 mM) was prepared using 
phosphate buffered saline (pH 7.4) and then sterile filtered and stored at 4ºC. At 44 hours 
of incubation, 40 µl of MTT was added to each well and the plates were incubated for a 
further four hours. Experimental media supernatant (180 µl) was removed from each well 
by slow aspiration and 150 µl DMSO was added to each well to stop the reaction and to 
solubilize the formazan crystals. After allowing the plates to stand for 3-4 minutes, they 
were shaken at 1020 rpm for four minutes using a plate shaker to obtain thorough formazan 
solubilization. The absorbance was then read at a test wavelength of 540 nm and a 
reference wavelength of 690 nm using a microtitre plate reader (Labsystems iEMS Reader 
MF) connected to a computer equipped with Ascent® software.  
 
 
 
No cell growth 
Cell growth 
Untreated cell controls  Blank cell-
free control 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.3: A 96-well microtitre plate prepared for use in the MTT assay. The clear wells 
indicate inhibition of cell growth whereas the purple wells indicate cell growth. 
 
The results were expressed as percentage cellular viability of the drug and cell-free 
controls, using equation (1). The percentage cellular viability data was plotted against their 
respective concentrations and after logarithmic transformation of the concentration, 
sigmoidal dose-response curves were generated by the Enzfitter® software. The 
concentration which inhibits 50% of cellular growth (IC50 value) was determined from the 
log sigmoid dose-response profile.  
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control free-cell of absMean  -control cell untreated of absMean 
 control free-cell of absMean  -abs  treatedDrug 
  iability Cellular v %
690)-(540690)-(540
690)-(540690)-(540 ×
=
       
(1) 
 
Where: - abs = absorbance 
 
The safety index relates the dose of a drug required to produce a desired effect to that 
which causes an undesired effect. The toxicity of the acetone extracts was compared to 
their antimalarial activity, using the safety index equation (2) below, to determine the 
degree of selectivity of the extracts for the Plasmodium parasite.  
 
Activity
Toxicity  Index Safety =                  (2) 
 
10.3 Results and discussion 
10.3.1 Acetone extracts 
Pelargonium acetone extracts showed a wide spectrum of toxicity, IC50 values varied from 
11.89 µg/ml to 195.13 µg/ml (Table 10.1). Chloroquine inhibits 50% cell growth at a 
concentration of 125.56 ± 5.04 µg/ml and quinine at 136.06 ± 4.06 µg/ml. The acetone 
extracts of P. sublignosum and P. citronellum (NBG) displayed the highest toxicities (IC50 
values of 11.89 ± 1.54 µg/ml and 19.14 ± 0.98 µg/ml, respectively). Pelargonium 
sublignosum is about 11-fold more toxic than the controls. Species exhibiting toxicity 
values close to that of the controls include P. capitatum (Strand), P. cordifolium (WSBG) 
and P. cucullatum (WSBG) (Figure 10.4). The IC50 values of P. vitifolium (178.48 ± 5.44 
µg/ml) and P. tomentosum (SBG) (195.13 ± 7.90 µg/ml) are higher than those reported for 
the controls (Figure 10.5). 
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 Table 10.1: In vitro toxicity results, antimalarial activity and safety index values for 
Pelargonium acetone extracts. 
 
Toxicity Antimalarial 
activity (µg/ml) (µg/ml) Species Safety 
Index Locality(Extracts) 
IC50 s. d. IC50 s. d. 
P. betulinum NBG 88.55 1.51 16.23 2.75 5.46 
P. capitatum Strand 101.59 1.75 9.81 0.34 10.36 
P. citronellum NBG 19.14 0.98 1.58 0.65 12.11 
P. citronellum SBG 59.94 2.33 1.74 0.79 34.45 
P. cordifolium NBG 74.70 2.17 10.84 0.75 6.89 
P. cordifolium WSBG 116.88 8.01 10.17 2.43 11.49 
P. crispum NBG 74.02 2.30 21.00 4.33 3.52 
P. cucullatum SBG 73.81 2.62 7.42 0.35 9.95 
P. cucullatum WSBG 118.89 5.32 nd nd - 
P. glutinosum SBG 31.44 1.27 11.07 1.15 2.84 
P. glutinosum WSBG 46.29 0.81 nd nd - 
P. graveolens SBG 83.31 2.56 22.46 3.21 3.71 
P. graveolens WSBG 80.48 0.94 9.48 1.17 8.49 
P. greytonense SBG 39.65 1.18 13.21 1.89 3.00 
P. hermanniifolium SBG 46.47 1.38 13.54 3.95 3.43 
P. hispidum SBG 84.30 1.16 12.23 1.93 6.89 
P. panduriforme SBG 32.93 3.75 1.34 0.29 31.83 
P. panduriforme WSBG 42.65 0.90 nd nd - 
P. papilionaceum NBG 53.76 1.60 5.15 0.36 10.44 
P. pseudoglutinosum NBG 30.54 5.46 7.93 0.75 3.85 
P. quercifolium SBG 85.61 1.93 2.66 0.36 32.18 
P. quercifolium WSBG 48.69 1.04 nd nd - 
P. radens SBG 30.81 1.23 1.90 0.39 16.22 
P. scabroide SBG 53.76 1.57 15.94 0.16 3.37 
P. scabrum SBG 37.78 1.72 16.10 0.02 2.35 
P. sublignosum SBG 11.89 1.54 9.01 1.22 1.32 
P. tomentosum SBG 195.13 7.90 17.62 4.84 11.07 
P. tomentosum WSBG 50.71 1.17 13.83 0.61 3.67 
P. vitifolium SBG 178.48 5.44 9.18 1.61 19.44 
- Chloroquine 125.56 5.04 0.06 0.003 2092.67 
- Quinine 136.06 4.06 0.03 0.002 4535.33 
 
Where: - NBG = National Botanical Garden (Kirstenbosch), SBG = Stellenbosch Botanical 
Garden, Strand = Strand region, WSBG = Walter Sisulu Botanical Garden (Johannesburg); 
s.d. = standard deviation; nd = not determined due to insufficient plant extract for testing; 
n = 3: triplicate measurements were performed for all samples.  
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Figure 10.4: Sigmoid dose-response curves for P. sublignosum (SBG), P. 
pseudoglutinosum (NBG), P. cucullatum (WSBG) and quinine. Where: - (NBG) = 
National Botanical Garden (Kirstenbosch), (SBG) = Stellenbosch Botanical Garden, 
(WSBG) = Walter Sisulu Botanical Garden (Johannesburg). 
 
 
Extracts from plant material of the same species collected from different localities 
(duplicate samples) which showed reasonably similar toxicity profiles include the P. 
glutinosum and P. panduriforme samples. In particular, the P. graveolens samples 
produced almost identical toxicity results (Figure 10.5). 
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Figure 10.5: The toxicity profile of the Pelargonium acetone extracts. Where: - (N) = National Botanical Garden (Kirstenbosch), (S) = 
Stellenbosch Botanical Garden, (St) = Strand region, (W) = Walter Sisulu Botanical Garden (Johannesburg). 
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 It is well-known that the toxicity can vary considerably for members of the same species of 
a plant growing in different areas; the geographical variation influences the composition 
and ratio of constituents. Moreover, members of the same species of a plant growing near 
each other can also vary considerably in toxicity (Steyn, 1934). In particular, P. 
tomentosum (SBG) and P. tomentosum (WSBG) produced greatly different IC50 values of 
195.13 ± 7.90 µg/ml and 50.71 ± 1.17 µg/ml, respectively; P. tomentosum (WSBG) is 
almost four-fold more toxic than P. tomentosum (SBG). Pelargonium citronellum (NBG) is 
about three times more toxic than P. citronellum (SBG) and the samples of P. cordifolium 
(NBG) and P. cucullatum (SBG) produced similar toxicity profiles and are about 1.6 times 
more toxic than their respective duplicate samples from Walter Sisulu Botanical Garden. 
Pelargonium quercifolium (WSBG) is almost twice as toxic as P. quercifolium (SBG) 
(Figure 10.5). The chemical constitution of the duplicate samples should be compared as 
this is fundamental in understanding the observed discrepancy in their toxicities. Variations 
in growing conditions such as solar radiation and water content can contribute to the 
synthesis of different related compounds in aromatic plants (Nuńez and De Castro, 1992). 
 
It was concluded from Chapter 4 that P. betulinum (NBG), P. cordifolium (WSBG), P. 
crispum (NBG) and P. cucullatum (SBG) and P. scabrum (SBG) acetone extracts have 
several similarities in their HPLC profiles. These species produced low toxic effects except 
for P. scabrum (SBG) (IC50 = 37.78 ± 1.72 µg/ml). Pelargonium crispum (NBG) and P. 
cucullatum (SBG) produced almost identical toxicity profiles (IC50 = 74.02 ± 2.30 µg/ml 
and 73.81 ± 2.62 µg/ml, respectively). HPLC analysis established that the chemical 
compositions of the P. papilionaceum and P. vitifolium acetone extracts are different 
(Chapter 4), this is further confirmed by their toxicity values. Pelargonium papilionaceum 
is about three times more toxic than P. vitifolium. Pelargonium glutinosum (SBG) has a 
similar compound, in substantial amounts, to the major compound present in P. 
pseudoglutinosum (Chapter 4). These species produced similar IC50 values of 31.44 ± 1.27 
µg/ml and 30.54 ± 5.46 µg/ml, respectively. 
 
Pelargonium cucullatum was employed to cure kidney ailments (May, 2000). This 
traditional use is considered safe since low cytotoxic effects (IC50 = 73.81 ± 2.62 µg/ml – 
118.89 ± 5.32 µg/ml) were produced by the two samples tested in this assay which used the 
human kidney epithelial (Graham) cell line. In addition, the toxicity profiles of P. 
 207
 betulinum and P. cucullatum (SBG and WSBG) indicate that they have the potential to be 
used for their reported benefits in wound-healing and gastro-intestinal related problems. 
Pelargonium papilionaceum appears to exert greater toxic effects (IC50 = 53.76 ± 1.60 
µg/ml) (Figure 10.5).  
 
Botanically-derived medicines are based upon the idea that they contain compounds which 
possess potent pharmacological activities (Kaur et al., 2005). However, the very 
compounds which promote health and relieve illness could be toxic to the human body. It 
was concluded from HPLC analysis (Chapter 4) that the Pelargonium acetone extracts 
contain numerous flavonoids. The antitumour effect of flavonoids on various tumour cell 
lines has been well documented. Flavonoids have been shown to arrest cell growth at more 
than one stage of the cell cycle (Pedro et al., 2005). Induction of apoptosis is one of a 
combination of biologic effects which could contribute to the antiproliferative activity of 
flavonoids (Rusak et al., 2005). Flavonoid derivatives may have contributed to the 
cytotoxicity recorded for the crude extracts. Furthermore, sesquiterpene lactones, iridoids 
and tannins produce long-term toxic effects (Neuwinger, 1996). The toxicity of plants may 
be ascribed to the presence of substances such as glucosides, resins, bitters, picrotoxins, 
toxalbumins, alcohols, lactones and organic acids (Steyn, 1934). Possibly, these 
aforementioned compounds impart toxic attributes to the Pelargonium extracts. Although, 
it must be noted that the Pelargonium plant material was extracted with acetone which 
mainly extracts flavonols (Cowan, 1999). 
 
It was concluded on the basis of the flavonoid patterns of P. betulinum (NBG), P. 
capitatum (Strand), P. graveolens (SBG), P. hispidum (SBG), P. panduriforme (SBG) and 
P. vitifolium (SBG) that these species share very characteristic flavonoid patterns (Chapter 
4). Pelargonium betulinum (NBG), P. graveolens (SBG) and P. hispidum (SBG) produced 
similarly low toxic values (IC50 = 83.31 ± 2.56 µg/ml – 88.55 ± 1.51 µg/ml). Pelargonium 
capitatum (Strand) also displayed low toxicity (IC50 = 101.59 ± 1.75 µg/ml) and P. 
vitifolium was non-toxic (Figure 10.5). It could be argued, from the assumption mentioned 
previously, that since numerous flavonoids were identified in these latter species, they 
should produce low IC50 values as did P. panduriforme (SBG) (32.93 ± 3.75 µg/ml). 
However, flavonoids are not a primary source of toxicity in mammals (Neuwinger, 1996). 
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 Pelargonium scabrum and P. sublignosum, with similar characteristic flavonoid patterns, 
both produced low toxicity profiles. 
 
Pelargonium betulinum, P. crispum, P. cordifolium (NBG and WSBG) and P. scabrum 
displayed remarkable anti-oxidant activities (Chapter 7). These extracts did not produce 
considerably toxic profiles except for the P. scabrum extract (Figure 10.5). Theoretically, 
the implication of this is that P. betulinum, P. crispum, P. cordifolium (NBG and WSBG) 
may produce anti-oxidant effects without producing considerable toxic effects. Plant 
remedies should offer a margin of efficacy over toxicity. This finding prompts further 
studies of these anti-oxidant active species, with regards to the isolation and elucidation of 
their anti-oxidant compound/s, followed by toxicity testing of these isolates with the 
potential of being utilized as therapeutic agents. 
 
The toxicity results were evaluated together with the MIC results (Chapter 5). Pelargonium 
citronellum (NBG) P. glutinosum (SBG), P. pseudoglutinosum (NBG), P. quercifolium 
(SBG), P. scabrum (SBG) and P. sublignosum (SBG) exerted considerable antimicrobial 
effects against the Gram-positive bacteria B. cereus and S. aureus. The latter species, 
except for P. quercifolium (SBG), produced considerable toxic effects, which were from 
about 3.5 to 11 times greater than the toxic effects produced by the controls. The results 
from the MTT assay suggest that the antimicrobial action of the extracts may be ascribed to 
general cytotoxic effects. For all the species tested, the toxicity IC50 values are lower than 
the concentrations required to produce an antimicrobial effect. This may be indicating that 
the mammalian cell membrane is more permeable to the effects of the extracts compared to 
Gram-positive and Gram-negative bacterial cell walls and the fungal cell wall. The greater 
selectivity of Pelargonium extracts for human kidney epithelial cells indicates that the 
toxic effects of botanical extracts need to be considered if such substances have the 
potential to be used as therapeutic antimicrobials in humans. However, P. cordifolium 
(NBG), P. crispum (NBG), P. quercifolium (SBG) have a niche in therapeutics due to their 
promising activity against both Gram-positive micro-organisms and their reasonably low 
toxicity profiles. However, one must consider that the results from in vivo toxicity studies 
may be very different. 
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 The antimalarial activity of the extracts may be due to their general toxic effects towards 
living cells. When comparing the toxicity and antimalarial data of the crude extracts (Table 
10.1) it can be seen that they are more selective for the Plasmodium parasite. The safety 
indices of the crude extracts and controls are presented in Table 10.1. The safety index of 
chloroquine and quinine is 2092.67 and 4535.33, respectively. The safety indices of the 
controls are appreciably higher than those of the tested extracts which range from 1.32 to 
34.45. The safety indices indicate that the extracts have a low degree of selectivity for the 
Plasmodium parasite. Pelargonium citronellum (SBG), P. panduriforme (SBG) and P. 
quercifolium (SBG) exhibited considerable antimalarial activity and appear to have the 
greatest selectivity for the Plasmodium parasite since these extracts demonstrated the 
highest safety indices (34.45, 31.83 and 32.18, respectively) among all the extracts tested 
(Table 10.1). Further investigations performed on P. citronellum (SBG), P. panduriforme 
(SBG) and P. quercifolium (SBG) should involve the isolating and testing of the active 
antimalarial compound/s. If several different compounds are responsible for each of their 
antimalarial activities recorded, then a drug containing a combination of such compounds 
could be developed to afford potentially potent antimalarial activity. 
 
10.3.2 Essential oils 
The MTT assay revealed that various Pelargonium essential oils are considerably more 
toxic to the human kidney epithelium cell line than the crude extracts (Table 10.2). 
Pelargonium graveolens (SBG) and the two P. panduriforme samples are extremely toxic 
(IC50 ≤0.10 µg/ml) in the test system used. These species are about 1256 and 1361 times 
more toxic than chloroquine and quinine, respectively. The two P. quercifolium samples 
and P. tomentosum (SBG) also produced substantial toxicity (IC50 ≤1.00 µg/ml – 8.81 ± 
1.46 µg/ml). Pelargonium tomentosum (WSBG) oil is the least toxic (IC50 = 30.20 ± 1.81 
µg/ml) of all the oils tested. This species is about four-fold more toxic than chloroquine 
and quinine. The order of decreasing toxicity of the essential oils is as follows: P. 
graveolens (SBG), P. panduriforme (SBG), P. panduriforme (WSBG) > P. tomentosum 
(SBG) > P. quercifolium (SBG) > P. quercifolium (WSBG) > P. scabrum > P. citronellum 
(NBG) > P. radens > P. tomentosum (WSBG) (Figure 10.6). 
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 Table 10.2: In vitro cytotoxicity (µg/ml) of various Pelargonium essential oils. 
 
 
Toxicity (µg/ml) 
 
Species Locality (Essential oils) 
IC50 s.d. n 
P. citronellum NBG 22.40 4.77 3 
P. graveolens SBG ≤0.10 - 3 
P. panduriforme WSBG ≤0.10 - 3 
P. panduriforme SBG ≤0.10 - 3 
P. quercifolium SBG 3.34 2.79 3 
P. quercifolium WSBG 8.81 1.46 3 
P. radens NBG 27.20 4.76 3 
P. scabrum SBG 17.80 3.55 3 
P. tomentosum SBG ≤1.00 - 3 
P. tomentosum WSBG 30.20 1.81 3 
Chloroquine - 125.56 5.04 3 
Quinine - 136.06 4.06 3 
 
Where: - s.d. = standard deviation; n = 3: triplicate measurements were performed for all 
samples; NBG = National Botanical Garden, SBG = Stellenbosch Botanical Garden, 
WSBG = Walter Sisulu Botanical Garden. 
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Figure 10.6: The decreasing order of toxicity of the various tested Pelargonium essential oils 
and the IC50 values of the controls. 
 The P. quercifolium essential oil samples produced promising anti-inflammatory activity 
(IC50 = 33.24 – 38.67 µg/ml) in the 5-LOX assay (Chapter 8). Pelargonium graveolens 
(SBG) and P. panduriforme (SBG) oils produced promising anti-fungal activity (MIC = 2 
mg/ml) (Chapter 5). Due to the aromatic, flavouring and antimicrobial properties of P. 
citronellum (NBG) it was anticipated that this oil may have application in the food, 
cosmetic and pharmaceutical industry (Chapter 5). The cytotoxicity IC50 values of these 
oils are lower than the concentrations required to produce pharmacological effects. This 
indicates that caution is required when using these oils for therapeutic benefits. 
 
The GC-MS data of the essential oils (Chapter 3, Table 3.2) were evaluated to gain insight 
as to the compounds possibly contributing to the toxic effects observed. Pelargonium 
citronellum (NBG) produced a similar toxicity profile to P. scabrum and to P. radens yet 
the cluster dendrogram (Chapter 3, Figure 3.2) did not show a close association of P. 
citronellum (NBG) with either of these two species. The P. panduriforme samples 
produced the same toxicity values (IC50 ≤0.10 µg/ml), these samples were clustered in the 
same cluster subgroup (FA). Pelargonium graveolens (SBG) is equally toxic; however, it is 
grouped in cluster (E) which diverges from cluster (F) at a low similarity coefficient. The 
two P. quercifolium samples, with similar IC50 values of 3.34 ± 2.79 µg/ml and 8.81 ± 1.46 
µg/ml, are grouped within the same cluster i.e. (F) but within different subgroups. 
Pelargonium quercifolium (WSBG) is found in the subgroup that contains the P. 
panduriforme samples (FA), but it is P. quercifolium (SBG) which produces an IC50 value 
more similar to that of the P. panduriforme samples, yet occurs in subgroup (FB). The 
essential oils of P. radens and P. tomentosum (WSBG) produced similar toxicity profiles 
(Figure 10.6). This similarity is not surprising as these species are closely related 
chemically. Interesting to note is that the two P. tomentosum samples produced different 
toxicity profiles (IC50 ≤1.00 µg/ml and IC50 = 30.20 ± 1.81 µg/ml), yet the dendrogram 
demonstrates that they are chemically similar, their OTUs diverge at a high degree of 
similarity. Pelargonium graveolens (SBG) is chemically similar to P. tomentosum (SBG), 
both these oils were extremely toxic (IC50 ≤0.10 µg/ml and IC50 ≤1.00 µg/ml, respectively).  
 
The “plant laboratory” generates secondary metabolites and often occurring in high 
concentrations are those constituents with remarkable properties (Neuwinger, 1996). p-
Cymene, isomenthone, menthone, viridiflorol, 14-hydroxy-β-caryophyllene, geranic acid, 
geranial and neral occur as main compounds in the various essential oils tested. Some of 
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 these compounds mentioned also occur at lower concentrations. In particular, p-cymen-8-ol 
was present as a common compound at low levels. A single active constituent or several 
structurally related compounds could collectively be causing the toxicity of the plants (van 
Wyk et al., 2002a).  
 
Seatlholo et al. (2006, In press) conducted a study on the biological activities of twenty 
essential oil constituents. The toxicity study revealed that nerolidol was the most toxic 
compound with an IC50 value of 1.00 ± 0.30 µg/ml. (E)-Nerolidol occurs at 2.8% in P. 
quercifolium (SBG). Linalool which occurs in P. citronellum (NBG) (1.8%) and in P. 
panduriforme (SBG) (4.4%) was also found to be toxic (IC50 = 20.00 ± 10.00 µg/ml) 
(Seatlholo et al., 2006, In press). However, menthone a major compound in the P. 
tomentosum samples (36.1-41.1%) showed low toxicity (IC50 = 120.00 ± 3.00 µg/ml) as 
did p-cymene (IC50 = 110.00 ± 10.00 µg/ml) which was the major compound in P. 
panduriforme (SBG) (45.4%), P. panduriforme (WSBG) (37.6%) and P. quercifolium 
(WSBG) (54.9%). This implies that various arrangements of compounds at low levels and 
not the major compounds identified maybe contributing to the toxic effects of the tested 
Pelargonium oils.  
 
‘Geranium oil’ has been reported to cause contact dermatitis (Klarmann, 1958; Mitchell 
and Rook, 1979). Geraniol, a compound found in ‘geranium oil’, causes sensitization (Keil, 
1947). Seatlholo et al. (2006, In press) showed that geraniol is toxic to human kidney 
epithelial cells (IC50 = 20.00 ± 1.00 µg/ml). The sensitizing or toxic compounds producing 
negative effects on the skin could be partly responsible for the toxic effects demonstrated 
by the oils towards human kidney epithelial cells. Geraniol occurs in low amounts in the oil 
samples of P. citronellum (NBG), P. panduriforme (SBG and WSBG) and P. scabrum.  
 
Three volatile oils from P. graveolens were assessed for anti-tumour action (Fang et al., 
1989). The compounds citronellol, citronellyl formate, geraniol and citronellyl acetate 
exhibited marginal anti-tumour activity. Such activity may be due to the general cytotoxic 
effects of the compounds. The sample of P. graveolens (SBG), proven to be toxic in the 
MTT assay (IC50 ≤0.10 µg/ml), contains 0.4% citronellol and trace amounts of citronellyl 
formate. 
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 The toxicity of a plant in humans cannot be accurately predicted by a specific test (van 
Wyk et al., 2002a). Additional human cell lines should be used to assess whether the 
toxicity values of the Pelargonium extracts and essential oils obtained in this study are 
consistent with those produced when testing with other cell lines and whether greater 
selectivity for certain human cell types exists. The human kidney epithelial cell line used in 
the MTT assay serves as a prototype for the other organ-cell types of the human body, thus 
the toxic effects produced by the acetone extracts and essential oils in this study provides 
some idea of the results one can anticipate when using other cell lines. 
 
The next step would be to investigate the toxic effects of the individual major compounds 
common to the oils, using standards of these compounds. Once this has been performed, 
the identified toxic compound/s can be isolated from the plant and chemical and biological 
investigations can be performed on the toxin/s. In this way, knowledge of those active 
principles possessing toxic properties can be broadened. Toxicity studies involving skin 
preparations would provide an indication of the toxicity profile of the extracts and oils if 
they were to be employed in topical dermatological preparations for cosmetic use. In vivo 
studies should be conducted on both the extracts and essential oils as although in vitro 
cellular toxicity was indicated by the MTT assay, this may not be relevant in vivo.  
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 CHAPTER 11: GENERAL CONCLUSION 
 
ESSENTIAL OIL COMPOSITION AND CHEMOTAXONOMY 
• Cluster analysis defined patterns of similarity between and among certain 
Pelargonium samples based on their essential oil data. Definite chemotaxonomic 
relationships were apparent between P. papilionaceum and P. vitifolium; P. 
graveolens and P. radens and between P. panduriforme and P. quercifolium. In 
particular, the chemical composition of P. graveolens (WSBG) and P. radens was 
almost identical, this is in line with the work of van der Walt and Demarne (1988). 
New chemical affinities were established among P. betulinum, P. hispidum and P. 
scabrum; P. capitatum (WSBG), P. glutinosum and P. quercifolium (SBG) and 
among P. graveolens, P. radens and P. tomentosum. Overall, incongruencies 
occurred between the chemotaxonomic appraisal and the current phylogenetic 
hypotheses of relationships. Only the close relationship between P. graveolens and 
P. radens as indicated by Bakker et al. (2004) was found to occur in the chemical 
analysis. 
 
• The two oil samples of P. panduriforme, collected from different localities, were 
chemically similar as were the duplicate samples of P. graveolens and P. 
tomentosum. The GC-MS results of the P. tomentosum oil samples were in general 
agreement with published data; this indicated that the composition of the oil is 
relatively stable. GC-MS analysis of the P. capitatum oil samples confirmed the 
findings of previous studies which indicated variability in the oil composition. 
Viljoen et al. (1995) concluded that several biochemical pathways exist in P. 
capitatum. Comparison of the present data of P. graveolens with a previous study 
(Rana et al., 2002), indicated that chemical variation pertaining to its oil can occur. 
The two hydrodistilled essential oil samples of P. quercifolium produced 
moderately incongruent chemical patterns in this study. Different local conditions 
can influence the oil composition (Lis-Balchin, 1991) producing variations between 
the same species growing in different areas. The genetic component may account 
for chemical variations noted; this component being far more pronounced than the 
environmental effects. Growth regulators, shading, distillation, storage, weeds, leaf 
ontogeny, drying and seasons all influence the chemical composition of 
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 Pelargonium species oil (Rana et al., 2002). The essential oil compositions of P. 
papilionaceum, P. vitifolium and P. citronellum were different from those of the 
other analysed species. 
 
• Ambrox (2.3%) was detected in the oil of P. glutinosum. The commercially most 
important constituent of the scarce natural ambergris is (−)-Ambrox® (Bolster et al., 
2001), it has the nature of the no longer employed natural ambergris and is 
fundamental in creating fragrances (Castro et al., 2002). An amount of 5.4% of 
cedrol was detected in P. betulinum. Several odourants with ambery odour 
characteristics have been developed from cedrol such as Cedramber®. A mixture of 
aldehyde compounds were detected in P. citronellum. The latter species is known 
for its strong lemon scent. Very high quantities (36.1-41.1%) of menthone were 
detected in the P. tomentosum samples. Large quantities (49.3-84.5%) of 
isomenthone were detected in the oils of P. graveolens, P. radens and P. 
tomentosum. These ketones have a mint-scent. Good quantities of citronellol (9.9%) 
and linalool (4.4%) were detected in P. capitatum (Strand) and P. panduriforme 
(SBG), respectively. Both citronellol and linalool are employed by the food 
industry in citrus beverages (Lis-Balchin, 1990). The Pelargonium essential oils 
may be a source of several other constituents of interest to the flavour and fragrance 
industries.  
 
CHEMICAL COMPOSITION OF THE NON-VOLATILE EXTRACTS 
• A particular compound (UV absorbance maximum: 206.2-218.0 nm, retention time: 
± 3.98 minutes) appeared to be characteristic of the Pelargonium species. It was the 
major compound present in P. hermanniifolium, P. graveolens, P. greytonense and 
P. vitifolium. HPLC analysis confirmed the presence of flavonoid derivatives in the 
acetone extracts. The tentative flavonoid patterns of the Pelargonium species were 
used as a means to compare the species chemically. The data suggested that the 
following taxa: P. betulinum (NBG), P. capitatum (Strand), P. graveolens (SBG), 
P. hispidum (SBG), P. panduriforme (SBG) and P. vitifolium (SBG) have 
numerous similarities in their chemical profiles. Pelargonium capitatum and P. 
vitifolium are related (van der Walt, 1977) and so are P. sublignosum and P. 
scabrum (van der Walt and Vorster, 1988); their similar flavonoid patterns 
confirmed this. The HPLC fingerprints of P. papilionaceum and P. vitifolium were 
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 chemically diverse. Such findings noted from HPLC analysis were in disparity with 
the results obtained from the essential oil chemistry analysis which provided 
evidence of a chemotaxonomic relationship between these two species. 
  
ANTIMICROBIAL ACTIVITY  
• The Pelargonium essential oils and acetone extracts showed a more selective 
antibacterial action against the test Gram-positive micro-organisms Bacillus cereus 
and Staphylococcus aureus. The essential oils displayed reduced antimicrobial 
activity compared to the acetone extracts. The antibacterial activity of P. 
citronellum (NBG) against B. cereus and S. aureus suggested that P. citronellum 
(NBG) oil may delay microbial contamination. Pelargonium citronellum (NBG) oil 
with its additional aromatic and flavouring properties could be employed as a 
natural food preservative. It also has the potential as a cosmetic or pharmaceutical 
preservative. The Gram-negative bacterium, Klebsiella pneumoniae, showed 
microbial resistance to all the tested essential oils except to P. citronellum (NBG); 
however, this latter oil displayed very weak anti-Gram-negative bacterial activity. 
The yeast Candida albicans was most susceptible to the oils of P. graveolens 
(SBG) and P. panduriforme (SBG). These latter oils may be potential sources of 
effective anti-Candida agents.  
 
• The P. pseudoglutinosum acetone extract displayed the greatest antimicrobial 
activity against the Gram-positive bacteria. The acetone extracts of P. glutinosum 
(SBG), P. scabrum and P. sublignosum also produced remarkable anti-Gram-
positive activity. Pelargonium betulinum and P. capitatum (Strand) extracts were 
most active against K. pneumoniae. Candida albicans was found to be least 
resistant to P. scabrum which was the second most active test substance against B. 
cereus. The presence of flavonoids in the non-volatile extracts may account for 
their observed antimicrobial activity.  
 
•  The non-volatile Pelargonium extracts are potentially good sources of 
antimicrobial compounds which may have the potential to be utilized in the 
development of novel, efficient antimicrobial drugs. Furthermore, they may provide 
additional benefits to conventional antimicrobial treatments. In particular, extracts 
of P. glutinosum, P. pseudoglutinosum, P. scabrum and P. sublignosum may 
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 contain active compounds which offer some preservative benefit and thus may have 
applications in the food, cosmetic or pharmaceutical industries. Furthermore, the 
abovementioned species, may be potential sources of topical antimicrobial agents 
for the treatment of wound infections involving S. aureus and may be sources of 
effective agents for nosocomial infections. However, one must not consider that 
natural products are the answer to the problem of microbial resistance. Klimek et 
al. (1948) found that S. aureus was able to develop resistance to allicin, a natural 
compound from garlic (Allium sativum).  
 
• The antimicrobial results obtained for the acetone extracts support the traditional 
use of various Pelargonium species for the treatment of various ailments such as 
wounds, abscesses, coughs, colds, sore throats and gonorrhoea. However, the 
antimicrobial data obtained for the essential oils in this study, did not correlate with 
previous reports documenting effective antimicrobial activity of ‘geranium oils’. 
Evaluation of the vapour of the essential oils may provide a better indication of 
their antimicrobial activity. 
 
• It was concluded that in the case of Pelargonium, essential oils do not enhance the 
antimicrobial activity of non-volatile extracts. However, the results suggested that 
the non-volatile compounds may improve the antimicrobial property of volatile 
compounds. 
 
• The results from the MTT assay suggested that the antimicrobial action of the 
extracts may be ascribed to general cytotoxic effects. The greater selectivity of the 
Pelargonium extracts for human kidney epithelial cells indicates that the toxic 
effects of those extracts with considerable antimicrobial activity need to be 
considered if such substances have the potential to be used as in vivo therapeutic 
antimicrobials. However, P. cordifolium (NBG), P. crispum (NBG), P. 
quercifolium (SBG) have a niche in therapeutics due to their promising activity 
against both Gram-positive micro-organisms and their reasonably low toxicity 
profiles. 
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 ANTI-OXIDANT ACTIVITY  
• Pelargonium betulinum, P. crispum, P. cordifolium (NBG and WSBG) and P. 
scabrum displayed exceptional DPPH-scavenging activity. The flavonoid 
derivatives present in the Pelargonium species may contribute to their in vitro anti-
oxidant activities. Extracts of numerous species may have a potential role in 
reducing or preventing oxidative stress which has been associated with several 
degenerative diseases. These extracts may thus be potential sources of natural anti-
oxidant supplements. There is the possibility for extracts of specific Pelargonium 
species to be employed in the skin care regimen to slow down skin ageing via its 
anti-oxidant properties. However, such statements require further evaluation in that 
the anti-oxidant function of Pelargonium extracts should be assessed in biological 
systems (in vivo). In addition, the food industry requires the anti-oxidative 
properties of botanical extracts; certain Pelargonium species may be of importance 
in this industry. 
 
• The abovementioned species did not produce considerable toxic profiles except for 
the P. scabrum extract. This prompts further studies of these anti-oxidant active 
species, with regards to the isolation and structure elucidation of their anti-oxidant 
compound/s, followed by toxicity testing of these isolates with the potential of 
being utilized as therapeutic agents. 
 
ANTI-INFLAMMATORY ACTIVITY 
• Pelargonium quercifolium essential oil was the most active oil in the in vitro 5-
lipoxygenase assay. The bioactivity of the essential oils would be assumed to 
correlate to the respective composition of the plant essential oils, the structural 
configuration and the functional groups of the chemical constituents and 
interactions between components (Dorman and Deans, 2000). Several chemical 
compounds, previously reported to produce in vitro inhibition of the 5-lipoxygenase 
enzyme (Baylac and Racine, 2003), were present at low levels in the active oils. 
These compounds may act collectively in a synergistic manner and in this way may 
contribute to their anti-inflammatory activity. Numerous terpenic and 
sesquiterpenic hydrocarbons may contribute to the activity of P. quercifolium. 
Pelargonium quercifolium, P. panduriforme, P. scabrum and P. citronellum may 
have promising therapeutic applications in various inflammatory and allergic 
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 conditions. The aforementioned Pelargonium essential oils may be useful 
ingredients in cosmetic products as the oils not only possess pleasant aromatic 
qualities but may offer skin soothing activity, through their inhibition of the 5- 
lipoxygenase enzyme. 
 
 ANTIMALARIAL ACTIVITY  
• General cytotoxicity may explain the antimalarial activity of the extracts. 
Pelargonium citronellum (SBG), P. panduriforme (SBG) and P. quercifolium 
(SBG) exhibited considerable antimalarial activity and these extracts produced the 
highest safety indices. This indicated that the latter extracts, compared to the other 
extracts, had greater selectivity for the Plasmodium parasite than for the human 
kidney epithelium (Graham) cells. The latter species deserve further investigations 
in terms of isolating and testing of their active antimalarial compound/s. If several 
different compounds are responsible for each of their antimalarial activities 
recorded, then a drug containing a combination of such compounds could be 
developed to afford potentially potent antimalarial activity. 
 
• Pelargonium pseudoglutinosum extract produced considerable antimalarial activity 
and exerted the greatest activity against the Gram-positive bacteria. However, it 
produced a low safety index value. This species requires further investigations with 
respect to the isolation of the active compounds. Such compounds in isolated form 
where other compounds do not exert an influence could be non-toxic. If this is the 
case then the active compounds could serve as templates for the development of 
therapeutic agents with novel modes of antimalarial and antimicrobial actions.  
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 TOXICITY  
• The acetone extracts of P. sublignosum and P. citronellum (NBG) displayed the 
highest toxicities. Species exhibiting very low toxic profiles included P. capitatum 
(Strand), P. cordifolium (WSBG) and P. cucullatum (WSBG). Pelargonium 
tomentosum (SBG) and P. vitifolium were non-toxic. Flavonoid derivatives may 
have contributed to the cytotoxicity recorded for the acetone extracts.  
 
• The essential oils showed high cytotoxicity towards the human cell line used in the 
MTT assay. Pelargonium graveolens (SBG) and the two P. panduriforme samples 
proved to be the most toxic. Pelargonium tomentosum (WSBG) oil was the least 
toxic. Various compounds (geraniol, nerolidol and linalool) previously reported to 
be toxic were present at low levels in the tested Pelargonium oils. Such compounds 
maybe contributing to their cytotoxicity. The cytotoxicity of the essential oils 
appears to be selective as the essential oils exerted poor antimicrobial activity. The 
greater selectivity of the oils shown for the human cells in this study needs to be 
further substantiated by using other human cell lines. Furthermore, other methods 
of testing the antimicrobial activity of the essential oils may provide a better 
indication of this selectivity. 
 
• The P. quercifolium essential oil samples produced promising anti-inflammatory 
activity in the 5-LOX assay. Pelargonium graveolens (SBG) and P. panduriforme 
(SBG) oils produced good anti-fungal activity. Due to the aromatic, flavouring and 
antimicrobial properties of P. citronellum (NBG) it was anticipated that this oil may 
have application in the food, cosmetic and pharmaceutical industry. The toxicity 
IC50 values of these oils are lower than the concentrations required to produce 
pharmacological effects. This indicates that the toxicity of these oils must be 
considered in accordance with their potential applications. 
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 This study intends to make a contribution towards the knowledge base of plant species with 
therapeutic potential. This study confirmed the presence of bioactive compounds in 
Pelargonium species and showed that the properties of Pelargonium species correspond to 
the traditionally held views. The food, cosmetic and pharmaceutical industries have 
recognized the value of natural ingredient utilization and have shifted their focus towards 
investigating and manufacturing alternative, more natural antimicrobials, antibiotics and 
anti-oxidants. The antimicrobial results together with the concomitant anti-oxidant activity 
make a compelling case for the potential use of certain non-volatile Pelargonium extracts 
in the aforesaid industries. However, studies involving well-designed human trials need to 
be conducted for further affirmation. A great deal still needs to be learned with regard to 
the precise mode of action of the compounds of those Pelargonium species demonstrating 
considerable activities.  
 
A quote by Juritz in 1915 remains relevant today: “South Africa still remains as indifferent 
as in Pappe’s day to the pharmacological possibilities of its almost inexhaustible flora” 
(Vorster, 1990). Many plant-derived substances have been fundamental in relieving human 
suffering which justifies the continued search for new and improved plant-derived drugs. 
Many more beneficial drug entities from the plant kingdom are yet to be discovered; much 
wealth and wonder is still held by Nature’s secrets.  
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 RECOMMENDATIONS FOR FURTHER RESEARCH 
 
• Phytochemical investigations 
It should be noted that for taxonomic reasons and due to time constraints plant material 
was obtained from botanical gardens. It is recommended that a thorough geographical 
variation study is performed on each species to explain the diversity within and between 
natural populations. 
 
Research on aromatic Pelargoniums has been restricted to the volatile compounds. The 
pharmacological results clearly indicate that the non-volatile compounds warrant further 
study as the HPLC assignments mentioned in the monograph section are tentative only. If 
these tentative identifications are confirmed then certain Pelargonium species can be 
utilized as a source for the isolation of natural flavonoids. A compound with a typical 
flavone UV spectrum occurred in high amounts in P. hispidum (SBG), P. panduriforme 
(SBG), P. papilionaceum (NBG) and P. tomentosum (SBG). Isolation, subsequent 
structural elucidation and biological testing of this compound should be carried out. 
 
In order to make a comprehensive validation of the differences in biological activities 
produced by some duplicate samples, their HPLC profiles need to be obtained and 
evaluated. 
 
• Antimicrobial activity 
Investigations to determine the antibacterial and antifungal effects of the vapours of the 
essential oils of Pelargoniums should be carried out. If such findings prove to be positive 
then there is the potential use of Pelargonium oils in the disinfection of hospital rooms and 
work environments. Before the clinical practice of vapour therapy of Pelargonium essential 
oils can be applied in whole-organism systems, their effectiveness in terms of parameters 
such as minimum exposure time for the therapeutic effect to occur and bactericidal vapour 
concentration should be subjected to animal and human studies (Inouye et al., 2001). 
 
Further antimicrobial investigations involving different micro-organisms should be 
performed on the non-volatile Pelargonium extracts. 
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 The non-volatile extract of P. pseudoglutinosum showed considerable activity against the 
Gram-positive bacteria. Further investigations of its antimicrobial activity should be 
performed. The rapidity of a bactericidal effect or the duration of a bacteriostatic effect can 
be determined by time-kill analysis (survival curve plot). In this analysis, the number of 
viable cells remaining in broth after the addition of the extract is plotted against time. The 
compound/s responsible for the antibacterial activity of P. pseudoglutinosum should be 
isolated. Once isolated other biological activities can be evaluated.  
 
Historically, tuberculosis is the largest single cause of death of the human species. 
Following a long period of declining incidence, there has been a reappearance of the 
disease over the last two decades. The uncontrolled usage of the currently available 
antimycobacterial drugs has resulted in the emergence of multidrug-resistant strains of 
Mycobacterium tuberculosis (Seidel and Taylor, 2004). “Umckaloabo” is highly valued by 
the southern African native population for its curative and palliative effects (Kolodziej, 
2002). This traditional drug originates from the root material of P. sidoides and P. 
reniforme and decoctions are used for the treatment of tuberculosis (Miller, 2002).  Seidel 
and Taylor (2004) reasoned that the supposed in vivo efficacy of “Umckaloabo” may be 
related to both direct antibacterial effects on pathogenic mycobacteria and to indirect 
immunomodulating properties of components of the extracts. Other Pelargonium species 
may prove to be valuable sources of new antimycobacterial drugs. 
 
• Anti-oxidant activity 
The exceptional anti-oxidant activities of P. betulinum, P. cordifolium, P. crispum and P. 
scabrum indicate that they possess bioactive compounds. Pursuing the isolation and 
biological studies of these active compounds in the future is justified. 
 
• Anti-inflammatory activity 
Pelargonium essential oils should be assessed for inhibitory activity towards the two 
isoforms of cyclo-oxygenase (COX-1 and COX-2). In this way, we will be able to screen 
for potential balanced inhibitors of 5-LOX and COX pathways. Such substances are 
important for the advancement of effective and safe anti-inflammatory therapy. 
 
The major compounds detected in the essential oils of P. citronellum (NBG), P. 
panduriforme (SBG and WSBG), P. quercifolium (SBG and WSBG) and P. scabrum 
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 (SBG), should be assessed individually to determine their contribution to the anti-
inflammatory activity displayed by the whole oil. 
 
• Antimalarial activity 
The antimalarial findings raise some interesting expectations about these plant extracts, 
indicating that further studies on the chemical and biological properties of their active 
components should be carried out. 
 
• Anticancer activity  
The anticancer potential of Pelargonium species should be investigated. Those 
Pelargonium species demonstrating both anti-inflammatory and anticancer properties, with 
a low toxicity profile, deserve consideration as adjuncts in cancer treatment or 
chemoprevention. 
 
• Antiviral activity 
The ever increasing number of people infected with the human immunodeficiency virus 
(HIV) has highlighted the importance of the development of novel antiretroviral agents. 
Investigations have focused on plant sources for possible novel therapeutics. The herpes 
simplex virus (HSV) is responsible for various life threatening diseases. There is the need 
to search for new and more effective antiviral agents for HSV infections since the 
chemotherapeutic agents available are either low in quality or have limited efficiency 
(Vijayan et al., 2004). The treatment of viral infections with current antiviral drugs often 
leads to the problem of viral resistance. Investigating Pelargonium species for potential 
antiviral activity is validated by the increasing need for substances with antiviral activity. 
 
• Other activities requiring investigation 
There are various other properties of Pelargonium species requiring further research (van 
Wyk et al., 2002b). These include wound-healing, antispasmodic and analgesic effects 
(Watt and Breyer-Brandwijk, 1962). Research into these other properties of Pelargoniums 
is well-founded as their importance within the realms of the cosmetic and pharmaceutical 
industries may be further developed. 
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 APPENDIX A: MONOGRAPHS OF SELECTED PELARGONIUM 
SPECIES 
 
Appendix A contains the monographs of the 21 Pelargonium species (section 
Pelargonium) included in this study. The species were selected according to the 
availability of fresh plant material from the botanical gardens (SBG, NBG and WSBG) and 
according to authenticity of taxonomic identification. 
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 1. Pelargonium betulinum (L.) L’Hérit. 
 
Synonym: 
P. georgense Knuth (van der Walt, 1985). 
 
Common names: 
Birch-leaf pelargonium, Camphor-scented pelargonium, ‘Kanferblaar’, ‘Maagpynbossie’, 
‘Suurbos’ (van der Walt, 1977; Lawrence and Notten, 2001). 
 
Botanical description: 
Pelargonium betulinum is a small upright or sprawling, bushy shrublet or shrub measuring 
0.3-1.3 m in height. The branches are woody and the leaves are small, asymmetrically oval 
or ovate, hard and leathery. The leaves resemble those of the European Birch trees (Betula 
species); this explains the derivation of the species name ‘betulinum’. The leaf blades are 
either almost hairless or covered with fine hairs. The leaf border is dentated with red-tipped 
teeth. The leaf margin of the plants from the Mossel Bay - Knysna regions is coarser than 
that of plants from the south-western Cape. The umbel-like inflorescence generally 
contains three to four flowers and sometimes up to six flowers. The plant is noticeable 
when in full bloom as the flowers are large and attractive. The flowers are most commonly 
pink and purple in colour, a white form is also found. Dark purplish streaks occur on the 
petals, particularly on the posterior two petals which are broader and darker than the three 
anterior ones. The seven-fertile stamens contain orange anthers (van der Walt, 1977; 
Lawrence and Notten, 2001). 
  
Distribution and habitat: 
Pelargonium betulinum is mostly located in the coastal areas of the winter rainfall region 
of South Africa, from Yzerfontein to Knysna (west coast to the east coast of the Western 
Cape). Pelargonium betulinum grows on sandy dunes and on flat landscapes. Pelargonium 
betulinum is frequently found growing with P. cucullatum. Hybrids of these two species 
are therefore common (van der Walt, 1977). 
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Figure 1.2: The geographical distribution of 
Pelargonium betulinum (All maps purchased 
and included with permission from SANBI). 
Figure 1.1: Pelargonium betulinum.
 
Traditional uses: 
The vapours (essential oils) obtained from the steamed leaves were inhaled to treat coughs 
and other chest-related problems (van der Walt, 1977). The leaves were used in wound 
healing ointments. The common name ‘Maagpynbossie’ (stomach-pain bush) was derived 
from the fact that this plant was used for the relief of stomach pain and flatulence 
(Lawrence and Notten, 2001). 
 
Remarks: 
The vernacular name ‘Kanferblaar’ (camphor leaf) or camphor-scented pelargonium is 
derived from the camphor-like odour produced when the leaves are crushed. The name 
‘Suurbos’ (sour bush) refers to the taste of the leaves (Lawrence and Notten, 2001). 
 
Chemical composition of the essential oil: 
Fresh plant material was collected from the National Botanical Garden (Kirstenbosch) and 
subjected to hydrodistillation for 3 hours. The oil yield was 0.04%. 
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 GC-MS profile and analysis 
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Figure 1.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
betulinum (NBG). 
 
Table 1.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
betulinum (NBG). 
 
RRI Compound Area % 
1032 α-pinene 0.13 
1280 p-cymene 0.24 
1384 heptyl acetate 0.09 
octyl acetate 5.74 1491 
1497 α-copaene 1.41 
1528 α-bourbonene 0.15 
1535 β-bourbonene 2.76 
1549 β-cubebene 0.20 
1553 octanol 0.12 
1572 β-ylangene 0.05 
1577 α-cedrene 0.60 
β-caryophyllene 5.28 1612 
1613 β-cedrene trace 
1661 allo-aromadendrene 0.64 
1664 1-nonanol 0.14 
1668 (Z)-β-farnesene 0.16 
1687 α-humulene 1.45 
1693 β-acoradiene 0.45 
1704 γ-muurolene 1.89 
1726 germacrene D 0.23 
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 RRI Compound Area % 
1740 α-muurolene 2.44 
1743 α-cadinene 0.24 
1766 1-decanol 0.51 
1773 δ-cadinene 2.59 
1776 γ-cadinene trace 
1786 ar-curcumene 0.14 
cis-calamenene 1853 0.99 
trans-calamenene 1871 0.05 
1898 1,11-oxidocalamenene 0.07 
1918 β-calacorene 0.09 
1941 α-calacorene 0.40 
1965 3-phenylpropyl acetate 2.99 
1984 γ-calacorene 0.18 
2001 isocaryophyllene oxide 0.65 
2008 caryophyllene oxide 2.82 
2045 humulene epoxide I trace 
2050 (E)-nerolidol 0.09 
2057 ledol 0.10 
2071 humulene epoxide II 0.76 
2080 cubenol 2.51 
2088 1-epi-cubenol 0.58 
2104 viridiflorol 0.25 
2131 hexahydrofarnesylacetone trace 
cedrol 5.40 2143 
T-cadinol 18.94 2187 
2209 T-muurolol 1.72 
2219 α-muurolol 0.78 
trans-α-bergamotol 2247 trace 
α-cadinol 4.45 2255 
2340 10-hydroxy-calamenene 0.53 
2407 hydroxy-α-calacorene* trace 
2900 nonacosane 0.10 
2931 hexadecanoic acid 0.69 
Total 72.79%  
 
*correct isomer not identified; trace: <0.05%; (NBG) = National Botanical Garden 
(Kirstenbosch). 
 254
 T-cadinol, a sesquiterpene, is the principle compound (18.94%) identified in the essential 
oil. Octyl acetate, β-caryophyllene, cedrol and α-cadinol are other major compounds, 
collectively making-up 20.87% of the total oil composition. 
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Figure 1.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium betulinum (NBG). 
 
  
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium betulinum collected 
from the National Botanical Garden (Kirstenbosch). 
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 HPLC profile and analysis 
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Figure 1.5: HPLC profile of the acetone extract of Pelargonium betulinum (NBG). 
  
Table 1.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium betulinum (NBG) acetone 
extract. 
 
Retention 
time (min)  
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.01 203.8  5.72 
4.85 207.3, 280.5  0.65 
5.27 214.4, 279.3  1.19 
6.56 215.6, 271.0  0.56 
9.36 207.3, 315  2.79 
10.22 206.2, 271.0  1.40 
11.61 219.1, 284.1  2.02 
12.25 219.1, 280.5  1.53 
13.70 222.6, 281.7  26.92 
14.30 222.6, 281.7  10.22 
14.75 222.6, 280.5  6.37 
15.78 222.6, 278.1  10.85 
17.24 220.3, 280.5  7.90 
17.93 220.3, 278.1  6.70 
18.34 263.9, 350.8 flavone 2.04 
18.74 255.7, 355.6 flavonol 2.37 
19.84 222.6, 280.5  1.93 
20.52 255.7, 354.4 flavonol 3.67 
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 Retention 
time (min)  
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
21.39 255.7, 350.8 flavone 4.89 
32.30 261.6  0.15 
34.18 265.1  0.11 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium betulinum in this study 
include the following: 
 
• The acetone extract produced promising antimicrobial activity. The extract was 
most active against the Gram-positive micro-organism B. cereus (MIC = 0.33 
mg/ml). 
 
• The Pelargonium betulinum extract displayed exceptional anti-oxidant activity 
(IC50 = 4.13 µg/ml) in the DPPH assay. Of all the extracts tested, this species 
displayed the highest anti-oxidant activity.  
 
• Pelargonium betulinum extract displayed antimalarial activity; an IC50 value of 
16.23 ± 2.75 µg/ml was obtained from the hypoxanthine incorporation assay. 
 
• The acetone extract exhibited low toxicity in the MTT assay (IC50 = 88.55 ± 1.51 
µg/ml). 
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 2. Pelargonium capitatum (L.) L’Hérit. 
 
Synonym: 
Pelargonium drummondii (van der Walt, 1985). 
 
Common name: 
Rose-scented pelargonium (van der Walt, 1977). 
 
Botanical description: 
Pelargonium capitatum is a shrubby or bushy, low growing (0.25-1 m tall) plant with side-
branches which can reach a length of 60 cm. The sprawling or upright stems are soft 
wooded. Long soft hairs cover the stems and leaves, which when crushed release a rose-
like aroma. The creased, velvety leaves have a cordate base and are deeply 3-6-lobed. The 
segments may also be lobed with a toothed leaf margin. The flower heads seem to be quite 
condensed; this is due to the short flower pedicles and the large number of flowers. Eight 
to twenty flowers are borne on each capitate (head-like) inflorescence. Generally, the petals 
are cyclamen-purple coloured with beetroot-purple stripes on the two posterior and larger 
petals. Pale pink and dark pink-purple coloured flowers can also be found. Each flower 
consists of seven fertile stamens (van der Walt, 1977).  
 
Distribution and habitat: 
The distribution of P. capitatum stretches from Lambert’s Bay (Western Cape) on the 
Atlantic coast southwards and then eastwards to Richards Bay (KwaZulu-Natal) on the 
Indian Ocean coast. Pelargonium capitatum is found growing on dunes or low sandy hill-
sides near the coast. Like other Pelargoniums, it usually grows in disturbed areas (van der 
Walt, 1977). 
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Figure 2.2: The geographical distribution of 
Pelargonium capitatum. 
Figure 2.1: Pelargonium capitatum in 
flower. 
 
Medicinal uses: 
The whole plant is a soothing, emollient herb (Bown, 1995). All plant parts are astringent 
(Grieve, 1984). It is taken internally to treat minor digestive ailments as well as kidney and 
bladder disorders. It is used for the relief of rashes and cracked skin (Bown, 1995).  
 
Other uses: 
Pelargonium capitatum is one of the Pelargoniums cultivated for its essential oil (van der 
Walt, 1977) which has the scent of roses. The essential oil is used in aromatherapy, skin 
care and is employed in perfumes. The leaves are used in pot-pourri (Bown, 1995).  
 
Remark: 
Pelargonium capitatum is closely related to P. vitifolium (van der Walt, 1977). 
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 Chemical composition of the essential oil: 
Hydrodistillation was carried out on fresh plant material for 3 hours.  
1. Pelargonium capitatum from Strand region yielded 0.02% oil, 
2. Pelargonium capitatum from Walter Sisulu Botanical Garden yielded 0.02% oil. 
 
GC-MS profiles and analyses 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
capitatum (Strand). 
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Figure 2.4: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
capitatum (WSBG). 
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 Table 2.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
capitatum. 
 
Area % RRI Compound Strand WSBG 
1032 α-pinene 0.19 - 
1202 3-hexanol 0.07 - 
1213 1,8-cineole - trace 
1280 p-cymene 0.07 - 
cis-rose oxide 1353 0.60 - 
trans-rose oxide 1365 0.27 - 
1402 heptyl isobutyrate - 0.48 
1459 acetic acid - 0.26 
1464 (E)-2-hexenyl butyrate - 0.47 
1466 α-cubebene 0.51 - 
1475 menthone 0.89 - 
1497 α-copaene 0.71 - 
1503 isomenthone 1.93 - 
1528 α-bourbonene 0.13 - 
1532 camphor - 0.07 
1535 β-bourbonene 1.52 - 
1553 linalool 0.29 0.12 
1553 octanol 0.24 0.09 
1562 isopinocamphone - 0.28 
1574 hexadecane 0.15 - 
1588 β-copaene trace - 
1589 isocaryophyllene 1.01 - 
1597 bornyl acetate 0.13 0.39 
octyl butyrate 2.08 1608 - 
1611 terpinen-4-ol - trace 
citronellyl formate 31.14 1612 - 
1612 β-caryophyllene - 0.19 
1617 guaia-6,9-diene 0.53 - 
1661 allo-aromadendrene 0.58 - 
1668 citronellyl acetate 0.92 - 
1674 γ-gurjunene 0.32 - 
1679 heptadecane 0.09 - 
1690 cryptone 0.19 - 
1698 geranyl formate 0.51 - 
1704 γ-muurolene 0.44 - 
1706 α-terpineol 0.25 0.28 
1719 borneol - 0.97 
1725 verbenone - 0.73 
1740 α-muurolene 1.35 0.58 
1744 α-selinene 0.26 - 
1750 β-dihydroagarofuran - 0.37 
cis-dihydroagarofuran 1755 - 0.16 
1765 geranyl acetate 0.15 - 
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 Area % RRI Compound Strand WSBG 
1766 1-decanol - 0.15 
citronellol 9.85 1772 - 
1800 octadecane 0.13 - 
1805 tridecanal - 0.29 
1809 citronellyl butyrate 0.23 0.24 
1837 myrtanol* - 0.09 
trans-carveol 1845 trace - 
cis-calamenene 1853 1.59 0.52 
1864 p-cymen-8-ol 0.44 - 
1868 (E)-geranyl acetone 0.39 - 
α-agarofuran 2.78 1916 - 
- 1998 furopelargone A 0.08 
2001 isocaryophyllene oxide - 0.28 
caryophyllene oxide 2.77 9.97 2008 
- 2030 norbourbonone 0.52 
2033 epi-globulol - 0.57 
2045 humulene epoxide I - 0.14 
2057 ledol 0.24 - 
2071 humulene epoxide II 0.47 0.13 
2080 cubenol - 0.56 
2088 1-epi-cubenol - 0.47 
2098 globulol - 0.12 
viridiflorol 24.00 2104 - 
furopelargone B 6.13 - 2110 
10-epi-γ-eudesmol 6.88 2127 - 
2131 hexahydrofarnesylacetone 0.54 - 
2143 cedrol - 0.29 
2144 spathulenol 0.39 - 
2185 γ-eudesmol - 0.28 
2187 T-cadinol 0.46 - 
2205 eremoligenol - 0.48 
2209 T-muurolol 0.31 0.08 
2210 agarospirol - 0.35 
2219 α-muurolol 0.38 0.26 
2228 valerianol - 0.87 
2249 cadalene 1.14 - 
4α-hydroxy-
dihydroagarofuran 2.23 2253 - 
2254 citronellic acid trace - 
β-eudesmol 2.93 2257 - 
2273 selin-11-en-4α-ol - 0.19 
2281 decanoic acid 0.25 0.09 
2300 tricosane - 0.08 
2316 caryophylladienol I 0.16 - 
2324 caryophylladienol II 0.27 - 
2340 10-hydroxy-calamenene - trace 
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 Area % RRI Compound Strand WSBG 
2357 14-hydroxy-β-caryophyllene 0.29 - 
2376 manoyl oxide - 0.56 
2384 farnesyl acetone 0.35 - 
2500 pentacosane 0.22 0.17 
2509 dodecanoic acid  0.46 0.14 
2617 tridecanoic acid - 0.20 
2670 tetradecanoic acid 0.94 - 
2700 heptacosane 0.08 trace 
2931 hexadecanoic acid 0.60 1.05 
Total 75.12% 64.96%  
 
*correct isomer not identified; trace: <0.05%; WSBG = Walter Sisulu Botanical Garden. 
 
Citronellyl formate, the major compound identified in P. capitatum (Strand), contributes 
31.14% to the total oil composition. Citronellol, a monoterpene, contributes 9.85% and the 
sesquiterpenes caryophyllene oxide and furopelargone B represent 2.77% and 6.13%, 
respectively. 
 
The principle compound in P. capitatum (WSBG) is the sesquiterpene viridiflorol which 
occupies 24.00% of the total oil composition. Other major compounds include 
caryophyllene oxide (9.97%) and 10-epi-γ-eudesmol (6.88%). Collectively, octyl butyrate, 
α-agarofuran, β-eudesmol and 4α-hydroxy-dihydroagarofuran make-up 10.02% of the total 
oil composition. 
 
There is considerable chemical variation between the two oil samples of P. capitatum. 
Caryophyllene oxide is the only major compound common to both the oil samples with a 
higher percentage occurring in P. capitatum (WSBG).  
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Figure 2.5: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium capitatum (Strand). 
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Figure 2.6: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium capitatum (WSBG). 
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 Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium capitatum collected 
from the Strand region. 
 
HPLC profile and analysis  
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Figure 2.7: HPLC profile of the acetone extract of Pelargonium capitatum (Strand). 
 
Table 2.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium capitatum (Strand) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.05 207.4  8.21 
4.92 202.8, 261.5  3.54 
5.51 205.1  7.59 
10.22 207.4  1.41 
11.94 220.3, 278.0, 314.7  1.03 
13.71 283.9 flavanone 1.23 
15.44 265.0, 351.6 flavonol 0.36 
15.88 260.3, 357.5 flavonol 8.51 
16.17 255.6, 351.6 flavonol 2.89 
17.57 255.6, 357.5 flavonol 1.55 
18.25 261.5, 348.0 flavone 1.37 
18.61 255.6, 354.0 flavonol 30.29 
19.03 255.6, 351.6 flavonol 2.93 
 265
 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
20.70 255.6, 354.0 flavonol 15.60 
21.43 254.4, 348.0 flavone 1.10 
32.88 261.5  0.87 
33.48 254.4, 354.0 flavonol 8.86 
36.00 267.4, 345.6 flavone 2.65 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium capitatum in this study 
include the following: 
 
• Pelargonium capitatum (Strand) acetone extract produced MIC values ranging 
from 1 - 2 mg/ml. 
 
• The P. capitatum (Strand) extract displayed substantial antimalarial activity (IC50 = 
9.81 ± 0.34 µg/ml). 
 
• The acetone extract (Strand) produced a low toxicity profile (IC50 = 101.59 ± 1.75 
µg/ml). 
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 3. Pelargonium citronellum J. J. A. van der Walt 
 
Common name: 
Lemon-scented pelargonium (van der Walt and Vorster, 1988).  
 
Botanical description: 
Pelargonium citronellum is a densely branched shrub and can reach a height of 2 m. The 
stems are herbaceous when young and hirsute with many glandular hairs. The lower 
surfaces of the leaves are conspicuously veined. The leaves are sparsely covered with 
rough, stiff hairs with glandular hairs interspersed. The margins of the leaves are 
irregularly serrate-dentate. Leaf characteristics are intermediary to those of P. scabrum and 
P. hispidum. Pelargonium citronellum leaves compared to those of P. scabrum are less 
scabrous, but more strongly aromatic. The lemon scent of the leaves and stems is attributed 
to the chemical substance, citronella, hence the epithet ‘citronellum’. Five to six and 
sometimes up to eight flowers are borne on the pseudo-umbel inflorescence. The flowers 
are pinkish to purple. The posterior two petals have characteristic dark purple markings and 
are spathulate to obovate and the anterior three petals are spathulate. Seven fertile stamens 
are present (van der Walt and Vorster, 1988). 
 
It is likely that P. citronellum evolved from the southern Cape form of P. scabrum, since 
the latter form resembles P. citronellum to a greater extent than the Western Cape form. 
Pelargonium scabrum can hybridize easily with other species and so it is also highly likely 
that P. citronellum originated from the hybridization of P. scabrum and P. hispidum (van 
der Walt and Vorster, 1988). 
 
Distribution and habitat: 
Pelargonium citronellum is restricted to the one degree square which includes the town of 
Ladismith in the Western Cape. It is commonly found growing on the northern foothills of 
the Langeberg range between Muiskraal and Herbertsdale. This distribution area receives 
most of its rainfall during winter months. Pelargonium citronellum is found near streams or 
rivulets (van der Walt and Vorster, 1988). 
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 Figure 3.2: The geographical distribution of 
Pelargonium citronellum. 
Figure 3.1: Pelargonium citronellum. 
 
Use: 
Pelargonium citronellum is grown as a culinary herb (van der Walt and Vorster, 1988). 
 
Chemical composition of the essential oil: 
Fresh plant material collected from the National Botanical Garden (Kirstenbosch) was 
hydrodistilled for 3 hours and yielded 0.36% of an orange-yellow essential oil. 
 
GC-MS profile and analysis 
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Figure 3.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
citronellum (NBG). 
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 Table 3.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
citronellum (NBG). 
 
RRI Compound Area % 
1048 2-methyl-3-buten-2-ol 0.12 
1112 anhydrolinalool oxide trace 
1174 myrcene trace 
1195 dehydro-1,8-cineole 0.20 
1203 limonene 0.05 
1280 p-cymene 0.11 
1348 6-methyl-5-hepten-2-one 0.43 
1391 (Z)-3-hexenol 0.12 
1419 photocitral B 0.17 
1429 perillene 0.05 
trans-linalool oxide (furanoid) 1450 0.14 
1452 1-octen-3-ol trace 
1459 acetic acid trace 
1464 (E)-2-hexenyl butyrate trace 
1473 (Z)-3-hexenyl 2-methylbutyrate trace 
cis-linalool oxide (furanoid) 1478 0.14 
cis/cis-photocitral 1482 0.28 
1497 α-copaene 0.05 
1503 isomenthone 0.06 
trans/trans-photocitral 1506 0.56 
1535 β-bourbonene trace 
1541 benzaldehyde 0.06 
linalool 1.78 1553 
1577 α-cedrene 0.54 
1602 6-methyl-3,5-heptadien-2-one trace 
1612 β-caryophyllene 0.59 
1613 β-cedrene trace 
1628 aromadendrene trace 
trans-p-mentha-2,8-dien-1-ol 1639 0.10 
trans-piperitol 1689 0.07 
neral 17.42 1694 
1706 α-terpineol 0.19 
geranial 27.21 1740 
1773 0.09 δ-cadinene 
1776 trace γ-cadinene 
1783 p-methylacetophenone 0.15 
1786 ar-curcumene 0.22 
1798 methyl salicylate trace 
1808 nerol 0.63 
1857 geraniol 0.98 
1864 p-cymen-8-ol 0.65 
1886 geranyl butyrate 0.07 
1937 2-phenylethyl alcohol 0.06 
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 RRI Compound Area % 
1941 α-calacorene 0.06 
2001 isocaryophyllene oxide 0.16 
2008 caryophyllene oxide 0.89 
2030 methyl eugenol 0.11 
2050 (E)-nerolidol trace 
2071 humulene epoxide II trace 
2098 globulol 0.23 
2104 viridiflorol trace 
2144 spathulenol 0.61 
2180 1-tetradecanol 0.08 
2239 carvacrol 0.24 
trans-α-bergamotol 2247 0.08 
2254 citronellic acid 0.05 
2255 α-cadinol 0.09 
2273 1-pentadecanol 0.06 
2308 nerolic acid 0.26 
2324 caryophylladienol II trace 
geranic acid 35.95 2349 
2392 caryophyllenol II 0.08 
Total 92.24 %  
 
trace: <0.05%; NBG = National Botanical Garden (Kirstenbosch). 
 
Geranic acid was identified as the main compound (35.95%) in the essential oil. The 
aldehydes, neral and geranial, collectively make-up 44.63% of the total oil composition. 
Linalool, a monoterpene, contributes 1.78% to the total oil composition. 
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Figure 3.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium citronellum (NBG). 
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 Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium citronellum collected 
from the National Botanical Garden (Kirstenbosch). 
 
HPLC profile and analysis  
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Figure 3.5: HPLC profile of the acetone extract of Pelargonium citronellum (NBG). 
 
Table 3.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium citronellum (NBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.02 209.7  1.83 
10.02 206.2, 273.4   1.61 
11.07 206.2, 260.4 isoflavone 1.79 
11.92 206.2, 268.7  2.05 
12.62 206.2, 280.5  1.42 
13.12 206.2, 279.3 flavanone 1.98 
14.32 220.3  2.42 
14.97 207.3, 277.0  2.65 
16.32 284.1  1.28 
17.88 206.2, 266.3, 353.2 flavonol 3.67 
19.48 209.7, 287.6 flavanone 2.33 
20.97 209.7, 271.0 flavanone 1.80 
21.82 209.7, 272.2 flavanone 1.36 
22.37 220.3  2.68 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
22.90 220.3, 279.3  2.72 
22.98 280.5 flavanone 1.86 
23.75 209.7, 274.6  1.72 
24.49 220.3, 277.0  4.45 
24.73 220.3, 272.2  2.04 
25.57 220.3, 277.0  1.64 
27.52 284.1 flavanone 1.24 
28.22 222.6, 2829  2.58 
28.63 287.6  1.25 
29.38 267.5, 349.6 flavone 3.38 
29.67 209.7, 282.9  1.57 
29.72 206.2, 274.6, 363.9  1.75 
30.16 268.7, 346.0 flavone 2.78 
30.46 209.7, 272.2, 349.6  3.02 
30.90 279.3  1.47 
31.65 287.6  5.11 
32.02 272.2, 397.4 flavanone 2.50 
32.30 29.7, 268.7  1.97 
32.52 275.8  2.98 
33.01 268.7, 290.0, 343.6  4.72 
33.12 236.8  1.40 
33.50 343.6  1.53 
34.18 201.5, 273.4  1.69 
34.47 222.6, 272.2  2.08 
35.28 232.0, 290.0 flavanone 1.08 
35.72 235.6, 290.0, 342.4  1.22 
36.38 230.9, 273.4, 344.8  4.38 
37.03 234.4, 290.0 flavanone 1.70 
37.90 234.4, 300.7, 349.6  1.41 
38.73 239.1, 269.9, 338.9  1.31 
41.78 236.8, 301.9, 349.6  1.51 
42.70 237.9, 277.0  1.05 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium citronellum in this study 
include the following: 
 
• Both P. citronellum acetone extracts showed substantial antibacterial activity 
against the Gram-positive bacteria. In particular, an MIC value of 0.16 mg/ml was 
produced by both the extract samples against S. aureus. Pelargonium citronellum 
(NBG) essential oil displayed moderate antimicrobial activity (MIC = 4 mg/ml) 
against the Gram-positive bacteria and the yeast strain. 
 
• The P. citronellum (SBG) extract produced low anti-oxidant activity (IC50 = 84.01 
± 16.08 µg/ml) whereas the P. citronellum (NBG) extract demonstrated promising 
anti-oxidant activity (IC50 = 23.70 ± 3.68 µg/ml). 
 
• Pelargonium citronellum essential oil (NBG) displayed moderate anti-
inflammatory activity (IC50 = 50.04 ± 7.06 µg/ml). 
 
• Both P. citronellum extract samples (NBG and SBG) showed pronounced 
antimalarial activity (IC50 = 1.58 ± 0.65 µg/ml and 1.74 ± 0.79 µg/ml, respectively). 
 
• The P. citronellum (NBG) extract produced substantial cytotoxicity (IC50 = 19.14 ± 
0.98 µg/ml), as did the essential oil (NBG) which produced an IC50 value of 22.40 
± 4.77 µg/ml in the MTT assay. The P. citronellum extract (SBG) produced a lower 
toxicity profile (IC50 = 59.94 ± 2.33 µg/ml). 
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 4. Pelargonium cordifolium (Cav.) Curtis 
 
Synonym: 
P. cordatum L’Hérit. (van der Walt, 1977). 
 
Common name: 
Heart-leaved pelargonium (van der Walt, 1977). 
 
Botanical description: 
Pelargonium cordifolium is a branching shrub reaching a height of 1-1.75 m. The main 
stem is woody at the base and has herbaceous side-branches covered with hairs. The leaves 
are cordate and flat or curled. The margin of the leaf is finely to coarsely toothed and 
unlobed or shallowly lobed. The lower surface of the leaf is lighter in colour and has a 
velvety texture due to the soft, wool-like hairiness. The extent of hairiness varies greatly. 
Plants found in the region of Humansdorp have leaves bearing many hairs, whereas some 
plants growing in the George area have leaves almost devoid of hairs. Three varieties have 
been documented on the basis of leaf characteristics. The branched inflorescence 
terminates in several 4-8-flowered umbel-like groups. The flowers resemble those of P. 
hispidum and P. papilionaceum, the posterior two petals being larger than the three anterior 
ones. The posterior pink or purple petals have dark purple veins. The anterior petals are 
lightly coloured. Seven fertile stamens are present (van der Walt, 1977; 1985). 
 
Distribution and habitat:  
Pelargonium cordifolium grows mainly near the coast in southern and eastern Cape. It 
grows in damp places in Fynbos or at forest margins or in forests (van der Walt, 1977). 
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Figure 4.1: Pelargonium cordifolium. Figure 4.2: The geographical distribution of 
Pelargonium cordifolium. 
The essential oil of P. cordifolium was not obtained due to insufficient plant material. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium cordifolium collected 
from the Walter Sisulu Botanical Garden. 
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 HPLC profile and analysis  
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Figure 4.3: HPLC profile of the acetone extract of Pelargonium cordifolium (WSBG). 
 
Table 4.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of Pelargonium cordifolium (WSBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance 
maxima (nm) 
Tentative 
identification 
% 
Integration 
4.13 209.8  4.25 
13.62 221.5, 281.5  4.45 
13.92 221.5, 278.0  52.24 
14.23 221.5, 278.0  14.41 
15.29 222.7, 279.2  4.41 
15.46 272.1, 351.6 flavanone 3.50 
15.79 223.8, 275.6  3.10 
17.59 255.6, 354.0 flavonol 8.69 
17.82 221.5, 279.2  4.95 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium cordifolium in this study 
include the following: 
 
• The acetone extract (NBG) produced promising antimicrobial activity. The extract 
was most active against B. cereus (MIC = 0.25 mg/ml). 
 
• Both extract samples (NBG and WSBG) exerted pronounced anti-oxidant activity 
in the DPPH assay with IC50 values of 5.01 ± 0.55 µg/ml and 5.31 ± 0.24 µg/ml, 
respectively. 
 
• Substantial antimalarial activity was displayed by both acetone extracts (IC50 = 
10.17 ± 2.43 µg/ml – 10.84 ± 0.75 µg/ml). 
 
• Pelargonium cordifolium extract (NBG) produced an IC50 = 74.70 ± 2.17 µg/ml in 
the MTT assay. Pelargonium cordifolium (WSBG) extract produced a lower 
toxicity profile (IC50 value of 116.88 ± 8.01 µg/ml). 
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 5. Pelargonium crispum (P. J. Bergius) L’Hérit. 
 
Common names: 
Crisped-leaf pelargonium (van der Walt and Vorster, 1988), Lemon geranium 
(http://www.ibiblio.org/pfaf/cgi-bin/arr_html?Pelargonium+crispum).  
 
Botanical description: 
Pelargonium crispum is an erect to decumbent shrubby species and has a height ranging 
from 0.2-0.75 m. The densely pubescent to strigose slender, branching stems become 
woody and brownish with age. The stems are interspersed with glandular hairs. The leaves 
are arranged alternatively along the stem. The slightly glabrous or pubescent leaf blades are 
somewhat trilobed and curled, dentate and cuneate at their bases. Leaf margins are coarsely 
dentate-serrate. The species name ‘crispum’ was derived from the evidently crisped (curly) 
leaves. The crushed leaves release a strong lemon scent much like lemon verbena 
(Genders, 1994). The inflorescence consists of 1-2(-3)-flowered pseudo-umbels. Petal 
colour ranges from white to dark pink-purple. The posterior two broadly spathulate, 
obovate petals have a carmine-rose colouring with dark red to dark purple markings 
veining towards the clawed petal base. The anterior rose or pale rose petals are spathulate 
with narrow claws. Each flower bears seven fertile stamens (Webb, 1984; van der Walt and 
Vorster, 1988).  
 
Distribution and habitat: 
Pelargonium crispum is found in the south-western winter rainfall region of the Cape. It 
grows on the lower slopes of mountains or on hills where the rainfall is low compared to 
the areas higher up on the mountains. It is found growing in sandy soil in the shelter of 
sandstone boulders (van der Walt, 1985; van der Walt and Vorster, 1988).  
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Figure 5.2: The geographical distribution of 
Pelargonium crispum. 
Figure 5.1: Pelargonium crispum in 
flower. 
 
Medicinal uses: 
All parts of the plant are astringent (Grieve, 1984). When required it can be harvested and 
used fresh (Bown, 1995).  
 
Edible uses: 
Due to the lemon aroma of the leaves, they are crushed and added as a flavourant to soups, 
fruit dishes, jellies, sorbets, ice cream and cakes (Facciola, 1990; Bown, 1995). The leaves 
can be used to line cake pans and in this way the essence infuses into the pastry (Facciola, 
1990). A tea can be made from the infusions of the leaves (Bown, 1995). 
 
Other uses: 
The strawberry and citral-scented essential oil extracted from the leaves and young shoots 
is used in the perfumery and soap-making industry (Usher, 1974). Dried leaves are used for 
pot-pourri and for making herb pillows (Bown, 1995). 
 
Remark: 
Pelargonium crispum is closely related to P. hermanniifolium (Berg.) Jacq. (Webb, 1984). 
 
The essential oil of P. crispum was not obtained due to insufficient plant material. 
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 Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium crispum collected 
from the National Botanical Garden (Kirstenbosch). 
 
HPLC profile and analysis 
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Figure 5.3: HPLC profile of the acetone extract of Pelargonium crispum (NBG). 
 
Table 5.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium crispum (NBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.03 212.1  15.31 
5.52 203.9  7.58 
10.03 205.1, 278.0  6.23 
13.69 221.5, 278.0  6.39 
13.98 220.3, 278.0  34.87 
14.30 221.5, 278.0  8.92 
14.91 222.7,278.0  2.78 
15.88 225.0, 278.0  4.43 
17.74 205.1, 255.6, 354.0 flavonol 5.82 
17.96 223.8, 278.0  1.49 
45.88 293.4  6.19 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium crispum in this study include 
the following: 
 
• The P. crispum (NBG) extract showed promising antimicrobial activity. MIC 
values of 0.38 mg/ml and 0.56 mg/ml were produced for the Gram-positive micro-
organisms, B. cereus and S. aureus, respectively. 
 
• Pelargonium crispum (NBG) was the second most active species in the DPPH 
assay, the acetone extract produced an IC50 = 4.49 ± 0.18 µg/ml. 
 
• The acetone extract (NBG) produced promising antimalarial activity (IC50 = 21.00 
± 4.33 µg/ml). 
 
• The P. crispum (NBG) acetone extract produced low cytotoxicity (IC50 = 74.02 ± 
2.30 µg/ml) in the MTT assay.  
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 6. Pelargonium cucullatum (L.) L’Hérit. 
 
Common names: 
Hooded-leaf pelargonium, Tree pelargonium, ‘Wilde malva’ (van der Walt, 1977). 
 
Botanical description: 
This species can grow to a height of more than 2 m making it one of the tallest 
Pelargonium shrubs. It is a widespread, sprawling, branched shrub with the base of the 
main stem half-woody. The younger parts and side branches are succulent. The species 
name comes from the Latin word ‘cucullatus’ meaning “hood” and refers to the  
characteristic shape of the cupped leaves. The leaves of the variety from the Table 
Mountain region are round or kidney-shaped and covered with long soft hairs. The margins 
of the leaves are slightly incised, irregularly toothed and have reddish tips. The leaves of 
plants from other areas along the coast are less cupped, have angularly incised margins, 
fewer hairs and characterize a transitional form to the leaves of the closely related, inland 
growing P. angulosum. The leaves of some forms release a strong billy goat-like scent 
when bruised. Four to ten flowers are borne on umbel-like inflorescences. The flowers are 
large and slightly sweet scented. There is a resemblance between the flowers of P. 
cucullatum and P. betulinum. Flower colour ranges from dark purple to light mauve. 
White-petalled forms also occur, but are rarely found. The posterior two petals are larger 
than the anterior three. Purple or red streaked veins occur on all five petals, but are more 
prominent on the posterior two petals. Seven fertile stamens are present (van der Walt, 
1977; van der Walt and Vorster, 1981; Webb, 1984). 
 
Distribution and habitat: 
This species is the most conspicuous of the Pelargoniums growing in the south-western 
Cape (van der Walt, 1977). It occurs near the coast between Saldanha and Elim (west of 
Bredasdorp) (van der Walt, 1977). It has a continuous distribution from Gordon’s Bay in 
the west to the area of Gansbaai in the east. A few isolated populations in the Cape 
Peninsula are separated from the rest by False Bay. The plants grow from near the high 
water mark on the narrow coastal flats to the lower foothills of the mountains (van der 
Walt, 1985). This species grows on sandy and granite slopes (May, 2000). 
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Figure 6.1: Pelargonium cucullatum in 
flower. 
Figure 6.2: The geographical distribution of 
Pelargonium cucullatum. 
 
Traditional uses: 
Pelargonium cucullatum was traditionally used to treat kidney ailments, colic, diarrhoea, 
coughs and fevers (van der Walt, 1977; May, 2000). For the treatment of bruises, stings 
and abscesses, the leaves were used as a poultice (May, 2000). It was also used as an 
emollient and as an antispasmodic (van der Walt, 1977). 
 
Remarks: 
Pelargonium cucullatum is one of the principal ancestors of regal pelargoniums (Webb, 
1984). Natural hybrids occur between P. cucullatum and P. betulinum (van der Walt, 
1977). 
 
The essential oil of P. cucullatum was not obtained due to insufficient plant material. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium cucullatum collected 
from the Stellenbosch Botanical Garden.  
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 HPLC profile and analysis  
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Figure 6.3: HPLC profile of the acetone extract of Pelargonium cucullatum (SBG). 
 
Table 6.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium cucullatum (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.95 213.3  5.14 
5.07 278.0  1.11 
6.61 215.6, 270.9  1.28 
12.02 218.0, 327.8  0.67 
12.38 278.0 flavanone 0.54 
12.87 221.5, 278.0  0.63 
13.36 220.3, 278.0  2.02 
13.71 220.3, 281.5  2.27 
14.10 221.5, 279.2   24.39 
14.33 221.5, 278.0  10.52 
14.83 220.3, 278.0  2.05 
15.52 221.5, 280.3  4.07 
15.92 221.5, 278.0  2.24 
16.23 221.5, 268.5, 349.2  1.43 
16.76 220.3, 278.0  3.73 
17.20 221.5, 280.3  5.11 
17.97 220.3, 278.0  12.80 
 284
 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
18.57 253.2, 363.4 isoflavone 3.44 
19.25 207.4, 255.6, 351.6  1.20 
20.16 221.5, 278.0  2.57 
20.79 207.4, 256.7, 351.6  2.39 
21.52 255.6, 348.0 flavone 5.81 
26.93 255.6, 366.8 flavonol 1.46 
32.85 261.5  1.72 
34.63 265.0  1.41 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium cucullatum in this study 
include the following: 
  
• Both P. cucullatum (SBG) and P. cucullatum (WSBG) extracts showed greater 
selectivity for the Gram-positive micro-organism B. cereus (MIC = 0.25 mg/ml and 
0.5 mg/ml, respectively). 
 
• The P. cucullatum (WSBG) extract produced considerable anti-oxidant activity 
(IC50 = 10.91 ± 0.54 µg/ml), whereas the P. cucullatum (SBG) extract produced 
moderate anti-oxidant activity (IC50 = 40.18 ± 5.65 µg/ml). 
 
• The P. cucullatum (SBG) extract displayed substantial antimalarial activity (IC50 = 
7.42 ± 0.35 µg/ml). 
 
• The acetone extracts (SBG and WSBG) produced low toxicity profiles (IC50 = 
73.81 ± 2.62 µg/ml and 118.89 ± 5.32 µg/ml, respectively) in the MTT assay. 
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 7. Pelargonium glutinosum (Jacq.) L’Hérit. 
 
Synonyms:  
Geranium viscosum, Geranium crataegifolium, Pelargonium erectum (van der Walt and 
Vorster, 1988). 
 
Common name: 
Pheasant’s foot geranium  
(http://www.ibiblio.org/pfaf/cgi-bin/arr_html?Pelargonium+glutinosum). 
 
Botanical description: 
Pelargonium glutinosum is an erect, branching shrub growing up to 1.8 m tall. It is noted 
for the glaucous appearance of its foliage. The shape of the hairs which cover the plant 
cause it to be sticky (the species name ‘glutinosum’ means very sticky). This species emits 
a pungent balm scent. The young stems are herbaceous and green becoming woody and 
brownish with age. The leaves are glabrous and palmately 5-lobed. The lobes have large, 
pinnately incised points. The lamina is cordiform in outline. Short, sharp-pointed hairs 
occur on the finely to coarsely dentate-serrate margins. One to eight flowers occur on each 
pseudo-umbel. Flower colour ranges from pale pink to dark pink. Dark pink-purplish 
markings and a large carmine spot occur on the posterior spathulate petals. The anterior 
three petals are spathulate with long narrow claws. The flowers have seven fertile stamens 
(Webb, 1984; van der Walt and Vorster, 1988).  
 
Distribution and habitat: 
It occurs from Piquetberg in the south-western Cape to the Kei River in the Eastern Cape. 
Its distribution pattern seems to be mainly associated with mountain ranges. In the Karoo 
regions where the annual rainfall is low, it is restricted to a mountainous habitat with 
rainfall very much higher compared to the nearby lower-lying regions. It grows in dry 
rocky places and in moist areas usually near running water such as streams (van der Walt 
and Vorster, 1988; Phillips and Rix, 1998).  
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Figure 7.2: The geographical distribution of 
Pelargonium glutinosum. 
Figure 7.1: Pelargonium glutinosum. 
                                 
Medicinal use: 
All parts of the plant are astringent (Grieve, 1984). 
 
Other use: 
The essential oil has a labdanum fragrance (Uphof, 1959). 
 
Remark: 
The leaves of P. panduriforme Eckl. & Zeyh. and P. quercifolium (L.f.) L’Hérit. are also 
sticky and release the same balm scent as P. glutinosum (van der Walt and Vorster, 1988). 
 
Chemical composition of the essential oil: 
Fresh plant material collected from Stellenbosch Botanical Garden was subjected to 
hydrodistillation for 3 hours. The essential oil yield was 0.02%. 
 
 287
 GC-MS profile and analysis 
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Figure 7.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
glutinosum (SBG). 
 
Table 7.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
glutinosum (SBG). 
 
RRI Compound Area % 
1100 undecane trace 
1203 limonene trace 
1213 1,8-cineole 0.12 
1280 p-cymene 0.46 
hexyl butyrate 3.22 1434 
1459 acetic acid 0.27 
1464 (E)-2-hexenyl butyrate 2.72 
1466 α-cubebene 0.24 
1475 menthone 0.67 
1493 α-ylangene 0.13 
1503 isomenthone 1.42 
1503 hexyl valerate 0.10 
1508 heptyl butyrate 0.41 
1532 camphor trace 
1535 β-bourbonene 0.33 
1549 β-cubebene 0.08 
1553 linalool 0.14 
1576 pentyl hexanoate 0.28 
1612 β-caryophyllene 2.51 
1614 hexyl tiglate 0.83 
1617 guaia-6,9-diene 0.32 
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 RRI Compound Area % 
1618 cadina-3,5-diene 0.32 
1628 aromadendrene 0.70 
1637 menthol 0.13 
1647 (E)-2-decenal 0.14 
1661 allo-aromadendrene 0.71 
1687 α-humulene 0.19 
1706 α-terpineol 0.22 
1707 ledene 0.87 
1740 α-muurolene trace 
1750 β-dihydroagarofuran 0.43 
1763 naphthalene 0.51 
1776 γ-cadinene trace 
1783 drimenene 0.14 
cis-calamenene 1853 1.30 
1868 (E)-geranyl acetone 0.18 
1886 geranyl butyrate 0.31 
1916 α-agarofuran 0.14 
1941 α-calacorene 0.18 
1953 palustrol 0.17 
2001 isocaryophyllene oxide 0.77 
caryophyllene oxide 6.32 2008 
2012 maaliol 0.18 
2030 methyl eugenol 0.27 
2050 (E)-nerolidol 0.23 
2057 ledol 0.44 
2071 humulene epoxide II 0.60 
2080 cubenol 1.00 
2088 1-epi-cubenol 0.21 
2098 globulol 0.86 
viridiflorol 8.88 2104 
2127 10-epi-γ-eudesmol 0.34 
spathulenol 6.92 2144 
2196 ambrox 2.32 
2247 trans-α-bergamotol 1.18 
2249 8,13-epoxy-15,16-dinor-labdane 0.39 
2279 sandaracopimaradiene 1.02 
8,13-epoxy-15,16-dinor-labd-12-
ene 2305 2.32 
2324 caryophylladienol II 0.08 
2376 manoyl oxide 1.83 
2396 8α-13-oxo-14-en-epi-labdane 1.81 
2438 kaur-16-ene 0.73 
 Total 59.59% 
 
 trace: <0.05%; (SBG) = Stellenbosch Botanical Garden. 
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 Viridiflorol makes-up 8.88% of the total oil composition. Caryophyllene oxide and 
spathulenol contribute 6.32% and 6.92%, respectively. Ambrox, an important constituent 
of the scarce natural ambergris, represents 2.32%. 
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Figure 7.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium glutinosum (SBG). 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium glutinosum collected 
from Stellenbosch Botanical Garden. 
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 HPLC profile and analysis  
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Figure 7.5: HPLC profile of the acetone extract of Pelargonium glutinosum (SBG). 
 
Table 7.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium glutinosum (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.07 212.0  13.38 
4.87 205.0  1.33 
5.43 203.8  1.41 
5.88 203.8, 269.9  1.63 
7.24 205.0  1.78 
7.94 207.3  4.04 
9.55 207.3  4.16 
10.21 205.0, 271.0  5.03 
10.97 207.3  9.58 
11.82 207.3, 271.0, 307.8  4.66 
12.24 207.3, 272.2  3.01 
12.41 202.7, 281.7, 313.8  3.11 
12.73 200.5, 328.1  1.11 
13.07 205.0, 280.5  1.71 
13.65 272.2  1.81 
14.01 210.9, 281.7  2.47 
14.62 200.5, 268.7  1.18 
15.90 255.7, 355.6 flavonol 3.35 
18.34 262.7, 349.6 flavone 3.05 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
21.32 255.7, 349.6 flavone 1.14 
23.06 262.7, 350.8 flavone 1.44 
29.25 267.5, 336.5 flavone 2.08 
32.26 268.7, 329.3 flavone 13.64 
34.15 250.9, 268.7, 343.6  1.10 
35.23 241.5  1.14 
35.53 261.6  2.58 
37.14 261.6  2.46 
39.62 268.7  6.63 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium glutinosum in this study 
include the following: 
 
• The P. glutinosum (SBG) extract displayed pronounced antibacterial activity (MIC 
= 0.078 mg/ml) against B. cereus and S. aureus. The MIC values produced by the 
P. glutinosum acetone extract (WSBG) against B. cereus and S. aureus were 0.25 
mg/ml and 0.5 mg/ml, respectively. 
 
• Pelargonium glutinosum (SBG) produced promising anti-oxidant activity (IC50 = 
16.41 ± 0.33 µg/ml) in the DPPH assay. The P. glutinosum (WSBG) extract 
displayed lower activity (IC50 = 29.17 ± 0.78 µg/ml). 
 
• Substantial antimalarial activity was produced by the acetone extract (SBG) (IC50 = 
11.07 ± 1.15 µg/ml) in the hypoxanthine incorporation assay. 
 
• Both extracts (SBG and WSBG) proved to be cytotoxic (IC50 = 31.44 ± 1.27 µg/ml 
– 46.29 ± 0.81 µg/ml) in the MTT assay. 
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 8. Pelargonium graveolens L’Hérit. 
 
Synonyms: 
Geranium radula, Pelargonium terebinthinaceum, Pelargonium asperum, Pelargonium 
intermedium (van der Walt and Vorster, 1988). 
 
Common names: 
Pelargonium roseum (O’Brien, 1983), Rose-scented pelargonium (van der Walt and 
Vorster, 1988), Rose geranium, Old fashion rose geranium, Sweet-scented geranium 
(http://www.ibiblio.org/pfaf/cgi-bin/arr_html?Pelargonium+graveolens). 
 
Botanical description: 
Pelargonium graveolens is a much-branched shrub growing up to 1.3 m high. It is strongly 
aromatic having a fine, true-rose scent (‘graveolens’ is the Latin word meaning heavily 
scented). The stems are herbaceous and green when young, becoming woody and brownish 
with age. The stems are densely interspersed with glandular hairs. The leaves are grey-
green and slightly hairy. The leaf blades are ovate to depressed ovate, pinnatipartite or even 
almost palmati-partite-cordate at the bases. The two large basal segments are usually 
further subdivided into five lobes. The peduncle has an umbel which bears 2-7 flowers. 
The petals have narrowly obovate bases, rounded tops and are entire in shape. The petals 
are white to pinkish-purple (rose-coloured). The two posterior petals are spathulate and 
each have a large carmine spot in the centre. The anterior petals are spathulate to 
oblanceolate with narrow claws. The flowers have seven fertile stamens (Webb, 1984; van 
der Walt and Vorster, 1988). 
 
Distribution and habitat: 
Pelargonium graveolens has two areas of distribution in southern Africa. One area of 
distribution is in Limpopo and the other in the south-eastern region of the Cape. In 
Limpopo, it occurs from Blouberg in the west to Wolkberg near Pilgrim’s Rest in the east. 
In the Cape, its distribution occurs from near George in the west to Grahamstown in the 
east. It is found near the Hex River in the south-western Cape (Webb, 1984). It is 
speculated that in earlier times, P. graveolens had a distribution which was continuous 
along mountain ranges from Zimbabwe to the Cape. It is found growing in moist places 
which are semi-shaded (van der Walt and Vorster, 1988). 
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Figure 8.1: Pelargonium graveolens. Figure 8.2: The geographical distribution of 
Pelargonium graveolens. 
 
Culinary uses: 
The raw flowers are added to salads (Facciola, 1990). The rose-scented leaves are added to 
desserts, jellies and vinegars. The fresh leaves are brewed to make a tea (Facciola, 1990; 
Bown, 1995). 
 
Medicinal uses: 
This plant has relaxant, anti-depressant and antiseptic effects. It reduces inflammation and 
controls bleeding (Bown, 1995). All parts of the plant are astringent (Grieve, 1984). 
Internally, it is used to treat pre-menstrual and menopausal problems, nausea, tonsillitis and 
poor circulation. It is used externally for the treatment of acne, haemorrhoids, eczema, 
bruises, ringworm and lice (Bown, 1995). The essential oil is applied locally in cervical 
cancer (Duke and Ayensu, 1985). 
 
Other uses: 
The ‘geranium oil’ obtained from P. graveolens is used in aromatherapy and in skin care. It 
is also used as a flavouring agent. The leaves are used in pot-pourri (Bown, 1995). 
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 Remark: 
The similar floral features and scent indicate a close relationship between P. graveolens 
and P. radens. Leaf characteristics distinguish these two species from one another (van der 
Walt and Vorster, 1988). 
 
Chemical composition of the essential oil: 
Hydrodistillation was carried out on fresh plant material for 3 hours.  
1. Pelargonium graveolens from Stellenbosch Botanical Garden yielded 0.22% oil, 
2. Pelargonium graveolens from Walter Sisulu Botanical Garden yielded 0.06% oil. 
 
 
GC-MS profiles and analyses 
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Figure 8.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
graveolens (SBG). 
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Figure 8.4: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
graveolens (WSBG). 
 
Table 8.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
graveolens. 
 
Area % RRI Compound 
SBG WSBG 
1014 tricyclene 0.07 trace 
1032 α-pinene 0.16 0.09 
1118 β-pinene 0.05 trace 
1174 myrcene 0.38 0.34 
1203 limonene 0.56 0.57 
1216 3-methylcyclopentanone 0.12 trace 
1218 β-phellandrene trace trace 
1280 p-cymene 0.87 0.85 
1327 3-methylcyclohexanone 0.08 trace 
cis-rose oxide 1353 trace trace 
trans-rose oxide 1365 - trace 
1384 α-pinene oxide - trace 
1391 (Z)-3-hexenol trace - 
1398 2-nonanone trace - 
1429 perillene trace 0.05 
trans-linalool oxide (furanoid)  1450 0.06 trace 
cis-1,2-limonene epoxide 1458 trace trace 
menthone 5.12 1.03 1475 
1481 (Z)-3-hexenyl isovalerate - trace 
isomenthone 65.78 83.30 1503 
1535 β-bourbonene trace trace 
1553 linalool 0.34 0.34 
1553 octanol - trace 
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 Area % RRI Compound 
SBG WSBG 
trans-p-menth-2-en-1-ol 1571 - trace 
cis-isopulegone 1580 - 0.11 
1586 pinocarvone - trace 
1587 methyl decanoate 0.10 - 
1600 β-elemene - 0.14 
1606 p-menth-3-en-8-ol trace trace 
1612 citronellyl formate trace trace 
1632 neoisomenthol 0.38 - 
1637 menthol 0.12 0.24 
cis-p-menth-2-en-1-ol 1638 - 0.26 
1662 isomenthol 0.07 - 
1668 (Z)-β-farnesene trace 0.06 
1690 cryptone 0.27 0.28 
1704 γ-muurolene 0.05 trace 
1706 α-terpineol 0.14 0.16 
1719 borneol - trace 
1740 α-muurolene - 0.25 
1741 β-bisabolene 0.46 - 
1748 piperitone 0.35 0.27 
1751 carvone 0.08 0.08 
1772 citronellol 0.35 0.38 
1773 δ-cadinene trace trace 
1783 p-methylacetophenone 0.07 0.06 
1798 methyl salicylate 0.06 - 
1802 cuminaldehyde trace 0.06 
1809 citronellyl butyrate - 0.05 
trans-carveol 1845 0.07 - 
cis-calamenene 1853 trace trace 
1864 p-cymen-8-ol 0.11 0.10 
1868 (E)-geranyl acetone trace - 
1885 2-phenylethyl propionate - 0.20 
1889 ascaridole trace - 
1896 2-phenylethyl isobutyrate - 0.09 
1937 2-phenylethyl alcohol - 0.08 
1941 citronellyl hexanoate - 0.05 
1941 α-calacorene 0.06 - 
1949 piperitenone trace - 
1984 γ-calacorene trace - 
1988 2-phenylethyl 2-methylbutyrate trace - 
2008 caryophyllene oxide 0.05 0.12 
2030 norbourbonone trace trace 
2050 (E)-nerolidol trace 0.51 
2080 cubenol trace 0.09 
2088 1-epi-cubenol 0.08 0.13 
2113 cumin alcohol - trace 
2131 hexahydrofarnesylacetone trace - 
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 Area % RRI Compound 
SBG WSBG 
2140 2-phenylethyl valerate - 0.23 
2143 cedrol - trace 
2187 T-cadinol - trace 
2198 thymol trace - 
2209 T-muurolol trace 0.07 
2-phenylethyl tiglate 1.32 1.90 2211 
2239 carvacrol 0.06 - 
2249 cadalene 0.12 0.30 
2254 citronellic acid 0.09 trace 
decanoic acid 12.93 2281 0.42 
2340 10-hydroxy-calamenene trace - 
2407 hydroxy-α-calacorene* 0.07 0.11 
2-decenoic acid* 3.93 2411 0.12 
2500 pentacosane - trace 
2509 dodecanoic acid 0.06 trace 
2617 tridecanoic acid - trace 
2670 tetradecanoic acid - 0.06 
2700 heptacosane - trace 
2900 nonacosane - 0.14 
2931 hexadecanoic acid - 0.11 
Total 95.04% 93.80%  
 
*correct isomer not identified; trace: <0.05%. 
 
Isomenthone is the major essential oil compound in P. graveolens (SBG) contributing 
65.78%. Decanoic acid made-up 12.93% of the total oil composition. Collectively, 
menthone, 2-phenylethyl tiglate and 2-decenoic acid contributed 10.37% to the total oil 
composition. 
 
Isomenthone is the major compound (83.30%) in P. graveolens (WSBG) oil. Menthone 
and 2-phenylethyl tiglate occur at 1.03% and 1.90%, respectively. 
 
The two oil samples display quantitative and qualitative similarities in their essential oil 
compositions. The major compound isomenthone is present in both the oil samples. 
Furthermore, menthone and 2-phenylethyl tiglate occur in substantial amounts in both the 
oil samples. 
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Figure 8.5: Chemical structures of the major compounds common to both essential oil 
samples of Pelargonium graveolens. 
 
 
 
Figure 8.6: Chemical structures of the other major compounds identified in the essential oil 
of Pelargonium graveolens (SBG). 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium graveolens collected 
from the Stellenbosch Botanical Garden. 
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 HPLC profile and analysis  
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Figure 8.7: HPLC profile of the acetone extract of Pelargonium graveolens (SBG). 
 
Table 8.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium graveolens (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
2.88 206.2  1.12 
3.29 206.2  1.11 
4.01 210.9  12.88 
4.85 206.2  2.91 
5.42 206.2  4.39 
7.23 248.6  0.96 
9.41 206.2, 316.2  8.26 
10.28 206.2, 269.9  1.82 
10.78 205.0, 286.5  4.54 
11.70 217.9, 326.9  3.81 
12.27 206.2, 279.3  1.38 
13.12 284.1  0.54 
13.38 228.5, 312.6  4.42 
13.69 227.3, 277.0  1.18 
14.10 282.9,326.9  4.22 
14.54 221.5, 272.2  3.38 
15.19 255.7, 353.2 flavonol 7.30 
15.93 229.1, 343.6 flavone 0.21 
16.25 255.7, 352.0 flavonol 1.07 
17.61 255.7, 354.4 flavonol 1.74 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
18.76 255.7, 354.4 flavonol 9.77 
19.19 255.7, 354.4 flavonol 4.29 
20.55 255.7, 354.4 flavonol 7.14 
20.98 240.3  1.15 
21.68 239.1, 268.7, 336.5  0.33 
22.04 240.3, 316.2  1.04 
26.51 254.5, 367.3  1.05 
31.69 242.7  0.31 
32.34 261.6  0.78 
34.20 265.1  0.50 
34.48 248.6  0.97 
35.59 267.5  0.40 
43.60 293.6  5.05 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium graveolens in this study 
include the following: 
 
• The P. graveolens (SBG) extract displayed moderate antimicrobial activity (MIC = 
2 mg/ml – 4 mg/ml). Pelargonium graveolens (SBG) essential oil displayed poor 
antibacterial properties, but showed good activity against C. albicans (MIC = 2 
mg/ml). 
 
• The P. graveolens (SBG) extract showed promising anti-oxidant activity (IC50 = 
14.49 ± 0.46 µg/ml). The P. graveolens (WSBG) extract produced a lower IC50 
value of 26.81 ± 1.80 µg/ml. 
 
• The essential oil (SBG) did not produce anti-inflammatory activity (IC50 >100 
µg/ml) in the 5-lipoxygenase assay. 
 
• Pelargonium graveolens (SBG) extract produced the lowest antimalarial activity 
(IC50 = 22.46 ± 3.21 µg/ml) of all the species tested. Pelargonium graveolens 
(WSBG) extract displayed substantial antimalarial activity (IC50 = 9.48 ± 1.17 
µg/ml). 
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 • The acetone extracts produced low toxicity profiles (IC50 = 80.48 ± 0.94 µg/ml - 
83.31 ± 2.56 µg/ml) in the MTT assay. The essential oil (SBG) was extremely toxic 
(IC50 ≤0.10 µg/ml). 
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 9. Pelargonium greytonense J. J. A. van der Walt 
 
Botanical description: 
Pelargonium greytonense is an erect, much-branched shrub growing up to 1 m high. This 
species is non-aromatic to aromatic. The young, herbaceous stems become woody, 
hirtellous with long soft hairs and glandular hairs interspersed. The leaves are shallowly 
3−(5-8)-palmatilobate to palmatipartite, the base is cordate and the apices of the lobes are 
obtuse. The lamina is cordiform in outline. The leaf margin is coarsely dentate. The 
evidently veined leaves have long soft hairs and numerous glandular hairs interspersed. 
Two to nine flowers occur on each pseudo-umbel. The flowers are white to pale pink. Dark 
red markings occur on the posterior two spathulate to obovate petals, the apices of which 
are obtuse. The anterior three petals are much narrower than the posterior two (van der 
Walt, 1985; van der Walt and Vorster, 1988).  
 
Pelargonium greytonense gives the impression of a rather young species due to the 
considerable morphological variation (particularly of leaf characteristics) that it exhibits. 
Many features of P. greytonense are intermediary between P. hermanniifolium (Berg.) 
Jacq. and P. papilionaceum (L.) L’Hérit. Pelargonium greytonense is probably a hybrid of 
these two species (van der Walt and Vorster, 1988).  
 
Distribution and habitat: 
Its distribution is confined to a small area in the south-western Cape. It is usually found on 
the southern slopes of the Riviersonderend Mountains. Pelargonium greytonense is 
plentiful in the village of Greyton, hence the epithet ‘greytonense’ (van der Walt and 
Vorster, 1988). The habitat requirements of P. greytonense are between those of the two 
reputed parent species. It is often found in ravines (van der Walt and Vorster, 1988).  
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Figure 9.1: Pelargonium greytonense
(van der Walt and Vorster, 1988). 
Figure 9.2: Geographical distribution of 
Pelargonium greytonense. 
The essential oil of P. greytonense was not obtained due to insufficient plant material. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium greytonense 
collected from Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 9.3: HPLC profile of the acetone extract of Pelargonium greytonense (SBG). 
 Table 9.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium greytonense (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.98 213.3  31.44 
4.94 208.6, 278.0  1.76 
6.68 214.5, 269.7  2.32 
11.43 206.3, 260.3, 293.4  1.16 
12.09 219.1, 327.8  1.91 
13.54 223.8, 278.0  1.93 
13.79 222.7, 278.0  2.42 
14.10 221.5, 278.0  5.40 
14.44 222.7, 255.6, 278.0  2.78 
16.06 225.0, 278.0  3.73 
22.09 269.7 isoflavone 1.37 
24.92 270.9, 313.5  1.57 
31.98 240.3, 278.0  2.10 
32.23 288.6 flavanone 20.21 
32.49 267.4, 313.5 isoflavone 10.94 
32.86 243.8, 268.5  1.45 
34.03 288.6  1.04 
34.82 287.4 flavanone 3.65 
45.91 292.2  2.83 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium greytonense in this study 
include the following: 
 
• The acetone extract (SBG) showed promising activity against B. cereus (MIC = 
0.25 mg/ml) and S. aureus (MIC = 0.5 mg/ml). 
 
• Substantial antimalarial activity (IC50 = 13.21 ± 1.89 µg/ml) was produced by the 
acetone extract (SBG). 
 
• The P. greytonense (SBG) extract is cytotoxic (IC50 = 39.65 ± 1.18 µg/ml). 
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 10.  Pelargonium hermanniifolium (Berg.) Jacq. 
 
Botanical description: 
Pelargonium hermanniifolium is an erect, often many-stemmed shrub and reaches a height 
of up to 1 m. It is usually non-aromatic. The stems are herbaceous when young but soon 
become woody, densely hirsute with glandular hairs interspersed, green but become 
brownish with age. The leaves resemble those of Hermannia, a genus of the family 
Sterculiaceae. The distichous leaves are sparsely strigose to strigose with glandular hairs 
interspersed. The lamina is narrowly to broadly obovate, 3-palmatilobate to 3-palmatisect 
with variably incised segments, often crisped. The base of the lamina is cuneate and the 
apex obtuse to acute. The leaf margin is crenate-serrate. The pseudo-umbels have one to 
two, sometimes up to three flowers each. The flowers are relatively large and are white to 
pink. Dark red markings occur on the posterior two, broadly spathulate petals, the apices of 
which are sometimes emarginate to cleft. The anterior three, spathulate petals have narrow 
claws (van der Walt and Vorster, 1981; van der Walt, 1985). 
 
Distribution and habitat: 
Pelargonium hermanniifolium grows in the Cape, from Worcester southwards to Caledon 
and eastwards to Swellendam. Pelargonium hermanniifolium is associated with a 
mountainous habitat, commonly found on the Riviersonderend Mountains. It is found on 
the higher slopes of mountains where precipitation is higher (van der Walt and Vorster, 
1981; van der Walt, 1985). 
 
Remark: 
Pelargonium hermanniifolium species is closely related to P. crispum (Berg.) L’Hérit. (van 
der Walt and Vorster, 1981). 
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Figure 10.1: Pelargonium hermanniifolium
in flower. 
Figure 10.2: Geographical distribution of 
Pelargonium hermanniifolium. 
 
Essential oil was not obtained for P. hermanniifolium. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium hermanniifolium 
collected from Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 10.3: HPLC profile of the acetone extract of Pelargonium hermanniifolium (SBG). 
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 Table 10.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium hermanniifolium (SBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.97 218.0  30.36 
4.99 210.9  3.26 
9.77 207.4, 315.9  3.77 
11.40 206.3, 259.1, 293.4  0.96 
11.59 207.4, 313.5  0.64 
15.67 261.5, 354.0 flavonol 1.25 
16.05 222.7, 278.0  0.83 
17.90 255.6, 354.0 flavonol 14.41 
29.62 278.0  36.98 
32.50 267.4, 308.8 isoflavone 0.22 
32.87 243.8  2.11 
34.64 265.0  1.30 
39.33 278.0  0.37 
41.69 278.0, 325.4  1.00 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium hermanniifolium in this study 
include the following: 
 
• The acetone extract (SBG) produced moderate antimicrobial activity (MIC = 1.5 
mg/ml – 3 mg/ml). 
 
• Substantial anti-oxidant activity (IC50 = 13.50 ± 0.73 µg/ml) was displayed by the 
P. hermanniifolium (SBG) extract. 
 
• An IC50 value of 13.54 ± 3.95 µg/ml was produced by the acetone extract (SBG) in 
the antimalarial activity. 
 
• The acetone extract (SBG) proved to be moderately toxic (IC50 = 46.47 ± 1.38 
µg/ml) in the MTT assay. 
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 11.  Pelargonium hispidum (L. f.) Willd. 
 
Common names: 
Hispid pelargonium, ‘Grofharige pelargonium’ (van der Walt and Vorster, 1981). 
 
Botanical description: 
Pelargonium hispidum is an erect, branched, slightly lemon-scented shrub, growing up to 
2.5 m high. The stems are woody at their bases, but above, they are herbaceous. The 
epithet ‘hispidum’ (which is the Latin word meaning covered with coarse, rigid, erect hairs 
which are harsh to the touch) refers to the indumentum of the leaves and stems. The 
numerous pubescent to hirsute leaves, occurring alternatively on the stems, have long 
petioles. The leaf blades are palmately 5-7-lobed and the lobes are tri-angled or ovate, 
sharp and denticulate. The flowering branches are profusely branched. Six to twelve 
flowers occur on each pseudo-umbel. The bases of the posterior two petals are narrow 
cuneate, obovate round or entire and wine-red feather-like markings run from the base to 
the central area of the petal. The three anterior petals are spathulate with long, narrow 
claws and are of a pale carmine colour, with darker pigmentation towards the bases. Petal 
colour ranges from deep carmine to pale carmine. The flowers have seven fertile stamens 
(Webb, 1984; van der Walt, 1985). Inflorescence and floral features indicate a close 
association among P. hispidum, P. cordifolium, P. papilionaceum and P. tomentosum (van 
der Walt, 1985). 
 
Distribution and habitat: 
Pelargonium hispidum commonly grows in the south-western Cape mountains, as well as 
in the Swartberg Range in the southern Cape from Piketberg eastwards to Meiringspoort 
(Oudtshoorn district). It is commonly found growing on the lower slopes of mountains, 
where it occurs in shady ravines, often near streams between boulders or on scree (van der 
Walt, 1985). 
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Figure 11.1: The flowers of Pelargonium 
hispidum. 
Figure 11.2: The geographical distribution 
Pelargonium hispidum. of 
 
Chemical composition of the essential oil: 
The fresh plant material collected from Stellenbosch Botanical Garden was subjected to 
hydrodistillation for 3 hours. An oil yield of 0.02% was obtained. 
 
GC-MS profile and analysis 
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Figure 11.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
hispidum (SBG). 
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 Table 11.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
hispidum (SBG). 
 
RRI Compound Area % 
1032 α-pinene trace 
1076 camphene trace 
1100 undecane trace 
1112 anhydrolinalool oxide trace 
1118 β-pinene trace 
1176 α-phellandrene 0.07 
1188 α-terpinene trace 
1203 limonene trace 
1213 1,8-cineole 0.17 
1218 β-phellandrene trace 
1225 (Z)-3-hexenal trace 
1246 (Z)-β-ocimene trace 
1255 γ-terpinene trace 
1266 (E)-β-ocimene trace 
1280 p-cymene 0.06 
1290 terpinolene trace 
1337 geijerene 0.08 
cis-rose oxide 1353 trace 
1391 (Z)-3-hexenol 0.11 
2-nonanone 2.53 1398 
1400 nonanal trace 
1400 (Z)-2-hexenol trace 
1429 (E)-2-octenal trace 
trans-linalool oxide (furanoid)  1450 0.05 
1452 1-octen-3-ol trace 
1473 (Z)-3-hexenyl 2-methylbutyrate 0.06 
1475 menthone 0.12 
1481 (Z)-3-hexenyl isovalerate 0.15 
1497 α-copaene 0.14 
1503 isomenthone 0.28 
1509 2-nonanol 0.22 
1532 camphor trace 
1553 linalool 0.65 
1553 octanol trace 
1587 methyl decanoate 0.05 
1589 isocaryophyllene 0.08 
1604 2-undecanone trace 
β-caryophyllene 8.55 1612 
1615 p-menth-1-en-9-al trace 
1618 cadina-3,5-diene 0.06 
1620 ethyl decanoate trace 
1637 menthol 0.08 
1668 citronellyl acetate trace 
1679 heptadecane trace 
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 RRI Compound Area % 
1681 (Z)-3-hexenyl tiglate 0.05 
1687 α-humulene 0.39 
1704 γ-muurolene 0.05 
1706 α-terpineol 0.47 
1707 ledene trace 
1714 (Z,E)-α-farnesene trace 
1740 α-muurolene 0.11 
1748 piperitone 0.06 
1750 β-dihydroagarofuran trace 
1758 (E,E)-α-farnesene 0.19 
1766 1-decanol trace 
1772 citronellol 0.28 
1773 δ-cadinene 0.28 
1776 γ-cadinene trace 
1799 cadina-1,4-diene  trace 
1808 nerol trace 
1809 citronellyl butyrate 0.10 
trans-carveol 1845 0.06 
cis-calamenene 1853 trace 
1857 geraniol 0.05 
1864 p-cymen-8-ol trace 
1868 (E)-geranyl acetone trace 
cis-carveol 1882 trace 
1941 α-calacorene 0.08 
1949 (E)-jasmone 0.05 
1966 (E)-12-norcaryophyll-5-en-2-one trace 
2008 caryophyllene oxide 0.48 
2050 (E)-nerolidol 0.16 
2084 octanoic acid 0.11 
2110 furopelargone B trace 
2127 10-epi-γ-eudesmol 0.10 
2184 nonanoic acid 0.42 
2187 T-cadinol trace 
2254 citronellic acid 0.81 
2257 decyl decanoate trace 
2257 β-eudesmol trace 
decanoic acid 47.01 2281 
2392 caryophyllenol II 0.08 
2-decenoic acid* 31.26 2411 
2509 dodecanoic acid 0.10 
2538 2-undecenoic acid* 0.11 
2900 nonacosane trace 
2931 hexadecanoic acid 0.11 
Total 96.48%  
 
*correct isomer not identified; trace: <0.05%; (SBG) = Stellenbosch Botanical Garden. 
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 Decanoic acid occupies 47.01% of the total oil composition. 2-Decenoic acid also occupies 
a large portion (31.26%) of the oil. 2-Nonanone and β-caryophyllene contribute 2.53% and 
8.55%, respectively. 
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Figure 11.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium hispidum (SBG). 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium hispidum collected 
from Stellenbosch Botanical Garden. 
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 HPLC profile and analysis  
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Figure 11.5: HPLC profile of the acetone extract of Pelargonium hispidum (SBG). 
 
Table 11.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium hispidum (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.98 212.0  8.83 
10.28 206.2, 269.  3.54 
11.79 220.3, 328.1  2.80 
13.12 286.5  1.14 
13.40 228.5, 313.8  3.55 
14.05 212.0, 297.1, 325.7  2.12 
16.26 255.7, 355.6 flavonol 13.88 
16.46 255.7, 353.2 flavonol 1.27 
18.40 262.7, 348.4 flavone 4.76 
18.78 255.7, 354.4 flavonol 5.61 
19.24 255.7, 354.4 flavonol 6.17 
19.63 255.7, 350.8 flavone 2.83 
20.56 255.7, 355.6 flavonol 10.57 
21.24 256.8, 349.6 flavone 31.52 
26.55 255.7, 360.5 flavonol 1.40 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium hispidum in this study include 
the following: 
 
• The P. hispidum (SBG) extract showed promising activity (MIC = 2 mg/ml) against 
K. pneumoniae.   
 
• The acetone extract (SBG) displayed considerable anti-oxidant activity in the 
DPPH assay.  An IC50 value of 12.78 ± 0.45 µg/ml was obtained. 
 
• Substantial antimalarial activity (IC50 = 12.23 ± 1.93 µg/ml) was produced by the 
acetone extract (SBG) in the hypoxanthine incorporation assay. 
 
• Pelargonium hispidum (SBG) extract displayed low toxicity in the MTT assay (IC50 
= 84.30 ± 1.16 µg/ml). 
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 12.  Pelargonium panduriforme Eckl. & Zeyh. 
 
Synonym: 
Pelargonium panduraeforme (Webb, 1984). 
 
Botanical description: 
Pelargonium panduriforme is a strongly balm-scented, erect, branched, glaucous and 
occasionally viscid shrub reaching a height of up to 1.75 m. The stems are fleshy and 
woody with long spreading short, dense hairs. Later, the stems become almost smooth, 
terete, erect and leafless below with branches similar to the stems. The leaves are usually 
soft to the touch and closely packed. The lamina is panduriform (fiddle-shaped) to 
cordiform in outline, pinnatilobate to pinnatipartite with two broad obtuse lobes at the base, 
and the middle lobe very large, usually coarsely incised. When dry, the finely toothed lobes 
curl at the margins. Two to twenty large pale pink to pink flowers are borne in umbel-like 
inflorescences. The two posterior pink petals are narrowly spathulate, obovate and entire. 
These petals are striped and spotted with deep crimson along the veins. The three anterior 
petals with long narrow claws are smaller, narrower and paler. Seven fertile stamens are 
present (Webb, 1984; van der Walt and Vorster, 1988). Pelargonium panduriforme is 
closely related to P. quercifolium (van der Walt and Vorster, 1988). 
 
Distribution and habitat: 
Pelargonium panduriforme is found growing in the Eastern Cape, where it occurs from 
Antoniesberg in the area of Willowmore eastwards close to Riebeeck East. It has also been 
collected near Engcobo. It grows abundantly on the Baviaanskloof and Kouga Mountains. 
Pelargonium panduriforme grows in areas of bushveld and on the lower foothills or 
ravines, close to streams (van der Walt and Vorster, 1988). 
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Chemical composition of the essential oil: 
Hydrodistillation was carried out on fresh plant material for 3 hours.  
1. Pelargonium panduriforme from Stellenbosch Botanical Garden yielded 0.48% oil, 
2. Pelargonium panduriforme from Walter Sisulu Botanical Garden yielded 0.35% oil. 
 
GC-MS profiles and analyses 
 
 
 
 
 
 
 
 
 
 
Figure 12.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
panduriforme (SBG). 
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00
Figure 12.2: The geographical distribution of 
Pelargonium panduriforme. 
Figure 12.1: Pelargonium panduriforme 
in flower.                                    
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Figure 12.4: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
panduriforme (WSBG). 
 
Table 12.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
panduriforme. 
 
Area % RRI Compound SBG WSBG 
1014 tricyclene - 0.62 
1032 α-pinene 0.60 0.28 
1035 α-thujene 1.00 0.08 
1076 camphene trace 0.08 
1118 β-pinene 0.13 trace 
1132 sabinene 0.51 0.17 
1136 thuja-2,4(10)-diene 0.10 - 
1159 δ-3-carene 0.25 - 
α-phellandrene 4.31 8.81 1176 
1188 α-terpinene 0.19 0.10 
1203 limonene 2.15 2.99 
β-phellandrene 3.95 1218 1.38 
1246 (Z)-β-ocimene trace 2.38 
1255 γ-terpinene 1.01 0.31 
1266 (E)-β-ocimene trace 0.23 
p-cymene 45.38 37.59 1280 
1290 terpinolene 0.08 - 
1385 allo-ocimene* - 0.09 
1413 rosefuran - 0.14 
1429 perillene trace 0.07 
1451 β-thujone trace - 
1452 α,p-dimethylstyrene 1.40 0.24 
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 Area % RRI Compound SBG WSBG 
1466 α-cubebene - 0.11 
cis-linalool oxide 
(furanoid) 1478 0.48 - 
1497 α-copaene 0.07 0.15 
1503 isomenthone - 0.31 
1541 benzaldehyde 0.13 - 
1549 β-cubebene - 0.25 
linalool 4.42 1553 - 
trans-dihydro-α-terpineol 1560 0.23 - 
trans-p-menth-2-en-1-ol 1571 - 0.60 
cis-dihydro-α-terpineol 1589 trace - 
1597 bornyl acetate 0.11 - 
1604 thymol methyl ether trace - 
1611 terpinen-4-ol 0.60 - 
1612 β-caryophyllene - 0.16 
1616 hotrienol 0.20 - 
1617 guaia-6,9-diene 0.10 0.14 
1628 aromadendrene 0.26 0.17 
1651 sabina ketone 0.06 - 
1661 allo-aromadendrene 0.30 0.11 
trans-pinocarveol 1664 trace - 
1677 epi-zonarene - 0.06 
1683 carvotanacetone 0.12 0.10 
1688 selina-4,11-diene - trace 
1690 cryptone 0.71 2.89 
1706 α-terpineol 0.52 - 
1707 ledene 0.73 - 
1726 germacrene D - trace 
1740 α-muurolene - 0.25 
1751 phellandral - 0.72 
1751 carvone - 0.35 
cis-piperitol 1758 trace 0.11 
1773 δ-cadinene 0.08 0.69 
1776 γ-cadinene trace 0.07 
1783 p-methylacetophenone 0.75 0.67 
1802 cuminaldehyde 0.66 1.20 
1809 citronellyl butyrate 0.11 - 
1823 p-mentha-1(7),5-dien-2-ol* 0.76 1.13 
1827 (E,E)-2,4-decadienal - 0.09 
trans-carveol 1845 trace 0.32 
cis-calamenene 1853 - 0.40 
1857 geraniol trace - 
p-cymen-8-ol 3.97 1864 2.90 
- 1865 isopiperitenone 0.11 
1886 geranyl butyrate 0.11 - 
1900 epi-cubebol - 0.19 
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 Area % RRI Compound SBG WSBG 
1916 α-agarofuran - 1.12 
1941 α-calacorene trace 0.11 
1941 citronellyl hexanoate 0.08 - 
1953 palustrol trace - 
1984 γ-calacorene - 0.06 
2008 caryophyllene oxide 0.11 0.38 
2030 methyl eugenol - 0.10 
2057 ledol 0.30 0.13 
2071 humulene epoxide II - 0.22 
2080 cubenol 0.10 0.44 
2088 1-epi-cubenol - 0.30 
2096 elemol 0.60 - 
viridiflorol 7.89 2104 - 
- 2110 furopelargone B 0.11 
2113 cumin alcohol 0.10 trace 
10-epi-γ-eudesmol 6.26 2127 0.10 
spathulenol 3.82 2144 1.89 
2185 γ-eudesmol 1.98 - 
2209 T-muurolol - trace 
2210 agarospirol - 0.48 
2219 α-muurolol - trace 
2228 valerianol - 0.78 
2239 carvacrol 0.90 1.32 
trans-α-bergamotol 2247 - 0.21 
2250 α-eudesmol 0.91 - 
4α-hydroxy-
dihydroagarofuran 3.83 2253 - 
2257 β-eudesmol 0.88 trace 
2384 1-hexadecanol trace - 
 Total 91.74% 90.12% 
 
*correct isomer not identified; trace: <0.05%. 
 
p-Cymene is the most abundant chemical constituent (45.38%) in the essential oil of P. 
panduriforme (SBG). Viridiflorol occurs at a substantial level of 7.89%. Other compounds 
contributing substantial amounts include α-phellandrene (4.31%), linalool (4.42%), p-
cymen-8-ol (3.97%) and spathulenol (3.82%). 
 
p-Cymene is the main compound (37.59%) in the hydrodistilled essential oil of P. 
panduriforme (WSBG). α-Phellandrene occupies 8.81% and 10-epi-γ-eudesmol represents 
6.26%. β-Phellandrene and 4α-hydroxy-dihydroagarofuran contribute 3.95% and 3.83% to 
the total oil composition. 
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Figure 12.5: Chemical structures of the major compounds identified in the essential oil of 
P. panduriforme (SBG) and in the essential oil of P. panduriforme (WSBG). 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium panduriforme 
collected from the Stellenbosch Botanical Garden. 
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 HPLC profile and analysis  
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Figure 12.6: HPLC profile of the acetone extract of Pelargonium panduriforme (SBG). 
 
Table 12.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium panduriforme (SBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.81 210.9  20.42 
9.38 207.3, 316.2  5.36 
10.75 269.9  2.47 
11.78 221.5, 275.8  1.96 
13.67 269.9  3.77 
14.02 209.7  8.61 
14.51 221.5, 272.2  4.45 
15.23 229.7, 277  1.39 
17.74 255.7, 354.4 flavonol 6.97 
18.34 262.7, 349.6 flavone 3.25 
20.53 255.7, 354.4 flavonol 5.10 
21.34 255.7, 349.6 flavone 22.83 
22.50 241.5, 337.7  1.79 
22.99 281.7 flavanone 1.31 
28.84 254.5, 300.7, 347.2  1.69 
30.47 256.8, 352.0  2.35 
31.32 243.8  0.62 
31.61 240.3, 330.5  0.85 
32.31 247.4  1.02 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
34.18 265.1  0.76 
36.51 273.4  1.12 
40.96 273.4, 325.7  0.84 
43.52 292.4  1.05 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium panduriforme in this study 
include the following: 
 
• The P. panduriforme (SBG) extract exhibited moderate antimicrobial activity (MIC 
values of 2 mg/ml were produced for all the test pathogens). The P. panduriforme 
(WSBG) extract showed improved activity against the Gram-positive micro-
organisms (MIC = 0.5 mg/ml for both B. cereus and S. aureus). The essential oil 
samples showed reduced antimicrobial activity. Pelargonium panduriforme (SBG) 
essential oil produced an MIC value of 2 mg/ml with respect to C. albicans.  
 
• Very low anti-oxidant activity was produced by the P. panduriforme (WSBG) 
extract in the DPPH assay (IC50 = 91.58 ± 4.45 µg/ml). 
 
• Both acetone extracts (SBG and WSBG) showed promising anti-inflammatory 
activity in the 5-lipoxygenase assay. IC50 values of 45.39 µg/ml – 45.58 µg/ml were 
obtained. 
 
• Pronounced antimalarial activity (IC50 = 1.34 ± 0.29 µg/ml) was produced by the 
acetone extract (SBG). The P. panduriforme (SBG) extract was the most active in 
the hypoxanthine assay. 
 
• The acetone extracts (SBG and WSBG) displayed cytotoxicity in the MTT assay. 
Pelargonium panduriforme (SBG) and P. panduriforme (WSBG) produced IC50 
values of 32.93 ± 3.75 µg/ml and 42.65 ± 0.90 µg/ml, respectively. The essential oil 
samples (SBG and WSBG) were extremely toxic; IC50 values of ≤0.10 µg/ml were 
produced by both samples. 
 323
 13.  Pelargonium  papilionaceum (L.) L’Hérit. 
 
Common names: 
Butterfly pelargonium, ‘Rambossie’ (van der Walt, 1977). 
 
Botanical description: 
Pelargonium papilionaceum is an upright, many-branched shrub growing more than 2 m 
high. The main stem is woody at the base and contains herbaceous villous side-branches. 
The sparsely villous, glandular, large leaves are cordate or roundly cordate; the upper 
leaves are entire and the lower ones shallowly 3-5-lobed. The leaf border can be described 
as finely toothed, serrulated or almost entire. The leaves of P. papilionaceum somewhat 
resemble those of P. vitifolium. However, the leaves of P. papilionaceum are more 
aromatic and more evidently veined on the upper side than the leaves of P. vitifolium. The 
vernacular name ‘Rambossie’ is derived from the unpleasant he-goat-like odour (fruity 
lemon scent) of the leaves. The inflorescence is umbel-like and consists of five to twelve 
flowers. The pedicels are long and covered with long soft hairs. The flowers contain two 
large posterior petals, which are reflexed, and three narrow anterior ones. ‘Papilionaceus’ 
is the Latin word meaning butterfly-like and the species name ‘papilionaceum’ refers to the 
two large posterior petals of the flower which resemble a butterfly. Flower colour is 
variable, from light pink to carmine. The posterior petals contain a distinguishing red-
purplish spot contrasting with an adjacent white spot. There are seven fertile stamens (van 
der Walt, 1977; 1985). Pelargonium papilionaceum could be confused with P. tomentosum 
and P. hispidum (van der Walt, 1985). 
 
Distribution and habitat: 
Pelargonium papilionaceum is found growing along the coast from Somerset West in the 
Western Cape stretching eastwards to Humansdorp in the Eastern Cape. The distribution of 
P. papilionaceum is associated with mountains. It is found in half-shady areas at the 
borders of indigenous forests, near streams and grows in kloofs or ravines (van der Walt, 
1977; 1985). 
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Figure 13.2: The geographical distribution 
of Pelargonium papilionaceum. 
Figure 13.1: Pelargonium papilionaceum
in flower. 
 
Traditional use: 
The leaves were used as an alternative to tobacco and smoked for medicinal purposes 
(Watt and Breyer-Brandwijk, 1962). 
 
Chemical composition of the essential oil: 
Fresh plant material collected from the National Botanical Garden (Kirstenbosch) was 
subjected to hydrodistillation for 3 hours. The oil yield was 0.17%. 
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 GC-MS profile and analysis 
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Figure 13.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
papilionaceum (NBG). 
 
Table 13.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
papilionaceum (NBG). 
 
RRI Compound Area % 
1014 tricyclene trace 
1032 α-pinene trace 
1100 undecane trace 
1174 myrcene trace 
1203 limonene trace 
1213 1,8-cineole  trace 
1225 (Z)-3-hexenal  trace 
1246 (Z)-β-ocimene 0.28 
1255 trace γ-terpinene 
1266 (E)-β-ocimene  0.08 
1280 p-cymene trace 
1290 terpinolene trace 
1337 geijerene trace 
1348 6-methyl-5-hepten-2-one trace 
cis-rose oxide 1353 0.05 
trans-rose oxide 1365 trace 
1385 allo-ocimene* trace 
1391 (Z)-3-hexenol trace 
1400 nonanal  trace 
1400 (Z)-2-hexenol trace 
1429 perillene trace 
trans-linalool oxide (furanoid)  1450 trace 
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 RRI Compound Area % 
1459 acetic acid trace 
1466 α-cubebene trace 
1503 isomenthone trace 
1541 benzaldehyde trace 
1553 linalool trace 
1553 octanol trace 
1569 neoisopulegol trace 
1570 methyl citronellate trace 
1571 trans-p-menth-2-en-1-ol trace 
1583 isopulegol trace 
1602 6-methyl-3,5-heptadien-2-one trace 
1612 0.12 β-caryophyllene 
1620 trace β-cyclocitral 
1647 (E)-2-decenal trace 
1668 citronellyl acetate trace 
1687 α-humulene trace 
1706 α-terpineol 0.26 
1748 piperitone trace 
1765 geranyl acetate trace 
1772 citronellol 0.12 
1809 citronellyl butyrate 0.29 
1825 geranyl propionate trace 
1857 geraniol trace 
1864 p-cymen-8-ol trace 
1868 (E)-geranyl acetone trace 
1886 geranyl butyrate 0.14 
1980 2-phenylethyl butyrate trace 
2008 caryophyllene oxide trace 
2084 octanoic acid trace 
2131 hexahydrofarnesylacetone trace 
2179 1-tetradecanol trace 
2184 nonanoic acid trace 
citronellic acid 96.16 2254 
2349 geranic acid 0.18 
2500 pentacosane trace 
2622 phytol trace 
2700 heptacosane 0.20 
2900 nonacosane 0.05 
2931 hexadecanoic acid trace 
Total 97.93%  
 
*correct isomer not identified; trace <0.05%; (NBG) = National Botanical Garden 
(Kirstenbosch). 
 
 327
 Citronellic acid is the major compound (96.16%) in the essential oil. 
 
 
 
citronellic acid 
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Figure 13.4: Chemical structure of the main compound, citronellic acid, identified in the 
hydrodistilled essential oil of Pelargonium papilionaceum (NBG).  
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium papilionaceum 
collected from the National Botanical Garden (Kirstenbosch). 
 
HPLC profile and analysis  
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Figure 13.5: HPLC profile of the acetone extract of Pelargonium papilionaceum (NBG). 
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 Table 13.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium papilionaceum (NBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.02 206.2  3.50 
4.82 206.2  1.38 
11.68 219.1, 325.7  6.72 
13.08 285.3  1.71 
13.35 228.5, 313.8  2.10 
13.79 229.7, 313.8  0.62 
14.10 234.4, 330.5  1.42 
16.24 254.5, 349.6 flavone 0.90 
18.36 262.7, 346.0 flavone 3.39 
19.35 254.5  13.16 
20.01 235.6  2.55 
20.53 255.7, 355.6 flavonol 5.42 
20.94 237.9  1.29 
21.22 254.5, 349.6 flavone 46.71 
22.07 243.8, 346.0 flavone 0.78 
32.31 261.6  0.38 
33.05 249.7  6.71 
34.19 265.1  0.24 
40.97 273.4, 326.9  1.03 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium papilionaceum in this study 
include the following: 
 
• The acetone extract (NBG) displayed promising activity against S. aureus (MIC = 2 
mg/ml) and C. albicans (MIC = 1.19 mg/ml). 
 
• The P. papilionaceum (NBG) extract displayed low anti-oxidant activity (IC50 = 
81.24 ± 13.44 µg/ml) in the DPPH assay. 
 
• The acetone extract (NBG) produced considerable antimalarial activity (IC50 = 5.15 
± 0.36 µg/ml). 
 
• The P. papilionaceum (NBG) extract displayed moderate toxicity (IC50 = 53.76 ± 
1.60 µg/ml) in the MTT assay. 
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 14.  Pelargonium pseudoglutinosum R. Knuth 
 
Synonym: 
Pelargonium uniondalense (van der Walt and Vorster, 1988). 
 
Botanical description: 
Pelargonium pseudoglutinosum is an erect to decumbent, many-branched, non-aromatic, 
viscid shrub up to 1 m high. Stems are herbaceous when young but soon become woody 
and are green but with age change to wine-red and eventually brown. Glandular hairs are 
present on the glabrescent to sparsely strigose leaves. The upper surface of the leaves have 
larger, dark purple veins. The lamina is ovate in outline, pinnatipartite to pinnatisect with 
irregularly incised segments and is sticky. The base is cuneate to obtuse and the apices of 
the segments are acute. Short conical hairs occur on the dentate margins. The pseudo-
umbels contain one to two pale pink to pink, relatively large flowers each. A dark pink 
blotch and purple markings occur on the posterior two, spathulate petals of which the 
apices are obtuse to emarginate. The anterior three, spathulate petals have long narrow 
claws (van der Walt, 1985; van der Walt and Vorster, 1988). 
 
There is a resemblance between P. pseudoglutinosum and P. glutinosum, hence the epithet 
‘pseudoglutinosum’ (‘pseudo’ meaning false) (van der Walt and Vorster, 1988). The leaves 
of P. pseudoglutinosum could be confused with those of P. glutinosum; however, the latter 
species lacks the purple veins and has aromatic leaves. A reliable attribute to distinguish 
the two species from one another is the 1-2-flowered pseudo-umbels (P. glutinosum has 
more than two flowers per inflorescence) (van der Walt, 1985). 
 
Distribution and habitat: 
Pelargonium pseudoglutinosum has a restricted distribution in the Western Cape. It is 
known only from Mannetjiesberg, Keurboomsrivier, Uniondale and Prince Alfred’s Pass. It 
grows in ravines near streams on well-drained soil (van der Walt, 1985; van der Walt and 
Vorster, 1988). 
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The essential oil of P. pseudoglutinosum was not obtained. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium pseudoglutinosum 
collected from the National Botanical Garden (Kirstenbosch). 
 
HPLC profile and analysis  
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Figure 14.2: The geographical distribution of 
Pelargonium pseudoglutinosum. 
Figure 14.1: Pelargonium 
pseudoglutinosum in flower.                 
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Figure 14.3: HPLC profile of the acetone extract of Pelargonium pseudoglutinosum
(NBG). 
 Table 14.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium pseudoglutinosum (NBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.77 206.3  7.39 
4.19 207.4  3.84 
5.48 207.4  5.25 
10.08 207.4  6.01 
29.73 267.4, 338.5 flavone 0.92 
32.63 267.4, 329.0 flavone 9.41 
32.82 267.4, 336.1 flavone 4.52 
33.10 253.2, 343.2  0.39 
34.56 268.5, 343.2 flavone 0.89 
35.53 260.3, 329.0  0.77 
35.73 245.0  0.61 
35.96 261.5  13.56 
40.23 278.0  19.22 
40.51 278.0  27.22 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium pseudoglutinosum in this 
study include the following: 
 
• Of all the extracts tested, the P. pseudoglutinosum (NBG) extract displayed the 
greatest activity (MIC = 0.039 mg/ml) against B. cereus and S. aureus. Promising 
activity (MIC = 0.54 mg/ml) was displayed against C. albicans. 
 
• The acetone extract (NBG) displayed moderate anti-oxidant activity (IC50 = 52.38 ± 
0.67 µg/ml) in the DPPH assay. 
 
• Considerably antimalarial activity was displayed by the acetone extract (NBG). An 
IC50 value of 7.93 ± 0.75 µg/ml was obtained in the hypoxanthine incorporation 
assay. 
 
• Substantial cytotoxicity (IC50 = 30.54 ± 5.46 µg/ml) was recorded for the P. 
pseudoglutinosum (NBG) extract. 
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 15.  Pelargonium quercifolium (L. f.) L’Hérit. 
 
Synonym:  
Pelargonium karrooense (van der Walt and Vorster, 1988). 
 
Common names: 
Royal Oak (O’Brien, 1983), Oak-leaved geranium (http://www.ibiblio.org/pfaf/cgi-
bin/arr_html?Pelargonium+quercifolium). 
 
Botanical description: 
Pelargonium quercifolium is a glaucous-green, erect, viscid shrub with stems which are 
herbaceous above, but woody at the base. It can grow up to 1.75 m high. This species has a 
somewhat unpleasant spicy, resinous scent (strong balm scent). The glossy, sticky leaves 
usually have a brown mark along the mid-rib and part of the veins. The leaves are almost 
scabrous, strigose with long soft hairs in between and densely interspersed with long 
glandular hairs. The lamina is 3-palmatisect to pinnatisect and the segments are irregularly 
pinnatifid to pinnatisect. The apices of the segments are acute to obtuse and the leaf 
margins are irregularly dentate-serrate. The epithet ‘quercifolium’ refers to the resemblance 
of the leaves to those of some Quercus species (oaks). Two to six flowers occur on each 
pseudo-umbel. The petals are pale to dark rose in colour. Deep carmine veining occurs on 
the posterior two narrowly obovate or oblong obovate petals which have obtuse to 
emarginate apices. The anterior petals are smaller and paler with long narrow claws. There 
are seven fertile stamens (O’Brien, 1983; Webb, 1984; van der Walt, 1985; van der Walt 
and Vorster, 1988). 
 
Distribution and habitat: 
Pelargonium quercifolium grows in the Western and the Eastern Cape. It is commonly 
found growing along the road between Oudtshoorn and Willowmore (van der Walt and 
Vorster, 1988). Pelargonium quercifolium is usually associated with Fynbos vegetation and 
commonly grows on rocky hills or on mountain slopes in Rhenosterbosveld (van der Walt 
and Vorster, 1988) and along the sides of roads (Phillips and Rix, 1998). 
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Figure 15.2: The geographical distribution of 
Pelargonium quercifolium. 
Figure 15.1: Pelargonium quercifolium in 
flower. 
 
Medicinal uses: 
Pelargonium quercifolium is a stimulant herb with a resinous aroma (Bown, 1995). All 
parts of the plant are astringent (Grieve, 1984). The plant is used for the treatment of 
rheumatism, hypertension and heart disease. The plant is used fresh in infusions (Bown, 
1995). 
 
Other uses: 
The essential oil has a labdanum fragrance (Uphof, 1959). The bruised leaves emit a warm 
strong aroma like incense (Genders, 1994). The dried leaves are used to make pot-pourri 
and are also added to insect-repellent sachets (Bown, 1995). 
 
Remark: 
Pelargonium quercifolium is a parent plant of many hybrids. Pelargonium quercifolium is 
closely related to P. panduriforme Eckl. & Zeyh. (van der Walt, 1985). 
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 Chemical composition of the essential oil: 
Hydrodistillation was carried out on fresh plant material for 3 hours. The oil yield was: 
1. Pelargonium quercifolium from Stellenbosch Botanical Garden: 0.07%,  
2. Pelargonium quercifolium from Walter Sisulu Botanical Garden: 0.26%.  
 
GC-MS profiles and analyses 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
quercifolium (SBG). 
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Figure 15.4: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
quercifolium (WSBG). 
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 Table 15.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
quercifolium. 
 
Area % RRI Compound SBG WSBG 
1032 α-pinene - 0.13 
1035 α-thujene - 0.19 
1118 β-pinene - trace 
1132 sabinene - 0.10 
1159 δ-3-carene - trace 
1176 α-phellandrene 0.79 1.13 
1203 limonene 0.27 0.22 
1218 β-phellandrene 0.33 0.20 
1230 butyl butyrate 0.05 - 
1246 (Z)-β-ocimene - trace 
1255 γ-terpinene 0.30 trace 
1266 (E)-β-ocimene - trace 
p-cymene 6.22 54.89 1280 
1290 terpinolene - trace 
1429 perillene - 0.15 
hexyl butyrate 8.16 1434 - 
1451 β-thujone - 0.09 
1452 α,p-dimethylstyrene 0.18 0.49 
(E)-2-hexenyl butyrate 6.34 1464 - 
1492 cyclosativene 0.15 - 
1493 α-ylangene - 0.07 
1497 α-copaene 0.10 - 
1503 hexyl valerate 0.07 - 
1508 heptyl butyrate 0.24 - 
trans-p-menth-2-en-1-ol 1571 - 0.19 
1600 β-elemene 0.09 - 
1608 octyl butyrate 0.41 - 
1611 terpinen-4-ol - 0.23 
1612 β-caryophyllene 0.10 - 
1614 hexyl tiglate 0.22 - 
1617 guaia-6,9-diene 0.12 trace 
1628 aromadendrene 0.10 0.13 
1661 allo-aromadendrene 0.77 0.05 
1683 carvotanacetone - trace 
1690 cryptone  trace 1.36 
1707 ledene 1.77 0.42 
1726 germacrene D 0.07 - 
1730 δ-guaiene trace 0.27 
1740 valencene 0.07 - 
1740 α-muurolene 0.45 0.18 
1748 piperitone - trace 
1751 phellandral - 0.33 
1751 carvone - 0.41 
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 Area % RRI Compound SBG WSBG 
1755 bicyclogermacrene 0.08 - 
cis-piperitol 1758 - trace 
1773 δ-cadinene 1.23 0.52 
1776 γ-cadinene 0.06 trace 
1783 p-methylacetophenone - 0.68 
1802 cuminaldehyde 0.08 0.84 
1823 p-mentha-1(7),5-dien-2-ol* 0.56 1.04 
1829 octyl hexanoate 0.08 - 
cis-calamenene 1853 0.07 0.22 
1864 p-cymen-8-ol 1.00 2.76 
1865 isopiperitenone - 0.05 
1886 geranyl butyrate - 0.23 
1941 α-calacorene 0.36 0.13 
1941 citronellyl hexanoate - 0.09 
1984 γ-calacorene 0.11 - 
2040 octyl octanoate 0.15 - 
2030 methyl eugenol - trace 
2050 (E)-nerolidol 2.75 - 
2057 ledol - 0.19 
2080 cubenol - trace 
2096 neryl hexanoate - trace 
2045 humulene epoxide I trace - 
viridiflorol 36.55 13.01 2104 
2105 geranyl hexanoate - trace 
2113 cumin alcohol  - trace 
2127 10-epi-γ-eudesmol - trace 
spathulenol 6.19 5.90 2144 
2179 1-tetradecanol 0.33 - 
cis-p-menth-3-ene-1,2-diol 2184 - trace 
2185 γ-eudesmol 0.27 - 
2187 T-cadinol - 0.85 
2193 β-betulenal 0.22 - 
2196 ambrox 0.43 - 
2198 thymol - 0.32 
2209 T-muurolol - trace 
2239 carvacrol 0.92 1.47 
2247 trans-α-bergamotol 0.64 trace 
2249 cadalene 0.55 - 
2255 α-cadinol - 0.05 
2273 1-pentadecanol - trace 
8,13-epoxy-15,16-dinor-labd-
12-ene 2305 1.37 - 
2349 geranic acid 0.07 - 
2357 14-hydroxy-β-caryophyllene 0.24 - 
2376 manoyl oxide 0.52 - 
2384 1-hexadecanol 0.23 - 
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 Area % RRI Compound SBG WSBG 
2396 8α-13-oxo-14-en-epi-labdane 0.52 - 
2509 dodecanoic acid 0.15 - 
2617 tridecanoic acid 0.17 - 
2622 phytol - trace 
2670 tetradecanoic acid 0.35 trace 
2822 pentadecanoic acid trace - 
2931 hexadecanoic acid trace - 
Total 83.62% 89.58%  
 
*correct isomer not identified; trace <0.05%. 
 
Viridiflorol (36.55%) is the main compound in P. quercifolium (SBG). The following 
compounds also occur in high amounts in P. quercifolium (SBG) essential oil: p-cymene 
(6.22%), hexyl butyrate (8.16%), (E)-2-hexenyl butyrate (6.34%) and spathulenol (6.19%). 
 
p-Cymene occupies 54.89% of the total oil composition of P. quercifolium (WSBG). 
Viridiflorol and spathulenol contribute 13.01% and 5.90%, respectively. 
 
The major compounds common to both P. quercifolium (SBG) and P. quercifolium 
(WSBG) include p-cymene, viridiflorol and spathulenol. Hexyl butyrate and (E)-2-hexenyl 
butyrate were absent in P. quercifolium (WSBG). 
 
 
 OH
H
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H
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Figure 15.5: Chemical structures of the major compounds found in both P. quercifolium 
(SBG) and P. quercifolium (WSBG) essential oil samples. 
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Figure 15.6: Chemical structures of the other major compounds identified in Pelargonium 
quercifolium (SBG) essential oil. 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium quercifolium 
collected from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 15.7: HPLC profile of the acetone extract of Pelargonium quercifolium (SBG). 
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 Table 15.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium quercifolium (SBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.95 212.0  6.81 
13.64 219.1, 271.0  1.20 
13.98 210.9  2.33 
14.50 221.5, 272.2  2.04 
15.88 255.7, 355.6 flavonol 1.52 
18.76 255.7, 355.6 flavonol 11.21 
20.50 255.7, 355.6 flavonol 7.11 
27.87 255.7, 359.0 flavonol 10.02 
28.23 260.4, 337.7 flavone 3.65 
29.68 249.7, 347.2 flavone 1.96 
29.95 266.3, 350.8 flavone 2.60 
30.26 254.5, 355.6 flavonol 4.98 
30.43 258.0, 298.3, 352.0  4.94 
30.77 262.7, 363.9 flavonol 1.62 
31.63 260.4, 338.9 flavone 16.06 
32.25 261.6  2.25 
32.61 252.1, 350.8 flavone 2.00 
33.02 254.5, 354.4 flavonol 7.62 
34.08 249.7, 344.8  6.34 
34.53 253.3, 352.0 flavonol 1.58 
36.42 261.6  0.82 
37.12 253.3  0.86 
40.06 262.7  0.49 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium quercifolium in this study 
include the following: 
 
• The P. quercifolium (SBG) extract produced promising antibacterial activity against 
B. cereus (MIC = 0.33 mg/ml) and against S. aureus (MIC = 0.16 mg/ml). The P. 
quercifolium (WSBG) extract inhibited the latter micro-organisms to a lesser extent 
(MIC = 1.00 mg/ml) but showed improved activity against K. pneumoniae and C. 
albicans (MIC values of 2 mg/ml and 1 mg/ml were obtained, respectively).  
 
• The P. quercifolium (SBG) extract produced substantial anti-oxidant activity (IC50 
= 17.15 ± 0.58 µg/ml), whereas the P. quercifolium (WSBG) extract showed much 
lower anti-oxidant activity (IC50 = 61.87 ± 3.19 µg/ml). 
 
• Of all the species tested, P. quercifolium (SBG and WSBG) produced the greatest 
inhibition of the 5-lipoxygenase enzyme (IC50 = 33.24 µg/ml – 38.67 µg/ml). 
 
• P. quercifolium (SBG) extract displayed pronounced antimalarial activity (IC50 = 
2.66 ± 0.36 µg/ml). 
 
• The P. quercifolium (SBG) extract produced a lower toxicity profile (IC50 = 85.61 ± 
1.93 µg/ml) than the P. quercifolium (WSBG) extract (IC50 = 48.69 ± 1.04 µg/ml). 
The essential oil samples proved to be very toxic. IC50 values of 3.34 ± 2.79 µg/ml 
and 8.81 ± 1.46 µg/ml were obtained for P. quercifolium (SBG) and P. 
quercifolium (WSBG), respectively. 
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 16.  Pelargonium radens H. E. Moore 
 
Synonym: 
Pelargonium radula (Cav.) L’Hérit. (van der Walt, 1977). 
 
Common names: 
Rasp-leaved pelargonium, Multifid-leaved pelargonium (van der Walt, 1977).  
 
Botanical description: 
Pelargonium radens is an upright, branching shrub reaching a height of 1 m. As the plant 
ages, the stem becomes woody toward the base. Rigid bristles are present on the 
herbaceous, slender side-branches. The leaves release a pungent rose and lemon scent 
when bruised. The leaves are triangular in outline, narrow and scabrid (deeply divided). 
Coarse, long, stiff, erect hairs are found on the upper surface making the leaves hard to the 
touch (almost scabrous). An important characteristic of the leaves are the margins of the 
narrow segments which are rolled under like a scraper. The species name ‘radens’ 
(scraping) or ‘radula’ (rasp or file) refers to the rasp-like leaves. Both the segments and 
apex are obtusely lobulate. At the base of the petioles are narrowly ovate or ovate stipules. 
The inflorescences are umbel-like and 2-6-flowered. The petals are pale purple or pink-
purple in colour. The posterior petals have conspicuous beetroot purple veins and blotches 
and have an entire or slightly notched tip. The plant contains seven fertile stamens (van der 
Walt, 1977; Webb, 1984). Pelargonium radens is rather similar to P. graveolens (Huxley, 
1992). 
 
Distribution and habitat: 
Pelargonium radens is confined to the eastern region of the Western Cape and the southern 
region of the Eastern Cape, where it occurs from near the vicinity of Barrydale eastwards 
along the coast to Engcobo (van der Walt, 1977). It grows on mountain sides and by rocky 
streams as well as in sheltered valleys (Phillips and Rix, 1998). 
 
 
 
 
 
 342
  
Figure 16.2: The geographical distribution of 
Pelargonium radens. 
Figure 16.1: The flower of Pelargonium 
radens. 
 
Medicinal uses: 
All parts of the plant are astringent (Grieve, 1984). A rub made from the fresh leaves can 
be used externally to relieve aching feet or legs (Bown, 1995). 
 
Other uses: 
The lemony scented essential oil is used in perfumery (Uphof, 1959). The dried leaves are 
used in pot-pourri as a fixative for other perfumes. The dried leaves are also used in insect-
repellent sachets (Bown, 1995). 
 
Chemical composition of the essential oil: 
The fresh plant material collected from the National Botanical Garden (Kirstenbosch) 
yielded 0.69% essential oil. 
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 GC-MS profile and analysis 
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Figure 16.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium radens 
(NBG). 
 
Table 16.1: Compounds identified in the hydrodistilled essential oil of Pelargonium radens 
(NBG). 
 
RRI Compound Area % 
1014 tricyclene 0.17 
1032 α-pinene 0.28 
1076 camphene trace 
1118 β-pinene 0.14 
1132 sabinene trace 
1174 myrcene 0.90 
1203 limonene 0.75 
1216 3-methylcyclopentanone trace 
1218 β-phellandrene 0.10 
p-cymene 1.06 1280 
1327 3-methylcyclohexanone 0.13 
1384 α-pinene oxide trace 
1429 perillene 0.10 
trans-linalool oxide (furanoid)  1450 0.05 
cis-1,2-limonene epoxide 1458 trace 
menthone 1.88 1475 
isomenthone 84.52 1503 
1553 linalool 0.58 
trans-p-menth-2-en-1-ol 1571 trace 
1572 β-ylangene 0.15 
cis-isopulegone 1580 trace 
1617 guaia-6,9-diene trace 
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 RRI Compound Area % 
1632 neoisomenthol 0.16 
1637 menthol 0.05 
1661 allo-aromadendrene trace 
1662 isomenthol trace 
1668 (Z)-β-farnesene trace 
1674 γ-gurjunene trace 
1687 α-humulene trace 
1690 cryptone 0.30 
1706 α-terpineol 0.12 
1719 borneol 0.05 
1725 verbenone trace 
1740 valencene trace 
1748 piperitone 0.61 
1751 carvone 0.07 
1772 citronellol 0.16 
1783 p-methylacetophenone 0.07 
1798 methyl salicylate 0.06 
1802 cuminaldehyde trace 
1809 citronellyl butyrate trace 
trans-carveol 1845 0.05 
1864 p-cymen-8-ol 0.10 
1885 2-phenylethyl propionate 0.07 
1896 2-phenylethyl isobutyrate 0.08 
1941 α-calacorene trace 
1965 citronellyl propionate 0.08 
1980 2-phenylethyl butyrate trace 
1988 2-phenylethyl 2-methylbutyrate trace 
1992 2-phenylethyl isovalerate  trace 
2008 caryophyllene oxide trace 
2030 norbourbonone trace 
2050 (E)-nerolidol 0.42 
2071 humulene epoxide II trace 
2080 cubenol 0.05 
2110 furopelargone B trace 
2140 2-phenylethyl valerate 0.11 
2144 spathulenol trace 
2209 T-muurolol trace 
2211 2-phenylethyl tiglate 0.83 
2239 carvacrol trace 
2255 α-cadinol 0.10 
2281 decanoic acid 0.09 
2411 2-decenoic acid* 0.05 
Total 94.49%  
          
*correct isomer not identified; trace <0.05%; (NBG) = National Botanical Garden 
(Kirstenbosch). 
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 Isomenthone makes-up 84.52% of the total oil composition. p-Cymene and menthone 
represent 1.06% and 1.88%, respectively.  
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Figure 16.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium radens (NBG). 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium radens collected 
from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis 
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Figure 16.5: HPLC profile of the acetone extract of Pelargonium radens (SBG). 
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 Table 16.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of Pelargonium radens (SBG) acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.99 210.9  11.04 
4.85 205.0  2.29 
8.29 205.0, 269.9  6.96 
10.25 206.2, 269.9  7.93 
10.92 207.3, 272.2  15.94 
11.77 326.9  7.16 
12.25 207.3, 272.2  6.09 
12.61 206.2, 280.5, 325.7  4.32 
12.77 207.3, 273.4  1.01 
13.09 202.7, 279.3  18.01 
13.67 278.1 flavanone 1.87 
14.17 233.2, 328.1  1.54 
14.65 219.1, 261.6  1.83 
15.14 207.3, 287.6, 332.9  1.46 
15.55 207.3, 267.5, 353.2  0.53 
16.34 208.5, 233.2  0.37 
30.01 267.5, 347.2 flavone 0.26 
31.68 241.5  0.54 
32.32 261.6  0.92 
34.19 265.1  0.83 
34.88 228.5  1.47 
35.57 267.5, 346.0 flavone 3.91 
43.55 293.6  3.71 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium radens in this study include 
the following: 
 
• The P. radens (SBG) extract was most active against B. cereus (MIC value of 0.5 
mg/ml). Weak antimicrobial activity (MIC = 8 mg/ml to >32 mg/ml) was 
demonstrated by the P. radens (NBG) essential oil. 
 
• The P. radens (NBG) essential oil did not exert anti-inflammatory activity in the 5-
lipoxygenase assay (IC50 >100 µg/ml). 
 
• Pronounced antimalarial activity (IC50 = 1.90 ± 0.39 µg/ml) was displayed by the P. 
radens (SBG) extract in the hypoxanthine incorporation assay. 
 
• The P. radens (SBG) extract and essential oil (NBG) sample proved to be cytotoxic 
(IC50 = 30.81 ± 1.23 µg/ml and 27.20 ± 4.76 µg/ml, respectively). 
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 17.  Pelargonium scabroide R. Knuth 
 
Botanical description: 
This non-aromatic species is an erect to decumbent, branched subshrub reaching a height 
of up to 0.75 m. The young stems are herbaceous and wine-red becoming woody and 
greyish-brown with age. The stems are villous to hispid with small glandular hairs in 
between. The leaves are almost scabrous (hard to the touch), hence the epithet ‘scabroide’. 
The upper surface of the leaf is glabrescent whereas the lower surface is strigose to hispid 
with small glandular hairs. The leaves are 3-palmatisect to pinnatisect with irregularly 
incised segments. The lamina is cordiform in outline and the leaf margins are coarsely 
serrate-dentate and wine-red. The wine-red young stems, with long hairs and typical leaf 
structure, distinguish P. scabroide from other species of the section. The pseudo-umbels 
have three to five flowers each. Petals are white to pale pink-purple with darker markings; 
feather-like dark pink to wine-red markings occur on the posterior two, spathulate petals 
and a pink streak occurs on the anterior three, narrowly spathulate petals (van der Walt and 
Vorster, 1988).  
 
Pelargonium scabroide and P. sublignosum Knuth have many features in common. Leaf 
characters are used to distinguish these two species from one another (van der Walt and 
Vorster, 1988). 
 
Distribution and habitat: 
Pelargonium scabroide has a small area of distribution. It grows on the mountains between 
Porterville and Touws River. It is also found in the south-eastern region of the Western 
Cape. It grows on sandy soil in the moist, shady habitats created by over-hanging 
sandstone boulders (van der Walt and Vorster, 1988). 
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The essential oil of P. scabroide was not obtained. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium scabroide collected 
from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
Figure 17.1: Pelargonium scabroide  
(van der Walt and Vorster, 1988). 
Figure 17.2: The geographical distribution of 
Pelargonium scabroide. 
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Figure 17.3: HPLC profile of the acetone extract of Pelargonium scabroide (SBG). 
 
 Table 17.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium scabroide (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.02 213.3  21.16 
5.22 215.6, 278.0  3.19 
6.64 214.5, 273.3  0.95 
10.51 286.3, 278.0  5.89 
12.32 212.1, 278.0  0.90 
13.32 203.9, 278.0  21.87 
13.68 216.8, 278.0  6.83 
13.98 219.1, 278.0  9.37 
14.31 278.0 flavanone 7.47 
14.88 209.8, 278.0  5.42 
15.40 206.3, 278.0  1.25 
15.94 222.7, 278.0  8.10 
16.83 219.1, 278.0  1.08 
18.05 221.5, 278.0  1.13 
20.78 220.3, 278.0  5.40 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium scabroide in this study 
include the following: 
 
• The P. scabroide (SBG) extract showed substantial activity against B. cereus (MIC 
= 0.25 mg/ml). The extract produced an MIC value of 1 mg/ml with respect to S. 
aureus and C. albicans and an MIC value of 2 mg/ml with respect to K. 
pneumoniae. 
 
• Promising antimalarial activity was displayed by the P. scabroide (SBG) extract 
(IC50 = 15.94 ± 0.16 µg/ml). 
 
• The P. scabroide (SBG) extract produced moderate toxicity, an IC50 value of 53.76 
± 1.57 µg/ml was obtained in the MTT assay. 
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 18.  Pelargonium scabrum (Burm. f.) L’Hérit. 
 
Common names: 
Rough-leaved pelargonium, Three-pointed pelargonium (van der Walt, 1977). 
 
Botanical description: 
This woody, erect and much-branched shrub can grow as tall as 2 m. The presence of rigid 
hairs on the stems makes them scabrous (harsh and rough to the touch). When crushed the 
leaves emit a distinctive pleasant lemon scent; this varies according to the locality. The 
leaves are angularly tri-lobed, palmately veined and the leaf outline is rhomboid. The 
leaves of plants growing further inland in the Western Cape are more narrow-lobed. The 
leaves can vary from being almost glabrous to scabrous with glands always present. The 
margins of the leaves are finely to coarsely toothed. The umbel-like inflorescences bear 
two to six flowers each. The colour of the relatively small flowers can range from white to 
dark pink or mauve. Purple stripes are present on the two posterior petals which are twice 
as large as the anterior three. The flowers have seven fertile stamens (van der Walt, 1977; 
Webb, 1984). The leaves of P. scabrum are similar to those of P. citronellum J.J.A. v.d. 
Walt; however, the flowers of the latter species differ considerably (van der Walt, 1985). 
 
Distribution and habitat: 
Pelargonium scabrum has a large distribution area. It is found growing from Steinkopf 
(west of the Northern Cape) southwards along the western coastal area to the south-western 
Cape and eastwards to Willowmore in the Eastern Cape. Its distribution is associated with 
dry mountainous habitats and grows on well-drained, sandy soil (van der Walt, 1977; 
1985). 
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Figure 18.1: The flower of Pelargonium 
scabrum. 
Figure 18.2: The geographical distribution 
of Pelargonium scabrum. 
Chemical composition of the essential oil: 
The fresh plant material collected from the Stellenbosch Botanical Garden was subjected to 
hydrodistillation for 3 hours. The oil yield was 0.12%. 
 
GC-MS profile and analysis 
 
 
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00
 
 
 
 
 
 
 
 
Figure 18.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
scabrum (SBG). 
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 Table 18.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
scabrum (SBG). 
 
RRI Compound Area % 
1014 tricyclene 0.06 
1032 α-pinene 0.13 
1035 α-thujene trace 
1076 camphene trace 
1118 β-pinene 0.26 
1132 sabinene trace 
1174 myrcene 1.37 
1203 limonene 0.17 
1213 1,8-cineole 1.26 
1280 p-cymene 0.99 
cis-rose oxide 1353 0.06 
trans-rose oxide 1365 trace 
1391 (Z)-3-hexenol trace 
1398 2-nonanone 0.08 
1400 (Z)-2-hexenol 0.05 
1429 perillene trace 
trans-linalool oxide (furanoid)  1450 0.05 
1466 α-cubebene trace 
1473 (Z)-3-hexenyl 2-methylbutyrate trace 
cis-linalool oxide (furanoid) 1478 0.11 
1481 (Z)-3-hexenyl isovalerate trace 
1497 α-copaene 0.22 
1503 isomenthone trace 
1532 camphor trace 
1541 benzaldehyde 0.13 
cis-α-bergamotene 1545 trace 
1553 linalool 0.65 
trans-α-bergamotene 1568 0.30 
1577 α-cedrene 0.27 
methyl decanoate 4.24 1587 
β-caryophyllene 3.88 1612 
cis-β-terpineol 1624 trace 
2-methyl-6-methylen-3,7-
octadien-2-ol 1626 0.24 
cis-p-menth-2-en-1-ol 1638 trace 
1661 allo-aromadendrene trace 
1668 citronellyl acetate 0.09 
1668 (Z)-β-farnesene 0.17 
1682 δ-terpineol trace 
1687 α-humulene 0.32 
1693 β-acoradiene 0.10 
1696 β-alaskene 0.07 
1704 γ-muurolene 0.19 
1706 α-terpineol 2.83 
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 RRI Compound Area % 
1740 α-muurolene trace 
1743 α-cadinene trace 
1773 δ-cadinene 0.69 
1776 γ-cadinene 0.63 
1786 ar-curcumene 0.65 
1798 methyl salicylate trace 
1834 citronellyl isovalerate 0.08 
cis-calamenene 1853 0.21 
1857 geraniol 0.09 
1864 p-cymen-8-ol 0.11 
1941 α-calacorene 0.33 
1969 (Z)-jasmone 0.05 
1981 heptanoic acid 0.06 
1984 γ-calacorene 0.12 
2001 isocaryophyllene oxide 0.35 
caryophyllene oxide 4.20 2008 
2020 caryophylla-8(14)-en-5-one 0.33 
2030 methyl eugenol 0.26 
2050 (E)-nerolidol 0.90 
2071 humulene epoxide II 0.07 
2080 cubenol 0.30 
2088 1-epi-cubenol 0.08 
2131 hexahydrofarnesylacetone trace 
2143 cedrol 0.70 
2170 β-bisabolol trace 
T-cadinol 6.08 2187 
β-betulenal 5.64 2193 
2204 clovenol 0.43 
2209 T-muurolol 0.24 
2272 14-acetoxy-β-caryophyllene 0.10 
decanoic acid 6.36 2281 
2316 caryophylladienol I 0.15 
2324 caryophylladienol II 2.27 
14-hydroxy-β-caryophyllene 27.93 2357 
2392 caryophyllenol II 0.93 
14-hydroxy-4,5-dihydro-β-
caryophyllene 2415 1.23 
2478 14-hydroxy-α-humulene 0.72 
2509 dodecanoic acid 0.94 
14-hydroxy-4,5-epoxy-β-
caryophyllene (β,β form) 2609 0.34 
14-hydroxy-4,5-epoxy-β-
caryophyllene (β,α form) 2663 1.07 
2670 tetradecanoic acid trace 
Total 82.93%  
 
trace <0.05%; (SBG) = Stellenbosch Botanical Garden. 
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 14-Hydroxy-β-caryophyllene is the major compound (27.93%) in P. scabrum (SBG) 
essential oil. Other major compounds include methyl decanoate (4.24%), β-caryophyllene 
(3.88%), caryophyllene oxide (4.20%), T-cadinol (6.08%), β-betulenal (5.64%) and 
decanoic acid (6.36%). 
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Figure 18.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium scabrum (SBG). 
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 Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium scabrum collected 
from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 18.5: HPLC profile of the acetone extract of Pelargonium scabrum (SBG). 
 
Table 18.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium scabrum (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.07 212.0  7.81 
10.21 205.0, 269.9  4.44 
12.25 212.0, 279.3  0.49 
13.06 205.0, 279.3  3.39 
13.76 217.9, 278.1  18.85 
14.26 219.1, 279.3  5.70 
14.84 209.7, 279.3  4.75 
15.78 222.6, 278.1  5.54 
17.66 255.7, 353.2 flavonol 12.79 
22.53 279.3  0.23 
31.73 288.8 flavanone 1.34 
31.89 275.8 flavanone 1.15 
32.03 271.0 flavanone 6.70 
32.36 239.1, 266.3, 359.0  9.37 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
32.80 266.3, 340.1 isoflavone 7.99 
33.01 292.4 flavanone 0.81 
33.47 236.8, 344.8  0.72 
33.62 288.8 flavanone 1.41 
34.06 293.6 flavanone 4.77 
34.86 292.4 flavanone 0.92 
35.73 292.4 flavanone 0.82 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium scabrum in this study include 
the following: 
 
• The P. scabrum (SBG) extract displayed considerable activity against B. cereus 
(MIC = 0.059 mg/ml) and S. aureus (MIC = 0.078 mg/ml). Pelargonium scabrum 
is the second most active species against B. cereus. Promising activity was 
produced with respect to C. albicans (MIC = 0.38 mg/ml). 
 
• An IC50 value of 7.15 ± 0.11 µg/ml was obtained in the DPPH assay, representing 
substantial anti-oxidant activity. 
 
• Pelargonium scabrum (SBG) essential oil displayed moderate anti-inflammatory 
activity (IC50 = 54.68 µg/ml) in the 5-lipoxygenase assay. 
 
• Promising antimalarial activity (IC50 = 16.10 ± 0.02 µg/ml) was produced by the P. 
scabrum (SBG) extract. 
  
• The P. scabrum (SBG) extract displayed toxic effects, an IC50 value of 37.78 ± 1.72 
µg/ml was obtained in the MTT assay. 
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 19.  Pelargonium sublignosum R. Knuth 
 
Botanical description: 
Pelargonium sublignosum is an erect, branched shrub with an overall glaucous appearance. 
This species grows up to 1 m tall and is non-aromatic or strongly sweet-scented. The stem 
is woody, becoming completely wood-like with age (the epithet ‘sublignosum’ refers to the 
woody stems). The stems are sparsely to densely villous interspersed with glandular hairs. 
The stems eventually become glabrous with a dark reddish-brown shining bark. The 
upturned branches are woody. The green to dull green leaves are sparsely hirtellous to 
villous, interspersed with glandular hairs. The lamina is cordiform in outline, and is deeply 
3−(5)-lobed, the broad lobes being blunt or rounded with dentate to coarsely dentate and 
often reddish edges. Three to nine flowers occur on each pseudo-umbel. Flower colour is 
white, light pink or pink. The petals have a general linear-spathulate shape and are long-
clawed at their bases. Feather-like pink-purplish markings occur on the posterior two petals 
(Webb, 1984; van der Walt 1985; van der Walt and Vorster, 1988).  
 
The leaves of P. sublignosum are similar to those of P. scabrum (L.) L’Hérit., it is likely 
that P. sublignosum evolved from P. scabrum. The resemblance in the habit, leaves and 
indumentum of P. sublignosum and P. scabroide Knuth may imply a relationship between 
these two species. The latter species are more distantly related to P. scabrum (van der Walt 
and Vorster, 1988). 
 
Distribution and habitat: 
The distribution of Pelargonium sublignosum is confined to a small south-western region 
of the Western Cape. It is restricted to mountainous areas and has been obtained only on 
Piquetberg and on the mountain ranges between Porterville and Ceres. It grows in moist 
habitats such as in ravines, frequently between rocks (van der Walt and Vorster, 1988). 
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The essential oil of P. sublignosum was not obtained. 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium sublignosum 
collected from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19.3: HPLC profile of the acetone extract of Pelargonium sublignosum (SBG). 
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Figure 19.2: The geographical distribution 
of Pelargonium sublignosum. 
Figure 19.1: Pelargonium sublignosum
in flower. 
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 Table 19.1: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium sublignosum (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.98 213.3  11.28 
6.64 214.5, 272.1  0.74 
10.18 210.9, 278.0  1.29 
10.62 206.3, 272.1  1.54 
11.41 208.6, 260.3  0.51 
12.37 210.9, 275.6  1.20 
13.35 207.4, 278.0  0.32 
13.69 213.3, 278.0  1.47 
13.99 219.1, 278.0  3.20 
14.35 215.6, 278.0  2.17 
14.89 209.8, 275.6  1.56 
15.49 218.0, 275.6  0.51 
15.91 222.7, 276.8  0.88 
16.81 218.0, 278.0  1.14 
17.83 255.6, 354.0 flavonol 0.54 
18.06 221.5, 276.8  1.11 
20.68 218.0, 278.0  2.36 
21.36 220.3, 275.6  1.53 
21.93 220.3, 275.6  1.54 
29.26 291.0 flavanone 0.55 
30.45 269.7, 351.6  0.31 
32.21 288.6 flavanone 0.18 
32.35 276.8 flavanone 1.51 
32.53 272.1 flavanone 9.55 
32.67 202.8, 267.4, 359.4  15.86 
33.16 266.2, 338.5 isoflavone 18.02 
33.44 292.2 flavanone 1.77 
34.01 229.7, 288.6  1.53 
34.38 292.2 flavanone 12.51 
35.23 292.2 flavanone 1.98 
36.09 292.2 flavanone 1.33 
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 Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium sublignosum in this study 
include the following: 
 
• The P. sublignosum (SBG) extract displayed considerable activity against S. aureus 
(MIC = 0.078 mg/ml). Substantial antimicrobial activity was also shown against B. 
cereus (MIC = 0.13 mg/ml). An MIC value of 0.5 mg/ml was obtained for C. 
albicans. 
 
• Substantial anti-oxidant activity (IC50 = 17.61 ± 3.18 µg/ml) was displayed by the 
P. sublignosum (SBG) extract. 
 
• Considerable antimalarial activity (IC50 = 9.01 ± 1.22 µg/ml) was produced by the 
P. sublignosum (SBG) extract. 
 
• Of all the extracts tested in the MTT assay, the P. sublignosum (SBG) extract was 
the most toxic (IC50 = 11.89 ± 1.54 µg/ml). 
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 20.  Pelargonium tomentosum Jacq. 
 
Synonym:  
Pelargonium micranthum Eckl. & Zeyh. (van der Walt and Vorster, 1981). 
 
Common name: 
Pennyroya pelargonium, Peppermint-scented pelargonium, Piperitum (van der Walt and 
Vorster, 1981). 
 
Botanical description: 
Pelargonium tomentosum is a decumbent, bushy, strongly peppermint-scented plant with 
erect branches. It reaches a height of 0.5 m. Long, thick hairs cover the stem which is 
woody at the base, but fleshy above. The large grey-green soft leaves have a thick 
tomentose (felt-like) covering on all surfaces which give it that velvety touch. The leaf 
blades have a broadly cordate outline and are 3−(5)-palmatilobate to 3−(5)-palmatipartite, 
the base is cordately incised and the apices of the lobes are obtuse (the leaf is shaped much 
like a grape leaf). The leaf margins are irregularly crenate-serrate. Four to fifteen flowers 
occur on each pseudo-umbel. The five petals are white, entire in general shape and are very 
small. Prominent carmine-red marks occur on the petals. Posterior petals are elliptic to 
obovate with eared bases. The three anterior petals are longer and narrower than the two 
posterior ones. There are seven fertile stamens (van der Walt and Vorster, 1981; Webb, 
1984; van der Walt, 1985). When not flowering, this species may be confused with P. 
papilionaceum (L.) L’Hérit. (van der Walt and Vorster, 1981). 
 
Distribution and habitat:  
Pelargonium tomentosum has been collected on the Hottentots Holland Mountains near 
Somerset West, on the Riviersonderend Mountains near Greyton and on the Langeberg 
range from Swellendam to Riversdale. It is rarely found on the Hottentots Holland 
Mountains but is abundant on the Langeberg range particularly near Swellendam. This 
species is restricted to mountains where it grows in semi-shaded, moist places (van der 
Walt, 1985). It is found on the margins of forests along streams (Phillips and Rix, 1998).  
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 Figure 20.2: The geographical distribution 
of Pelargonium tomentosum. 
Figure 20.1: Pelargonium tomentosum in 
flower. 
 
Medicinal uses: 
All parts of the plant are astringent (Grieve, 1984). The fresh leaves are used as a poultice 
for the relief of bruises and sprains (Bown, 1995). 
 
Edible uses: 
Often used as a culinary herb (van der Walt and Vorster, 1981). Due to their strong mint 
scent, the leaves and flowers are used to flavour cakes, puddings, pies, biscuits, etc. 
(Facciola, 1990; Bown, 1995). The fresh leaves are used to make a peppermint-flavoured 
tea (Bown, 1995). 
 
Other uses: 
A peppermint-scented essential oil is obtained from the plant (Chittendon, 1956). The dried 
leaves are used in pot-pourri (Bown, 1995). 
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 Chemical composition of the essential oil: 
Hydrodistillation was carried out on fresh plant material for 3 hours after which a pale 
yellowish-green oil was obtained. The oil yield was: 
1. Pelargonium tomentosum from Stellenbosch Botanical Garden: 0.27% 
2. Pelargonium tomentosum from Walter Sisulu Botanical Garden: 0.21% 
 
GC-MS profile and analysis 
 
 
 
 
 
 
 
 
 
 
 
Figure 20.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
tomentosum (SBG). 
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Figure 20.4: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
tomentosum (WSBG). 
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 Table 20.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
tomentosum. 
 
Area % RRI Compound SBG WSBG 
1014 tricyclene 0.44 0.25 
1032 α-pinene 0.50 0.29 
1076 camphene 0.05 trace 
1118 β-pinene trace trace 
1132 sabinene trace trace 
1146 δ-2-carene - trace 
1174 myrcene 0.76 0.41 
limonene 1.48 1.25 1203 
1216 3-methylcyclopentanone trace trace 
1218 β-phellandrene 0.63 0.14 
1246 (Z)-β-ocimene trace - 
1266 (E)-β-ocimene trace - 
1280 p-cymene 1.07 0.79 
1384 α-pinene oxide trace trace 
1406 fenchone trace trace 
1429 perillene trace trace 
1452 α,p-dimethylstyrene trace - 
cis-1,2-limonene epoxide 1458 - trace 
menthone 41.14 36.06 1475 
isomenthone 49.29 56.63 1503 
1535 β-bourbonene trace trace 
1541 benzaldehyde trace trace 
1553 linalool trace 0.12 
1556 8,9-limonene epoxide* - trace 
trans-p-menth-2-en-1-ol 1571 trace 0.10 
1583 isopulegol trace - 
1586 cyperene - trace 
1592 neomenthol 0.29 0.10 
1596 α-guaiene trace - 
1600 β-elemene trace 0.10 
1612 β-caryophyllene 0.43 - 
1632 neoisomenthol trace trace 
1637 menthol 0.57 0.24 
cis-p-menth-2-en-1-ol 1638 0.06 0.10 
cis-p-mentha-2,8-dien-1-ol 1678 - trace 
1687 α-humulene 0.09 trace 
1690 cryptone 0.16 0.27 
1706 α-terpineol 0.06 0.11 
1707 ledene 0.10 trace 
1719 borneol trace trace 
1726 germacrene D 0.06 - 
1741 β-bisabolene 0.07 - 
1748 piperitone 0.49 0.41 
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 Area % RRI Compound SBG WSBG 
1751 carvone trace trace 
cis-piperitol 1758 trace trace 
1783 p-methylacetophenone trace trace 
1802 cuminaldehyde trace 0.06 
1811 p-mentha-1,3-dien-7-al - trace 
1823 p-mentha-1(7),5-dien-2-ol* trace - 
trans-carveol 1845 trace trace 
1864 p-cymen-8-ol trace trace 
1885 2-phenylethyl propionate trace - 
1896 2-phenylethyl isobutyrate - trace 
1949 piperitenone 0.05 - 
2001 isocaryophyllene oxide trace 0.05 
2008 caryophyllene oxide 0.17 0.18 
2057 ledol - trace 
2071 humulene epoxide II trace trace 
2098 globulol - trace 
2104 viridiflorol trace - 
2113 cumin alcohol trace trace 
2131 hexahydrofarnesylacetone trace - 
2144 spathulenol trace - 
2184 nonanoic acid trace - 
2198 thymol trace - 
2209 T-muurolol - trace 
2211 2-phenylethyl tiglate trace trace 
2239 carvacrol trace - 
2254 citronellic acid trace trace 
2255 α-cadinol trace trace 
2279 sandaracopimaradiene trace - 
2700 heptacosane - trace 
2900 nonacosane trace trace 
2931 hexadecanoic acid - 0.06 
 Total 97.96% 97.72% 
 
 *correct isomer not identified; trace <0.05%. 
 
Isomenthone and menthone are the major compounds present in both the P. tomentosum 
essential oil samples. Limonene contributes 1.48% to the P. tomentosum (SBG) oil sample 
and 1.25% to the P. tomentosum (WSBG) oil sample. 
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Figure 20.5: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium tomentosum (SBG and WSBG). 
 
 
Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium tomentosum 
collected from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 20.6: HPLC profile of the acetone extract of Pelargonium tomentosum (SBG). 
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 Table 20.2: The retention times, UV absorbances maxima and percentage integrations of 
the major peaks identified in the HPLC profile of the Pelargonium tomentosum (SBG) 
acetone extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
4.03 207.3  4.49 
4.84 205.0  2.22 
5.50 280.5  2.97 
7.23 248.6  1.26 
9.48 206.2, 317.4  5.37 
10.75 206.2  1.33 
12.01 208.5, 317.4  0.33 
12.70 227.3, 284.1  0.90 
14.66 235.6  0.93 
18.43 262.7, 348.4 flavone 9.50 
21.01 241.5  2.59 
21.54 256.8, 344.8 flavone 52.27 
23.72 260.4, 337.7 flavone 0.98 
24.14 254.5, 348.4 flavone 2.72 
26.53 255.7, 373.3 flavonol 2.21 
28.00 255.7, 359.0 flavonol 8.27 
31.69 241.5  0.45 
32.31 261.6  0.84 
34.19 265.1  0.38 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium tomentosum in this study 
include the following: 
 
• Pelargonium tomentosum (SBG) extract produced moderate antimicrobial activity 
(MIC = 2 mg/ml - 2.33 mg/ml). The essential oil samples demonstrated poor 
antimicrobial activity (MIC = 8 mg/ml to >32 mg/ml). 
 
• Promising anti-oxidant activity (IC50 = 28.16 ± 2.65 µg/ml - 21.73 ± 0.99 µg/ml) 
was displayed by the acetone extracts (SBG and WSBG). 
 
• The P. tomentosum (SBG and WSBG) oil samples were inactive in the 5-
lipoxygenase assay (IC50 >100 µg/ml). 
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 • The acetone extracts (SBG and WSBG) produced promising antimalarial activities 
(IC50 = 13.83 ± 0.61 µg/ml - 17.62 ± 4.84 µg/ml). 
 
• The P. tomentosum (SBG) extract proved to be non-toxic (IC50 = 195.13 ± 7.90 
µg/ml). The P. tomentosum (WSBG) extract was moderately toxic (IC50 = 50.71 ± 
1.17 µg/ml). Pelargonium tomentosum (SBG) essential oil was extremely toxic 
(IC50 ≤1.00 µg/ml). Pelargonium tomentosum (WSBG) essential oil was the least 
toxic of all the oil samples tested, but still produced substantial cytotoxicity (IC50 = 
30.20 ± 1.81 µg/ml). 
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 21.  Pelargonium vitifolium (L.) L’Hérit. 
 
Common names: 
Vine-leaved pelargonium, Balm-scented pelargonium (van der Walt, 1977). 
 
Botanical description: 
An erect and strongly balm-scented shrub growing 0.5-1 m tall. At the base, the main stem 
is woody while the side branches are herbaceous and villous. The rough leaves are cordate 
in shape and are 5-lobed, but mostly 3-lobed. Stiff hairs cover the leaf blades making them 
rough to the touch. The leaf margins are irregularly toothed and coarse. The leaves of P. 
vitifolium resemble those of the vine, hence the epithet ‘vitifolium’ (where ‘viti-’ is the 
Latin word meaning vine). Ovate stipules are present at the base of the petioles. The 
inflorescences resemble those of P. capitatum since they are capitate-like; however, they 
are less hairy and contain no more than twelve flowers. The colour of the petals range from 
light pink to carmine. Violet-purple flecks occur on the posterior two petals which are 
narrow at their base, obovate with rounded tops and entire. Seven fertile stamens are 
present (van der Walt, 1977; Webb, 1984).  
 
Pelargonium vitifolium is closely related to P. capitatum and also has features in common 
with P. papilionaceum. Compared to P. capitatum, the leaves of P. vitifolium are more 
glandular and strongly aromatic, but not crinkled (van der Walt, 1977). 
 
Distribution and habitat: 
Pelargonium vitifolium is confined to the region of the south-western and southern Cape, 
occurring from the Cape Peninsula and eastwards along the coast to Knysna. Its 
distribution is associated with mountains, where it is specifically confined to the lower 
slopes, growing in half-shaded areas by streams between boulders or on scree (van der 
Walt, 1977; 1985). 
 
 
 
 
      
 
 371
 Figure 21.1: Pelargonium vitifolium in 
flower. 
Figure 21.2: The geographical distribution of 
Pelargonium vitifolium. 
 
Medicinal uses: 
All parts of the plant can be used as an astringent (Grieve, 1994). A citronella-scented 
essential oil is obtained from the plant (Uphof, 1959). 
 
Chemical composition of the essential oil: 
Hydrodistillation (3 hours) of the fresh plant material collected from the Stellenbosch 
Botanical Garden yielded 0.05% oil. 
 
GC-MS profile and analysis 
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Figure 21.3: GC-MS profile (TIC) of the hydrodistilled essential oil of Pelargonium 
vitifolium (SBG). 
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 Table 21.1: Compounds identified in the hydrodistilled essential oil of Pelargonium 
vitifolium (SBG). 
 
RRI Compound % Area 
1213 1,8-cineole 0.05 
1280 p-cymene 0.16 
1337 geijerene trace 
1348 6-methyl-5-hepten-2-one trace 
cis-rose oxide 1353 trace 
trans-linalool oxide (furanoid)  1450 trace 
1452 1-octen-3-ol trace 
1459 acetic acid trace 
1466 α-cubebene trace 
1487 citronellal trace 
1491 octyl acetate trace 
1493 α-ylangene trace 
1497 α-copaene 0.37 
1528 α-bourbonene trace 
1535 β-bourbonene 0.07 
1549 β-cubebene trace 
1553 linalool 0.20 
1553 octanol trace 
1569 neoisopulegol 0.26 
1570 methyl citronellate 0.07 
1583 isopulegol 0.33 
trans-isopulegone 1584 trace 
1588 β-copaene trace 
1612 β-caryophyllene 0.18 
1612 citronellyl formate 0.07 
1628 aromadendrene 0.13 
1661 allo-aromadendrene 0.13 
1668 (Z)-β-farnesene trace 
1685 isovaleric acid trace 
1704 0.22 γ-muurolene 
1706 α-terpineol 0.17 
1707 ledene trace 
1740 valencene 0.05 
1740 α-muurolene 0.35 
1748 piperitone 0.15 
1750 β-dihydroagarofuran 0.10 
citronellol 2.24 1772 
1815 valeric acid 0.05 
cis-calamenene 1853 0.08 
1857 geraniol trace 
1864 p-cymen-8-ol trace 
1868 (E)-geranyl acetone 0.06 
1898 1,11-oxidocalamenene trace 
1916 α-agarofuran 0.54 
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 RRI Compound % Area 
1941 α-calacorene trace 
1984 γ-calacorene trace 
2001 isocaryophyllene oxide trace 
2008 caryophyllene oxide 0.57 
2050 (E)-nerolidol 0.06 
2071 humulene epoxide II 0.07 
10-epi-γ-eudesmol 7.10 2127 
2131 hexahydrofarnesylacetone 0.06 
2184 nonanoic acid 0.05 
2187 T-cadinol 0.92 
2210 agarospirol 0.36 
2211 2-phenylethyl tiglate 0.26 
2219 α-muurolol trace 
2228 valerianol trace 
citronellic acid 74.65 2254 
2340 10-hydroxy-calamenene 0.16 
2392 caryophyllenol II 0.13 
2931 hexadecanoic acid 0.16 
Total 90.58%  
 
trace <0.05%; (SBG) = Stellenbosch Botanical Garden. 
 
Citronellic acid makes-up a large portion (74.65%) of the total oil composition. Citronellol 
and 10-epi-γ-eudesmol represent 2.24% and 7.10%, respectively. 
 
citronellol 
OH 
OH
10-epi-γ-eudesmol citronellic acid 
OH
O
 
Figure 21.4: Chemical structures of the major compounds identified in the essential oil of 
Pelargonium vitifolium  
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 Chemical composition of the acetone extract: 
HPLC analysis was performed on the acetone extract of Pelargonium vitifolium collected 
from the Stellenbosch Botanical Garden. 
 
HPLC profile and analysis  
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Figure 21.5: HPLC profile of the acetone extract of Pelargonium vitifolium (SBG). 
 
Table 21.2: The retention times, UV absorbance maxima and percentage integrations of the 
major peaks identified in the HPLC profile of the Pelargonium vitifolium (SBG) acetone 
extract. 
 
Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
3.24 203.9  2.23 
3.72 206.3  3.32 
4.11 208.6  21.20 
4.98 206.3, 263.8  4.91 
5.40 206.3, 278.0  8.91 
9.82 206.3, 320.6  1.78 
11.39 216.8, 260.3, 293.4  0.77 
12.02 219.1, 327.8  4.71 
13.37 226.2, 278.0  1.12 
13.72 227.4, 287.4  0.59 
14.00 221.5, 278.0  7.54 
14.34 285.1 flavanone 2.28 
14.76 263.8, 349.2  1.37 
15.59 228.5, 269.7, 332.5  1.21 
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 Retention 
time (min) 
UV absorbance Tentative 
identification 
% 
Integration maxima (nm) 
15.92 233.2, 272.1  0.50 
16.35 255.6, 351.6 flavonol 0.88 
17.82 255.6, 354.0 flavonol 1.63 
18.51 261.5, 349.2 flavone 2.51 
21.34 257.9  2.01 
21.59 255.6, 348.0 flavone 3.11 
22.40 241.4  0.81 
29.74 242.6  8.13 
32.20 200.6  0.86 
32.52 272.1  0.72 
32.67 267.4, 356.3  0.83 
32.84 261.5  1.36 
33.18 266.2, 338.5  1.47 
34.39 292.2  0.64 
34.62 265.0  0.15 
36.88 275.6  0.56 
44.56 272.1  7.53 
49.50 255.6  1.76 
52.09 269.7  2.61 
 
 
Summary of bioactivity results: 
In vitro pharmacological activities recorded for Pelargonium vitifolium in this study 
include the following: 
 
• The P. vitifolium (SBG) extract produced substantial antibacterial activity against 
B. cereus (MIC = 1 mg/ml). 
 
• Considerable antimalarial activity (IC50 = 9.18 ± 1.61 µg/ml) was produced by the 
P. vitifolium (SBG) extract. 
 
• The acetone extract (SBG) produced low cytotoxicity in the MTT assay, an IC50 
value of 178.48 ± 5.44 µg/ml was obtained. 
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 Glossary of monograph terms 
 
Acute: leaves having a sharp but not extended point. 
 
Carmine: a deep red with a tinge of purple; light crimson. 
 
Cleft: divided into lobes by notches extending halfway, or further, from the margin to the 
midrib or to the base. 
 
Cordate: heart-shaped. 
 
Cordiform: heart-shaped. 
 
Crenate: a leaf margin with rounded projections. 
 
Cuneate: wedge shaped leaves with the point of the wedge forming the base of the lamina.  
 
Cyclamen: any one of a group of plants with heart-shaped leaves and showy white, purple, 
pink, or crimson flowers, whose five petals bend backward. 
 
Decumbent: describing a stem that lies along the ground. 
 
Dentate: referring to a leaf margin that is toothed, having outward-pointing indents. Leaf 
margins finely toothed in this way are termed denticulate. 
 
Distichous: leaves arranged alternately in two vertical rows on opposite sides of a stem. 
 
Elliptic: oval in outline. 
 
Emarginate:  a leaf, petal or sepal that is indented at its tip. 
 
Glabrous: a surface devoid of hairs or other projections. 
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 Glaucous: surfaces having a waxy greyish-blue bloom. 
 
Herbaceous: having stems that are usually soft and not woody. 
 
Hirsute: covered with rather coarse hairs. 
 
Hirtellous: minutely hirsute. 
 
Hispid: covered with rough or stiff hairs. 
 
Indumentum: a dense or sparse covering, usually of hairs. 
 
Lamina: the flattened blade-like portion of the leaf. 
 
Lobate: reference to a leaf that is divided into curved or rounded sections attached to each 
other by an entire central area. 
 
Lobulate: having small lobes. 
 
Oblanceolate: shaped like a lance head but with the tapering end at the base. 
 
Obovate: inversely ovate (egg-shaped). 
 
Obtuse: describing a leaf apex which is blunt or rounded. 
 
Ovate: shaped like an egg, with the broadest part nearest the point of attachment. 
 
Palmate: a leaf having four or more leaflets arising from a single point. 
 
Palmatilobate: leaf margin palmately cut ⅛ to ¼ to the base of the leaf blade. 
 
Palmatipartite: leaf margin deeply palmately cut but not to the base of the blade. 
 
Palmatisect: leaf margin deeply palmately cut to the base of the blade. 
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 Pandurate/ Panduriform: fiddle-shaped. 
 
Partite: divided into parts. 
 
Pinnate: having a series of leaflets, of a compound leaf, arranged on each side of a 
common stalk. 
 
Pinnatifid: leaf margin pinnately cut to the midrib. 
 
Pinnatilobate: leaf margin pinnately cut ⅛ to ¼ the way to the midrib. 
 
Pinnatipartite: leaf margin deeply pinnately cut, but not to the midrib. 
 
Pinnatisect: leaf margin deeply pinnately cut to the midrib. 
 
Pubescent: general term indicating hairiness; with densely spaced, short, weak hairs. 
 
Reflexed: describing a structure which is sharply bent backwards. 
 
Reniform: kidney-shaped. 
 
Scabrous: rough to the touch with small points of projections. 
 
Serrate: referring to a leaf margin that is toothed, having forward-pointing indents. 
 
Spatulate (spathulate): describes structures with a broad apex and a long narrow base. 
 
Strigose: covered with stiff and straight bristles or hairs; hispid. 
 
Terete: smooth, cylindrical and tapering. 
 
Tomentose: a surface densely covered in short hairs. 
 
Trichomes: any outgrowth from an epidermal cell. 
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 Villous: describing something as having a hairy appearance due to a covering of long soft 
curly trichomes. 
 
Viscid: covered with a sticky secretion. 
 
(van der Walt, 1977; Tootill 1984; van der Walt and Vorster, 1988). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 380
 APPENDIX B 
 
AROMATIC PELARGONIUMS – THEIR ESSENTIAL OILS AND 
PHARMACOLOGICAL PROPERTIES 
 
Jacqueline Y. Lalli1, Alvaro M. Viljoen1, Sandy F. van Vuuren1, Hüsnü C. Başer2. 
 
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, 7 York Road, Parktown 2193, South Africa. 
2Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470, 
Eskişehir, Turkey. 
 
Introduction: 
Pelargonium species belong to the Geraniaceae family which encompasses 5 genera. Of 
the 270 Pelargonium species, inhabiting the subtropical and temperate zones of the world, 
about 219 species occur in southern Africa. Many unscented and scented Pelargonium 
species have been used in folk medicines by the Sotho, Xhosa and Zulus to treat various 
ailments, many of which are caused by bacteria and fungi. A plenitude of research has been 
focused on Pelargoniums, namely P. graveolens, P. capitatum and P. radens, which are the 
main fragrant species used as the source of ‘geranium oil’.  
 
Research objectives: 
To investigate the essential oil chemistry and to analyse the volatile and non-volatile plant 
extracts for positive in vitro biological activities. 
 
Methodology: 
The volatile compounds found within the leaves and stalks of selected Pelargonium species 
were extracted by hydrodistillation. The analytical assessment of gas chromatography 
coupled to mass spectroscopy (GC-MS) was used to investigate the composition of the 
Pelargonium essential oils. The non-volatile compounds were extracted by using acetone 
as the solvent. The hydrodistilled oils were assessed for anti-inflammatory activity by 
carrying out the in vitro 5-lipoxygenase assay. The acetone extracts were analysed for free 
radical-scavenging capacity by the DPPH (2,2-diphenyl-1-picrylhydrazyl) assay. 
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 Antimicrobial assays (disc diffusion and the microplate dilution method) were performed 
on the plant extracts and the essential oils.  
 
Results: 
Analogous chemical patterns were identified for some of the oils, confirming the 
taxonomic relationship between certain plant species; this being demonstrated for P. 
papilionaceum and P. vitifolium. The essential oils of P. quercifolium and P. panduriforme 
showed good inhibitory activity against the 5-lipoxygenase enzyme system with IC50 
values of 33.24 – 38.67 µg/ml and 45.39 – 45.58 µg/ml, respectively. Exceptional anti-
oxidant activity was displayed by the crude extracts of P. betulinum and P. crispum having 
IC50 values of 4.13 ± 0.14 µg/ml and 4.49 ± 0.18 µg/ml, respectively. The crude extracts of 
P. glutinosum, P. scabrum and P. sublignosum exhibited good antimicrobial activity 
against the test organisms, B. cereus and S. aureus. The essential oils showed reduced 
antimicrobial activity compared to the plant extracts.  
 
Conclusion:  
The positive biological activities manifested by the essential oils and crude extracts render 
concrete substantiation for the use of such species for traditional medicinal purposes. An 
inquest into these biological activities is well-grounded by the fact that pharmaceutical and 
cosmetic industries are investigating alternative, more natural antimicrobials and anti-
oxidants. 
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